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6Introducti on:
Towards sustainable management 
of arboviral diseases
A multi disciplinary mixed-methods approach 





Over the past decades, arboviral diseases have emerged in the tropics and sub-tropics of Lati n America, Asia, 
Africa and beyond [1-4]. The term arbovirus (arthropods-borne virus) refers to viruses being transmitt ed by 
arthropods, such as mosquitoes and ti cks [5]. Over 400 arboviruses have been documented [6]. Amongst 
the most common and important arboviruses are dengue, chikungunya and Zika, which are transmitt ed 
by the day-biti ng mosquitoes of the Aedes spp., i.e. Ae. aegypti  and Ae. albopictus [7,8]. The diseases 
are spread in areas where Ae. spp. reside, including areas where over 40-50% of the world’s populati on 
lives (Figure 1) [9,10]. The upcoming transmission of these arboviral diseases are driven by urbanisati on, 
globalizati on and internati onal mobility [11]. In the past years, devastati ng epidemics showed the major 
consequences of these diseases on community and individual health. Hence, it is important to prevent 
these diseases and improve medical care of aff ected populati ons.
In this thesis, the impact and preventi on of dengue and chikungunya were investi gated. Zika was not 
examined since major epidemics emerged aft er data-collecti on was performed at the study sites (Curaçao 
and Venezuela) (Figure 1).
Figure 1. Global predicted distributi on of dengue, chikungunya and Zika. 
By Patt erson J, Sammon M, Garg M. Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World. Western Journal of 
Emergency Medicine. 2016 Nov;17(6):671.
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Study sites
This thesis focused on two different study sites, i.e. Curaçao and Venezuela, which are neighbouring 
countries at the Caribbean Sea. Both countries confronted a devastating chikungunya outbreak in 2014, 
on an endemic background of all four serotypes of dengue [12]. The countries have a different political 
and socio-economic situation. This allowed us to obtain insights on the impact of arboviral transmission 
on Curaçao with a relatively compact, stable and affluent background, compared to Venezuela with a very 
unstable political background with poor socio-economic standards.
The disease presentation of dengue and chikungunya might be relatively similar in neighbouring countries. 
However, the impact and management of these disease can be considerably different due to behavioural 
and socio-economic strata, e.g. as education, access to care and preventive behaviour. In the following 
paragraphs we first describe dengue and chikungunya. Then, we introduce some of the principles of the 
behavioural and interdisciplinary research methodology, which was applied in this thesis.
Dengue and chikungunya
Dengue
Over the last decades, dengue has increasingly spread to formerly unaffected areas [4]. While only 
nine countries faced annual transmission of the virus before 1970, currently over 100 countries have 
established annual dengue transmission [13]. Four different, but closely related serotypes of the dengue 
flavivirus exist, i.e. DEN-1, DEN-2, DEN-3 and DEN-4. When infected, a person acquires lifelong immunity 
for the particular serotype. Dengue disease is characterized by an abrupt onset of fever normally lasting 
for 2-7 days. Skin erythema, myalgia, arthralgia, headache and generalized body pain are amongst the 
symptoms which can occur [8]. Dengue may evolve into severe dengue, characterized by (I) plasma leakage 
and shock, (II) bleeding manifestations and/or (III) severe organ impairment [8]. Clinical management of 
dengue is normally not complicated and relies mainly on cardiovascular resuscitation [8]. When early onset 
of treatment is secured, severe dengue morbidity can be reduced from 20% to 1% [14,15].
Chikungunya
Chikungunya virus is an alphavirus, first described in Tanzania in 1952. The name ‘chikungunya’ has its 
origin in the local Kimakonde language, meaning ‘to walk bent over’. This refers to the characteristic 
debilitating musculoskeletal pains caused by chikungunya disease, forcing people to walk contorted [16]. 
Chikungunya outbreaks were not frequently reported up until 2005 when the virus spread rapidly, causing 
major epidemics in islands in the Indian ocean, India and Southeast Asia. Currently, over 60 countries 
have reported chikungunya transmission [16]. Chikungunya typically has an abrupt acute disease onset, 
normally characterised by fever and debilitating joint pains. Often other symptoms can be present, such 
as myalgia, rash, headache, fatigue and nausea [17-22]. These symptoms can last 2-12 days, or may linger 
on as chronic chikungunya disease. A high proportion of infected individuals develop a chronic disease 
typically including musculoskeletal impairment [23]. This chronic disease could last for years and has major 
consequences for physical and mental quality of life [24-26]. Treatment is focused on pain-relieve, there is 
currently no anti-viral treatment available [16].
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Impact of chikungunya
The long-lasting consequences of chikungunya have a major impact on the quality of life of affected persons 
[23]. Several studies showed, on top of the physical consequences, an impact on the emotional well-
being of chikungunya patients [24-26]. It is not unlikely that long-lasting symptoms, e.g. musculoskeletal 
symptoms and fatigue, lead to lower emotional well-being or depression. However, to date, scientific 
literature provides little in-depth insights in this possible interplay of physical and emotional well-being. 
Furthermore, little is known on the influence of chikungunya on participation in normal daily life activities, 
such as work, household chores and social activities.
Health behaviour, a neglected topic in tropical research
Sociological and behavioural determinants of dengue and chikungunya can explain health outcomes, by 
addressing topics such as access to care, quality of life and preventive health behaviour. Currently, prominent 
research disciplines in the field of medical care are pathology and physiology. Based on pathological and 
physiological principles, research aims to develop medicines, vaccines or other treatment. Though health 
behaviour receives considerable less attention in research, it is a major determinant of health outcomes. 
It has been recognized that effective health promotion interventions should be based on health behaviour 
theories, in order to address local behaviours, to be applicable, and sustainable for the local beneficiaries 
[27,28]. Therefore, it is important to strengthen health behaviour research.
The definition of health is described by the WHO as ‘a state of complete physical, mental, and social well-
being not merely the absence of disease’ [29]. Hence, health is a multidimensional concept [30-32], which 
may differ per individual, health condition and cultural context. 
Health behaviours are driven by many complex determinants, which have been described in theory. These 
theories have successfully been applied in global health research. Regarding arboviral diseases (dengue 
and malaria), these theories served as theoretical framework to examine motivations for treatment seeking 
and preventive behaviours of various communities [33-37], and to develop efficient health education [38]. 
Two important health behaviour theories are the Health Belief Model (HBM) and the Theory of Planned 
Behaviour (TPB) [39-41]. These theories are based on similar concepts to understand the likelihood of 
(preventive) health behaviour. Though using similar concepts, the HBM and TPB have their unique 
concepts and value as well. The HBM includes the concept ‘perceived threat of a condition’, resulting from 
the perceived seriousness of and the perceived susceptibility (risk to acquire) to a disease [39,40]. On the 
other hand, the TPB recognizes the role that ‘subjective norms’ (the behaviour and influence of ‘significant’ 
other individuals) play in predicting health behaviours [41]. Later in this introduction we elaborate more 
on these health behaviour theories.
Interdisciplinary research and mixed methods
Different research disciplines (i.e. medicine, psychology and sociology) contribute substantially to achieving 
improved quality of life and preventive health behaviour. However, interdisciplinary research remains 
relatively scarce. This might be caused by low knowledge or undervaluation of other disciplines, but could 
also be a result of the challenge to combine different research methods in scientific valid ways. 
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Quantitative and qualitative research methods are two important research methods for global health 
research. In health research, quantitative research relies on statistics to e.g. observe patterns and estimate 
incidences of diseases in order to provide a generalizable outcome [42]. On the other hand, qualitative 
research is not designed to provide generalizable results, but to obtain in-depth understanding of motives 
and perceptions influencing e.g. patterns in health behaviour [43]. Therefore, a combination of these 
two research methods (mixed-methods) provides both in-depth and (to a certain degree) generalizable 
results leading to a valuable comprehensive view on a (global) health-problem (such as impact on QoL of 
chikungunya and promoting preventive behaviours).
11
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Research questions of this thesis
This thesis examines the impact and health promoting behaviour of chikungunya and dengue in Curaçao 
and Venezuela. The first chapters focus on dengue in Venezuela and describe access to care, and health 
seeking behaviour for dengue and fever in a community in Venezuela. Then, communities’ mosquito 
control practices and ways to in improve community participation in mosquito breeding site control are 
examined in Venezuela and Curaçao. The last chapters focus on the impact and sequelae of chikungunya 
disease, and examine the influence of co-infection with dengue on these sequelae. The chapters regarding 
Venezuela are based on common data sources. Likewise, this generally applies to the chapters regarding 
Curaçao.
Dengue and health behaviours in Venezuela
Dengue is endemic in Venezuela. Dengue-like diseases were already described in Venezuela in 1828 and 
1946 [44]. However, the first epidemic of dengue in the country was reported in 1989-1990 [45]. Since 
then, dengue outbreaks occur on a regular base. The poor socio-economic circumstances and behavioural 
factors were facilitators for the increase of dengue cases in urban areas [14,15]. A major epidemic was 
established in 2010, when more than 120,000 cases were reported of which 8% were identified as severe 
dengue infections [46]. As for the Venezuelan population, people tend to seek medical treatment in a 
relatively late stage of disease (>3 days after onset symptoms [47]), when severe disease manifestations 
may already have emerged [48]. Insights in health seeking behaviour and access to care might therefore 
improve prompt medical treatment of dengue with an additional decrease of mortality due to dengue.
Research objective 1: 
To investigate the health seeking behaviour (Chapter 2) and access to 
care (Chapter 3) of dengue and fever amongst a community in Maracay, 
Venezuela.
Mosquito control in Curaçao and Venezuela 
Currently, there are no widely available treatments or vaccines for dengue, chikungunya and Zika. 
Therefore, the only effective way to prevent these diseases is vector control [49,50]. Mosquitoes breed 
in stagnant water, which is usually available around people’s houses, especially in rainy seasons. Typical 
breeding places are e.g. car tires, water containers, pet drinking bowls or garbage cans. Hence, mosquitoes 
can be prevented from multiplication by covering these potential sources, or eliminate stagnant water 
[51,52]. This type of vector control is called ‘source reduction’ and has shown its potency by reducing 
dengue incidences. Source reduction has also shown to be more effective than application of insecticides, 
which is limited by insecticides resistance and inadequate vector control infrastructure [36,53].
Efforts in the past illustrate the challenge to achieve sustainable vector control. In the 1950s and 1960s, 
an intensive mosquito elimination program had reduced the vector drastically in Latin America. However, 
after cessation of this program, the vector of these arboviral diseases returned causing major epidemics of 
arboviral diseases [54]. From the latter we learn that mosquito breeding site control will only be sustainable 
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when based on mutual efforts from both governmental bodies and communities, as was also recognized 
by several studies [53,55-57]. The challenge though, is that mobilizing communities in mosquito control is 
often hard to achieve.
Research objective 2: 
To investigate (behavioural) determinants and possible interventions 
related with improved communities’ mosquito control in Venezuela 
(Chapter 4) and Curaçao (Chapter 5).
Theoretical background
To strengthen scientific value of the study, this aim was performed using mixed-method research based on 
a theoretical framework. We examined the behavioural determinants of mosquito breeding site control 
performed by the community, based on an integrated theoretical model (Figure A in S2 Additional file 
Chapter 5). This framework was built on the HBM and the TPB.
 
The concepts of the HBM are the perceived susceptibility (the risk perception to the threat) and the 
perceived severity to a treat. The evaluation of the latter concepts result in a perceived threat of a disease, 
which predicts if a person is willing to engage in preventive behaviour. However, this preventive behaviour 
should be perceived as effective (perceived benefits) and performable without significant obstacles 
(perceived barriers). Further, the person must believe that he/she has the ability to perform the behaviour, 
which is the self-efficacy (Figure 1 in S2 Additional file Chapter 5).
The TPB predicts the likelihood that a person engages in preventive behaviour through the attitudes 
towards behaviour, subjective norms and the perceived behavioural control. The attitudes towards 
behaviour results from a valuation of accessible beliefs (positive and negative) about the behaviour, 
the concept subjective norms covers the influence (actions and pressure) of significant others, and the 
perceived behavioural control refers to the individual’s evaluation of easiness or hardship of carrying out 
the behaviour (Figure 1 in S2 Additional file Chapter 5).
Using the aforementioned theories (HBM and TPB), we focused on assessing the likelihood (intention) 
of the health behaviour (performing mosquito breeding site control). This concept is the most significant 
predictor of the actual performed behaviour. Another important concept is the self-efficacy for the 
behaviour. If self-efficacy is low, this will lower (the intention to perform) the behaviour. As depicted in 
Figure 1 in S2 Additional file Chapter 5, several other concepts influence the likelihood of behaviour. The 
likelihood of performing preventive behaviour will rise if the perceived threat of a condition is high (i.e. 
a higher perceived susceptibility and increased perceived severity of the condition, more cues to action), 
when the attitudes towards the behaviour are positive, and when subjective norms are supportive [39-41].
The impact of chikungunya on quality of life
Over the past years, chikungunya was introduced in the Americas. In December 2013, chikungunya 
transmission was reported in the Caribbean island of Saint Martin [58]. Soon other countries followed [59] 
resulting in over one million confirmed or suspected cases throughout the Americas [2]. At the start of 
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2014, chikungunya transmission became evident in Curaçao, resulting in high attack rates within a formerly 
naïve population [2]. The epidemic ceased in the first months of 2015, when an estimated 50,000-75,000 
individuals had been infected with chikungunya.
As was described before, the acute disease of chikungunya is characterized by a sudden onset of fever 
and devastating arthralgia [17-22]. Accompanied by other symptoms, chikungunya may linger on as sub-
chronic and chronic disease which may last up to years [23] with consequent impact on physical and 
emotional QoL [24-26]. To date, only few studies were dedicated to assess QoL of chikungunya patients 
with quantitative research methods, and none have investigated this topic using mixed-method research.
Research objective 3:
To obtain an in-depth understanding of the impact of chikungunya on 
quality of life of infected individuals (Chapter 6, 7), and examine its link 
with coping strategies (Chapter 7).
Theoretical background
We investigated the Health-Related Quality of Life (HRQoL) using quantitative and qualitative methods. 
HRQoL is a multidimensional concept which refers to physical, emotional and social well-being [60-62]. This 
was assessed with quantitative methods by using a widely accepted, relatively short but comprehensive 
HRQoL questionnaire; the RAND-36/SF-36 [63,64]. Furthermore, these same concepts (physical, emotional 
and social well-being) were examined with qualitative methods and linked to Lazarus’ theory on coping 
strategies. This theory categorized coping strategies in ‘problem-focused’ (aimed at targeting the cause of 
stress) or ‘emotional’ (aimed at e.g. acceptance of the stressor) strategies [65,66].
Clinical manifestations of chikungunya and concomitant dengue
Research objective 4:
a. To design a tool which can be used to easily and rapidly assess severity 
of chronic chikungunya sequelae (Chapter 6).
b. To assess the influence of concomitant chikungunya and dengue on 
disease manifestations (Chapter 8).
To date, there is still no consensus on how to define and characterize chronic chikungunya disease. 
Furthermore, the similar acute disease manifestations of chikungunya and dengue make it difficult to 
distinguish these diseases at acute presentation. Both diseases are transmitted by the same vector (Aedes 
spp.) in the same areas, which means that the diseases can be transmitted concurrently. Concomitant 
transmission of chikungunya and dengue have been reported in many countries [67], and this might also 
be the case in Curaçao, where dengue has been endemic since years [68]. There is limited knowledge on 
the clinical consequences in the case that individuals are co-infected with these viruses, due to the scarcity 
of studies regarding this topic [69-71]. 
14
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Outline of this thesis per chapter
This thesis investigates arboviral diseases in two countries and is ordered chronologically, based on time of 
data-collection. In the first chapters, we present the data on dengue collected in Venezuela in 2013-2014. 
The studies on mosquito breeding site control which were performed in both study sites, are subsequently 
presented. Lastly, we present the studies on chikungunya, which were performed in Curaçao in 2015. 
In the case of dengue, people in Venezuela tend to seek care when they might already have developed 
severe disease manifestations. Therefore, we investigated the health seeking behaviour of dengue and 
fever in Chapter 2, in order to find ways to promote prompt medical treatment of dengue. Another barrier 
to obtain timely healthcare for dengue might be the complex healthcare situation of Venezuela. Hence, the 
access to care may be limited for Venezuelan people. To assess this problem, Chapter 3 examines access 
to care, and perceived motivations and barriers to obtain healthcare at the different health centres of 
Venezuela. 
Venezuela has established ideal circumstances for mosquitoes, with a consequent rise of arboviral 
diseases [14,15]. A key to improve mosquito control will be source reduction in and around people their 
homes. Therefore, we assessed communities’ knowledge, attitudes and practices towards dengue and 
mosquito breeding site control in Chapter 4. Arboviral diseases are a constant threat for Curaçao as well. 
Community participation in mosquito breeding site control is crucial to achieve sustainable mosquito 
control and lower the burden of arboviral diseases [27, 30-32]. In Chapter 5 we examined the perceptions 
on and performance of personal protection against mosquitoes and mosquito breeding site control of the 
communities in Curaçao. Mixed-methods were used based on two behavioural theories, i.e. the Health 
Believe Model [39,40] and the Theory of Planned Behaviour [41], in order to examine ways to improve 
community participation in mosquito breeding site control.
Chikungunya has caused major burden on community level in Curaçao. While the acute disease of 
chikungunya is known to be debilitating, a considerable proportion of infected people remain with 
chronic complaints [24]. To date, there is no consensus on how to define chikungunya chronic disease. 
We investigated chronic disease sequelae and its impact on Quality of Life (QoL), and provided a new 
tool to classify chikungunya chronic disease severity in Chapter 6. Quantitative research methods were 
used to describe chronic sequelae and impact on QoL in Chapter 6. Chapter 7 examines the impact on 
Health-Related QoL with qualitative research methods, in order to obtain in-depth understanding of how 
chikungunya disease affects people’s QoL. Furthermore, Chapter 7 investigates how coping strategies are 
linked to the Health-Related QoL impairment of chikungunya.
The arboviral diseases chikungunya and dengue circulate in the same areas, making it possible to acquire 
both infections on the same time [54]. A concomitant chikungunya and dengue infection might have 
implications for disease development. However, knowledge on this topic is very limited. Therefore, we 
compared acute and chronic disease manifestations of chikungunya mono-infected vs. (recent) chikungunya 
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2 AbstractBackgroundDengue in Venezuela is a major public health problem with an increasing incidence of severe cases. Early diagnosis and ti mely treatment infl uences the outcome of dengue illness, as delay in care-seeking is sig-nifi cantly associated with complicati ons leading to severe dengue. We aimed to understand patt erns of health seeking behaviour (HSB) in individuals exposed to high dengue incidence in order to improve early att endance to health centres. MethodsBetween September 2013 and February 2014 a cross-secti onal household survey was performed in Maracay, Venezuela. Intended HSB of adults and children’s parents/guardians was assessed with respect 
to fever or suspected dengue. Data was collected through structured questi onnaires from 105 individuals. 
Results
Most individuals felt at risk of dengue and believed it could be a deadly disease. In the case of suspected 
dengue, the majority (60%) would choose to fi rst seek medical help versus fi rst treati ng at home, in contrast 
to 11% in the case of fever . Amongst those who decided to visit a doctor, a suspected dengue infecti on 
would prompt them to search medical help earlier than if having only fever (p<0.001). Multi variate analysis 
modelling showed that the independent factors associated with the intenti on to fi rstly visit a doctor versus 
treati ng at home in the case of dengue were feeling at risk (OR=3.29; p=0.042) and being an adult (as 
opposed to caring for a child as a parent/guardian; OR=3.33, p=0.021), while having had a previous dengue 
infecti on (OR=0.29; p=0.031) and living in the neighbourhood Caña de Azúcar (OR=0.28, p=0.038) were 
negati vely associated with seeking medical care as their fi rst acti on
Conclusion
Knowledge of HSB related to dengue is scarce in the Americas, our study att empts to contribute to a 
bett er understanding of HSB in this region. Improving early dengue disease recogniti on and awareness 
may enhance prompt att endance to medical care in aff ected populati ons and thereby reduce mortality 
and severity of dengue. Especially for those with a previous dengue infecti on, eff orts have to be made to 




The rapid spread of dengue in the last decade has brought this disease higher in the public health agenda 
worldwide. Dengue is transmitted by day-biting mosquitoes and typically presents with sudden fever and 
flu-like symptoms. In a proportion of cases, severe disease can ensue which if not promptly treated can 
be lethal. In Venezuela, the frequency of dengue epidemics and severe disease is on the increase. Delay 
in care-seeking has been related to the development of serious disease complications. In this study, we 
describe the health-related behaviour intentions people have when they face a dengue infection, to find 
ways to promote prompt medical care attendance. Few studies of this kind exist in the Americas. We 
found that in case of fever alone, people would mostly prefer to first treat the disease at home while in the 
case of suspected dengue they would choose to promptly visit a doctor. These intentions are encouraging. 
However, since people often do not realize they have dengue, they may not perform their planned 
behaviour. Moreover, we found several factors that made people choose to visit promptly a doctor: being 
an adult (as opposed to caring for a child as a parent/guardian), place of residence, feeling at risk and 
not having had a previous dengue infection. Therefore, we suggest that raising risk perception and the 
knowledge on dengue symptoms and transmission route could improve earlier health centre attendance 




Dengue fever, a viral vector-borne disease spread by the day-biting mosquitoes Aedes aegypti and A. 
albopictus, is a global health problem of increasing importance [1]. Currently, dengue affects over 2.5 
billion people living in dengue endemic areas, which comprises 40% of the world’s population[2]. According 
to estimations of the WHO, 50-100 million dengue infections occur every year, leading to 500 000 cases 
of severe disease that need hospitalisation [2]. However, recent estimations speak of approximately 400 
million dengue infections annually [3]. Where in the 1950s dengue cases were reported in only nine 
countries, today more than 125 countries in the tropics and subtropics are endemic for dengue [4]. In 
the Americas, almost all countries struggle with recurrent epidemics [5]. The poverty, poor sanitation 
and overcrowding that accompanies the uncontrolled urbanisation in this region creates environments in 
favour of vector-breeding and rapid spread of the virus, which leads to serious obstacles in disease control 
[6]. 
Dengue has become a major public health problem in Venezuela, with epidemics of increasing magnitude 
regularly occurring against a background of an established endemic situation. Initial descriptions of 
dengue-like illness in Venezuela based on clinical manifestations date from 1828 and 1946 [7]. Since 
the first dengue hemorrhagic fever epidemic reported in the country in 1989-1990 and the second in 
the Americas [8], the frequency of severe cases has increased. Between 1989 and 2007, the highest 
proportion (35%) of severe dengue cases within the Americas were reported in Venezuela [9]. In effect, 
dengue transmission in Venezuela has become perennial with poverty-related socio-economic factors and 
behavioural determinants fuelling the increasing incidence of dengue in the urban areas of the country 
[9, 10].The most recent and largest dengue outbreak took place in 2010 with more than 120.000 reported 
cases, of which 8% represented severe cases [11]. 
Early diagnosis and adequate supportive care are of great importance in the management of dengue so as 
to avoid the development of complications and severe disease. Thereby, early treatment intervention can 
reduce the case fatality rate from 20% to 1% or less [1, 12]. While knowledge and possibilities to diagnose 
and treat dengue fever increase, efforts have to be made to make these new developments accessible for 
those who have a dengue infection. An important factor to be taken into consideration is the patient’s 
health seeking behaviour (HSB), because for early diagnosis and supportive care, people must have the 
intention and the means to seek medical care early in the disease. Therefore, local studies on health 
believes and practices, HSB and access to care with respect to dengue fever are needed to identify barriers 
and opportunities for applying these new developments in diagnostics and treatment [13]. Insights in 
HSB of dengue could help to attain a reduction of late diagnosis, an increase of treatment adherence and 
improvement of health promotion strategies applied to a specific culture [14]. 
Two important health behaviour theories are the Health Believe Model (HBM) [15] and the Theory of 
Planned Behaviour (ToPB) [16]. A central concept in the HBM is the ‘perceived susceptibility’, which refers 
to the perceived chance of acquiring a condition (in this article also referred to as ‘risk perception’). The 
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‘perceived susceptibility’ and the ‘perceived severity’ leads to the formation of  ‘perceived threat’ of 
a certain condition. The likelihood of performing a certain health behaviour is directly linked to a) the 
perceived threat, b) the perceived benefits and barriers of the suggested behaviour change, c) the self-
efficacy and d) the cues to action [15, 17]. The ToPB links the attitude towards behaviour, subjective norms 
and perceived behavioural control to behavioural intentions and behaviour [16, 18].
In Venezuela, patients with a suspected dengue infection tend to seek medical help beyond the third 
day after the onset of fever [19]. At this time, the patient may be already critically ill [20]. Delay in care-
seeking is found to be significantly associated with complications leading to severe dengue [21], which 
stresses the importance of understanding HSB and access to care for dengue patients. However, research 
on HSB applied to dengue appears to be scarce, especially in the Americas, as the majority of studies 
addressing (partially) this topic have been performed in Asia [22-28]. Moreover, the published literature on 
HSB related to dengue was not [22-25, 27, 28], or was only partly [26] based on health behaviour theories.
This study aims to understand the patterns of HSB in the Venezuelan population exposed to high dengue 
incidence in order to find ways to improve early attendance to health centres and medical care. We 
compared HSB intentions of adults and of parent/guardians with respect to their children in the case 
of fever or suspected dengue. By using quantitative data supplemented with qualitative data based on 






In August 2010 a prospective, community-based cohort study was set up in Maracay, Venezuela. Maracay 
is one of the largest cities of Venezuela with dengue hyper-endemicity [9, 29]. It is the capital of Aragua 
state with an estimated of 1.300.000 inhabitants [30]. Aragua state witnessed the highest incidence of 
dengue in Venezuela in 2012, reaching nearly 7000 reported cases of which 2% were severe [11].  The 
study site and design has been described elsewhere [10]. Briefly, three neighbourhoods within Maracay 
called Candelaria, Caña de Azúcar and Cooperativa were selected for their high dengue incidence. All 
neighbourhoods are served by public (governmental primary and secondary) health centres [11].. Patients 
that require further specialised treatment are referred to the main public tertiary level hospital, the 
Hospital Central de Maracay. Private hospitals and clinics are also part of the health system. 
Study design
Within the cohort study, 2014 individuals aged 5-30 years old living in 840 households were enrolled at 
the start of the study and followed annually [12]. The present study was performed during the September 
2013 and February 2014 annual survey. A cross-sectional survey of a sub-sample of the cohort participants 
was carried out to gather quantitative and qualitative data on HSB intentions at community level of the 
general population exposed to dengue. 
The study was conceptualised to first address the interviewees’ HSB with respect to fever only as a symptom 
of several possible diseases. Subsequently, individuals were enquired about their HSB in regard to a specific 
disease, in this case a suspected dengue infection. Therefore, the study uses aspects of the HBM theory 
to incorporate the concepts of susceptibility and severity in the analysis to understand the HSB after the 
onset of fever as this symptom could lead to the individual perceiving susceptibility to multiple conditions 
[15, 17]. This theory was not applied in the data collection but aided in the analysis and interpretation of 
the results.  
Study population
A randomized sub-sample of approximately 260 households included in the cohort study was selected. 
One individual was interviewed in each household. The intention was to interview an equal number of 
adults and parents or guardians of children (<18 years old) who were already participating in the cohort 
study. Adults (18 years and older) were randomly chosen from all present adults at the moment of visiting 
the selected households. 
Data collection
A structured questionnaire, the HSB-questionnaire, was developed containing pre-coded and open 
questions on socio-demographic and socio-economic details, knowledge of dengue symptoms and dengue 
transmission, risk perception, pathways of HSB in relation to presenting fever and suspicion of dengue 
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infection. With respect to the parents/guardians interviewed, questions on HSB and risk perception 
referred to the child, while adults were interviewed with respect to their own attitudes and practices. The 
questionnaires were prepared in English, translated to Spanish, pre-tested and adapted in a pilot study. 
Data on socio-economic variables were collected from a household questionnaire which was applied as 
part of the annual survey of the cohort study. 
Socio-demographic and socio-economic characteristics
From the HSB-questionnaire we gathered demographic characteristics of the interviewed person: age, 
place of residence (neighbourhood), level of education, occupation and religion. Additional socio-economic 
data was gathered in the household questionnaire, and included characteristics of the residence (type of 
residence, number of persons living in the household, number of rooms (bathrooms not included), roof 
type, floor material, availability of all public services (piped water, electricity, gas and garbage collection), 
total income per household, and ownership of 19 different household items. Socio-economic data was 
used as proxy markers to estimate socio-economic status of the individuals.
Knowledge on dengue 
Individuals were asked if they had heard about dengue previously.  Dengue knowledge was assessed 
through open questions in two aspects: a) transmission knowledge by asking “how do you think people 
get infected with dengue?” and b) symptoms knowledge with the question “which are the symptoms 
of dengue?”. Correct answers to the open questions were: ‘by (the bite of) a mosquito’ (transmission 
knowledge); and ‘fever, headache, eye pain, body pain, face redness/rash, muscle pain, abdominal 
pain, sore throat, vomiting, diarrhoea, malaise, nausea, bleeding, fainting, dizziness, itching’ (symptoms 
knowledge). The ‘overall knowledge score’ (maximum score: 17 points) was derived by adding one point 
per correct answer, which equalled the sum of the transmission (maximum score: 1) and the symptom 
(maximum score: 16) knowledge scores (S1 Table). This methodology and scoring of knowledge was used 
in several other studies [31-33].
Behavioural characteristics
These were enquired through open questions: ‘what would you do if you/your child had fever’; and 
‘what would you do if you think that you/your child have/has dengue’. Pre-coded options were: a) staying 
and treat at home (‘home treatment’), b) ‘visit a medical doctor’, c) ‘alternative treatment’ (alternative 
medicine practitioner, traditional healer, community leaders, friends), d)‘call a medical doctor’, e)‘another 
action’, or f)‘no action’. After each action mentioned, the person was asked: ‘would you do anything else?’ 
for up to three additional actions. If ‘home treatment’ was mentioned, interviewees were asked to specify 
the type of home treatment. If ‘go to the doctor’ was mentioned, they were asked when and to which 
health centre they would choose to go and if they would visit other health centres if needed. After asking 
if the interviewed individual chose to seek a medical doctor in the case of a possible dengue infection, we 
enquired what would make him/her decide to seek medical help. Possible pre-coded options were: the 
number of days of fever, temperature of the fever, the appearance of new symptoms  or another reason 
(which was written down). If any of the first three options was mentioned, respondents were asked to 




Perception of the risk of acquiring a dengue infection (either referred to children or adults) was assessed 
during the interview with the following questions: ‘Do you think that you are at risk of contracting dengue?’ 
or ‘Do you think that your child is at risk of contracting dengue?’. The possible answers were ‘yes’, ‘no’, or 
‘I don’t know’. These questions were then used as proxy for measuring perceived susceptibility from the 
HBM.
Qualitative data 
During the interview, some individuals spontaneously explained what motivated the answers they gave. 
In other occasions we asked the individual to explain the reasons for their answer(s). Questions asked 
and answers given were written down on the spot or directly after the interview. The qualitative data are 
presented here to provide the contextual information given by the respondents in the survey.
Data Analysis
Information collected in the questionnaires was entered into a database using Epi Info (Epi Info, version 
3.5.4). Data was checked for consistency and analysed anonymously. Chi-square test or Fisher’s exact test 
were used to assess proportions. Continuous variables were converted into ordered categorical variables 
when suitable. For normally distributed quantitative data, means were compared using Student’s t-test 
otherwise, the Mann-Whitney U test was used. The Wilcoxon signed rank test was used for comparing 
related means within individuals when comparing HSB of fever and dengue while pair-wise proportions 
were compared with a McNemar’s test. Significance was determined at 5% level. Principal components 
analysis [34,35] was utilised to weigh socio-economic variables, obtain a relative score and classify 
individuals into low, average and high socio-economic status. Logistic regression was used to compare 
crude and adjusted odds ratios (OR). Multivariate logistic regression analysis was used to determine 
variables independently associated with the intended first action reported in HSB pathways for fever and 
suspected dengue. Variables with a p-value ≤0.2 after adjusting by age group and sex were fitted into these 
multivariate models and adjusted for further confounders. Effect modification was analysed and resulting 
models compared by a likelihood ratio test. Two separate final models are presented, one in the case of 
fever and the second in the case of intended suspected dengue (Table 1). Data was analysed using SPSS 
(SPSS Inc., version 20.0, Chicago, Illinois) and STATA (Stata Statistical Software: Release 10. College Station, 
TX,) softwares.
Ethic statement
This study was approved by the Ethics Review Committee of the Biomedical Research Institute, Carabobo 
University (Aval Bioetico #CBIIB(UC)-014), Maracay, Venezuela; the Ethics, Bioethics and Biodiversity 
Committee (CEBioBio) of the National Foundation for Science, Technology and Innovation (FONACIT) 
of the Ministry of Science, Technology and Innovation, Caracas, Venezuela; and by the Regional Health 
authorities of Aragua State (CORPOSALUD Aragua). All adult participants signed written informed consent 
forms, and a parent or guardian of any child participant provided written informed consent on their behalf. 




Between September 2013 and February 2014, we conducted a cross-sectional study within the third annual 
survey of a dengue community-based cohort study in three neighbourhoods of Maracay city, Venezuela 
[10]. We aimed to understand the HSB and access to care of a population exposed to hyperendemic dengue 
transmission. Individual and household-related interviews were conducted targeting adults and parents/
guardians of children living in the area of study. Because of violence in the country and in our area of study 
during anti-governmental protests in February and March 2014 [36-38], the original sample size of 260 
subjects was not reached. Overall, 105 individuals were interviewed where 54 interviews referred to HSB 
of adults (“adult questionnaire”) and 51 to caregivers of children (“child questionnaire”). In addition, 92 
household socio-economic questionnaires were applied. 
General characteristics
We described the general features, dengue knowledge and socio-economic characteristics of the study 
population and compared individuals interviewed with the adult versus the child questionnaire (S1 Table, 
S2 Table).  The 105 interviewed individuals had a mean age of 40 years (range: 18–87 years) and were mostly 
females (86.7%).  Children caregivers were older than those queried with the adult questionnaire (mean 
age 44 vs. 35 years respectively;  p<0.001). This was expected, as those who cared for children were mainly 
mothers or grandmothers. Most of the interviewed individuals lived in Candelaria neighbourhood (68.6%). 
We were unable to complete the planned interviews in the other two neighbourhoods (Cooperativa and 
Caña de Azúcar) because of the previously mentioned anti-governmental protests. The majority of the 105 
respondents completed secondary school (51.9%) or higher education (31.7%) and were housewives or 
domestic workers (53.8%). Those interviewed with the adult questionnaire had a higher education level 
and consisted of a higher proportion of students than parents/guardians of children. As in the rest of the 
country, the majority of the individuals professed a catholic religion (75.2%) (S1 Table).
Most persons lived in households with five to six rooms (46.7%) and households were mainly occupied 
by more than five inhabitants (71%). Households of children caregivers were more crowded than those of 
the ones interviewed with the adult questionnaire (p=0.003), and had a lower monthly income (p=0.003) 
and socio-economic status (p=0.004). There were no statistically significant differences between adults 
and parents/guardians with respect to the availability of public services, persons per household and the 
amount of household rooms (S2 Table).
Knowledge
The majority of interviewed individuals (n=103; 98.1%) indicated that they had heard about dengue and 
showed good knowledge about dengue transmission. In response to the open question “how do you think 
people get infected by dengue?”, 95.2% (n=100) mentioned ‘the bite of a mosquito’ or similar. In response 
to the open question “what are the symptoms of dengue?’’, nearly half (n=47; 44.8%) mentioned up to 
three correct symptoms, the rest (n=58; 55.2%) pointed out 4 or more, with a range of 0-8 symptoms. The 
overall knowledge score ranged from 1-9 correct answers (S1 Table).
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Risk perception and reported previous dengue infection
The majority of the individuals (n=73; 69.5%) reported to feel at risk of dengue. Almost all subjects (n=103; 
98.1%) also believed that people could die from dengue disease. Feeling at risk was equally reported when 
referred to children and adults (n=37; 72.5% vs. n=36; 69.2%; p=0.711). Finally, 33 out of 103 respondents 
(32%) mentioned that they/their child(ren) had dengue previously while one person did not know. 
Although a previous  dengue infection was mentioned more frequently by parents/guardians of children 
than by adults (36.0% vs. 28.8% respectively) the difference was not significant (p=0.440).
Intended health seeking behaviour pathways in the case of fever or 
suspected dengue
In order to understand the steps people would take in their search for health care, interviewees were 
confronted with the open questions: ‘what would you do if you/your child had fever’; and ‘what would 
you do if you think that you/your child had dengue’.  In the case of fever, most people chose to first treat 
fever at home (n=88; 83.8%) versus only 12 (11.4%) who mentioned that they would first seek medical 
help. In the case of dengue, the opposite was observed: most people would first visit a doctor (n=63; 60%), 
while nearly a third decided they would first treat dengue at home (n=31; 29.5%; p<0.001). Measuring the 
temperature at home was mentioned by 35 (33.3%) respondents in the case of fever and 29 (27.6%) in 
suspected dengue. 
Less frequently proposed initial actions in the case of fever were ‘performing blood tests in a laboratory’ 
(usually referring to a full blood count or platelet count tested at public or private laboratories), ‘inform 
my/the mother’, and ‘to rest’, while two adults decided they would take no action mentioning as reasons: 
‘I will recover myself’, ‘there is no need for visiting a doctor in case of fever’ and ‘I don’t like doctors’. 
Other first intended actions mentioned with respect to dengue were ‘to perform blood tests’, ‘to call a 
medical doctor’, ‘to visit an alternative doctor (not further specified)’ and ‘other’ (inform mother, change 
the clothes of the child and use a mosquito net, call the dengue project staff, evaluate the disease). There 
were people who mentioned to do a blood test before going to the doctor. A tradeswoman and mother of 
a 9 years-old child explained this, referring to her daughter (the quote is abbreviated): ‘When I go to the 
doctor, he will tell me to go to a laboratory to do blood tests. If I do a blood test before going to the doctor, 
this will save me the cost of one consultation.’ This woman told us she would test for platelets when asked 
what she would do if she thought her daughter would have dengue.
The first three actions individuals anticipated taking in the circumstance of fever or dengue, stratified 
by behaviour in the case of adults or children are presented as a flowchart in Fig 1. Only the pathways 
that begin with either ‘home treatment’ or ‘visit medical doctor’ are shown, as these included 92.4% 




Fig 1. Intended health seeking behaviour pathways in the case of fever and suspected dengue.
_
x = mean day when visiting a medical doctor; R= range of day chosen to visit a doctor  (min – max). The upper-left and upper-
right panel show the first three steps intended to take in the case of fever by parents/guardians referring to their child and adults, 
respectively. The lower-left and lower-right panel show the first three steps intended to take in the case of suspected dengue by 
parents/guardians referring to their child and adults, respectively. Percentages correspond with their contribution to the child sample 
(fever: n=51 & dengue: n=47) or the adult sample (fever: n=49 & dengue: n=47).
No differences were found when comparing the intended first actions and pathways between parents/
guardians and adults in the case of fever, since most of them decided they would first treat fever at home, 
as depicted in the upper-left (parents/guardians of children) and upper-right panel (adults) of Fig 1. 
Concerning dengue, differences were observed when comparing the intended first actions and pathways 
of children caregivers and adults, as can been seen in the lower left (parents/guardians) and lower right 
panel (adults) of Fig 1. In the case of dengue, more adults than parents/guardians reported to first visit a 
doctor (n=36; 76.6% vs. n=27; 57.4%; p=0.048), however children would have been taken earlier to the 
doctor than adults (mean day chosen to visit a doctor: 1.3 (n=47) in children versus 1.5 (n=46) in adults; 
p=0.108) (Fig 1). The combination of first treating at home and afterwards visiting a doctor, as a second 
step in the HSB pathway for suspected dengue, was reported more frequently by caregivers of children 
compared to adults (n=18; 38.3% vs. n=9; 19.1%; p=0.040)(Fig 1). 
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Determinants of intended first action of the HSB pathways for fever or 
suspected dengue
To explore the association of determinants with the intended first action for both fever and dengue, we 
compared the characteristics of those who would first treat at home versus those who intended to first 
visit a doctor in univariate analysis (S3 Table). The tested characteristics included child/adult-sample, age, 
sex, place of residence, education, occupation, religion, monthly income, socio-economic status, overall 
knowledge on dengue, reporting a previous dengue infection and risk perception. In the case of fever, 
those who would first visit a doctor were likely to be people with a lower educational level (p=0.069), other 
variables did not show a significant association, probably due to the small sample size of those choosing to 
visit a doctor (n=12). In relation to suspected dengue, the participants who chose to treat firstly at home 
consisted of higher proportions of people living in Caña de Azúcar (p=0.058) and caregivers of children 
(p=0.048). All other tested variables did not show a significant association with any of the intended actions 
(S3 Table).
Table 1 shows the final multivariate models of factors that remained independently associated with visiting 
a doctor as the first intended action (instead of choosing home treatment) for either fever or suspected 
dengue. Respondents with a lower level of education were more likely to seek medical help as their first 
action in the case of fever, this relation was nearly significant. In the case of suspected dengue, individuals 
who referred having had a dengue infection in the past preferred to first treat dengue at home instead 
of going to a doctor firstly. Moreover, feeling at risk of dengue infection, not living in Caña de Azúcar 
neighbourhood and  being an adult (as opposed to a child caregiver) in the case of suspected dengue were 
directly associated with the intention to first seek medical help (Table 1). 
In order to determine whether the intention to first treat at home would make people choose to go later 
to a doctor, we compared the day of seeking medical care from those who would first treat at home with 
those who would go firstly to the doctor. Those who intended to first treat at home reported a significant 
delay in their intentions to seek medical help versus those who intended to go to a doctor in the case of 




Table 1. Final model of factors independently associated with first intended action in the case of fever 
and dengue.
Final model of factors independently associated with visiting a doctor as the first intended action versus home treatment in the case 
of fever and dengue.
Home treatment
Overall, 90 (85.7%) individuals stated they would treat fever at home at any time in their health seeking 
decision process while only 38 (36.2%) would take this decision in the case of suspected dengue infection 
(p<0.001). Paracetamol (an antipyretic) was the most commonly chosen home treatment overall while 
taking a cold bath/shower and oral rehydration were the second most common types of home treatments 
in the case of fever and dengue, respectively (Fig 2).
Within the people who reported to treat fever at home, most would use paracetamol (n=86, 95.6%) to 
lower the temperature, followed by a cold bath/shower (n=31, 34.4%), oral rehydration (n=8; 8.9%), body 
sponging with a wet compress or sponge (n=7; 7.8%) and other ways of home treatment (n=7; 7.8%) such 
as rubbing the body with alcohol/cream, taking aspirin, other medication or rest. Paracetamol was also the 
most common choice among those who would treat dengue at home (n=30; 78.9%), however, the use of 
oral rehydration (n=9; 23.7%) was cited more frequently than in the case of fever, opposite to the use of a 
cold bath/shower (n=7; 18.4%). Other (n=2; 5.3%) home treatments for dengue included body sponging or 
rest. Combinations of home treatment for fever and dengue stratified by child or adult are shown in Fig 2. 
The different choices for home treatment showed no significant differences between children and adults. 
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Table 1. Final model of factors independently associated with first intended action in the 395 
case of f ver and dengue. 396 
Final model of factors independently associated with visiting a doctor as the first intended action 
versus home treatment in the case of fever and dengue  
OR (95% CI) p-value 
FEVER 
  
Education    
Illiterate/ pre or primary school  1  
Secundary school 0.25 (0.06 – 1.01) 0.051 
University/ university polytechnic  0.18 (0.03 – 1.05) 0.057  
DENGUE    
Place of residence    
Candelaria 1  
Cooperativa 1.06 (0.17 – 6.66) 0.953  
Caña de Azúcar  0.28 (0.08 – 0.93) 0.038  
Children vs. adults    
Children (caregivers) 1  
Adults 3.33 (1.20 – 9.21) 0.021  
Reported previous dengue infection    
No  1  
Yes  0.29 (0.09 – 0.89) 0.031  
Risk perception    
Not feeling at risk 1  
Feeling at risk 3.29 (1.04 – 10.40) 0.042  
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(n=86, 95.6%) to lower the temperature, followed by a cold bath/shower (n=31, 34.4%), oral 406 
rehydration (n=8; 8.9%), body sponging with a wet compress or sponge (n=7; 7.8%) and 407 
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2Fig 2. Home treatment choices for fever and dengue.The percentages correspond to their contribution to those who mentioned to treat at home when answering the adult questionnaire 
(fever: n=45; dengue: n=12) or the child questionnaire (fever: n=45; dengue: n=26).The categories of treatment combinations in fever 
and dengue are equal in meaning. However, reporting to treat at home with ‘paracetamol’ (P) and ‘other treatment’ (OT) varies 
between the categories of home treatment of fever and dengue. P and OT are placed within brackets if not all subjects within the 
category used additionally P or OT. OT may refer to the following: rubbing the body with alcohol/cream, body sponging, aspirin, other 
medication or rest.
Day when seeking medical help 
If people reported to seek medical help when they/their child would have fever or suspected dengue, they 
were subsequently asked on which day after onset of first symptoms they would visit the doctor. Most 
parents/guardians of children and adults would seek medical help on day 2 after fever onset, but when 
dengue was suspected most people would go on day one to the doctor (Fig 3). Parents/guardians would 
take their children earlier to the doctor in case of dengue than in case of fever (mean: 1.30 days vs. 1.78 
days; p<0.001). Referred to adults the mean reported day was 1.47 in case of dengue and 1.96 in case of 
fever (p<0.001). Although children would visit the doctor earlier than adults, this difference was neither 
significant in the case of fever (p=0.206) nor for dengue (p=0.162). 
Reasons for visiting a doctor in the case of suspected dengue 
The most frequently reported reasons that prompted individuals to visit a doctor in suspected dengue 
were the appearance of new symptoms  (n=81; 77.1%), the rise of body temperature (n=78; 74.3%) 
and the persistence of fever (n=35; 33.3%). Almost 10% (n=10) of the people stated ‘dengue is a severe 
disease’ as a reason to seek medical help.  The most frequent symptoms mentioned were headache (n=36; 
34.3%), corporal pain (n=32; 30.5%) and weakness (n=27; 25.7%). Other typical dengue symptoms were 
mentioned less frequently: rash (n=18; 17.1%), vomiting (n=11; 10.5%), eye pain (n=9; 8.6%) and muscle 
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pain (n=1; 1.0%). Moreover, warning symptoms were not frequently indicated as reasons to seek medical 
help: vomiting (n=11; 10.5%), bleeding (n=9; 8.6%), abdominal pain (n=6; 5.7%). The mean temperature 
referred by interviewees was 39.4°C (range: 38.0°C - 42.0°C) while persistence of fever ranged between 
one to four days with a mean of two days. There were no significant differences when comparing the 
reasons to seek medical care in suspected dengue between children and adults. 
Fig 3. Day when seeking medical help in case of dengue and fever




Health seeking behaviour and access to care in relation to dengue disease in the Americas are scarcely 
described in the literature. Through a cross-sectional household community-based study, we provide 
insights in the intended HSB and access to care of a population exposed to endemic dengue transmission 
in Venezuela [10]. We showed that i) there is a difference in intended pathways to care in the case of a 
suspected dengue infection as opposed to fever, and between children caregivers and adults when dengue 
is suspected; ii) medical care would be sought earlier in the case of a suspected dengue infection than 
in the case of fever; and iii) having had a previous dengue infection, being a child carer and living in the 
neighbourhood Caña de Azúcar were determinants for treating  a dengue infection first at home, while 
feeling at risk of dengue was associated with initial health centre attendance.
Our study found that most individuals intended to look for medical help as their first action if they 
suspected a dengue infection while treating at home would be their first choice in case of fever only (Fig 1). 
Considering the HBM, fever is not enough a cue to action to make the respondents proceed as for dengue. 
The uncertainty of the conditions reduces the ability of fever to increase the perception of susceptibility 
to dengue [39-44]. Half of the participants in our study identified three or less symptoms characteristic 
of dengue. Taking into account that a dengue infection is likely to present with fever as a chief symptom, 
the latter group is likely to initially follow the pathways they described for fever when they actually have 
dengue. Studies in Colombia [42] and Cambodia [22] found that the majority of dengue infections were 
first treated at home. These findings correspond with the intended pathway for fever found in the current 
study, where home treatment was frequently chosen above medical care. Contrariwise, when a dengue 
infection was suspected, the participants in our study would seek immediate medical attention as was 
reported in Thailand and Malaysia [25, 26]. Our results show that, if people would identify that they or 
their children have a dengue infection, they would reach for medical attention earlier and minimise the 
likelihood of developing complications during dengue disease in agreement with a study in Brazil [45]. 
These tendencies are encouraging indicating that our study population perceives dengue as a more serious 
ailment than other causes of fever and is reflected by the reported appearance of new symptoms and a 
rising body temperature as chief reasons to seek medical help. This is in line with a study in Cambodia, 
where the perceived severity of dengue illness in children was found to influence the selection of 
therapeutic options [22].  
We show that children’s parents/caretakers and adults have similar HSB intentions when referring to fever, 
but not when referring to dengue. While in the case of dengue the majority of parents/carers and adults 
would firstly look for a doctor, a higher proportion of children were initially treated at home (Fig 1, Table 1). 
However, when comparing the day of seeking medical care of all HSB pathways which included a doctor’s 
visit, children would still be taken earlier to a doctor than adults (Fig 1). Other studies addressing HSB of 
dengue only refer either to adults or carers of children without comparisons between these two groups 
[22, 25, 26, 42]. The results from our study suggest that it may be wise to consider targeting children 
caregivers and adults separately when health promotion campaigns are performed, since their intended 
HSB may be different.
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Home treatments used in dengue vary according to country or region and include herbs and over-the-
counter medicines like paracetamol [22, 46] or liquids such as water [46], carbonated isotonic sports 
drinks, fruit and vegetable juices and frog or crab soup [26]. We found that fever was treated at home most 
frequently with paracetamol or a cold/tepid bath, while dengue was mostly managed with paracetamol or 
oral rehydration. In Venezuela, a cold/tepid bath or showering is indicated by health personnel to rapidly 
lower the temperature especially in children. Oral rehydration was also frequently mentioned denoting 
that information obtained at health centres and given during dengue campaigns reaches the population. It 
is important to stress that from the medical point of view, home treatment of a suspected dengue infection 
should be followed quickly by a doctor’s visit so that the patient can be properly monitored by medical 
personnel [1].
Contrary to expected, a previously experienced dengue infection did not necessarily result in an intended 
prompt health care seeking. This is worrying since those with previous dengue antibodies are more at risk 
to develop severe disease from a subsequent heterologous dengue infection [47-49]. Efforts should be 
made to promote prompt doctor attendance for these individuals. Also surprisingly, univariate analysis 
indicated that a higher education level was associated with the intended choice for home treatment in 
the case of fever (p=0.069), in agreement with a study in Thailand [25]. Finally, the place of residence and 
caring for a child were also associated with intended home treatment of suspected dengue. Caña de Azúcar 
neighbourhood is one of the most densely populated areas of Maracay [50]. A recent study showed that 
people in this neighbourhood lived in smaller houses and more crowded conditions (which are surrogate 
markers of poverty) and were at higher risk of acquiring a recent dengue infection than Candelaria and 
Cooperativa neighbourhoods [10]. This may explain the lower health centre attendance in agreement with 
studies on malaria in Africa [51, 52]. We found no other characteristics of the neighbourhood Caña de Azúcar 
that could explain the preference of its inhabitants to treat a dengue infection firstly at home.  
The fact that individuals who felt at risk of dengue were more likely to search firstly medical help has 
been described earlier [26] and can serve as a focus when promoting  timely health centre attendance. 
Several studies show that (ongoing) reports of outbreaks and media coverage can increase the awareness 
and risk perception of a disease [53-55]. An increased risk perception may not only encourage immediate 
health centre attendance, but also influences community participation in protective behaviour [15, 26, 
54]. Therefore, timely, complete and trustworthy information on the dengue and health situation in a 
country should positively impact the population at risk with regards to early health centre attendance 
and improvement in protective behaviour . These messages should 1) promote prompt HC attendance 
when dengue is suspected (“visit your doctor as soon as you think you have dengue”), and 2) stress the 
importance of attention to warning symptoms of dengue when fever recedes (“when fever goes, look for 
the following warning signs in yourself or your sick child: severe abdominal pain, persistent vomiting, etc”). 
Limitations 
Due to the political unrest that took place during the study period, data collection was not completed 
for all three neighbourhoods and the majority of the interviewees resided in  Candelaria neighbourhood. 
However, this population was considered to be representative of most urban areas from Maracay city 
minimising selection bias. Education, monthly income and socio-economic status were significantly 
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lower in the child sample, nonetheless these variables were controlled for in the multivariate analysis. 
The difference in socio-demographic and socio-economic characteristics between the adults and parents/
guardians of children can be attributed to the fact that almost half of the children in Aragua State, 
Venezuela, are part of a household run by a single mother, who have generally a lower degree of education 
and a lower income [30]. 
A strength of the study was that data was collected from a well characterised cohort study population 
of which socio-economic and epidemiological data was available. Moreover, contrary to hospital-based 
studies, our study design made us able to include people who would avoid attending health centres, 
thus obtaining insight in their intended HSB. Furthermore, people were interviewed at home, providing 
a safe and confident environment. Finally, the analysis was strengthened with the conceptualisation that 
included aspects of the HBM. For future studies, we recommend to apply the conceptualisation at the 
stage of data collection.
Conclusions
In the current study, we were able to describe intended HSB in the case of dengue and fever at community 
level. Our results suggest that for the people who intend to seek medical care in the case of a dengue 
infection, self-diagnosis might be an obstacle. The differences found in HSB between fever and dengue 
imply that fever does not increase the perceptions of susceptibility to dengue. As mentioned before, a 
delay in care-seeking is associated with a higher mortality and complications during dengue disease [1,12]. 
Therefore, the early intended medical care-seeking in the case of a suspected dengue infection shown in 
this study suggests a possible improvement of HSB and prognosis if an algorithm or tool can be designed 
to diagnose dengue at home. In addition, we found that those who previously had a dengue infection were 
more likely to treat a next infection firstly at home. Since this group has a higher chance of developing 
a severe dengue disease, efforts have to be made to promote prompt health centre attendance in this 
group. In this, raising awareness and risk perception of dengue by media coverage and information at 
health centres may improve this favourable behaviour. Comparing the results of the current study (HSB 
intentions) with those of the actual HSB taken by people, such as in health centre-based studies, could 
reveal other possible barriers for achieving the intended HSB. More community and health centre-based 
studies should be performed to achieve a wider view and stronger conclusions on HSB for people exposed 
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S1 Table. Socio-demographic characteristics and knowledge about dengue of interviewed individuals. 
ap-value corresponds to the comparison between the child and adult questionnaire responses; bFrom the total sample, only one 
person was illiterate;  cFrom the total sample, one person was a Jehovah’s witness; dRange overall knowledge score: 1-9 correct 
answers; *Fishers exact test. 
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S1 Table. Socio-demographic characteristics and knowledge about dengue of 
interviewed individuals. 






Age (n=103) n  (%) n (%) n (%) p-valuea 
18-30 39 (37.9) 8 (16.3) 31 (57.4)  
31-50 34 (33.0) 25 (51.0) 9 (16.7)  
>50 30 (29.1) 16 (32.7) 14 (25.9) <0.001 
Sex (n=105)        
Females 91 (86.7) 47 (92.1) 44 (81.5)  
Males 14 (13.3) 4 (7.8) 10 (18.5) 0.108 
Place of residence (n=105)        
Candelaria 72 (68.6) 36 (70.6) 36 (66.7)  
Cooperativa 11 (10.5) 4 (7.8) 7 (13.0)  
Caña de Azúcar 22 (21.0) 11 (21.6) 11 (20.4) 0.693 
Education (n=104)        
Illiterate/ pre or primary schoolb 17 (16.3) 11 (21.6) 6 (11.3)  
Secondary school 54 (51.9) 31 (60.8) 23 (43.4)  
University/ university polytechnic 33 (31.7) 9 (17.6) 24 (45.3) 0.009 
Occupation (n=104)        
Student 16 (15.4) 4 (7.8) 12 (22.6)  
Housewife/Domestic-/manual 
worker 
56 (53.8) 34 (66.7) 22 (41.5)  
Merchant/ Employee/ Office 
worker/ Professional/ University 
staff 
32 (30.8) 13 (25.5) 19 (35.8) 0.022 
Religion (n=101)        
No religion 6 (5.9) 0 (0.0) 6 (11.3)  
Catholic 76 (75.2) 37 (77.1) 39 (73.6)  
Christian/Protestant/Evangelistc 19 (18.8) 11 (22.9) 8 (15.1) 0.046* 
Overall knowledge score on 
dengued (n=105) 
       
≤4 correct answers 48 (45.7) 21 (41.2) 27 (50.0)  




Legend S1 Table: a p-value corresponds to the comparison between the child and adult 
questionnaire responses; bFrom the total sample, only one person was illiterate;  cFrom the 
total sample, one person was a Jehovah’s witness; dRange overall knowledge score: 1-9 
correct answers; *Fishers exact test.  
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S2 Table. Socio-economic characteristics of interviewed individuals.
ap-value corresponds to the comparison between the child and adult questionnaire responses; bNumber of rooms, bathrooms not 
included; cMinimum wages at time of the study was 2703 VEF - 3270 VEF; *Fishers exact test. 
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Availability of complete public 
services (n=91) 
n  (%) n (%) n (%) p-valuea 
No 4 (4.4) 3 (6.8) 1 (2.1)  
Yes 87 (95.6) 41 (93.2) 46 (97.9) 0.284* 
Persons per household (n=87)        
2-4 25 (28.7) 11 (27.5) 14 (29.8)  
5-6 28 (32.2) 12 (30.0) 16 (34.0)  
≥7 34 (39.1) 17 (42.5) 17 (36.2) 0.831 
Household roomsb (n=90)        
2-4 35 (38.9) 21 (47.7) 14 (30.4)  
5-6 42 (46.7) 18 (40.9) 24 (52.2)  
≥7 13 (14.4) 5 (11.4) 8 (17.4) 0.234 
Crowding (persons/room) (n=86)        
<1.50 57 (66.3) 20 (50.0) 37 (80.4)  
≥1.50 29 (33.7) 20 (50.0) 9 (19.6) 0.003 
Monthly income (VEB)c (n=76)        
≤7000 VEB (minimum wages) 38 (50.0) 26 (66.7) 12 (32.4)  
>7000 VEB 38 (50.0) 13 (33.3) 25 (67.6) 0.003 
Socio-economic status (n=90)        
Low 38 (42.2) 23 (52.3) 15 (32.6)  
Average 30 (33.3) 17 (38.6) 13 (28.3)  
High 22 (24.4) 4 (9.1) 18 (39.1) 0.004 
 3 
Legend S2 Table: a p-value corresponds to the comparison between the child and adult 4 
questionnaire responses; bNumber of rooms, bathrooms not included; c Minimum wages at 5 
time of the study was 2703 VEF - 3270 VEF; *Fishers exact test.  6 
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S3 Table. Socio-demographic and socio-economic characteristi cs related to the intended fi rst acti on of 
the HSB pathway in the case of fever and dengue; home treatment vs. visiti ng a doctor.
 2










Visit a doctor 
n=63 
Agea  n (%) n (%) n  (%) n  (%) 
18-30 32 (37.2) 2 (16.7) 10 (33.3) 21 (33.9) 
31-50 30 (34.9) 4 (33.3) 13 (43.3) 20 (32.3) 
>50 24 (27.9) 6 (50.0) 7 (23.3) 21 (33.9) 
p-valueb 0.268*    0.489 
Sex         
Females 78 (88.6) 11 (91.7) 29 (93.5) 53 (84.1) 
Males 10 (11.4) 1 (8.3) 2 (6.5) 10 (15.9) 
p-valueb 1.000* 0.325* 
Place of residence         
Candelaria 61 (69.3) 8 (66.7) 17 (54.8) 48 (76.2) 
Cooperativa 9 (10.2) 2 (16.7) 3 (9.7) 6 (9.5) 
Caña de Azúcar 18 (20.5) 2 (16.7) 11 (35.5) 9 (14.3) 
p-valueb 0.787* 0.058*  
Educationc          
Illiterate/ pre or primary schoold 12 (13.8) 5 (41.7) 3 (9.7) 14 (22.6) 
Secondary school 48 (55.2) 5 (41.7) 18 (58.1) 30 (48.4) 
University/ university polytechnic 27 (31.0) 2 (16.7) 10 (32.3) 18 (29.0) 
p-valueb 0.069* 0.312 
Occupationc         
Student 13 (14.9) 2 (16.7) 7 (22.6) 7 (11.3) 
Housewife/Domestic-/manual worker 48 (55.2) 8 (66.7) 18 (58.1) 35 (56.6) 
Merchant/ Employee/ Office worker/ 
Professional/ University staff 
26 (29.9) 2 (16.7) 6 (19.4) 20 (32.3) 
p-valueb 0.686* 0.231* 
Religione         
No religion 3 (3.5) 1 (9.1) 1 (3.3) 3 (4.9) 
Catholic 67 (78.8) 7 (63.6) 21 (70.0) 50 (82.0) 
Christian/Protestant/Evangelistf 15 (17.6) 3 (27.3) 8 (26.7) 8 (13.1) 
p-valueb 0.327* 0.250* 
Monthly income (VEB)g         
≤7000 VEB  32 50.0 5 62.5 14 56.0 22 48.9 
>7000VEB 32 50.0 3 48.6 11 44.0 23 51.1 
p-valueb 0.711* 0.568 
Socio-economic statush         
Low 33 (43.4) 5 (50.0) 10 (37.0) 25 (46.3) 
Average 27 (35.5) 3 (30.0) 11 (40.7) 17 (31.5) 
High 16 (21.1) 2 (20.0) 6 (22.2) 12 (22.2) 
p-valueb 1.000* 0.669 
Child/adult – sample     
Child 44 (50.0) 7 (51.0) 20 (64.5) 27 (42.9) 
Adult 44 (50.0) 5 (59.0) 11 (35.5) 36 (57.1) 
p-valueb 0.588 0.048  
Overall knowledge dengue         
≤4 correct answers 38 (43.2) 7 (58.3) 15 (48.4) 28 (45.7) 
≥5 correct answers 50 (56.8) 5 (41.7) 16 (51.6) 35 (54.3) 
p-valueb 0.322 0.829  
Reported previous dengue infectioni         
No  58 (67.4) 10 (83.3) 18 (60.0) 46 (73.0) 
Yes 28 (32.6) 2 (16.7) 12 (40.0) 17 (27.0) 
p-valueb 0.334*  0.205  
Risk perceptionj         
Not feeling at risk  24 (27.6) 3 (25.0) 11 (36.7) 14 (22.2) 
Feeling at risk 63 (72.4) 9 (75.0) 19 (63.3) 49 (77.8) 





an=86 for subjects choosing home treatment in case of fever; n=30 for subjects choosing home treatment in case of dengue; n=62 for 
subjects choosing visiti ng a doctor in case of dengue; bp-value corresponds to the comparison between intending to treat at home 
or visiti ng a doctor as fi rst acti on for each case: fever or suspected dengue. cn=87 for subjects choosing home treatment in case of 
fever; n=62 for subjects choosing visiti ng a doctor in case of dengue;  dFrom the total sample, there was one person illiterate; en=85 
for subjects choosing home treatment in case of fever; n=11 for subjects choosing visiti ng a doctor in case of fever; n=30 for subjects 
choosing home treatment in case of dengue; n=61 for subjects choosing visiti ng a doctor in case of dengue; fFrom the total sample, 
one person was a Jehovah’s witness; gn=64 for subjects choosing home treatment in case of fever; n=8 for subjects choosing visiti ng 
a doctor in case of fever; n=25 for subjects choosing home treatment in case of dengue; n=45 for subjects choosing visiti ng a doctor 
in case of dengue; hn=76 for subjects choosing home treatment in case of fever; n=10 for subjects choosing visiti ng a doctor in case of 
fever; n=27 for subjects choosing home treatment in case of dengue; n=54 for subjects choosing visiti ng a doctor in case of dengue; 
in=86 for subjects choosing home treatment in case of fever; n=30 for subjects choosing home treatment in case of dengue; jn=87 for 
subjects choosing home treatment in case of fever; n=30 for subjects choosing home treatment in case of dengue; *Fisher’s exact test.
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3 AbstractBackground Dengue is a major public health problem in Venezuela. Timely health centre (HC) att endance is crucial in reducing mortality and severity from dengue. The healthcare system in Venezuela comprises a multi faceted public and private sector. We assessed the intended HC att endance and perceived moti vati ons/barriers for access to care in the case of fever and dengue in a high dengue transmission urban area.MethodsA cross-secti onal household survey was performed in Maracay, Venezuela. Structured questi onnaires including open-ended questi ons were applied to 105 children’s carers (n=51) and adults (n=54). Quanti tati ve and qualitati ve analyses were done.
Results
In the case of an illness episode, individuals would decide to sequenti ally att end several diff erent HCs 
unti l their healthcare needs were met. The most frequent intended fi rst and second HC choices for fever 
(fi rst 78.8%; second 38.5%) and dengue (fi rst 80.8%; second 41.3%) were traditi onal ambulatorios. Terti ary 
level HCs (private and public hospitals) were menti oned later in the pathways, more oft en in the case of 
dengue. Individuals choosing a private HC had a higher educati on level (fever/dengue: p=0.018/p=0.008). 
Qualitati ve data showed that logisti c, economic and quality of care aspects infl uenced the intended 
preferences: individuals preferred to fi rst att end traditi onal HCs as they trusted the care given there, but 
perceived barriers were long waiti ng ti mes and the lack of diagnosti c and treatment supplies. The private 
care, which was considered to provide the best care, was mainly accessible to those with a health insurance. 
Conclusion
Access to care in Venezuela is currently a complex situati on where individuals need to juggle between the 
diff erent available public and private HCs in order to obtain proper and ti mely care and medical supplies. 
Health centre capacity (treatment supplies and personnel) and barriers for access to care should be 




Dengue is a rapidly spreading viral vector-borne disease currently present in 128 countries. An estimated 
3.97 billion people are at risk of becoming infected with dengue [1]. The virus is spread by infected Aedes 
mosquitoes, principally by Ae. aegypti [2]. It is estimated that annually 390 million people are infected with 
one of the four circulating dengue viruses [3], making dengue a global health problem of great importance. 
When symptomatic, dengue presents as a flu-like disease with a variety of nonspecific symptoms. In a 
certain proportion, dengue develops into a severe form characterized by plasma leakage and possibly 
shock, sometimes occuring within 3 days after fever onset [2,4,5]. If complicated disease ensues, careful 
intravenous fluid resuscitation is essential for survival and recovery of the patient [2]. Early healthcare 
attendance is thus critical in reducing both the rate of dengue severe disease and the mortality of dengue 
patients [2,6]. Identifying reasons for delay in care seeking is therefore essential [7]. Access to care depends 
on the affordability, physical accessibility and acceptability of services and not just on the availability of 
sufficient supplies [8]. Understanding the behaviours, motivation for choice and barriers from a bottom-
up approach, addressing the broader socio-political context is important in developing successful health 
interventions [9].
Dengue transmission in Venezuela has become perennial and a major public health problem. Epidemics of 
increasing magnitude regularly occur against a background of an established endemic situation [10]. The 
first dengue haemorrhagic fever epidemic was reported in 1989-1990 [11], followed by several outbreaks 
in 2000-2010. The most recent epidemic, in 2010, accounted for more than 120,000 cases of which almost 
10,000 (8%) were severe [10]. 
The healthcare system in Venezuela comprises a public and a private sector under the umbrella of the 
Ministry of Health [12]. The public sector was designed to offer medical care and most medications free 
of charge. It has a network of urban and rural out-patient health centres (HCs) at primary and secondary 
level named “Ambulatorios type I or type II”. Patients that cannot be managed as outpatients, are referred 
to tertiary level HCs (hospitals). The private sector comprises private practices and private hospitals where 
patients need to pay either via their health insurance or directly. In 2003, the Venezuelan government 
launched the Mission Barrio Adentro (‘Barrio Adentro’ means ‘inside the slum’) to improve access to care 
for people with limited resources and income [13-15]. The Mission Barrio Adentro (MBA) was set up as 
a parallel healthcare system , based on a cooperation between Venezuela and Cuba, where Venezuelan 
oil supplies were linked to the establishment of HCs run by Cuban doctors [15,16]. Although aimed at 
improving the state of healthcare in the country, there are contradictory opinions on its performance 
[13,15-20].
Research on HC attendance in relation to dengue remains scarce, especially in the Americas. Literature 
on  HC attendance in Venezuela focuses mainly on a top-down approach, while the attitudes of the 
community towards the different HCs in Venezuela are scarcely described. Therefore, the aim of this study 
was threefold: (1) to describe the healthcare facility preferences of the community in the case of fever and 






Aragua state witnessed the highest incidence of dengue in Venezuela in 2012, reaching nearly 7000 
reported cases (~430 cases per 100.000 inhabitants) of which 2% were severe [10]. Maracay is one of the 
largest cities of Venezuela and has dengue hyper-endemicity [21,22]. It is the capital of Aragua state with 
an estimated 1.3 million inhabitants [23]. Within Maracay, three neighbourhoods called Candelaria, Caña 
de Azúcar and Cooperativa were selected as our study sites owing to their high dengue incidence [24]. All 
are served by public (traditional and parallel) and private HCs. Patients that require further specialised 
treatment are referred to the main public tertiary level hospital: Hospital Central de Maracay, or to private 
hospitals. 
Study design
A cross-sectional study was carried out to gather quantitative and qualitative data on health centre seeking 
intentions at community level of the general population exposed to dengue. This study was performed 
within one of the annual surveys (September 2013 and February 2014) of a running community-based 
prospective cohort study. A detailed description of the study set up was published earlier [24].  Briefly, the 
cohort study was set up between August 2010 and January 2011, to assess epidemiological, behavioural, 
clinical and viral characteristics related with dengue disease and transmission. A total of 2014 individuals 
aged 5-30 years old living in 840 households within the three study neighbourhoods were enrolled in the 
cohort after written informed consent. Individuals were followed weekly and through annual surveys [24]. 
Study population
This research aimed to understand health seeking behaviour (HSB) [25] and HC choices of adults and 
parents/guardians of children in Maracay, Venezuela. Assuming that around 80% of the individuals would 
seek treatment at a traditional primary/secondary HC in the case of fever, with a sample error of 5% and a 
confidence level of 95%, a total of 245 participants will be required to estimate the prevalence of people 
visiting these type of HCs. Anticipating on possible missing data, we aimed to enroll 260 individuals. In 
order to interview one individual per household, a random sample of 260 households out of the 840 
households belonging to the cohort study was selected. However, 105 interviewed participants were 
finally interviewed because violence during anti-governmental protests in February and March 2014 in 
the country [26-28] precluded the enrolment of further individuals. One individual was interviewed in 
each household alternating adults and parents/guardians of children (<18 years old) who were already 
participating in the cohort study. In the case of children, we interviewed their parents or carers. Adults 
(≥18 years) were randomly chosen from all the adults included in the cohort that were present at the 
moment the selected household was visited. Informed consent for this study had already been obtained 




A standardized questionnaire targeting community intended HSB and access to care, hereinafter referred to 
as HSB-questionnaire, was developed [25], including pre-coded and open questions on socio-demographic, 
knowledge on dengue, dengue risk perception, and pathways of health centre attendance in relation to 
presenting fever and suspicion of dengue infection. Finally, individuals were asked to rank the quality 
of available health centres in their area. Adults were interviewed about their own risk perception and 
healthcare attendance. For parents/guardians, these questions were related to the child. From a second 
questionnaire, we recorded household socio-economic variables. The questionnaires were prepared in 
English, translated to Spanish, pre-tested and adapted through a pilot study in Maracay. Interviews took 
place at the participants’ home and were performed by trained experienced local interviewers.
Socio-demographic, socio-economic characteristics and knowledge on dengue
From the HSB-questionnaire demographic characteristics of the interviewed person were gathered: 
age, place of residence (neighbourhood), level of education, occupation and religion. Additional socio-
economic data was gathered with the household questionnaire. Socio-economic data was used as proxy 
markers to estimate socio-economic status of the individuals [25]. Dengue knowledge was assessed by 
open questions regarding dengue transmission and symptoms. The knowledge score was derived from the 
sum of the correct answers on transmission routes (bite of a mosquito) and symptoms (fever, headache, 
eye pain, body pain, face redness/rash, muscle pain, abdominal pain, sore throat, vomiting, diarrhoea, 
malaise, nausea, bleeding, fainting, dizziness, itching) in a scale of 0 to 17 [25]. 
Health centre preference pathways
Behavioural intentions in relation to the pathways people would choose when seeking to attend a HC were 
assessed by the following sequential open questions: ‘what would you do if you/your child had fever’; and 
‘what would you do if you think that you/your child have/has dengue’. If ‘going to the doctor or to a HC’ 
was mentioned, people were asked when and to which HC they would firstly seek medical help. They were 
then asked, in the case they would not be satisfied with the care in the firstly chosen HC, to cite the next 
HC options (if applicable) in order of preference up to a maximum of four HC. HC choices were ranked in 
chronological order, resulting in a HC preference pathway for each participant.
Logistics, affordability and quality of health centres
We asked interviewees to assess the quality of the medical care they would expect to receive in each type 
of HC if they would present with a dengue episode. Individuals were also asked whether or not they would 
attend each HC in case of a suspected dengue infection, and to estimate the travel time and costs. From 
the household questionnaire, the means of transport to HCs were obtained. The quality of dengue-related 
medical care (diagnostic and treatment capacity) of each HC was assessed using a 5 point ‘Likert-item’ scale 
from 1 to 5, where 1 was defined as very poor, 3 as average and 5 as very good. The assessed HCs were:   
1. The traditional public healthcare system: a) Ambulatorio, a public outpatient primary or secondary 
level HC; b) Hospital, a tertiary level HC; 
2. The parallel public healthcare system (‘Misión Barrio Adentro’): a) Barrio Adentro I, hereinafter referred 
51
3
to as “MBAI”, a small public outpatient primary HC; b) Diagnostic centres or “Centros de Diagnóstico 
Integral” (CDI), a public outpatient primary or secondary HC, usually equipped with diagnostic facilities 
such as radiology and a laboratory ;
3. The private healthcare system: a) Private practice, a specialised primary private outpatient surgery; b) 
Private hospital, a private tertiary level HC. 
An overview of capabilities of the different local HCs is provided  in Additional File 1.
The health insurance system in Venezuela is a complex one. A large proportion of the population does 
not have a health insurance, especially those having a ‘self-employed’ or informal occupation (housewife, 
domestic or manual-worker, street vendors and the like) or are unemployed. These individuals usually 
attend the public health system or pay out-of-the pocket for private care. Individuals employed in 
governmental or private companies/institutions enjoy a collective health insurance. Those with higher 
income take on private health insurance. However, given the rapid inflation in the country, the maximum 
annual amount insured is rapidly reached when attending private care and if needed, individuals may be 
referred to the public health system. 
Qualitative data 
During the interview, individuals gave spontaneous explanations and clarifications about the reasons for 
their choices. In other occasions we asked the individual to explain the reasons for their answer(s). Where 
possible, transcriptions were made in verbatim and in other situations detailed notes were taken after the 
survey interview.
Data Analysis
Information collected in the questionnaires was entered into a database using Epi Info (Epi InfoTM, version 
3.5.4). Data was checked for consistency and analysed anonymously. The association of socio-demographic 
and socio-economic variables with the  intended private versus public HC attendance of individuals in the 
case of fever or suspected dengue was explored through univariate analysis. Differences in proportions 
were analysed using a chi-square test or Fisher’s exact test when applicable. Continuous variables were 
converted into ordered categorical variables when suitable. The McNemar’s test was applied to paired 
nominal data when comparing health centre attendance of fever and dengue. A multivariate binary logistic 
regression was performed to describe characteristics of the population visiting public and private HCs 
in the case of fever and suspected dengue. General characteristics with a p-value ≤0.2 in the univariate 
analysis were included in a multivariate model to test their influence on HC attendance. Variables with 
lowest significance were eliminated backwards, until all variables in the model showed significance. 
Significance was determined at the 5% level. Quantitative data was analysed using SPSS (SPSS Inc., version 
20.0, Chicago, Illinois) and checked using STATA (Stata Statistical Software: Release 10. College Station, TX,) 
software. 
Qualitative data (motives and barriers for accessing health centres) from the open questions in the survey 
was analysed using Atlas.ti (Atlas.ti GmbH, Berlin parts copyright by Cincom Systems, Inc: version 7.5.4), 
following the principles of the grounded theory [29]. Data was examined using codes, which refer to an 
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issue, topic, idea or opinion evident in the data [29]. In the first analytical step, 70 codes were used. In the 
second step, 12 code families were used. Each of the six HCs were analysed with two code families (adding 
up to a total of 12 code families): 1) motivations related to the choice of HCs 2) barriers for accessing 
HCs. Reasons mentioned by five or more individuals in relation to motives or barriers were marked as 
‘most reported reasons’, reasons marked as ‘other reasons’ were mentioned by up to four individuals. This 
ranking is not meant for representativeness rather as a manner to group and differentiate the responses.
Ethics statement
The study was approved by the Ethics Review Committee of the Biomedical Research Institute, Carabobo 
University Maracay, Venezuela (Aval Bioetico #CBIIB(UC)-014); the Ethics, Bioethics and Biodiversity 
Committee (CEBioBio) of the National Foundation for Science, Technology and Innovation (FONACIT) of the 
Ministry of Science, Technology and Innovation, Caracas, Venezuela; and by the Regional Health authorities 
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In total, 105 individuals were interviewed with the HSB-questionnaire where 54 interviews referred to 
adults and 51 to children. In addition, 92 household socio-economic questionnaires were applied. Finally, 
87 individuals provided information used for the qualitative data analysis. In Table 1 (total sample column) 
the general characteristics of the study population are shown. Interviewed individuals had a median age 
of 36 years (range: 18–87 years; Q1-Q3: 25-53 years) and were mainly women (Table 1). As in the rest of 
the country, the majority of the individuals professed a catholic religion. The majority of the interviewed 
individuals (n=72; 68.6%) lived in Candelaria. We were unable to complete the planned interviews 
in the other two neighbourhoods (Cooperativa and Caña de Azúcar) because of violence during anti-
governmental protests in February and March 2014 in the country [26-28]. Most interviewed individuals 
completed secondary school and most were housewives or domestic workers.
Health centre pathways
Nearly all individuals (n=103; 99%) would decide to seek medical help at some point during their HSB 
sequence if they or their child(ren) had fever or a suspected dengue infection [25]. The pathways 
of intended HC choices are summarized in Figure 1. The figure shows from left to right the first, and if 
applicable the second, third and fourth sequential choices of HCs in case of fever and dengue. Overall, 
HC preferences were similar for both fever and suspected dengue, although various HC pathways were 
observed. As shown in Figure 1 the most frequent first choice of HC was an ambulatorio, both in the case 
of fever (n=82; 78.8%; 95% CI=69.1%-86.2%) and dengue (n=84; 80.8%; 95% CI=71.5%-88.1%). These were 
followed, in order of preference, by a CDI (n=10; 9.6%) a private practice (n=4; 3.8%), a MBAI (n=2; 1.9%), 
and a private hospital (n=1; 1.0%) in the case of fever, while for dengue people chose a CDI (n=9; 8.7%), the 
public hospital (n=4; 3.8%), a private hospital (n=3; 2.9%), a MBAI (n=2; 1.9%) and a private practice (n=1; 
1.0%). The most frequently mentioned second choice for HCs were again the ambulatorios, both for fever 
and dengue. Tertiary level HCs (private and public hospitals) were mainly mentioned  later in the pathways. 
Individuals would go to the latter health centres at some point in their pathway more often in case of 
dengue (n=61; 58.7%) than fever (n=46; 44.2%; p=0.001). There were no statistical significant differences 
observed comparing children with adults for their preferred HCs choices. 
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Table 1. Univariate analysis of general characteristics by intended private versus public/no HC attendance.
an corresponds to the subjects of the  total sample; bn corresponds to the sample used to compare between the intention to attend a 
private HC or not in the case of fever or suspected dengue; cp-value derived from the comparison between intending to visit a private 
health centre or not. dOnly one person was illiterate; eOne person was a Jehovah’s witness; fMinimum wages at time of the study were 
VEF 2703 - VEF 3270;  gRange knowledge score: 1-9 correct answers; *Fisher’s exact test.
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 Fever Suspected dengue 
 Total sample Intended private HC 
attendance  
Intended private HC 
attendance  
 No Yes No Yes 
n (%) n (%) n (%) n (%) n (%) 
Age (n=103a; 102b)           
18-30 39 (37.9) 29 (39.7) 10 (34.5) 29 (40.8) 10 (32.3) 
31-50 34 (33.0) 22 (30.1) 11 (37.9) 22 (31.0) 11 (35.5) 
>50 30 (29.1) 22 (30.1) 8 (27.6) 20 (28.2) 10 (32.3) 
p-valuec  0.746 0.714 
Sex (n=105a; 104b)           
Females 91 (86.7) 64 (86.5) 26 (86.7) 62 (86.1) 28 (87.5) 
Males 14 (13.3) 10 (13.5) 4 (13.3) 10 (13.9) 4 (12.5) 
p-valuec  1.000* 1.000* 
Place of residence (n=105a; 104b)           
Candelaria 72 (68.6) 51 (68.9) 20 (66.7) 48 (66.7) 23 (71.9) 
Cooperativa 11 (10.5) 8 (10.8) 3 (10.0) 8 (11.1) 3 (9.4) 
Caña de Azúcar 22 (21.0) 15 (20.3) 7 (23.3) 16 (22.2) 6 (18.8) 
p-valuec  0.943* 0.945* 
Education (n=104a; 103b)           
Illiterate/ pre or primary schoold 17 (16.3) 14 (19.2) 3 (10.0) 15 (21.1) 2 (6.3) 
Secondary school 54 (51.9) 44 (60.3) 9 (30.0) 41 (57.7) 12 (37.5) 
University/university polytechnic 33 (31.7) 15 (20.5) 18 (60.0) 15 (21.1) 18 (56.2) 
p-valuec  0.001* 0.001 
Occupation (n=104a; 103b)           
Student 16 (15.4) 10 (13.7) 6 (20.0) 11 (15.5) 5 (15.6) 
Labour: Housewife/Domestic-/manual worker 56 (53.8) 46 (63.0) 9 (30.0) 44 (62.0) 11 (34.4) 
Non-labour: Merchant/Employee/Office 
worker/Professional/University staff 
32 (30.8) 17 (23.3) 15 (50.0) 16 (22.5) 16 (50.0) 
p-valuec  0.007* 0.016* 
Religion (n=101a; 100b)           
No religion 6 (5.9) 3 (4.2) 3 (10.3) 4 (5.7) 2 (6.7) 
Catholic 76 (75.2) 53 (74.6) 22 (75.9) 50 (71.4) 25 (83.3) 
Christian/Protestant/Evangeliste 19 (18.8) 15 (21.1) 4 (13.8) 16 (22.9) 3 (10.0) 
p-valuec  0.445* 0.329* 
Monthly income (VEF)f (n=76a; 75b)           
≤7000 VEF (minimum wages) 38 (50.0) 27 (50.9) 10 (45.5) 26 (50.0) 11 (47.8) 
>7000 VEF 38 (50.0) 26 (49.1) 12 (54.5) 26 (50.0) 12 (52.2) 
p-valuec  0.665 0.862 
Socio-economic status(n=90a; 89b)           
Low 38 (42.2) 27 (42.2) 10 (40.0) 26 (42.6) 11 (39.3) 
Average 30 (33.3) 23 (35.9) 7 (28.0) 22 (36.1) 8 (28.6) 
High 22 (24.4) 14 (21.9) 8 (32.0) 13 (21.3) 9 (32.1) 
p-valuec  0.576 0.527 
Child/adult – sample (n=105a; 104b)           
Child 51 (48.6) 36 (48.6) 14 (46.7) 36 (50.0) 14 (43.8) 
Adult 54 (51.4) 38 (51.4) 16 (53.3) 36 (50.0) 18 (56.3) 
p-valuec  0.855 0.556 
Knowledge score (n=105a; 104b)           
≤4 correct answers 53 (50.5) 37 (50.0) 16 (53.3) 37 (51.4) 16 (50.0) 
≥5 correct answers 52 (49.5) 37 (50.0) 14 (46.7) 35 (48.6) 16 (50.0) 
p-valuec  0.758 0.896 
Previous dengue infectiong (n=102a; 101b)           
No 69 (67.6) 47 (66.2) 22 (73.3) 47 (67.1) 22 (71.0) 
Yes 33 (32.4) 24 (33.8) 8 (26.7) 23 (32.9) 9 (29.0) 
p-valuec  0.481 0.703 
Risk perception (n=103a; 102b)           
Not feeling at risk  30 (29.1) 19 (26.4) 11 (36.7) 19 (27.1) 11 (34.4) 
Feeling at risk 73 (70.9) 53 (73.6) 19 (63.3) 51 (72.9) 21 (65.6) 
p-valuec  0.299 0.457 
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Figure 1. Intended pathways of healthcare seeking in case of fever and suspected dengue. 
The flowcharts in the figure show the health centre attendance pathways that people intended to take in the case of fever (left column) 
or in the case of a suspected dengue infection (right column). From left to right, the first to the fourth sequential HC choices are shown. 
‘nfc’= no further choice; ‘Amb’= Ambulatorio; ‘Hosp’= hospital; ‘MBAI’= Mission Barrio Adentro I; ‘CDI’=Centro de Diagnóstico Integral 
(diagnostic center); ‘PPrac’= Private practice; ‘PHosp’= Private Hospital; NoHC= No attendance to a health centre.
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Private healthcare vs. public healthcare/no HC attendance
The reported pathways indicate that some individuals would attend private HCs at a stage during their 
HSB (fever: n=30; 28.8% vs. dengue: n=32; 30.8%; p=0.727), while others solely considered the public HCs 
or would not go to any of the HCs (fever: n= 74; 71.2% vs. dengue: n=72; 69.2%). Univariate analysis was 
performed to identify socio-demographic and socio-economic characteristics possibly associated with the 
choice of private HC (Table 1). People with a higher education and those with a non-labour occupation 
would be more likely to attend a private HC, both in the case of fever (p=0.001; p=0.007, respectively) and 
in the case of suspected dengue (p=0.001; p=0.016, respectively). There were no statistically significant 
differences observed in gender, age, place of residence, religion, monthly income, socio-economic status, 
child vs. adult, knowledge on dengue, reporting having had a dengue infection in the past, and dengue 
risk perception (Table 1). The multivariate analysis is presented in Table 2 and shows that those with a 
university (polytechnic) level of education would visit private health care more often in the case of fever 
(OR=5.60; p=0.018)  and suspected dengue  (OR=9.00; p=0.008) compared to those having had  pre or 
primary education or were illiterate. The latter group would visit public health centres in higher proportions.
Table 2. Final model of factors independently associated with private versus public health centre 
attendance in the case of fever and suspected dengue 
 
Accessibility and quality of health centres
Table 3 shows the proportion of individuals that would consider attending each of the HC in case of a 
dengue episode and the score given to the quality of care and the logistics involved in accessing each HC. 
Individuals were first asked if they would attend each of the HC and their answers were “yes, no or don’t 
know (DK)”. Most of the individuals would attend the public-traditional HCs, with a similar choice for public-
parallel and private HCs. The highest quality scores were given to private practices (mean = 4.5) and private 
hospitals (mean = 4.2), followed by the main public hospital, ambulatorios and CDIs, and MBAIs which 
received the lowest score (p>0.001; Friedman test).  With respect to logistics related to access to care, the 
majority of individuals (n=70; 79.5%) reported to walk to their preferred HCs as these were located in the 
vicinity of their homes. Other means of transport were using their own car (n=14; 15.9%), by bus (n=6; 
6.8%), by taxi (n=3; 3.4%) or their own motorcycle (n=3; 3.4%). The mean expected costs for a return trip to 
the HC were zero Venezuelan Bolívar (VEF)a when walking and 3 VEF when a car or motorcycle was utilised, 
while the costs of using a bus (mean=26 VEF) or taxi (mean= 43 VEF) were reported to be higher. 
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Illiterate/ pre or primary school 1 
 
Secondary school 0.96 (0.23 – 4.02) 0.949 
University/university polytechnic 5.60 (1.35 – 23.23) 0.018  




Illiterate/ pre or primary school 1 
 
Secondary school 2.20 (0.44 – 10.98) 0.338  
University/university polytechnic 9.00 (1.77 – 45.79) 0.008 
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Table 3. Perceived quality of dengue care and access to care logistics in relation to HCs
The first column shows whether or not people would visit a particular HC in the case of suspected dengue (‘yes’, ‘no’ or ‘don’t 
know’(DK)). Mean and Inter Quartile Range (IQR) scores assigned to the expected medical care for dengue disease (scale of 1(very 
poor) to 5(very good)) are presented under the heading “quality score dengue care”. The columns under the headings ‘travel time’ 
and ‘travel costs’ (right) show the reported estimated travel time in minutes and the estimated travel costs in the local currency 
Venezuelan Bolivar (VEF). DK= number of people that answered ‘don’t know’.
Motivations and barriers for HC choice – qualitative aspects
Table 4 shows the motivations to present at a HC as reported by the interviewed individuals when ranking 
the quality of care and/or deciding to attend a specific HC or not (Table 3). The perceived barriers to attend 
a HC are shown in Table 5. 
A positive previous experience was a common reason to attend any of the public healthcare institutions 
(Table 4), while the expectation that a paid care would be better was one of the major drives to attend 
private HCs. Even though the ambulatorios were the most frequently chosen HC (Figure 1), their quality of 
care was not ranked higher than other public healthcare institutions (Table 3). Among the reasons to seek 
medical care at an ambulatorio were the proximity to the place of residence, the expectation of receiving 
a good treatment/medical care and the habit of attending this traditional healthcare institution (Table 4). 
Most reported barriers against presenting to an ambulatorio or that gave these HCs a lower score in the 
reported quality of care were i) the previously experienced long waiting times to obtain medical care and 
ii) the current absence of free medication/ infusions/ needles and other medical materials, which forced 
people to purchase them in pharmacies or from local street vendors. Similar barriers to care were expressed 
with respect to the public hospital, that is the absence of medical materials and the long waiting times, 
including crowded emergency and triage departments as a third major barrier. It was mentioned that the 
absence of medical material in the hospital lead to worse health outcomes of poor people, because they 
could not afford buying medicines out of pocket. 
The absence of medical material was perceived to be less of a problem in the parallel public system (MBAIs 
and CDIs), compared to the traditional HCs (ambulatorio and hospitals).  However, interviewees reported to 
distrust the medical and paramedical staff working at the parallel system and the diagnosis and treatment 
obtained in these HCs. Individuals mainly attributed their distrust to the fact that these HCs were primarily 
staffed with Cuban doctors. This was also reflected by a preference of some individuals to first visit an 
ambulatorio to obtain a diagnosis of their ailments from a Venezuelan doctor, followed by a visit to one of 
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n (DK) mean n (DK) Mean 
Costs 
Public,  Ambulatorio 103 (98.1) 2 (1.9) 0 (0.0) 105 (0) 3.7 3-4-5 102 (0) 9.0 100 (1) 5.1 
traditional Main public Hospital 86 (81.9) 18 (17.1) 1 (1.0) 95 (10) 3.8 3-4-5 102 (0) 37.5 101 (0) 75.8 
Public,  MBAI 70 (66.7) 35 (33.3) 0 (0.0) 88 (17) 3.5 3-3-5 101 (1) 7.7 99 (2) 3.7 
parallel CDI 74 (70.5) 30 (28.6) 1 (1.0) 88 (16) 3.7 3-4-5 102 (0) 10.9 100 (1) 4.9 
Private Private practices 74 (70.5) 30 (28.6) 1 (1.0) 89 (15) 4.5 3.5-4-5 98 (4) 35.3 97 (4) 62.5 
 Private hospitals 68 (64.8) 37 (35.2) 0 (0.0) 89 (15) 4.2 4-5-5 97 (2) 35.9 99 (2) 67.7 
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Most reported positive reasons to seek medical attention at the private healthcare system (private 
practices and private hospitals) related to the good care expected at a paid institution which should be 
properly staffed and supplied with medical materials. As stated by the interviewees: “if one has to pay for 
a treatment, then the care given is probably better”. The quality of care of private HCs was rated highest 
(Table 3). Another prominent reason to go to private practices was the already present bond of trust with 
the doctors or because they knew the doctor for a very long time. The barriers portrayed against seeking 
care at these HCs were mainly based on the high costs incurred (Table 5). Individuals mentioned that the 
lack of a sufficiently high insurance policy or the ability to pay further care was believed to lead to worse 
care or a refusal of further treatment.  In Venezuela, health insurance companies reimburse a fixed and 
maximum yearly amount for specific medical costs. How much this is, depends on the premium that the 
person pays to the insurance company. Those individuals who would attend the private system indicated 
that they had a health insurance that could cover the medical expenses. However, some were unwilling 
to spend their insurance on dengue treatment, but preferred to keep their insurance for ‘more severe 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In this study, we aimed to identify the intended health centre preferences in relation to a possible episode 
of fever or dengue, and understand the reasons and perceived barriers in the healthcare seeking process 
of individuals exposed to hyperendemic dengue transmission. To this end, we conducted a cross-sectional 
household study within the third annual survey of a dengue community-based cohort study in three 
neighbourhoods in Maracay city, Venezuela [24]. We show that people would sequentially visit several 
different HCs in order to satisfy their healthcare needs. Although various HC pathways were observed, 
the majority of individuals showed similar HC preferences, i.e. traditional ambulatorios were the first and 
second choices for most people. However, tertiary level HCs (hospitals) were more often selected in the 
case of a suspected dengue episode. Several socio-economic and quality (affordability, accessibility and 
acceptability) considerations influenced the intended health centres choices. 
Patients in Venezuela are currently confronted with an array of different HCs where to seek medical help, 
from the private sector to the traditional and parallel public health systems [12]. Various HC pathways were 
observed in our study showing that individuals would seek help in several different HCs until appropriate 
diagnosis and treatment would be obtained. Similar to our findings, women in Cambodia searched 
different means to find treatment for their dengue affected child shifting from one sector to another, 
from public and private practices, to purchasing over the counter medications and/or herbal remedies [7]. 
In Thailand, where a pluralistic medical system exists, individuals switch between alternative treatment 
seeking pathways until they are satisfied [31]. 
Despite the different pathways observed in our study and of the parallel health system being created to 
improve access to care [17], most individuals would select as their first and second HC option the traditional 
primary/secondary outpatient HC: the ambulatorio. This is in accordance with a study in Thailand, where 
two major treatment seeking pathways were identified based on the first treatment alternative [31]. There 
was also only little difference between the pathways for a suspected dengue infection and fever, though 
in the case of dengue tertiary HCs were more frequently chosen at some point during their care seeking 
process. Considering a previous study within the same population, this may be linked to a higher perceived 
severity of dengue disease compared to fever alone [25]. 
Participants of this study expressed different incentives (symptoms, duration and severity of fever) 
to perceive a condition as severe, prompting them to visit a doctor. A suspected dengue infection was 
perceived as a more serious event than ‘fever’, leading to immediate healthcare searching, preferably on 
day one of onset of symptoms. Several determinants for choosing to directly visit a doctor instead of first 
treating at home were identified in this population. These results are described in an earlier published 
study, providing a basis to understand the HC preferences of the study population [25].
An important reason to attend an ambulatorio was the trust in the staff and the medical care received 
at these instances. However, barriers mentioned by the interviewees were the long waiting times to 
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be seen by a doctor and the shortage of medications and medical resources for treatment available in 
the ambulatorios. This obliged people to purchase these from pharmacies or street vendors. The same 
barriers were reported with regard to the main public hospital, based on experiences people had with the 
care received there. The Venezuelan Ministry of Health is in charge of the infrastructure and provision of 
medical equipment and supplies of both the traditional and parallel health systems. However, a decreased 
budget and consequently a shortage of medical supplies and equipment occurring in the traditional 
health system during the past decade has been stated by health professionals and Venezuelan health 
policy makers [12,17-19,26,27,32]. In 2007, the director of the “Coche Hospital” in Caracas, explained the 
following: ‘‘The funds we receive for 1 year of medicines does not cover our costs for three months, and 
the rest of the year we have to ask for loans and request help from the Ministry of Health’’. In the area 
covered by that hospital, 90% of the budget for HCs and hospitals was spent paying the salaries of medical 
staff, which left little to spend on medical supplies and infrastructure [17].   
Interestingly, shortages of drugs and medical supplies in the MBAI and CDI were reported less prominently. 
A possible explanation for this is that, in contrast to the financing of the traditional public health system, 
the state budget and distribution of supplies of the parallel public health system has been warranted by 
its linkage to the revenue of the national oil industry [14,15]. Still, in our study, the better availability of 
medical material and medicines was not an incentive to primarily choose to seek medical help at the 
parallel health system. The lower reported intended attendance to the parallel system may be caused by 
the belief that it is meant for the poor [13], while our study population originated not only from the poor 
class, but also from the low-middle and middle classes. We could not entirely derive this explanation from 
our data, however, preferential targeting of health services to disadvantaged groups has been previously 
described [33].
In our study, perceptions about the severity of the disease seemed to play a role as well. Some of the 
interviewed individuals explained that they only visit the parallel system for ‘small pains’, but not to be 
treated for a suspected dengue infection. Another important barrier to attend a parallel system HC was the 
presence of Cuban medical staff who were not trusted by many of our interviewees. Indeed, confidence 
in health care worker has been identified as an important determinant for uptake of healthcare, e.g. in 
the case of malaria [34,35].Contrary to our results, another study from a community around Caracas, 
Venezuela’s capital city, reported a high confidence in Cuban doctors based on the egalitarian physician- 
patient relationship they had achieved [13]. In the literature, differing opinions about the quality of the 
academic preparation and care given by Cuban doctors and Venezuelan “community medical doctors” 
trained at a short parallel medical program in Venezuela are expressed [15, 17, 26]. Some say Cuban 
health professionals have greater experience in primary care [15],  others argue that only 10% of the 
Cuban doctors working in Venezuela are properly qualified to practice medicine while the rest are trained 
as technicians [17]. Based on the literature and on our study, different reasons for the distrust of the 
Venezuelan parallel health system by a number of individuals may be considered: a)political reasons, b)
perceptions that Cuban doctors are not adequately trained [17] , c)preferential targeting of health services 
to disadvantaged groups [33]. However it is important to state that no grounded conclusions can be drawn 
about these opinions regarding Cuban doctors working in Venezuela. Consequently, we recommend to put 
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effort in investigating underlying believes leading to the decrease in access to care for those distrusting the 
parallel system.
A previous study in Venezuela had associated a lower socio-economic status and living further away from 
a health centre to delays in healthcare seeking [36]. In our study, those with a higher education were 
independently associated with the intention to visit the private health system. No univariate association 
was observed with monthly income and the socio-economic-score based on possessions, however, since 
education is an important socio-economic marker, we consider our results to be in line with several studies 
that describe that the private HCs are less accessible for the poorer population in Venezuela unless they 
have a health insurance [16,33,37]. In our study, the private practices and private hospitals which cover the 
whole private system, were generally believed to provide the highest quality of care in case of a dengue 
infection. Nevertheless, due to the lack of a health insurance and a low budget, the vast majority did not 
consider visiting a private HC. This left the public hospital as the only option for obtaining tertiary care for 
many participants despite the problems described above. Financial barriers to obtain medical treatment 
are also likely to reduce uptake of proper care in other health conditions, such as malaria [38,39], HIV/AIDS 
[40,41], antenatal care [42,43] and acute and chronic cardiovascular disease [44,45].
In this study, a quantitative research design was complemented with a qualitative part. The qualitative data 
explored the reasons and barriers behind the observed pathways to care identified using a quantitative 
approach. This mix of study methods allowed us to obtain a deeper understanding of the HC choices 
in the case of a fever or dengue infection at community level in individuals exposed to hyperendemic 
dengue transmission. Another strength of this study is that it was carried out in a well-characterised study 
population [24], and  individuals were interviewed at home providing a safe and confident environment. 
Because of the community-based nature of the study, we were able to capture a broad scale of opinions 
including those from individuals who may never visit a HC. A weakness of this study is that primarily 
women around the age of 40 were included and that the research was conducted mainly in one of the 
three neighbourhoods restricting the originally calculated sample size. A smaller sample size may have 
decreased the power of the quantitative study and should be taken into account. Given the smaller sample 
size, the sample error of the proportion to be estimated was 8.3% (ambulatorio attendance for fever) - 
8.6% (ambulatorio attendance for dengue), instead of the 5% we estimated initially. On the other hand we 
believe that sample bias is small as the population of Candelaria is composed of different socio-economic 
strata which are representative of the general urban population of Maracay and of Venezuela. We expect 
that opinions expressed in this study are also representative for a significant part of the poor, low-middle 
and middle class living in the urban areas of Venezuela. However, research in other Venezuelan regions and 
settings should be performed to confirm this. For logistic and ethical reasons, recording the conversations 
was not possible, therefore we had to write and summarize patient’s opinions. This mode of data-collection 
may be less accurate and provide less in-depth information than we could have obtained when recording 
and could be considered as a weakness of this study.  On the other hand, recording conversations could 




Access to care in Venezuela is currently a complex situation where individuals need to juggle between the 
different available public and private HCs in order to obtain proper and timely care and medical supplies. 
The preference of most people to visit the traditional system in case of fever and dengue points out the 
importance of improving and maintaining the quality of healthcare given at these institutions. The parallel 
system was created out of the vision that there was a need for healthcare transformation [15]. In our study, 
these HCs did not face the same problems described for the traditional HCs. Still people often did not 
intend to visit the parallel HCs for various reasons. Our study shows that higher educated individuals were 
more likely to attend the better quality-perceived healthcare (private healthcare) suggesting an inequity in 
access to care. Barriers in access to health care included long waiting times, crowdedness, distrust in staff/
diagnoses/treatment of doctors having the Cuban nationality and high costs. Moreover, many participants 
pointed out the lack of medical material in the free traditional healthcare system, which forced them to 
buy these materials in pharmacies. Considering this, possibilities for treatment may be limited for those 
who cannot buy these materials. To decrease inequality in access to health care, policymakers in Venezuela 
should focus on improving health system performance in terms of acceptability of care (provided by the 
parallel health system) and availability of care (presence of (free) medication, reduction of waiting times 
and crowdedness). A study on out-of-pocket expenses in case of dengue could give broader insights into 
the financial burden of dengue in Venezuela. Additional research covering more diseases and carried out 
in other Venezuelan urban areas could broaden the insights into the access to care in Venezuela.
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Additional file 1 table: Overview of the characteristics of the different health centres in Venezuela.
124 hours / 7 days a week. 2Blood samples are taken on day 5 after symptoms onset and sent to the regional epidemiological laboratory 
for diagnosis (serology). 3More recently (after the period of our study), venezuelan students have been trained as MIC.
 
Overview of the characteristics of the different health centres in Venezuela. 
                                                         Public health system     Public health system Private health system 
 Traditional health system Parallel health system   
 Primary/secondary HC Tertiary HC Primary HC Primary HC Primary HC Tertiary HC 
 Ambulatorio Hospital MBAI CDI Private practice Private hospital 
Short overview of services offered 
Emergency adult/paediatric, general medicine, 
obstetric/gynecology, healthy child control. 
Secondary HC offer the above plus most specialities: 
internal medicine, pediatrics, obstetric/gynecology, 
pneumonology, gastroenterology, odontology, 
pharmacy. 
Emergency adult/paediatric and all 
specialities. Laboratory and radiological 
facilities and other diagnostic procedures 
depending on the speciality. 
General practitioner, 
emergency. 
Emergency, general practitioners 
(MIC), some specialities, 
laboratory and other diagnostic 
facilities depending on the HC. 
 
Comprehensive and more 
dedicated/personalised 
attention, faster in most of 
the cases (no delays nor 
waiting times), doctor’s 
surgeries are less crowded. 
Emergency adult/paediatric and all 
specialities. 
Advanced laboratory and 
radiological/imaging  facilities and other 
diagnostic procedures depending on the 
speciality. 
Number of physicians and 
supporting staff 
Varies depending on the size of the HC:  
- Physicians: 2 to 36  
- Supporting staff: 4 to 60 
450 
physicians: 1-3  
Supporting staff: 1-6 
physicians: 8-12  
Supporting staff: 10-20 
Usually one doctor and one 
nurse or an assistant.  
Variable, depending on the size of the 
hospital. 
Specialisations of physicians 
Primary HC: General practitioners, one or two senior 
practitioners. 
Secondary HC: General practitioners, several senior 
specialised physicians depending on HC size. 
All specialties and sub-specialities. 
So called ‘Integral Community 
doctors’(médicos integrales 
comunitarios (MIC)l), from the 
Cuban delegation3. 
General practitioners (MIC), some 
specialities. 
All specialities except 
emergency and delivery. 
All specialties and sub-specialities. 
Drop-in clinic or permanent staff  
(that follows patient longitudinally) 
Intern young doctors rotate yearly. Senior physicians 
(specialized) are permanent staff. 
Intern young doctors rotate yearly. 
Resident and senior physicians 
(specialized) are permanent staff. 
Drop-in clinic. Probably both. 
Permanent staff, patients are 
followed longitudinally and 
doctors are available 24/71 
via their mobile phones. 
Mostly permanent staff. Specialised 
physicians also have their private practices 
in these hospitals, so that  patients are 
followed longitudinally and doctors are 
available 24/71 via their mobile phones. 
Opening hours 24/71 24/71 6 hours per day 24/71 (in most of the cases) 6 – 8 hours per day 24/71 
Availability of hospitalisation Yes, short hospitalisation (<72h): between 2 – 12 beds. Yes No Yes, between 6 – 10 beds No 
Yes, number of beds varies depending on 
the size of the hospital (40-100 beds) 
Laboratory availability 
Yes, available in secondary HCs and in some primary 
HCs. 
Laboratory of secondary HC are available 24/71. 
Yes, 24/71. No 
Yes, available for basic 
haematological tests (full blood 
count, biochemistry). 
No. If needed, patient is 
referred to private 
laboratory. 
Yes. 24/71  
Emergency facilities Yes Yes Some Yes No Yes 
Dengue diagnostics Physicians follow national guidelines2. Physicians follow national guidelines2. Based on clinical parameters. 
CDIs use rapid serological 
diagnostic tests made in Cuba. 
Results are not reported to the 
Regional Ministry of Health. 
Physicians follow national 
guidelines2 or refer the 
patient to a private 
laboratory with molecular or 
serological dengue diagnosis. 
Yes, molecular or serological. 
Other diagnostics 
Mainly in secondary HC (full blood count, 
biochemistry). 
yes none 
Some CDI may have more advance 
diagnostics. 
If needed, patient is referred 
to private laboratory. 
Yes, advanced diagnostic facilities. 
Imaging diagnostics Only in secondary HC. yes none yes 
If needed, patient is referred 
to private facilities. 
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Dengue, a viral mosquito-borne disease currently aff ects over 2.5 billion people living in endemic areas 
worldwide. In vector control, social mobilisati on and community behavioural changes are of crucial 
importance. Here, we identi fi ed the factors infl uencing community dengue preventi ve practi ces in a high 
transmission urban area in Venezuela. Between September 2013 and February 2014, a cross-secti onal 
study at household level was carried out in Maracay city, Venezuela. A pre-coded questi onnaire was used 
to obtain informati on on people’s knowledge, atti  tudes and use of preventi ve practi ces in relati on to 
dengue. Concomitantly, entomological data was collected from households. In 80% of the 105 included 
households, 1 to 5 preventi ve practi ces (e.g. repellents, insecti cides) against mosquito bites were used. 
However, 57% of the examined houses had potenti al Aedes breeding sites indoors and/or outdoors, most of 
which positi ve for Aedes spp. larvae/pupae. Preventi ve practi ces were  associated with a previous dengue 
infecti on (p=0.030) and a bett er knowledge on dengue symptoms and transmission route (p=0.020). In 
turn, knowledge was associated with feeling at risk (p<0.001), a previous dengue infecti on (p=0.010) 
and reported exposure to informati on sources of dengue (p=0.011). Even though the knowledge level 
of the community over transmission ways was high, and most of the individuals took measures to avoid 
mosquito bites, potenti al mosquito breeding sites were present in almost two thirds of the examined 
properti es. Health promoti on acti viti es in Venezuela should aim at raising awareness at community level 





Dengue is a viral vector-borne disease spread by the day-biting mosquitos Aedes aegypti and Ae. albopictus. 
The global number of people infected in 2010 was estimated to be 390 million, of which around 14% 
occurred in the Americas [1]. Venezuela is one of the countries with the highest burden of dengue in the 
region [2], where severe disease and recurrent epidemics on a background of perennial transmission are a 
major public health problem [3]. Maracay city has become one of the most important endemic urban areas 
of the country with the co-circulation of all four dengue serotypes [4].
No vaccine or specific antiviral treatment against dengue is widely available yet. Therefore, the most 
effective way to prevent and control the spread of dengue continues to be the reduction or elimination of 
human-vector contact [5,6]. Effective vector control strategies include community-based larvae control, 
adult mosquito management and the use of personal protection [7]. Community-based larvae control 
consists of environmental management, i.e. alterations in the environment to minimize vector breeding, 
especially in close proximity with humans, and source reduction by application of chemical larvicides in 
possible breeding containers before the dengue season or during outbreaks in densely populated areas 
[6]. Adult mosquito management currently comprises chemical insecticide spraying in areas where dengue 
cases are reported, to reduce transmission by lowering the adult vector population [8]. In addition, the 
spread of the disease can be reduced by using personal protection against mosquito bites, for example 
insect repellents or adult reduction devices, such as mosquito repelling vaporizing tablets. Individual and 
community contributions to dengue control are of importance for the success of dengue control programs; 
studies show that community involvement in environmental management can reduce the Aedes larval 
infestation indices in domestic areas [9,10].
However important, social mobilization in dengue control is often difficult to achieve. It is challenging to 
motivate people to prioritize dengue among other acute health and environmental concerns, especially 
during inter-epidemic periods or when vector breeding continues unabated in neighboring households 
or other sites such as informal dumps [6,11]. By revealing characteristics of the community knowledge, 
attitude and practices (KAP), a KAP study can offer valuable information for the development of health 
promotion approaches, and suggest intervention strategies that are specific to the socio-cultural context 
in which they have to take place [12].
Studies on KAP, mosquito breeding sites and possible associations between these components related 
to dengue are not abundant in the Americas. Though most people in Venezuela are aware of dengue 
as a disease, preventive measures to avoid mosquito breeding sites are not always taken [13]. To our 
knowledge, there are no previous studies published on KAP and mosquito breeding sites for dengue in 
Venezuela. 
In order to improve dengue control of communities exposed to endemic dengue transmission, we aimed to 
(1) describe Knowledge, Attitudes and Practices (KAP) concerning dengue, and (2) investigate determinants 





The study was conducted in three neighborhoods in Maracay city, Aragua state, Venezuela: Candelaria, 
Caña de Azúcar and Cooperativa. These neighborhoods were selected owing to their high dengue 
incidences. With a population of 1,300,000  [14], Maracay is one of the largest cities in Venezuela where 
dengue is hyper-endemic [4,15].
Study design
A cross-sectional study was carried out to gather data on KAP related to dengue at community level. This 
study was performed within one of the annual surveys (September 2013 to February 2014) of a running 
community-based prospective cohort study. A detailed description of the study set up was published earlier 
[16]. Briefly, in August 2010 a total of 2014 individuals aged 5-30 years in 840 randomly selected households 
within the study sites were enrolled after written informed consent through house-to-house visits [16]. 
A subsample of 260 households of the cohort-study was randomly selected for the cross-sectional KAP 
survey that is described here. However, individuals from 105 households were finally interviewed because 
violence during anti-governmental protests in February and March 2014 in the country [17-19] precluded 
the enrolment of further individuals.
Study population
In each household, one individual was interviewed. The intention was to interview an equal number of 
adults and parents or guardians of children (<18 years old) who were already participating in the cohort 
study, following the selection criteria described elsewhere [20]. Briefly, this selection was made to 
investigate health seeking behavior (HSB) of dengue and fever, comparing HSB of parents or guardians 
referring to their children and HSB of adults referring to themselves [20]. Adults (18 years and older) were 
randomly chosen from all present adults at the moment of visiting the selected households. 
Data collection
A structured individual questionnaire was developed containing pre-coded and open questions on socio-
demographic details, knowledge of dengue symptoms and transmission, and risk perception. Data on 
socio-economic variables and preventive practices were collected from a household questionnaire which 
was applied as part of the annual survey of the overarching cohort study. The questionnaires were prepared 
in English, translated to Spanish, pre-tested and adapted in a pilot study.  
Socio-demographic characteristics 
Data on socio-demographic characteristics included age, place of residence (neighborhood), educational 
level, occupation and religion.  
Awareness of dengue and personal experience
To assess the level of familiarity with dengue, individuals were asked if they had heard about dengue 
and from which source. In addition, people were asked if they or, if applicable, their child had a dengue 
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infection in the past. 
Knowledge
To measure the general dengue knowledge of the community, people were asked about dengue 
transmission routes and symptoms in open questions. Answers were used to calculate a knowledge score, 
by adding the number of dengue symptoms that the individual correctly mentioned. Symptoms marked 
as correct included fever, headache, eye pain, body pain, red face/rash, muscle pain, abdominal pain, 
vomiting, diarrhea, malaise, nausea, bleeding, itching, sore throat, dizziness and fainting. In addition, one 
point was added if the individual mentioned the correct transmission mode (‘the bite of a mosquito’ or 
similar utterances).
Attitude
We assessed the perceived severity of dengue in the community by asking people if they thought someone 
can die when infected with dengue. In addition, people were asked whether or not they felt at risk of 
acquiring dengue, and why. Questions about risk perception referred to a child when a parent/guardian 
was interviewed, and to the individual in question when it concerned the adult questionnaire.      
Preventive practices 
To gain insight in the use of personal protection against dengue in the community, people were presented 
with a list of possible mosquito-bite preventive practices at household level. Individuals were asked which 
of the following preventive measures were used in their household: door and window screens, mosquito 
nets, spraying of insecticides indoors, application of repelling creams or oils on the skin, mosquito 
repelling plants, mosquito repelling oils and herbal infusions. Additional preventive methods mentioned 
spontaneously by the interviewees were recorded under “other” and later classified accordingly. A score 
was developed by counting the number of reported preventive measures (Table 1) per household, assigning 
one point per measure mentioned.   
Larval survey
To obtain an estimate of the degree to which mosquito larvae control measures were taken at household 
level, we examined the indoor and outdoor areas of the residence for the presence of potential Aedes 
breeding sites. Samples of larvae and/or pupae were collected from every breeding site available (natural or 
artificial) in the household and were transported to the laboratory for further taxonomic identification.21-23
Data analysis
Information collected in the questionnaires was entered into a database using the Epi Info (Epi InfoTM, 
version 3.5.4) software. Data was checked for consistency and analyzed anonymously using SPSS (SPSS Inc., 
version 20.0, Chicago, Illinois). Differences in proportions were analyzed with Pearson’s Chi-squared test or 
Fisher’s exact test if appropriate. Continuous variables were analyzed using the Student’s t-test if data was 
normally distributed (in that case the mean and standard deviation (SD) were provided), otherwise using 
the Mann-Whitney U test accompanied with median and quartiles (Q1, median, Q3). Associations between 
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continuous variables were assessed using the Pearson correlation or the Spearman’s rank correlation 
coefficient. Socio-economic data was analyzed using principal component analysis [24,25] to obtain a 
relative measure of socio-economic status. Based on these data, individuals were divided into groups with 
a low, average and high socio-economic status [20]. Binary logistic regression analyses were performed to 
examine the effects of several variables on the ‘number of preventive practices’ and ‘presence (or not) of 
mosquito breeding sites’, respectively. Variables with an association of p<0.20 in the univariate analyses 
were included in the multivariate regression analyses. Variables were stepwise backward removed until 
only significant variables (selected using univariate analyses) remained. A dichotomized variable was used 
(cut-off point: median) when analyzing preventive practices in the binary logistic regression analyses.
Ethical statement
The study was approved by the Ethics Review Committee of the Biomedical Research Institute, Carabobo 
University (Aval Bioetico #CBIIB(UC)-014), Maracay, Venezuela; the Ethics, Bioethics and Biodiversity 
Committee (CEBioBio) of the National Foundation for Science, Technology and Innovation (FONACIT) 
of the Ministry of Science, Technology and Innovation, Caracas, Venezuela; and by the Regional Health 
authorities of Aragua State (CORPOSALUD Aragua). All participants signed a written informed consent at 




The adult-questionnaire was applied to 54 households, and the child questionnaire to 51 households. In 
addition, 92 socio-economic questionnaires were applied. The socio-demographic characteristics of the 
study population are fully described in a previous study [20]. Briefly, most of the respondents were women 
(n=91, 86.7%), and the median age was 36 years (IQR: 25 – 53 years). More than 80% of the people had 
a secondary school or higher level of education. Half of all respondents were housewives or domestic 
workers (n=52, 49.5%). Most individuals lived in the neighborhood Candelaria (n=72, 68.6%), followed by 
Caña de Azúcar (n=22, 21.0%) and Cooperativa (n=11, 10.5%). Seventy six socio-economic questionnaires 
provided information about the household’s monthly income resulting in a median of VEF 7500, with an 
IQR of VEF 5000-10000 (Minimum wages at the time of the study ranged between VEF 2703 - VEF 3270).
Preventive practices against mosquito bites
In 74 (81.3%) out of the 91 households where data on preventive practices was collected, people reported to 
employ at least one measure to avoid contact with mosquitos. Up to five preventive measures (median=1; 
IQR: 1-3) were reported per household (Table 1) and these are presented in Table 2. The most frequently 
mentioned preventive measure was the application of personal repellents followed by the use of spray 
insecticides within the house, the use of a fan, using mosquito nets and repellent tablets or insecticide 
coils.  Although almost 70% (n=62) of the households had an air conditioner (mainly in the sleeping rooms), 
only individuals from 6 households reported this as a preventive method against mosquito bites. Plants or 
other natural elements, such as plant or animal oils/herbal infusions, to repel mosquitoes, were reported 
to be used in eight (8.8 %) households.
Table 1. Number of preventive measures and number of mosquito breeding sites per household.
aHouseholds with information on preventive practices. bHouseholds searched for breeding sites.
Aedes mosquito breeding sites
Seventy-two households in Caña de Azucar and Candelaria were searched in- and outdoors for Ae. aegypti 
or Ae. albopictus breeding sites. In these households, up to five mosquito breeding sites were found 
(median: 1; IQR: 0-2) (Table 1). Breeding sites were identified in 41 (56.9%) of the households, and in 
almost all of these (n=39; 95.1%) at least one of the breeding sites was positive for Aedes spp. larvae or 
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 Mosquito breeding 
sitesb (n=72) 
 n (%)  n (%) 
0 17 (18.7)  31 (43.1) 
1 34 (37.4)  14 (19.4) 
2 16 (17.6)  14 (19.4) 
3 16 (17.6)  5 (6.9) 
4 4 (4.4)  7 (9.7) 
5 4 (4.4)  1 (1.4) 
 622 




pupae. Overall, there were 90 breeding sites found in the 72 households (Table 1). Most of these (n=78; 
86.7%) were found outdoors (garden, patios) while twelve (13.3%) were identified indoors. Sources of 
mosquito breeding sites found are listed in Figure 1. Almost all (93.3%) of the breeding sites were positive 
for Ae. aegypti or Ae. albopictus larvae and/or pupae. 
Table 2 Measures mentioned by individuals to avoid mosquito-man contact
aThe percentage corresponds to the number of households mentioning the use of the preventive measure. Since more than one 
answer was possible, the total does not add up to 100%.
bMosquito annihilation lamps; electric racquets; incense; close doors; ‘we lock ourselves in the house’. 
Figure 1. Sources for mosquito breeding sites found  
Proportion of breeding sites out of the total sample size (n=90). Other breeding sites included: discarded toilet; gutter; puddle, ponds.
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Table 2 Measures mentioned by individuals to avoid mosquito-man contact 625 
Measure (households: n=91) n           (%a) 
Repellents  44 (48.4) 
Insecticides 39 (42.9) 
Fan 11 (12.1) 
Mosquito nets 11 (12.1) 
Mosquito repellent tablets/coil 11 (12.1) 
Burning cardboard 7 (7.7) 
Air conditioning 6 (6.6) 
Door and window screens 5 (5.5) 
Repelling plants 5 (5.5) 
Herbal infusions/ Repelling oils 3 (3.3) 
Otherb 8 (8.8) 
 626 
a The percentage corresponds to the number of households mentioning the use of the 627 
preventive measure. Since more than one answer was possible, the total does not add up to 628 
100%. 629 
b Mosquito annihilation lamps; electric racquets; incense; close doors; ‘we lock ourselves in 630 




Community dengue knowledge and past dengue infection
Almost all people had heard of dengue (n=103, 98.1%), the reported information sources are listed in Table 
3. Participants mentioned up to six different sources of information (mean= 2.5; SD=1.1). More than 30% 
(n=33, 31.4%) referred that they or their child had had dengue in the past.  
Almost all respondents knew dengue is transmitted by the bite of a mosquito (n=100, 95.2%). Eight people 
(7.6%) responded that stagnant water was the source of dengue infections and one (1.0%) thought that 
dengue could be transmitted by kissing an infected person.  With respect to the knowledge of dengue 
symptoms, almost all individuals (97.1%, n= 102) referred to fever as a symptom of dengue. Symptoms 
mentioned by the interviewees are listed in Table 3. Participants mentioned up to eight different, correct 
dengue symptoms (mean: 3.9, SD: 1.7).  
People achieved a mean knowledge score of 4.8 (SD: 1.8) based on their responses to the questions about 
dengue symptoms and transmission routes. We explored the attitudes and socio-demographic factors 
influencing the knowledge score. Individuals professing a religion (Catholics and other Christians) had 
a higher mean knowledge score (mean=4.9; SD=1.7) than non-religious individuals (mean=2.7; SD=1.6; 
p=0.002). Income was negatively associated with knowledge. People with a lower monthly income (<VEF 
7000) had on average more knowledge of dengue symptoms and transmission than those with a higher 
income (mean =5.3 vs. 4.3, respectively; p=0.013). Feeling at risk of dengue was associated with knowledge 
(feeling at risk: n=73, mean knowledge score=5.2; SD 1.8 versus not feeling at risk: n=30, mean knowledge 
score=3.7; SD 1.4; p<0.001). People that reported a previous dengue infection had more knowledge about 
dengue (n=33, mean knowledge score=5.5; SD=1.8) than people without this experience (n=69, mean 
knowledge score=4.5; SD=1.7; p=0.010). The dengue knowledge score was in turn found to be correlated 
with the reported number of different dengue information sources (Pearson correlation: r=0.247, p=0.011). 
The other KAP and socio-demographic characteristics: sex, age, education, occupation, neighborhood and 
socio-economic status, were not significantly associated with dengue knowledge. 
Community perceptions of risk and severity  
Almost all participants (n=102; 98.1%) thought a dengue infection is potentially deadly and more than 70% 
(70.9; n=73) of the participants thought they themselves were, or that their child was, at risk of contracting 
dengue. The reasons for people (not) to feel at risk of contracting dengue are listed in Table 4. Interestingly, 
for seven out of twelve people (58.3%) who stated not to feel at risk of dengue because there were no 
breeding sites in and around their households, one or more breeding sites were found.    
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Table 3. Dengue information sources and knowledge on dengue symptoms
aThe percentage corresponds to the number of individuals that mentioned each dengue information source/symptom. Because most 
individuals mentioned more than one dengue information source/symptom, the total does not add up to 100%.
bOther: work, mass media, pharmacy, (personal) experience
cDengue warning symptoms for developing severe dengue. 
dNot symptoms of dengue (not included in knowledge score)
eLow platelets, red eyes, flu, heavy eyes, weight loss (all not included in knowledge score)
Table 4. Reasons for (not) feeling at risk for a dengue infection
aProportions within the population who felt (n=73)/ did not feel (n=30) at risk of dengue.
b‘there are mosquitoes at school’, ‘presence of dark places’, ‘the necessary measures to fight dengue are not being taken’, ‘children are 
not bothered by mosquitoes’, ‘dengue is in the environment’ 
c‘I am immune to dengue’, ‘I scare mosquitoes’, ‘There are no mountains near’ and ‘I don’t have a garden’
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Table 2 Measures mentioned by individuals to avoid mosquito-man contact 625 
Measure (households: n=91) n           (%a) 
Repellents  44 (48.4) 
Insecticides 39 (42.9) 
Fan 11 (12.1) 
Mosquito nets 11 (12.1) 
Mosquito repellent tablets/coil 11 (12.1) 
Burning cardboard 7 (7.7) 
Air conditioning 6 (6.6) 
Door and window screens 5 (5.5) 
Repelling plants 5 (5.5) 
Herbal infusions/ Repelling oils 3 (3.3) 
Otherb 8 (8.8) 
 626 
Table 3. Dengue information sources and knowledge on dengue symptoms 627 
Responses on question: Where did you hear about dengue? (n=105) 
 n  (%a)  n (%a) 
TV 59 (56.2) Radio 11 (10.5) 
Health center 46 (43.8) Dengue project 5 (4.8) 
Friends/family/neighbors 35 (33.3) Leaflets 5 (4.8) 
School/University 34 (32.4) Internet 4 (3.8) 
Newspaper 32 (30.5) Otherb 7 (6.7) 
Campaigns from the regional 
Ministry of Health 
29 (27.6)    
Responses on question:  What are the symptoms of dengue?  (n=105) 
 n (%a)  n (%a) 
Fever 102 (97.1) Nausea 7 (6.7) 
Headache 60 (57.1) Abdominal painc 7 (6.7) 
Malaise 41 (39.0) Sneezing/ coughingd 6 (5.7) 
Muscle pain 36 (34.3) Sore throat 3 (2.9) 
Red face / rash  35 (33.3) Running nosed 3 (2.9) 
Vomitingc 31 (29.5) Itching 3 (2.9) 
Body pain 24 (22.9) Dizziness 2 (1.9) 
Bleedingc 19 (18.1) Fainting 1 (1.0) 
Diarrhea 19 (18.1) Othere 6 (5.7) 
Eye pain 13 (12.4)    
 628 
a The percentage corresponds to the number of individuals that mentioned each dengue 629 
information source/symptom. Because most individuals mentioned more than one dengue 630 
information source/symptom, the total does not add up to 100%. 631 
ᵇ Other: work, mass media, pharmacy, (personal) experience 632 
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Table 4. Reasons for (not) feeling at risk for a dengue infection 637 
 638 
a P oportions within the populat o  who felt (n=73)/ did not feel (n=30) at risk of dengue. 639 
b ‘there are mosquitoes at school’, ‘presence of dark places’, ‘the necessary measures to fight 640 
dengue are not being taken’, ‘children are not bothered by mosquitoes’, ‘dengue is in the 641 
environment’  642 
c ‘I am immune to dengue’, ‘I scare mosquitoes’, ‘There are no mountains near’ and ‘I don’t 643 
have a garden’ 644 
645 
Reasons for feeling at risk Total n=73 Reasons for not feeling at risk Total n=30 
 n (%a)  n  (%a) 
Mosquitoes in the household 46 (63.0) No (uncovered/stagnant) water around 10 (33.3) 
Presence of stagnant/stored water 27 (37.0) We protect ourselves against mosquitoes 9 (30.0) 
Dengue cases in the vicinity 21 (28.8) No rubbish nearby 9 (30.0) 
Mountains/hills nearby 14 (19.2) No dengue cases nearby 7 (23.3) 
Rubbish nearby 14 (19.2) No mosquitoes in the household 6 (20.0) 
Rain 5 (6.8) No breeding sites around 6 (20.0) 
Canal/River nearby 5 (6.8) Otherc 4 (13.3) 
Otherb 15 (20.5)    
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Factors related to preventi ve practi ces and presence of mosquito 
breeding sites
Preventi ve measures taken by people in the community to avoid mosquito-man contact, and presence of 
mosquito breeding sites at parti cipant premises were tested for their relati on with general characteristi cs, 
dengue risk percepti on and dengue knowledge of the study populati on using univariate analyses (Table 
5). A higher knowledge score (p=0.020) and a previous dengue infecti on (p=0.030) were associated with 
preventi ve practi ces (Table 5). Because the variable of ‘preventi ve practi ces’ was not suitable for a linear 
logisti c regression – the residuals did not show a normal distributi on – this variable was dichotomized 
based on the median. The individuals performing a lower number of preventi ve practi ces (0 or 1 preventi ve 
practi ces; n=51) were compared with the individuals performing a higher number of preventi ve practi ces 
(2 or more; n=40). The fi nal model of the binary logisti c regression of the preventi ve practi ces showed no 
signifi cant associati ons with the knowledge score (OR=1.17; 95%CI: 0.91-1.50; p=0.229) or with a previous 
dengue infecti on (OR=1.83; 95%CI: 0.72-4.70; p=0.207). No variables were (independently) associated with 
the presence of mosquito breeding sites. The signifi cant results of the univariate analyses of determinants 
for knowledge and preventi ve practi ces were visualized in a KAP-framework in Figure 2.
Figure 2. Factors related to knowledge and preventi ve practi ces
This model was draft ed based on the KAP framework. Associati ons with P ≤ 0.05 are displayed. All relati ons are positi ve relati ons, 
based on univariate analyses. If an arrow has two arrowheads, we assumed that causality could go either way.
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Table 5. Univariate analyses of preventive practices and presence of mosquito breeding sites
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Table 5. Univariate analyses of preventive practices and presence of mosquito breeding sites 646 
 Number of preventive practices takena  
Presence of mosquito 
breeding sitese 
   No Yes 
n Quartiles Mean (sd)  n (%) n (%) 
Age         
18-30 35 1-1-3 1.60 (1.26)  9 (30.0) 14 (34.1) 
31-50 29 1-1-2.5 1.72 (1.22)  9 (30.0) 16 (39.0) 
>50 25 0-1-3 1.60 (1.58)  12 (40.0) 11 (26.8) 
p-value 0.787b  0.492f 
Sex         
Females 79 1-1-3 1.68 (1.37)  25 (80.6) 36 (87.8) 
Males 12 1-1-2 1.42 (1.00)  6 (19.4) 5 (12.2) 
p-value 0.697c  0.513g 
Place of residence         
Candelaria 60 1-1-3 1.68 (1.38)  22 (71.0) 31 (75.6) 
Cooperativa 11 1-1-2 1.27 (1.01)  0 (0.0) 0 (0.0) 
Caña de Azúcar 20 1-2-3 1.75 (1.33)  9 (29.0) 10 (24.4) 
p-value 0.631b  0.658f 
Education         
Illiterate/ pre or primary schooli 14 0-1-2 1.36 (1.50)  6 (20.0) 8 (19.5) 
Secondary school 49 1-1-2.5 1.67 (1.28)  14 (46.7) 17 (41.5) 
University/university polytechnic 27 1-1-3 1.81 (1.33)  10 (33.3) 16 (19.0) 
p-value 0.437b  0.877f 
Occupation         
Student 14 0.75-1-2.25 1.57 (1.40)  5 (16.7) 4 (9.8) 
Labour: Housewife/Domestic-/manual worker 48 1-1-3 1.77 (1.43)  17 (56.7) 19 (46.3) 
Non-labour: Merchant/Employee/Office 
worker/Professional/University staff 28 1-1-2 1.54 (1.10)  8 (26.7) 18 (43.9) 
p-value 0.848b  0.333g 
Religion         
No religion 5 0.5-2-2.5 1.60 (1.14)  2 (6.7) 2 (5.0) 
Catholic 66 1-1-2.25 1.61 (1.39)  23 (76.7) 29 (72.5) 
Other Christian/Protestant/Evangelistj 16 1-2-3 1.88 (1.20)  5 (16.7) 9 (22.5) 
p-value 0.645b  0.813g 
Monthly income (VEF)k         
≤7000 VEF 38 1-2-3 1.89 (1.41)  9 (42.9) 17 (48.6) 
>7000 VEF 38 1-1-3 1.68 (1.38)  12 (57.1) 18 (51.4) 
p-value 0.501c  0.678f 
Socio-economic status         
Low 38 0.75-1-3 1.68 (1.45)  8 (36.4) 15 (40.5) 
Average 30 1-1-2.25 1.60 (1.40)  7 (31.8) 12 (32.4) 
High 22 1-1-3 1.68 (1.04)  7 (31.8) 10 (27.0) 
p-value 0.847b  0.917f 
Previous dengue infection         
No 61 1-1-2 1.41 (1.20)  22 (71.0) 29 (70.7) 
Yes 27 1-2-3 2.15 (1.51)  9 (29.0) 12 (29.3) 
p-value 0.030c  0.983f 
Risk perception         
Not feeling at risk  24 1-1-2 1.46 (1.14)  12 (38.7) 11 (27.5) 
Feeling at risk 65 1-1-3 1.68 (1.39)  19 (61.3) 29 (72.5) 
p-value 0.662c  0.317f 
Knowledge scorel      p-value 0.020d 




aStatistical tests were performed using a standardized variable. P-values were derived from (1) a comparison of mean preventive 
practices taken, using bKruskal-Wallis test or cMann-Whitney U test or (2) a correlation with the amount of preventive practices taken, 
using a dSpearman’s Rho; eP-values were derived from (1) the comparison of proportions/means between presence of mosquito 
breeding sites or not, using a  fChi-square test or gFisher’s exact test or hStudent’s t-test. iOne person was illiterate; jOne person was 





In an effort to elucidate the determinants of community behavior in relation to mosquito preventive 
practices, we performed a cross-sectional KAP survey in three neighborhoods in Maracay City, Aragua 
State, Venezuela. We found that although one or more preventive practices against mosquito bites 
were reported in 80% of the households, almost 60% of these had potential mosquito breeding sites in 
their premises with most of them positive for Aedes larvae or pupae. A higher knowledge on dengue 
transmission and symptoms and having had a previous dengue infection were associated with performing 
a higher number of preventive practices, based on univariate analyses.
The use of preventive measures was widespread in the community with four out of five households 
reporting at least one method to avoid contact with mosquitos. Repellents and insecticide sprays were 
the most popular among the different anti-mosquito methods reported, in agreement with a study  in 
Jamaica [26] and Puerto Rico [27]. Contrary to our results, studies in Sri Lanka [28], Pakistan [29] and 
Laos [30] found that mosquito nets were a popular method of protection against dengue. However, this 
may not always be effective since mosquito nets are used at night whereas Ae. aegypti  feeds at daytime 
[28]. Interestingly, not all preventive measures were recognized as such by the interviewees: even though 
almost every household had an air conditioning in one or more of the rooms, only a few stated that staying 
in the room with air conditioning was a way to avoid mosquito bites. 
Despite that interviewees seemed to put effort in protecting themselves against dengue, more than half 
of the examined households contained potential Aedes spp. breeding sites. This suggests that community 
awareness of the importance of identifying and eliminating breeding sites within their houses (indoors) 
and gardens/patios (outdoors) may not be high.  No associations were found between the number or 
presence of Aedes breeding sites in people’s households and any of the variables studied. Several previous 
studies found an association between presence of mosquito breeding sites and dengue knowledge [31,32], 
while others found no association, like the present study [33]. It should be noted that the studies differ in 
their ways of determining knowledge on dengue and the methods used to explore the relation between 
knowledge and practices [34].    
Several barriers for mosquito breeding site elimination have been identified among which are 
misconceptions about dengue, invisibility of dengue compared to other (chronic) diseases and the lack 
of acceptance of responsibility for dengue prevention [27]. Others found that a lack of self-efficacy, lack 
of perceived benefit and a low or unsure perceived susceptibility play a role as barriers for dengue larvae 
control [35]. Interviewees who stated to feel at risk because they are convinced that the mosquitos come 
from mountains, hills, rivers or canals nearby (see Table 4), might not see the benefit of removing breeding 
sites from their premises.  The same accounts for those expressing a low perceived susceptibility (‘I am 
immune to dengue’, ‘I scare mosquitos’, see Table 4). In Puerto Rico it was found that although most people 
recognized the need to eliminate breeding sites, some perceived it as a useless effort since mosquitos are 
always present. Instead they used repellents, insecticides and screens to protect themselves from dengue 
[27]. In our study, mosquito breeding sites were mainly found outdoors with the most frequent being small 
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plastic or metal containers and buckets or containers from 10-20L (see Figure 1). Living in a dwelling where 
water was stored, long-lasting deficits in public services such as frequent and prolonged interruptions in 
water supply and electricity, and irregular garbage collection have been associated with higher dengue 
incidence and persistence in Maracay [18,36]. Shortage of piped-water supply has worsened in recent years 
in Venezuela, prompting people to store water intradomiciliary maintaining adequate breeding conditions 
for dengue vectors during the dry season and throughout the year [17,18,36,37]. The relationship between 
irregular water supply, water storage in the community and an increase in Ae. aegypti habitats has been 
described before [38-40].
Almost everyone had heard of dengue through on average two different sources. Television and information 
received at health centers were, next to word-of-mouth, the most frequently reported dengue information 
fonts, in agreement with a study in Laos [30]. Information received via television was also found to be the 
most prominent source in studies in Jamaica and Sri Lanka [28,41], suggesting this medium is well suited 
for informing communities about dengue. Media coverage is important to inform the community about 
dengue prevention. In a focus group study on dengue in Puerto Rico, women defined the concept of an 
“important problem” as a situation that is presented in the newspapers and on television news programs. 
Limited presence in the media might cause people to minimize the importance of the disease and its 
prevention [27].
With regard to the individual’s risk perception of the disease, almost everyone was aware of the potential 
lethality of a dengue infection and the majority (70%) of the people felt that they or their child were at 
risk of acquiring dengue. Apart from risk perception, we attempted to measure people’s general dengue 
knowledge by assessing both knowledge about dengue transmission as well as dengue symptoms. The 
results point out that the interviewees had an average knowledge about dengue symptoms but a good 
understanding about its transmission route. Almost everyone knew dengue is transmitted by mosquitos. 
A few people additionally mentioned that dengue is transmitted by stagnant water however, it is likely 
that in general this was meant as a source of mosquitoes rather than the actual source of infection. The 
good understanding about dengue transmission and the potential risk of infection originated by breeding 
sites is also reflected in the reasons people gave for (not) feeling at risk, such as the alleged absence or 
presence of uncovered stored water in the vicinity. As for the symptoms of dengue, people were able to 
name on average four correct symptoms and almost everyone mentioned the most important symptom 
of dengue, which is fever. Similar levels of dengue knowledge were found in Costa Rica and Cuba [34,42]. 
However, studies in Jamaica found a much lower symptom knowledge level [41,42]. These differences and 
similarities might be explained by variations in dengue endemicity in other geographical areas and/or the 
nature and frequency of national dengue campaigns.
Thus, even though the majority of individuals had heard of dengue and felt at risk, and had a good knowledge 
of dengue transmission and of the risk factors involved, more than half of the examined households 
contained mosquito breeding sites.  This suggests that dengue prevention in Maracay, Venezuela is 
predominantly focused towards avoiding mosquito bites rather than elimination of their breeding sites. 
In our study, the number of preventive practices related to personal protection against mosquitos were 
associated with a higher level of dengue knowledge, suggesting that a gain in knowledge might lead to 
changing practices. Similar results were found in Laos [30] and Puerto Rico [43], but not in Thailand [32].
85
4
Preventive practices were also associated with a previous dengue infection. Concomitantly, we found a 
positive relation between a past dengue episode and dengue knowledge (Figure 2). Other studies provide 
possible explanations for these interrelations. Firstly, people with a previous dengue episode might 
be more inclined towards seeking information about the disease and its prevention, as was suggested 
in a study in Pakistan [44]. Secondly, in Costa Rica people with a previous dengue infection perceived 
preventive practices as more important [42]. In the same study, interviewees considered that education 
and having had a previous dengue infection were the most effective ways to convince others to perform 
more preventive practices [42].  
In our study, we found no association between dengue risk perception and the number of preventive 
practices reported, contrary to a study in Cuba [34]. The positive relationship between knowledge about 
dengue and risk perception was previously described in Cuba too [34]. In Venezuela, there is a high 
awareness about dengue given the current perennial transmission and the co-circulation of the four dengue 
serotypes, which increases the incidence of severe disease [4]. Notwithstanding, people tend to expect 
the Ministry of Health and the government to take actions with respect to the elimination of mosquito 
breeding sites and protective measures against dengue such as insecticide fogging of the community [45]. 
Similar attitudes are reported in other countries such as Cuba [46], Yemen [47], Curaçao [48], Pakistan [29] 
and Puerto Rico [27]. 
Due to anti-governmental protests in early 2014 in Venezuela [17-19], we were not able to carry out all the 
260 intended interviews, resulting in a smaller sample size of 105. This reduced the possibility of detecting 
associations that are small or moderate in magnitude. The variable measuring preventive practices was 
not suitable for a linear logistic regression. We therefore decided to perform a binary regression with 
a dichotomized variable. This probably reduced the statistical power and could be the reason for not 
finding independent significant relations in the multivariate analyses. Furthermore, the interviewed 
individuals were mainly women which may have implications for the generalizability of our results to the 
whole population in Maracay. However, it is important here to note that in Venezuela mainly women take 
the responsibility for running the household or are actually the household heads, therefore, we assume 
that they are the main decision-makers with regard to dengue prevention and health care in general. We 
therefore believe that the results of this study are representative of the population of Maracay city, and 
to a lesser extent also of other urban areas of Venezuela. A strength of the study was that the interviews 
were conducted in people’s own homes, providing a safe and familiar environment. Due to the overarching 
cohort study, there was a large amount of data available from the sample used in this particular study, 
which was used to interpret the results. Therefore we believe that our study offers valuable insights in the 
knowledge, attitude and practices regarding dengue in this community. 
Clarifying determinants of dengue related practices provides input for developing effective community 
mobilization and communication strategies to promote behavioral change as part of routine vector control 
programming [49]. Further research has to identify communities’ knowledge on the vector and prevention 
of dengue, and how this knowledge is put into practice. In addition, possible barriers for elimination of 
potential mosquito breeding sites in this community should be identified. This would be valuable in the 
process of designing evidence-based programs to achieve community involvement in the combat against 
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5 AbstractBackgroundAs the arboviral diseases dengue, chikungunya and Zika emerge in the Americas, so does the need for sustainable vector control policies. To successfully achieve mosquito control, joint eff orts of both commu-niti es and governments are essenti al. This study investi gates this important, but by-and-large neglected topic. MethodsIn June and July 2015, a cross-secti onal mixed methods study applying a survey questi onnaire (response rate of 82.5%; n = 339), in-depth interviews (n = 20) and focus group discussions (n = 7; 50 parti cipants) 
was performed in Curaçao. The study was designed based on an integrated theoreti cal framework of the 
Health Belief Model and the Theory of Planned Behaviour.
Results
 Parti cipants showed a good knowledge of, and a high-level performance of mosquito breeding site 
control (MBSC) practi ces. Personal protecti on against mosquitoes (e.g. topical repellents) was perceived 
as relati vely less eff ecti ve thus practi ced to lower extent compared to MBSC practi ces (i.e. larval source 
management). A lower intenti on to perform MBSC was independently associated with: (i) sati sfacti on on 
governmental MBSC (P = 0.012); (ii) barriers to perform MBSC practi ces, i.e. ‘Government doesn’t control 
other breeding sites’ (P = 0.005), ‘Don’t know how to control breeding sites’ (P = 0.041), and ‘a mosquito 
does not transmit dengue’ (P = 0.016), 3) atti  tudes towards MBSC (P = 0.001) and self-effi  cacy (person’s 
perceived ability to act)  to perform MBSC (P = 0.002). Mixed-methods evidence highlights three possible 
ways of improving community parti cipati on in MBSC. First, it highlights the need for ongoing media 
coverage, targeti ng (i) communiti es’ percepti ons on transmission routes of dengue and chikungunya, and 
(ii) presence of car ti res in yards. Secondly, it shows that promoti on of governmental acti viti es in MBSC 
can enhance MBSC of communiti es, if people develop a sense of responsibility to perform MBSC at their 
own properti es. Thirdly, this study describes the presence of key persons in communiti es, who could be 
engaged in mosquito control policies to improve MBSC in neighbourhoods.
 Conclusion
This study reveals gaps between policy and communiti es’ lived realiti es. These gaps might be overcome 
with the proposed interventi ons, resulti ng in a higher performance of MBSC in the community in Curaçao. 
Furthermore, this study shows how interdisciplinary mixed methods research can provide important, 




The arboviral diseases dengue, chikungunya and Zika impact seriously on public health in endemic 
countries. Untreated dengue can evolve into severe variants and eventually cause shock or death [1]. 
Chikungunya is known for its chronic, lingering, mainly musculoskeletal complaints with a major impact on 
quality of life [2-6]. Zika is ill-famed for congenital Zika syndrome [7], Guillain-Barré syndrome frequency 
[8], sexual transmissibility [9] and a rare but life-threatening immune-induced thrombocytopenia [10].
These viruses are transmitted by Aedes spp., mainly Ae. aegypti and Ae. albopictus, that flourish in large 
parts of Southeast Asia, the Americas and Africa, and beyond. In these regions, dengue outbreaks occur on 
a regular basis [11]. In Curaçao, where dengue is endemic for all four serotypes [12], chikungunya caused 
a major outbreak in 2014–2015 where approximately 50–75% of the population was infected [6]. High 
proportions of chikungunya infected individuals (64%) still suffered from the chronic effects of this disease 
[6]. In January 2016, the first locally transmitted Zika case in Curaçao was reported, heralding an epidemic 
[13].
Despite the high burden of disease that dengue, chikungunya and Zika cause, marketed vaccines are 
not available yet. Treatment strategies for all three diseases currently focus on symptom relief. Outdoor 
personal protection against mosquitoes relies mainly on topical repellents, but these face numerous 
practical concerns and are often not suitable for efficient long-term use [14, 15]. Meanwhile, the only 
effective way to reduce the burden of these diseases is prevention, which is mainly dependent on vector 
control [16, 17].
New methods of vector control using genetic manipulation of Ae. aegypti or endosymbiotic bacteria are 
promising for large-scale field application [18], but are not yet widely used for vector control. Efficacy of 
long-lasting insecticides applied to curtains or bed nets is poor [19], given the day-biting behaviour of the 
Aedes spp. Application of insecticides is challenged by growing resistance to temephos and pyrethroids 
of larvae and adult mosquitoes of the Ae. aegypti [20]. In the meantime, larval source control remains an 
effective mosquito control strategy [18, 21].
Identifying and eliminating standing pools of water on a large scale is impractical, expensive and not suitable 
for sustainable vector control, if conducted solely by government bodies [18]. Meanwhile, examples of 
mosquito control strategies with community involvement are successful in the short and long term [21-
24]. Consequently, complimentary efforts are needed from centralized (governmental) initiatives and the 
community to enhance effectiveness and sustainability of mosquito control methods [16, 21].
It remains challenging to achieve community participation in mosquito breeding site control (MBSC). 
Preventive health behaviours are driven by many social and psychological factors, which need to be 
addressed for forging and implementing of an effective health policy [25, 26]. As crucial as it is, community 
participation in vector control for dengue and chikungunya remains a neglected topic in scientific literature. 
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The scarcity of community-based, mixed-method approaches using theoretical frameworks in this field are 
illustrative for the detachment of theory and practice, recognized as a problem in global health research 
[27-30].
Several health behaviour theories have been developed to understand determinants of behaviour and 
to provide a basis for effective health policy [25]. Two important theories for preventive behaviour are 
the Health Belief Model (HBM) and the Theory of Planned Behaviour (TPB). Both theories are validated, 
and effectively applied in preventive behaviour interventions. Central concepts in the HBM are the 
‘perceived susceptibility’ and the ‘perceived severity’ of the condition, leading to the ‘perceived threat’ 
of the condition. The HBM proposes that the perceived threat of a condition, the perceived benefits and 
barriers of preventive behaviour, the self-efficacy (a person’s perceived ability to perform the behaviour) 
and the cues to action predict behaviour [30, 31] (Additional file 1: Figure S1). The Theory of Planned 
Behaviour (TPB) combines the attitude towards behaviour, subjective norms and perceived behavioural 
control, resulting in behavioural intentions and behaviour [32]. The HBM and TPB are theories with 
unique value for health-promotion interventions. Hence, a combination of theories may result in the most 
effective interventions [25, 33]. In this study, the HBM was applied to understand the risk perceptions of 
participants and by combining the TPB we were able to measure their perceived control and subjective 
norms that influence intentions for MBSC.
To our knowledge, no studies combining qualitative and quantitative research methods based on the TPB 
or HBM to investigate community participation in MBSC have been published to date. We address this 
knowledge gap here by (i) describing communities’ perceptions and practices of preventive behaviours in 
MBSC; (ii) analysing communities’ behavioural intentions to control mosquito breeding sites, based on the 
TPB and the HBM; and (iii) proposing targets for health interventions to enhance community participation 
in MBSC. The study aims were addressed using qualitative and quantitative approaches on sociological, 
psychological and epidemiological grounds. This study design enables an in-depth, comprehensive and 





In June and July 2015, a cross-sectional mixed method study using individual questionnaires, in-depth 
interviews (IDIs) and focus group discussions (FGDs) was performed to assess community participation in 
MBSC in Curaçao. The study was designed based on an integrated theoretical framework of the HBM and 
TPB (Additional file 1: Figure S1).
Study site
Curaçao is a Caribbean island in the southern Caribbean Sea located around 100 km off the Venezuelan 
coast. In October 2010, Curaçao became an autonomous country within the Kingdom of the Netherlands 
[34]. Curaçao has a surface area of 444 km2 and a population of approximately 150,000 inhabitants [35]. 
It is home to people from different ethnic backgrounds, with an Afro-Caribbean majority [36]. Most of 
the population resides in the capital Willemstad and its surroundings, located in the central-south part of 
the island (Fig. 1), the main economic area of the country [35]. Curaçao is a relatively wealthy Caribbean 
island with a GDP per capita of 22,600 dollar (2012). It has a semi-arid climate with a rainy season from 
September to January and a dry season from February to June [37, 38]. Generally, all people have access 
to potable tap water which means that water storage is limited. The central government of Curaçao is 
responsible for vector control in all neighbourhoods. Vector control activities are performed by the vector 
control unit of the government. Routine surveillance concern inspection and application of larvicides and 
fogging at sites at risk for mosquitoes. During epidemics these activities are intensified and focused on 
properties around suspected arboviral transmission.
Quantitative methods
Study population
Adult subjects with a serologically or clinically confirmed chikungunya infection (of which two were self-
diagnosed) during the 2014–2015 chikungunya epidemic were selected from a representative patient 
sample from twenty general practitioners across the country. Eligible individuals were invited and 
interviewed at their homes. 
Data collection
An individual questionnaire containing pre-coded questions was designed in Dutch. After a pilot-study, it was 
adapted and translated into Papiamentu, Spanish and English. Training was provided to interviewers prior 
to field mobilization. All interviewers were local, experienced interviewers working for the Central Bureau 
of Statistics of Curaçao and speaking all four mentioned languages. The questionnaire addressed socio-
demographic characteristics and chikungunya chronic disease persistence by applying the Curaçao Long-
term Chikungunya Sequelae Score (CLTCS Score), to measure perceived severity of long-term chikungunya 
disease. This score was calculated using four (5-point Likert-item) questions. More information on the 
methodology of the scale can be obtained from a recent publication [6]. 
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Fig. 1 Distribution of the study population among geozones of Curaçao, mean number of cases per 1,000 
inhabitants. 
Reproduced and modified from Jelte Elsinga et al. Long-term chikungunya sequelae in Curaçao: burden, determinants and a 
novel classification tool. The Journal of Infectious Diseases (2017) jix312, https://doi.org/10.1093/infdis/jix312. Published by 
Oxford University Press on behalf of the Infectious Diseases Society of America (IDSA), online at: https://academic.oup.com/jid/
article/3926074/Long-term-chikungunya-sequelae-in-Curacao-burden?searchresult=1. This material is covered by a Standard License 
only. For permissions please email:journals.permissions@oup.com. With permission of Oxford University Press
Constructs of the HBM and TPB
The behavioural target was defined as follows; ‘to check the house and yard for mosquito breeding sites 
every week and eliminate the breeding sites if necessary, in the coming rainy season’. This behavioural 
target was measured by assessing the Behavioural Intention to perform Mosquito Breeding Site Control 
(BIMBSC) (Additional file 2). The constructs of the HBM and TPB and their modifying variables (satisfaction 
on government’s mosquito control action, and knowledge on transmission route of chikungunya and 
dengue) were measured using multiple five-point Likert items or binary items which were analysed 
separately or merged into a Likert scale after analysis for internal consistency. Questions were adapted 




Participants indicated from which sources they received their information relating to chikungunya and 
dengue among the presented media and education sources. Two ‘interpersonal sources’ were also 
assessed: general practitioner and family/friends/neighbours. The subject’s perception of chikungunya 
and dengue transmission routes was tested by asking him/her to indicate all possible transmission routes 
of these diseases among the presented options.
Attitudes and behaviours towards personal protection and mosquito breeding 
site control
Data on perceptions and performance of personal protection against mosquitoes and MBSC practices was 
obtained. Participants rated proposed measures on their effectiveness and frequency of performance, 
applying a five-point Likert item.
Data analysis
SPSS Data Entry Station (SPSS Inc. 1996–2003, version 4.0.0) was used for quantitative data entry. Data 
were checked for consistency and analysed anonymously. Participants were divided by geozone [35] 
(neighbourhood), which were visualized in Fig. 1 using ArcGIS (ArcGIS Desktop: Release 10.3. Redlands, 
CA: Environmental Systems Research Institute). Associations between categorical variables were analysed 
using Chi-square test or Fisher’s exact test when appropriate. Continuous data was compared using a 
Mann Whitney U-test or a Student’s t-test. The concepts of the HBM and TPB were tested for their internal 
consistency using the Cronbach’s Alpha test. If the Cronbach’s Alpha was > 0.60, the items were combined 
resulting in a Likert scale representing the measure for the corresponding construct of the HBM/TPB. If 
Cronbach’s Alpha was < 0.60, items were analysed separately, or only the most representative item to 
measure the concept was used. The questions assigned to constructs of the HBM/TPB are presented in 
Additional file 2, and their Cronbach’s Alpha in Additional file 1: Table S1. All concepts of the HBM and 
TPB and the modifying variables were Z-transformed, and correlations were performed using Spearman’s 
rho. A binary logistic regression was performed to identify which concepts of the HBM and TPB were 
independently associated with the BIMBSC. Significance was determined at 5% level. Data were analysed 
using SPSS (SPSS Inc., version 22.0, Chicago, Illinois).
Qualitative study methods
Study population
Participants of the IDIs were adult laboratory-confirmed chikungunya patients. Concerning the FGDs, 
seven representative population groups (50 participants in total) of Curaçao were selected based on socio-
economic status (Additional file 1: Table S2): (i) residents born in the Netherlands; (ii) local youth; (iii) 
interviewers of the survey; (iv-vii) people from the neighbourhoods of Rooi Santu, Seru Fortuna, Souax and 
Koraalspecht. The focus group with the survey interviewers aimed at understanding underlying reasons 
for particular survey results. Participants for the qualitative methods were recruited via snowballing 





Qualitative research methods consisted of IDIs and FGDs based on the Grounded theory. The Grounded 
theory is an analytical strategy to make visible the steps in analyses, to move from data to theoretical 
explanations [40]. The HBM and the TPB were used to develop a theoretical framework, which is presented 
in Additional file 1: Figure S1. Interview guides were made based on this framework and adapted after pilot 
interviews. The FGDs consisted of 4–10 individuals with similar socio-economic backgrounds. The FGDs 
were applied in Dutch or Papiamentu, depending on participant(s) preferences. Interviews were recorded, 
translated, transcribed and analysed using codes and code families (see below).
Data analysis
Qualitative data were analysed using Atlas.ti (version 7.5.4). Data were examined using codes, which 
refer to an issue, topic, idea or opinion evident in the data [40]. We employed two cycles of inductive 
(emerging from data) and deductive (pre-defined from theory) coding. In the first cycle of analysis, 20 
codes were used when analysing the FGDs and IDIS. These codes were assigned to 9 code families, which 
were analysed in the second cycle of analysis. The code families represented perceptions towards: actions 
of the government in mosquito control, personal protection against mosquitoes, transmission route of 
chikungunya, information sources on chikungunya/dengue, community initiatives in mosquito control, 




General characteristics of the study population
A total of 411 individuals were invited in June and July 2015 to join this study, of which 339 participated 
(response rate: 82.5%). Table 1 summarizes the socio-demographic characteristics of the study population. 
The reasons for non-contacting (selected individuals who were not reached) and non-response were 
presented elsewhere [6]. Figure 1 shows the mean number of participants per 1,000 inhabitants per 
geozone. The BIMBSC score ranged from 3 (lowest intention) to 15 (highest intention) (Q1 = 12; median 
= 15; Q3 = 15). Of the participants, 63.0% (n = 208) scored the highest possible BIMBSC score. The 
characteristics of the participants of the IDIs and FGDs are presented in Additional file 1: Table S2.
Table 1: Socio-economic characteristics of the study population, stratified by behavioural intention 
score to perform mosquito control (BIMBSC score)
aP-value corresponds to the comparison of the proportions between the groups BIMBSC < 15 and BIMBSC = 15 (maximum score)
bTotal is 338, total < 15 group is 121
cTotal is 332, total < 15 group is 117, total 15 group is 207
dAntillian Guilder; 1 ANG = 0.56 USD
eMinimum wages 2015 = 1420 ANG (based on a 40 hour workweek). Nine participants missed data on their BIMBSC and were 
excluded from analysis
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Table 1 Socio-econo ic characteristics of the study population, stratified by behavioural 
intention score to perform mosquito control (BIMBSC score) 
 Total (n = 339) BIMBSC score < 
15 (n = 122) 
BIMBSC score 
= 15 (max.) (n 
= 208) 
P-valuea 
 n (%) n (%) n (%)  
Age     
18–40 years 75 (22.1) 32 (26.2) 43 (20.7)  
41–60 years 172 (50.7) 54 (44.3) 111 (53.4)  
> 60 years 92 (27.1) 36 (29.5) 54 (26.0) 0.263 
Sex     
Female 247 (72.9) 87 (71.3) 154 (74.0)  
Male 92 (27.1) 35 (28.7) 54 (26.0) 0.590 
Education     
Illiterate/primary school 80 (23.6) 25 (20.5) 49 (23.6)  
Secondary school 128 (37.8) 52 (42.6) 75 (36.1)  
Intermediate vocational school 84 (24.8) 30 (24.6) 53 (25.5)  
University (of applied sciences) 47 (13.9) 15 (12.3) 31 (14.9) 0.663 
Occupationb     
Unemployed/student/housewife/voluntary 63 (18.6) 17 (14.0) 44 (21.2)  
Paid job (domestic or manual) 144 (42.6) 53 (43.8) 87 (41.8)  
Paid job (not domestic nor manual) 67 (19.8) 25 (20.7) 40 (19.2)  
Retired 64 (18.9) 26 (21.5) 37 (17.8) 0.427 
Incomec     
0–999 ANGd,e 35 (10.5) 15 (12.8) 20 (9.7)  
1000–2499 ANG 136 (41.0) 50 (42.7) 82 (39.6)  
2500–4999 ANG 118 (35.5) 36 (30.8) 78 (37.7)  
> 5000 ANG 43 (13.0) 16 (13.7) 27 (13.0) 0.592 
Disease status chikungunya (CLTCS)     
Recovered 126 (37.2) 44 (36.1) 81 (38.9)  
Mildly affected 121 (35.7) 48 (39.3) 71 (34.1)  
Highly affected 92 (27.1) 30 (24.6) 56 (26.9) 0.635 
 
aP-value c rresponds to the comparison of the proportions between the groups BIMBSC < 15 
and BIMBSC = 15 (maximum score) 
bTotal is 338, total < 15 group is 121 
cTotal is 332, total < 15 group is 117, total 15 group is 207 
dAntillian Guilder; 1 ANG = 0.56 USD 
eMinimum wages 2015 = 1420 ANG (based on a 40 hour workweek). Nine participants missed 
data on their BIMBSC and were excluded from analysis 
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Communities’ attitudes and practices towards MBSC
Different possible measures preventing mosquitoes from breeding and preventing people from being 
bitten by mosquitoes were assessed for effectiveness and actual use. The answers were ordered by actual 
use and are presented in Figs. 2, 3; Additional file 1: Tables S3 and S4. Concerning the MBSC measures, 
people valued the measures preventing stagnant water as most effective. The majority stated that they 
exercised these measures ‘often’ (score = 4) or ‘always’ (score = 5). Those who possessed car tires indicated 
that they removed them infrequently (median: 2 ‘sometimes’), while in general this was perceived as a very 
effective precaution. Spraying insecticides, scrubbing away mosquito eggs and adding Abate [insecticidal 
granules (temephos)] to water containers were perceived as effective measures, but to a lesser extent. 
Consequently, they were also performed in a lower degree (Fig. 2, Additional file 1: Table S3).
Fig. 2 Measures taken by the community preventing mosquitoes from breeding in yards/houses 
(perceptions of effectiveness and actual use). 
The blue bar represents the actual taking of a precautionary measure (1, never; 2, sometimes; 3, regularly; 4, often; 5, always), whereas 
the red bar represents the perceived probability that the measure prevents mosquitoes from breeding (1, not at all; 2, does not; 3, 
maybe; 4, does; 5, definitely). The bottom edge shows the 25th percentile, the top edge shows the 75th percentile and separation of 
light and dark (blue or orange) shows the median. When the lighter part is not visible, the median and the 25th percentile coincide in 
the same value. When the darker part is not visible, the median and the 75th percentile coincide in the same value
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Fig. 3 Measures taken by the community preventing oneself from being bitten by mosquitoes (perceptions 
of effectiveness and actual use). 
The blue bar represents the actual taking of a precautionary measure (1, never; 2, sometimes; 3, regularly; 4, often; 5, always), 
whereas the red bar represents the perceived probability that the measure prevents the mosquitoes from biting them (1, not at all; 
2, does not; 3, maybe; 4, does; 5, definitely). The bottom edge shows the 25th percentile, the top edge shows the 75th percentile 
and separation of light and dark (blue or orange) shows the median. When the lighter part is not visible, the median and the 25th 
percentile coincide in the same value. When darker part is not visible, the median and the 75th percentile coincide in the same value
Communities’ attitudes and practices towards prevention of mosquito 
bites
In general, people perceived the measures to prevent themselves from being bitten as less efficient than 
the measures to prevent mosquitoes from breeding (Figs. 2, 3; Additional file 1: Tables S3 and S4). The 
measures were ordered based on the actual use, and presented in Fig. 3. The majority of the participants 
reported using measures to prevent themselves from being bitten at least ‘regularly’ (score ≥ 3) by 
eliminating mosquito breeding sites, using a fan, healthy eating, spraying with insecticides and by using 
insecticides inside the house and in the yard (Additional file 1: Table S4). There was no major variation 
between the perceived effectiveness of measures. The 25th–75th percentile of the effectiveness of all 
measures (except for ‘MBSC practices’ and ‘don’t water plants’) scored between ‘sometimes’ (score = 2) 
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and ‘often’ (score = 4).
Qualitative results concerning repellent use and wearing long-sleeved 
clothes
Participants expressed concerns regarding protecting themselves by wearing long-sleeved clothes. They 
narrated that mosquitoes could bite through the clothes and it was too warm to wear long-sleeved clothes. 
Regarding mosquito repellents, participants expressed different opinions. Some mentioned that they used 
it always. Others stated that they had stopped using repellents, because of the effort it took to buy and 
use it, while the repellent only protected them for a relatively short time or had not worked at all. Another 
barrier to use repellents concerned the perception that the repellents could be toxic if used too often.
HBM and TPB constructs and BIMBSC
The perceived susceptibility of the participant to the acquisition of chikungunya and dengue was moderately 
low (Q1 = 13, median = 15, Q3 = 19; range of possible scores: 7–35), while the perceived severity of 
chikungunya and dengue showed moderately high scores (Q1 = 35, median = 40, Q3 = 45; range of possible 
scores: 10–50). The scores of the other constructs of the HBM and TPB were assessed as ‘moderately high’ 
or ‘high’. Tables S1 and S5 in Additional file 1 show the scores of the constructs of the HBM and TPB and 
their Cronbach’s Alpha value. 
Barriers towards mosquito breeding site control
The scores of the perceived barriers towards MBSC (1: no barrier at all – 5: fully agree that the issue is 
a barrier) for the community are presented in Table S6 in Additional file 1. The assessed barriers were in 
general not perceived as major issues, except for the barrier: ‘Government doesn’t control other breeding 
sites’ (Q1 = 2, median = 4, Q3 = 5).
Multivariate analysis of the BIMBSC 
To assess the associations between the psychological constructs and the BIMBSC, univariate analyses on 
the general characteristics were performed between those with a BIMBSC score < 15 (lower intention) vs 
15 (maximum intention) (Table 1). The concepts of the HBM and the TPB were tested with the BIMBSC 
score using a Mann Whitney U-test (Additional file 1: Table S1). Consequently, a binary logistic regression 
was performed including the variables associated at a significance level of P ≤ 0.20. Variables were back-
wise eliminated until only significant variables were left. The final model is presented in Table 2.
The construct of the TPB ‘attitude towards the behaviour’ (performing MBSC), the self-efficacy (a person’s 
perceived ability to perform the behaviour) to perform MBSC and the belief that a mosquito transmits 
dengue were positively related with a maximum BIMBSC score of 15. On the other hand, satisfaction on 
governmental breeding site control, and two barriers (‘Don’t know how to control breeding sites’ and 
‘Government doesn’t control other breeding sites’) had an independent negative relation with the BIMBSC.
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Table 2: Final model of factors independently associated with a maximum intention vs a lower Behavioural 
Intention to perform Mosquito Breeding Site Control (BIMBSC)
aSelf-efficacy: the belief that a person is capable of performing the health behaviour
bUsing the normalized value (z-value), OR = 1.38, 95% CI: 1.06–1.79), P = 0.016
Intervention strategies to enhance community participation in MBSC
To understand community participation in MBSC, the quantitative data on psychological determinants of 
BIMBSC and the qualitative data from the IDIs and the FGDs were analysed. These analyses were performed 
to identify intervention strategies that may enhance community participation in MBSC. Based on the latter 
analyses, three possible intervention methods to improve the BIMBSC were proposed and presented in 
the next section.
Intervention 1: Media and education sources on chikungunya and dengue 
promote BIMBSC
The first proposed intervention is to promote MBSC via media and education (cues to action). Most 
participants referred having heard of chikungunya and dengue through television, radio and the newspaper 
(Fig. 4 and Additional file 1: Table S7). To explore associations between usage of different media sources 
and psychological constructs, the reported media and education sources of each individual were added 
up. These information sources ranged from 0–13 sources, with a median of 5 sources (Q1 = 3; Q3 = 8). 
Separately from the media and education sources, the interpersonal information sources were also 
assessed (Fig. 4).
To explore the role of media and education coverage when promoting MBSC, correlations of the number 
of media and education sources and the determinants of the BIMBSC (Table 2) were analysed using 
a Spearman’s rho test (Additional file 1: Table S8). The (indirect) associations of media and education 
coverage on MBSC promotion is presented in Fig. 5.
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Table 2 Final model of factors independently associated with a maximum intention vs a lower 
Behavioural Intention to perform Mosquito Breeding Site Control (BIMBSC) 
 Odds Ratio (95% CI) P-value 
Barrier: ‘Don’t know how to control breeding sites’  0.77 (0.59–0.99) 0.041 
Barrier: ‘Government doesn’t control other breeding sites’ 0.67 (0.51–0.89) 0.005 
Attitude towards behaviour (performing MBSC) 2.14 (1.56–2.93) 0.001 
Self-efficacya 1.54 (1.17–2.04) 0.002 
Satisfaction on governmental MBSC 0.71 (0.54–0.93) 0.012 
Believing that dengue is transmitted by a mosquitob   
No 1  
Yes 2.93 (1.22–7.05) 0.016 
 
aSelf-efficacy: the belief that a person is capable of performing the health behaviour 





Fig. 4  Information sources on chikungunya and dengue. GGD - Medical and Public Health Service of 
Curaçao
Fig. 5 Influence of media and education sources on the BIMBSC via psychological constructs. 
The media and education sources show positive relations with an individual’s BIMBSC via the variables in the green box. The media 
and education sources show a negative relation with an individual’s BIMBSC via the variable in the red box. Relations with the BIMBSC 
are significant independent associations. Relations with the media and education sources are significant associations revealed by a 
Spearman’s rho test. Knowledge on transmission routes of dengue and chikungunya was significantly correlated (Spearman’s rho = 
0.393, P < 0.001). A ‘minus’ indicates a negative association, a ‘plus’ indicates a positive association. Self-efficacy refers to the belief 
that a person is capable of performing the health behaviour
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Media and education promote the BIMBSC in several ways (Fig. 5). First, media and education promoted 
BIMBSC via a positive relation with ‘believing that a mosquito transmits dengue’. The latter positive 
effect might be stimulated by its positive relation with ‘believing that a mosquito transmits chikungunya’. 
Furthermore, the BIMBSC was promoted via a positive relation with self-efficacy for MBSC, and via a direct 
negative relation with the perceived barriers for MBSC.
Apart from these enhancing effects on the BIMBSC, the amount of media and education sources also 
showed a negative effect: media and education sources promoted satisfaction on governmental actions on 
mosquito control, which in turn was associated with a lower BIMBSC.
Improving messages to the public: quantitative analysis of transmission route of 
chikungunya and dengue
Media and education sources enhanced BIMBSC via improvement of perceptions on transmission route of 
chikungunya and dengue (Fig. 5). In this section, the perceptions on the transmission routes are investigated 
in depth, with the aim to provide grounds for effective messages to the public. 
Quantitative analysis showed that most people believed that chikungunya and dengue were transmitted 
by mosquitoes (chikungunya: 81.3% and dengue: 90.1%) (Fig. 6, Additional file 1: Table S9). However, 
only 49.9 and 54.4% of the participants (referring to chikungunya and dengue, respectively) believed 
that this was the only route of transmission of both diseases. The remaining participants believed that 
next to a mosquito, also other transmission routes existed for chikungunya and dengue, of which ‘the air’ 
(33.8 and 20.4%, respectively), ‘bad hygiene’ (19.3 and 24.6%, respectively) and ‘water’ (11.0 and 16.2%, 
respectively) were among the most commonly mentioned transmission routes of chikungunya and dengue 
(Fig. 6, Additional file 1: Table S9).
Fig. 6  Perceived transmission routes of chikungunya and dengue
Improving messages to the public: qualitative analysis of the transmission route 
of chikungunya
Different opinions about the transmission route of chikungunya were expressed in the group discussions. 
Among these, the transmission route ‘a virus, via a mosquito’ was regularly mentioned. However, doubts 
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about this theory were expressed, based on personal observations. Participants found it difficult to 
understand that transmission through mosquitoes could have caused such an explosive epidemic, while 
mosquitoes had been living on Curaçao for many years: 
Man, aged 60-70 years, FGD: ‘because always always always we 
have mosquitoes here. In the last two years we have chikungunya. 
That surprises the population. Because always, always we have had 
mosquitoes here.’ 
Hence, different perceptions on transmission routes besides the biomedical one existed, i.e. transmission 
through the air, (poor) hygiene, a virus (no mosquito), water, or ‘it goes around’ (Additional file 1: Table 
S10).
Intervention 2: Effects of the government’s MBSC actions on individual BIMBSC
Quantitative analysis of governmental actions
Two independently associated determinants of the BIMBSC concerned perceptions on governmental 
actions in mosquito control. Dissatisfaction demonstrated both negative and positive effects on the 
BIMBSC (Additional file 1: Table S5). The score of the satisfaction on government’s action was moderately 
low (Q1 = 1, median = 3, Q3 = 4), and demonstrated an independent negative association with the BIMBSC 
(P = 0.012) (Table 2). The lack of government’s action in MBSC was perceived as a barrier (Q1 = 2, median 
= 4, Q3 = 5), more often for those participants scoring a lower BIMBSC (P = 0.005) (Table 2).
Qualitative analysis of governmental actions
Most interviews brought up the topic of ‘waste problem’ (garbage) when talking about MBSC. The latter 
indicates that improper planning regarding waste disposal in Curaçao was linked to the presence of mosquito 
breeding sites by the community. Accordingly, participants expressed discontent with the government’s 
role in managing waste in Curaçao, but also regarding the spraying of insecticides and the low visibility of 
the government’s actions against mosquito breeding sites. Although spraying of insecticides was observed 
and appreciated by the participants, dissatisfaction existed on the infrequency and unprecise manner of 
how this spraying was performed. 
Man, aged 70–80 years, FGD: ‘I think that they only have one little 
trailer with a spray system in Curaçao that drives around the whole 
island.’ Women, aged 60–70 years, FGD: ‘Yes! With 90 kilometres an 
hour, I have seen them.’
Discontent with the government actions led to community mobilization in mosquito control in the 
neighbourhoods Souax and Seru Fortuna, guided by community key persons. 
Man, aged 60–70 years, FGD: ‘I don’t agree with how he (the 
minister) talks because he places all the responsibility (to clean their 
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neighbourhoods from waste) on the common people, and sidelines the 
government completely. (…) Ask for assistance of the neighbourhoods 
and there are many neighbourhoods willing to organize, there are many 
people who are willing to seriously put effort in this. And we are willing 
to help. (…) The last time we fixed the problem ourselves. With a truck 
and [empty] warehouse etc. Without their (the government’s) decision 
we removed the waste, for nothing. But the government should not 
think that this is going to be done all the time through us.’
Other participants argued that MBSC policies of the government would enhance MBSC of the community. 
Consequently, more communication and exposure of government’s actions against mosquito breeding 
sites (i.e. surveillance and application of larvicides and adulticides, cleaning of waste) could motivate them 
to also ‘help’ and to perform MBSC.
Although explanations existed of how discontent with government’s actions in MBSC coincided with 
community initiatives to control mosquito breeding sites, there was a strong call for more action from 
the government’s side. Out of the FGDs, a topic list was made on the actions that participants wanted the 
government to do (Table 3).
Table 3 Actions that people want the government to take in mosquito controla
aThe order of the topics does not represent importance
Intervention 3: Promoting community participation via key persons
The participants of the FGDs and IDIs demonstrated willingness to help or cooperate in MBSC, or, maybe 
even perceived as more important, the need to clean up their neighbourhoods. Different initiatives were 
described in which communities were mobilized to clean the neighbourhood. Guided by community key 
persons (which could be individuals or neighbourhood centres), community mobilization was achieved in 
Souax (described earlier), Rooi Santu, Seru Fortuna and in Piscadera. In Seru Fortuna, a day was organized 
to clean the neighbourhood. One of the participants stated that this has boosted awareness and willingness 
to clean houses and gardens in the neighbourhood. 
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Table 3 Actions that people want the government to take in mosquito controla  
Actions 
More spraying of insecticides 
Continuing program of information dissemination through media 
Inform the community on governmental actions on mosquito control 
Active tracing and managing of possible mosquito breeding sites in the neighbourhoods 
Clean up the garbage dumps in the neighbourhoods 
Improve roads 
Educate children in schools on mosquito breeding site management 
An ‘environment-police’, which can be called if illegal waste dump is observed 
More attention to prevention: ‘act proactive, not reactive’ 
 





Man, aged 40–50 years, IDI: ‘We did it. And it was in the news, ‘Oh 
the people of Seru Fortuna themselves have… eh yes, hand in action 
and they cleaned their part’, and then the others in their street also 
did it (cleaned their properties). Ooh it is like that, positive, it reaches 
others: ‘I am also going to clean my part (property)’. This time I am late 
(referring to the cleaning of his own property).’
The participant expressed that more initiatives to clean Seru Fortuna were planned, also targeting the 
involvement of youth and children. These ‘cleaning days’ would be made as attractive as possible to involve 
more people by providing food, drinks and a pleasant experience. Another initiative to involve local youth 
in the cleaning of a street was initiated by an individual. He narrated how he was cleaning one street where 
a lot of waste is dumped.
Man, aged 60–70 years, IDI: ‘ It is ‘street keep Curaçao clean’. I am 
cleaning a street where is now a lot of garbage. (…) And these (street) 
signs I am going to hang up.’
A school was invited to draw the ‘keep Curaçao clean’ (street) signs in different languages. In this way, 
local youth was involved in MBSC and awareness of the consequences of poor waste management was 
raised. The initiatives described above were organized by communities or individuals, independent from 




This study used an interdisciplinary mixed methods approach, to understand perceptions and attitudes 
of the community towards mosquito breeding site control (MBSC). Furthermore, it aimed to provide a 
theoretical basis for intervention methods to improve community participation in MBSC, based on the 
TPB and the HBM. Three intervention methods were proposed to enhance community action towards 
MBSC: (i) ongoing media attention; (ii) visibility of governmental MBSC policies; and (iii) engagement of 
key persons in local communities.
Individuals recognized water source management as an effective way to reduce mosquito breeding sites, 
and stated that they performed this often. This reflects a good knowledge and a high reported performance 
of MBSC. Participants perceived removing car tires from yards to be highly effective, but relatively few 
of them reported performing this behaviour. Whilst being difficult to clear from water, car tires provide 
formidable breeding conditions where mosquitoes flourish [41]. It has been recognized that tires may 
greatly contribute to a mosquito population [42]. Hence, car tires in yards may represent an important 
source of mosquitoes on Curaçao. People expressed moderate confidence and reported moderate 
application of personal protection against mosquito bites. Repellents containing DEET, or wearing long-
sleeved clothes are widely recommended in health promotion campaigns for personal protection [43, 
44], but were not used often because of inconvenience and doubts on efficacy. Further health messages 
concerning repellents and long-sleeved clothes might have little value, if the latter two concerns cannot be 
addressed. Of interest was the widespread belief that ‘healthy eating’ would prevent people from being 
bitten by mosquitoes. This belief might promote false feelings of safety for those people who eat healthily, 
and could therefore be targeted in future health interventions.
The behavioural intention to perform mosquito breeding site control (BIMBSC) was high and accordingly, 
all constructs of the TPB showed high scores. Interestingly, the relatively low perceived susceptibility to 
dengue and chikungunya did not result in low intentions to perform MBSC. This can be also linked to the 
fact that the perceived severity of chikungunya and dengue could be one of the motivating factors for 
performing MBSC. Notwithstanding the high knowledge on, and intention to perform MBSC, it remains 
vital to improve the preventive behaviours. This is in particular important for these households where little 
MBSC is performed. The vector (Aedes species) can have a relatively short flight range of about 30 metres 
[45]. However, under some circumstances, the flight range can be up to 400 metres [46], making one 
household with mosquito breeding sites a threat for all who live close to this area. 
The multivariate analysis revealed the constructs and variables independently associated with the 
BIMBSC, namely attitudes towards MBSC, self-efficacy of MBSC, believing that a mosquito transmits 
dengue, satisfaction and dissatisfaction on governmental actions. The strongest independent predictor 
of the BIMBSC was the attitudes towards MBSC. The presented qualitative data relating to communities’ 
perceptions and actions provided in-depth insights into these attitudes. Self-efficacy, which is the belief that 
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a person is capable of performing the behaviour, has shown to be in particular important for performing 
repeated health behaviours [47]. This study shows the same regarding MBSC.
The multivariate analysis, together with the qualitative data were the basis for three possible intervention 
strategies to improve the BIMBSC: (i) media and education coverage (cues to action); (ii) government’s 
action; and (iii) use of community key persons.
Intervention method 1: Education and media coverage (cues to action), 
grounded in local realities
Education and media coverage warning of epidemics serve as a cue to action for the community to perform 
preventive activities. The low perceived barriers to perform MBSC and the higher perceived benefits of 
MBSC and severity of chikungunya and dengue demonstrated in this study, might contribute to increase 
the favourable impact of cues to action (media and education) [29]. As was suggested in literature [31, 33] 
(and shown in this study), cues to action enhanced behaviour (BIMBCS) via other constructs of the HBM 
and the TPB (Fig. 5).
Based on our findings, messages to the public should include the transmission route of chikungunya and 
dengue. Half of the participants believed that the only way of transmitting dengue or chikungunya was via a 
mosquito, while the remaining participants believed that (apart from a mosquito) other transmission routes 
existed like transmission via air, water or through poor hygiene practices. Not recognizing that mosquitoes 
could transmit dengue had direct negative consequences on BIMBSC. Since knowledge on transmission 
routes of chikungunya and dengue were correlated, targeting both diseases in campaigns may have a 
favourable effect on mosquito breeding site control practices. Participants of the FGDs suggested that 
education in schools can carry messages from children to parents, and might be a suitable intervention to 
enhance community knowledge of MBSC (Table 3). This is in agreement with other studies [48]. The results 
of the qualitative analyses revealed different underlying attitudes and beliefs on transmission, which could 
specifically be targeted in education or in media campaigns (Additional file 1: Table S10).
Intervention method 2: governmental action
Cooperation in water source management between community and government is crucial in mosquito 
control [21]. When people were satisfied with the government’s actions, they showed lower BIMBSC-
scores. On the other hand, when they placed the responsibility to control mosquito breeding sites solely 
on the government, they also had a lower BIMBSC-score (Table 2, Fig. 5). Messages to the public could 
potentially tackle these phenomena. First, people should be aware that, although crucial, MBSC measures 
taken by the government are often not enough to adequately control the mosquito population. This means 
that even if an individual is satisfied with governmental actions, his/her own MBSC remains important. 
Secondly, the government should be aware that its actions in MBSC have potentially direct and indirect 
positive effects in mosquito control. The direct effect is achieved via the government’s water source 
management in public spaces. A potential indirect effect may be reached via media coverage of the MBSC 
activities performed by the government, which in turn lowers the barriers for individuals to perform MBSC 
(Fig. 5). Again, these messages will have higher impact if grounded in local realities [26]. The results of the 
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qualitative research of this study can be used to achieve this (Table 3, Additional file 1: Table S10).
Intervention method 3: key persons/community initiatives
The described individual and community initiatives regarding waste management demonstrated the 
presence of key persons for MBSC in Curaçao. These key persons were locals, willing to act proactively and 
had the ability to motivate community participation in MBSC. Neighbourhood centres and key persons can 
play an important role [26, 49] as ‘ambassadors’ of MBSC in their community, by raising awareness and 
initiating mosquito breeding site control actions. Furthermore, they may provide valuable information to 
the government concerning community realities with regard to MBSC.
Limitations and strengths
This study was limited by its cross-sectional design. Future performance of MBSC was predicted using 
‘behavioural intentions’. While the behavioural intention is recognized as the best predictor for behaviour, 
it is no substitute for actual behaviour. Furthermore, the study population of the survey consisted only of 
people who were (clinically or via serology) diagnosed chikungunya patients, which could be considered 
as a cue to action to perform MBSC. However, nearly all inhabitants of Curaçao had been exposed to this 
cue to action, by having closely experienced the effects of chikungunya. The study population consisted 
of more females than males. This might not be a major issue, since women are mainly responsible for 
housekeeping (and MBSC around the house) in Curaçao. A strength of the study was the interdisciplinary, 
mixed methods study design. This study design, based on health behaviour theories, is unique in the 
field of MBSC. Furthermore, a population representing all socio-economic and demographic groups of 
Curaçao was included in this study. Finally, participants were interviewed in a safe environment, chosen 





The results of this study show how health belief theories serve to understand community participation in 
MBSC. The outcomes of this study can be used for health policies in Curaçao. The policies should target 
(i) improving community access to information on transmission routes of dengue and chikungunya; (ii) 
reducing the practices of storing used car tires in yards; (iii) enhancing visibility of government’s MBSC and 
the communities’ sense of responsibility to perform MBSC; and (iv) creating a network of local key-persons/ 
‘ambassadors’ of MBSC who promote MBSC in their own neighbourhood. The qualitative research provided 
in-depth understanding of quantitative associations, which helps to target the public in an efficient and 
culturally sensitive way. To close the gap between science, implementation and communities’ lived reality, 
it is important that similar mixed-method approaches in different countries are conducted to promote one 
of the most effective strategies in MBSC, which is community participation.
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Table S1. Univariate analysis of the concepts of the Health Belief Model and Theory of Planned Behaviour 
vs the behavioural intention score to perform mosquito breeding site control: BIMBSC-score (< 15 vs 15).
aThe p-value corresponds to the comparison between the maximum vs. a lower BIMBSC; aThe correlation of the BIMBSC and the tested 
concept was positive (+), negative (-) or neutral (=); cPerceived benefits – probability that MBSC would prevent the participant, family 
and neighbours from becoming infected by dengue and chikungunya; dSelf-efficacy - the belief that a person is capable of performing 
the health behaviour
Additional file 1 
Additional file 1: Table S1. Univariate analysis of the concepts of the Health Belief Model and 
Theory of Planned Behaviour vs. the Behavioural Intention Score to perform Mosquito Breeding 















Behavioural intention to perform mosquito breeding site control (BIMBSC) 3 1 - 5 0.774 n/a n/a 
Health Belief Model     
Perceived threat Susceptibility (chikungunya and dengue) 7 1 – 5 0.669 0.320 - 
 Severity (chikungunya and dengue) 10 1 – 5 0.814 0.074 + 
 Cues to action      
 # of media sources (chikungunya and dengue) 2 0 – 7 0.807 0.213 + 
 # of interpersonal sources (chikungunya and dengue) 2 0 – 2 0.628 0.446 - 
Perceived benefitsc  6 1 – 5 0.956 0.836 + 
Perceived barriers Don’t know how to control breeding sites 1 1 – 5 n/a 0.000 - 
 Don’t like to control breeding sites 1 1 – 5 n/a 0.012 - 
 Neighbours don’t control breeding sites either 1 1 – 5 n/a 0.035 - 
 No mosquitoes at my property 1 1 – 5 n/a 0.379 - 
 Government doesn’t control other breeding sites 1 1 – 5 n/a 0.051 - 
 No other possibilities for storing waste than in my 
garden 
1 1 – 5 n/a 0.102 - 
 More mosquitoes are at nearby mondi’s (forest, 
country side) 
1 1 – 5 n/a 0.486 - 
 Someone else controls breeding sites (for me) 1 1 – 5 n/a 0.996 = 
 No physical ability 1 1 – 5 n/a 0.005 - 
 I am only at home when it’s dark 1 1 – 5 n/a 0.308 - 
Self-efficacyd  2 1 – 5 0.873 0.000 + 
Theory of planned behaviour     
Attitude towards behaviour 6 1 – 5 0.632 0.000 + 
Subjective norms 9 1 – 5  0.771 0.001 + 
Perceived behavioural controls 1 1 – 5  n/a 0.001 + 
Modifying factors   
Knowledge Believing that chikungunya is transmitted by a 
mosquito 
1 0 – 1 n/a 0.954 + 
 Believing that dengue is transmitted by a mosquito 1 0 – 1 n/a 0.002 + 
Satisfaction on governmental mosquito breeding site control 1 0 – 5  n/a 0.116 - 
 
aThe p-value corresponds to the comparison between the maximum vs. a lower BIMBSC; bThe 
correlation of the BIMBSC and the tested concept was positive (+), negative (-) or neutral (=); 
cPerceived benefits – probability that MBSC would prevent the participant, family and neighbours 
from becoming infected by dengue and chikungunya; dSelf-efficacy - the belief that a person is 





Figure S1. Theoretical framework Theory of Planned Behaviour and Health Belief Model. 
Constructs of the Health Belief Model: Perceived susceptibility – the perception of the risk to acquire the disease/condition; Perceived 
severity – the perceived seriousness of the disease/condition; Perceived benefits – the perceived positive consequences of performing 
the health behaviour; Perceived barriers – the perceived obstacles to perform the health behaviour; Self-efficacy – the belief that a 
person is capable of performing the health behaviour; Cues to action – triggers to engage people in performing the health behaviour. 
Constructs of the Theory of Planned Behaviour: Attitude towards behaviour – the evaluation of accessible positive and negative beliefs 
about the health behaviour; Subjective norms – the perceptions of an individual’s belief about the health behaviour, influenced by 


























Additional file 1: Figure S1. Theoretical framework Theory of Planned Behaviour and Health Belief 
Model 
Constructs of the Health Belief Model: Perceived susceptibility – the perception of the risk to acquire 
the disease/condition; Perceived severity – the perceived seriousness of the disease/condition; 
Perceived benefits – the perceived positive consequences of performing the health behaviour; 
Perceived barriers – the perceived obstacles to perform the health behaviour; Self-efficacy – the 
belief that a person is capable of performing the health behaviour; Cues to action – triggers to 
engage people in performing the health behaviour.  
Constructs of the Theory of Planned Behaviour: Attitude towards behaviour – the evaluation of 
accessible positive and negative beliefs about the health behaviour; Subjective norms – the 
perceptions of an individual’s belief about the health behaviour, influenced by significant others; 




Perceived seriousness (severity) of 
chikungunya & dengue 
Likelihood of performing 
mosquito breeding site control 
Cues to Action 
- Presentation disease symptoms 
- Mass media coverage of epidemics 
- Nearby chikungunya / dengue 
cases  
Perceive benefits of mosquito breeding 
site control 
Demographic variables (age, sex, 
education, occupation, income) 
 
Structural variables  
- Knowledge about transmission 
routes of chikungunya and dengue - 
- Knowledge about eradication of 
breeding sites. 
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Table S2. Characteristics of the focus groups.
aBased on local classification (homes, amenities, public services) socio-economic status was arrived at as relevant to the local context 
in Curaçao.  bAll participants of the in-depth interviews had a laboratory-confirmed chikungunya infection.
Additional file 1: Table S2. Characteristics of the focus groups 
 








Residents from the 
Netherlands 8 6 6 61-71 high 
Local youth 4 2 0 19-24 middle 
Interviewers of the survey 4 3 0 64-67 middle-high 
Rooi santu 8 4 7 51-80 middle-high 
Seru Fortuna 9 8 8 18-70 low 
Souax 7 4 1 34-72 low 
Koraalspecht 10 10 9 55-97 low-middle 
In-depth interviews 20 12 20b 36-87 low-middle-high 
 
aBased on local classification (homes, amenities, public services) socio-economic status was arrived at 
as relevant to the local context in Curaçao.  bAll participants of the in-depth interviews had a 
laboratory-confirmed chikungunya infection. 
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Table S3. Measures to prevent mosquitoes from breeding indoor and/or outdoor. 
The score on ‘perception of effectiveness’ reflects the perceived probability that the measure prevents mosquitoes from breeding 
(1=not at all; 2=does not; 3=maybe; 4=does; 5=definitely). The score of the actual use represents the actual use of the measure 
(1=never; 2=sometimes; 3=regularly; 4=often; 5=always). *Abacte - insecticidal granules (temephos)
 
Additional file 1: Table S3. Measures to prevent mosquitoes from breeding indoor and/or outdoor 
 
The score on ‘perception of effectiveness’ reflects the perceived probability that the measure prevents 
mosquitoes from bre ding (1 not at ll; 2=does not; 3=maybe; 4=does; 5=definitely). The score of the 
actual use represents the actual use of the measure (1=never; 2=sometimes; 3=regularly; 4=often; 
5=always). *Abacte - insecticidal granules (temephos) 
 Perception of effectiveness Actual use 
 Mean (sd) n Quartiles 
25 – 50 – 75 
Mean (sd) n Quartiles 
25 – 50 – 75 
Refresh water in flower vases or feeding bowls 
for pets every day 
4.21 (0.76) 338 4 – 4 – 5 4.34 (1.01) 179 4 – 5 – 5 
Turn buckets upside down 4.32 (0.79) 338 4 – 4 – 5 4.23 (1.14) 283 4 – 5 – 5 
Discard rubbish in the yard 4.46 (0.64) 338 4 – 5 – 5 4.13 (0.99) 326 3 – 4 – 5 
Cover water in the yard 4.28 (0.78) 338 4 – 4 – 5 3.65 (1.55) 324 3 – 4 – 5 
Cover water in the house 4.06 (0.87) 338 4 – 4 – 5 3.61 (1.51) 337 2 – 4 – 5 
Spray insecticide (bug spray) 3.62 (0.96) 338 3 – 4 – 4 3.09 (1.25) 338 2 – 3 – 4 
Remove car tires from the yard 4.36 (0.77) 338 4 – 4 – 5 2.93 (1.49) 44 2 – 2 – 4.75 
Scrub away mosquito eggs (with e.g. a sponge) 3.82 (1.00) 337 3 – 4 – 5 2.87 (1.54) 337 1 – 3 – 4 
Add Abate* to containers for collecting rain 
water 
3.92 (0.96) 337 3.5 – 4 – 5 2.68 (1.56) 122 1 – 2 – 4 
Don’t park the car near the house 2.25 (1.00) 338 1 – 2 – 3 1.71 (1.32) 253 1 – 1 – 2 
Don’t water plants 1.58 (0.72) 338 1 – 1 – 2 1.19 (0.61) 295 1 – 1 – 1 
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Table S4. Measures preventing mosquito bites. 
The score on ‘perception of effectiveness’ reflects the perceived probability that the measure prevents from mosquito bites (1=not 
at all; 2=does not; 3=maybe; 4=does; 5=definitely). The score of the actual use represents the actual use of the measure (1=never; 
2=sometimes; 3=regularly; 4=often; 5=always).
 
Additional file 1: Table S4. Measures preventing mosquito bites 
 
 
The score on ‘perception of effectiveness’ reflects the perceived probability that the measure prevents 
from mosquito bites (1=not at all; 2=does not; 3=maybe; 4=does; 5=definitely). The score of the actual 
use represents the actual use of the measure (1=never; 2=sometimes; 3=regularly; 4=often; 
5=always). 
 
 Perception of effectiveness Actual use 
 Mean (sd) n Quartiles 
25 – 50 – 75 
Mean (sd) n Quartiles 
25 – 50 – 75 
Eliminate mosquito breeding sites in the 
house and yard 
4.28 (0.82) 337 4 – 4 – 5 4.07 (1.14) 336 3 – 4.5 – 5 
Use a fan 3.16 (1.00) 337 2 – 3 – 4 3.43 (1.31) 338 2 – 4 – 5 
Eat healthily 2.71 (1.24) 336 2 – 3 – 4 3.07 (1.52) 337 2 – 3 – 5 
Spray with insecticide 3.53 (0.95) 337 3 – 4 – 4 3.15 (1.26) 338 2 – 3 – 4 
Use insecticides in the house and yard 3.53 (0.97) 337 3 – 4 – 4 2.72 (1.25) 337 2 – 3 – 4 
Use electric mosquito rackets 3.34 (0.99) 337 3 – 3 – 4 2.70 (1.34) 338 2 – 2 – 4 
Use Coils (plagatox) 3.22 (1.05) 336 2 – 3 – 4 2.35 (1.34) 337 1 – 2 – 4 
Screens in front of doors/ windows 3.26 (0.98) 337 3 – 3 – 4 2.30 (1.54) 337 1 – 1 – 4 
Use air conditioning 2.85 (1.13) 337 2 – 3 – 4 2.24 (1.44) 337 1 – 2 – 3 
Use DEET or bug repellent (lotion/spray) 
every day 
3.38 (1.00) 337 3 – 3 – 4 2.21 (1.21) 337 1 – 2 – 3 
Use Vape – insecticidal vaporizer 3.06 (0.97) 335 2 – 3 – 4 1.84 (1.17) 337 1 – 1 – 2 
Use (sticky) mosquito traps 2.77 (1.07) 335 2 – 3 – 4 1.81 (1.20) 334 1 – 1 – 2 
Wear long sleeves/pants during the day 2.63 (0.98) 336 2 – 3 – 3 1.77 (1.03) 336 1 – 1 – 2 
Use a mosquito net at night 3.18 (1.03) 337 2 – 3 – 4 1.48 (0.98) 337 1 – 1 – 2 
Don’t water plants 1.68 (0.79) 336 1 – 2 – 2 1.20 (0.64) 338 1 – 1 – 1 
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Table S5. Scores of concepts of the Health Belief Model and Theory of Planned Behaviour. 
aPerceived benefits – probability that MBSC would prevent the participant, family and neighbours from becoming infected by dengue 
and chikungunya; bSelf-efficacy - the belief that a person is capable of performing the health behaviour






Mean (sd) n Quartiles 
25 – 50 – 75 
Behavioural intention to perform mosquito breeding site control (BIMBSC) 3-15 13.45 (2.58) 330 12 – 15 – 15 
Health Belief Model   
Perceived threat Susceptibility (chikungunya and dengue) 7-35 16.16 (5.06) 332 13 – 15 – 19 
 Severity (chikungunya and dengue) 10-50 39.69 (6.99) 331 35 – 40 – 45  
 Cues to action    
 # of media sources (chikungunya and dengue) 0-14 5.11 (3.01) 328 3 – 5 – 8 
 # of ‘peer’ sources (chikungunya and dengue) 0-4 1.13 (1.12) 328 0 – 1 – 2 
Perceived benefitsa  6-30 21.67 (6.25) 333 18 – 20 – 30 
Perceived barriers Don’t know how to control breeding sites 1-5 1.41 (0.94) 333 1 – 1 – 1 
 Don’t like to control breeding sites 1-5 1.38 (0.90) 333 1 – 1 – 1 
 Neighbours don’t control breeding sites either 1-5 1.35 (0.83) 333 1 – 1 – 1 
 No mosquitoes at my property 1-5 1.74 (1.10) 332 1 – 1 – 3 
 Government doesn’t control other breeding sites 1-5 3.45 (1.61) 333 2 – 4 – 5 
 No other possibilities for storing waste than in my 
garden 
1-5 1.34 (0.85) 333 1 – 1 – 1 
 More mosquitoes are at nearby mondi’s (forest, 
country side) 
1-5 2.10 (1.51) 332 1 – 1 – 3 
 Someone else controls breeding sites (for me) 1-5 2.19 (1.46) 333 1 – 1 – 3 
 No physical ability 1-5 1.65 (1.13) 333 1 – 1 – 2 
 I am only at home when it’s dark 1-5 1.31 (0.79) 333 1 – 1 – 1 
Self-efficacyb  2-10 8.73 (1.78) 332 8 – 10 – 10 
Theory of planned behaviour   
Attitude towards behaviour 6-30 27.12 (2.77) 332 26 – 28 – 30  
Subjective norms 9-45 34.65 (5.39) 333 31 – 35 – 39 
Perceived behavioural controls 1-5 3.96 (1.37) 333 3 – 5 – 5 
Modifying factors 
Knowledge Believing that chikungunya is transmitted by a 
mosquito 
0-1 0.81 (0.39) 337 1 – 1 – 1 
 Believing that dengue is transmitted by a mosquito 0-1 0.90 (0.30) 333 1 – 1 – 1 
Satisfaction on governmental mosquito breeding site control 0-5 2.70 (1.45) 333 1 – 3 – 4 
 
aPerceived benefits – probability that MBSC would prevent the participant, family and neighbours 
from becoming infected by dengue and chikungunya; bSelf-efficacy - the belief that a person is 
capable of performing the health behaviour 
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Table S6. Barriers for eliminating breeding sites. 
Barriers were assessed with a 5-point Likert item (1: no barrier at all – 5: fully agree that the issue is a barrier). 
Additional file 1: Table S6. Barriers for eliminating breeding sites 
 Mean (sd) n Quartiles 
25 – 50 – 75 
Don’t know how to control breeding sites 1.41 (0.94) 333 1 – 1 – 1 
Don’t like to control breeding sites 1.38 (0.90) 333 1 – 1 – 1 
Neighbours don’t control breeding sites either 1.35 (0.83) 333 1 – 1 – 1 
No mosquitoes at my property 1.74 (1.10) 332 1 – 1 – 3 
Government doesn’t control other breeding sites 3.45 (1.61) 333 2 – 4 – 5 
No other possibilities for storing waste than in my garden 1.34 (0.85) 333 1 – 1 – 1 
More mosquitoes are at nearby mondi’s (forest, country side) 2.10 (1.51) 332 1 – 1 – 3 
Someone else controls breeding sites (for me) 2.19 (1.46) 333 1 – 1 – 3 
No physical ability 1.65 (1.13) 333 1 – 1 – 2 
I am only at home when it’s dark 1.31 (0.79) 333 1 – 1 – 1 
 
Barriers were assessed with a 5-point Likert item (1: no barrier at all – 5: fully agree that the  
issue is a barrier).
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Table S7. Information sources of chikungunya and dengue. More answers were possible. 
More answers were possible. *GGD= Medical and Public Health Service of Curaçao
 






chikungunya n=337; dengue n=329 
n (%) n (%) 
Media sources     
Television 260 (77.2) 240 (72.9) 
Radio 241 (71.5) 225 (68.4) 
Newspaper 178 (52.8) 168 (51.1) 
School/ education 14 (4.2) 23 (7.0) 
Internet sites 52 (15.4) 42 (12.8) 
Government campaigns/ GGD* 95 (28.2) 96 (29.2) 
Social media (Twitter/Facebook etc.) 40 (11.9) 28 (8.5) 
Peer sources     
From the general practitioner  65 (19.3) 53 (16.1) 
Family/  friends/ neighbours 142 (42.1) 116 (35.3) 
 
More answers were possible. *GGD= Medical and Public Health  
Service of Curaçao 
124
5
Table S8. Spearman’s correlation matrix of concepts significantly associated with ‘number of media and 
education sources’. 
*Correlation is significant at the 0.05 level (2-tailed); **Correlation is significant at the 0.01 level (2-tailed); Barrier 1 = Don’t know 
how to control breeding sites; Barrier 2= Government doesn’t control other breeding sites; aSelf-efficacy - the belief that a person is 
capable of performing the health behaviour
Additional file 1: Table S8. Spearman’s correlation matrix of concepts  
significantly associated with ‘number of media and education  
sources’. 
  
Number of media 
and education 
sources 
Barrier 1 Correlation Coefficient -0.128* 
p-value 0.021 
n 324 
Barrier 2 Correlation Coefficient -0.130* 
p-value 0.019 
n 324 
Self-efficacya Correlation Coefficient 0.127* 
p-value 0.023 
n 323 
Stating that a mosquito 
transmits chikungunya 
Correlation Coefficient 0.191** 
p-value 0.001 
n 328 
Stating that a mosquito 
transmits dengue 





breeding site control 
Correlation Coefficient 0.123* 
p-value 0.027 
n 324 
*Correlation is significant at the 0.05 level (2-tailed); **Correlation is  
significant at the 0.01 level (2-tailed); Barrier 1 = Don’t know how to  
control breeding sites; Barrier 2= Government doesn’t control other  
breeding sites; aSelf-efficacy - the belief that a person is capable of  
performing the health behaviour
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Table S9. Knowledge on chikungunya and dengue transmission routes. 
More answers were possible. 






Transmission routes  
chikungunya n=337; dengue n=333 
n (%) n (%) 
Water 37 (11.0) 54 (16.2) 
Coughing/sneezing 29 (8.6) 33 (9.9) 
Low hygiene 65 (19.3) 82 (24.6) 
A mosquito bite 274 (81.3) 300 (90.1) 
The air ‘airu’ 114 (33.8) 68 (20.4) 
Sex 7 (2.1) 4 (1.2) 
(Deep) Kissing 9 (2.7) 12 (3.6) 
Touching a (chikungunya/ dengue) 
patient 12 (3.6) 16 (4.8) 
Visiting the general practitioners’ 
office 17 (5.0) 15 (4.5) 
 
More answers were possible. 
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Table S10. Reported modes of infecti on in focus groups




The air / 
contagious 
- Man, aged 20-30 years, FGD: ‘(…) I think, well. Many people have got it. I don’t think that 
mosquitoes bite so many people. I think that that thing [is] in the air itself so, and that I think.’ 
- Woman, aged 60-70 years, FGD: ‘It is like when we catch a cold. The air transfers it to other 
people. (…) someone gets it and the other who lives with him (or her) also gets it (…)’ 
Hygiene Woman, aged 60-70 years, FGD: ‘It is not the mosquitoes. It is our own hygiene. We are the 
caregivers of ourselves [we need to take care of ourselves].’ 
It goes around Woman, aged 60-70 years, FGD: ‘I once thought, it is like something that goes around. I feel it in my 
hand and my knee today and my neighbour a bit further away felt it also in his hand and knee. This 
is how it goes around. I got dengue and it is not comparable.’ 
A virus (no 
mosquito) 
- Man, aged 40-50 years, FGD: ‘ (…) If it is a thing… let me say we had already mosquitoes and they 
fly, every day, every moment. A virus it is, it is a snapshot, do you get it? A virus comes and then it 
goes. But a virus stays in the air and you never know when it will attack you. (…)’ 
- Woman, aged 60-70 years, FGD: ‘he (chikungunya) gets us in the leg first. It’s a virus. (…) Woman 
(expressing her doubts): ‘but that a mosquito can bite everyone in the leg…’ 
Water Woman, aged 70-80 years, FGD: ‘(…) Just we had the impression that even the water that we drink, 
or [use to] to wash, can’t that bring the virus more easily to people?’ 
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Additi onal fi le 2: Survey instrument Theory of Planned Behaviour and 
Health Belief Model, ordered by concept.
This document is presented in the following chapter: ‘Survey instruments and interview guides’.
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6 AbstractBackgroundBeyond the acute illness phase, chikungunya consti tutes a public health problem given its chronic disease phase, which may include long-term arthralgia, arthriti s, fati gue and depression. Currently, there is no consensus on how to defi ne chikungunya chronicity. MethodsA comprehensive cross-secti onal survey was performed in Curaçao in June-July 2015 to evaluate 304 adult laboratory-confi rmed chikungunya pati ents 3-16 months aft er diagnosis. We developed a novel tool, the Curaçao Long-Term Chikungunya Sequelae (CLTCS) Score to classify chronic chikungunya disease, and esti mate its burden regarding disease durati on, clinical presentati on and impact on quality of life (QoL). 
Results
Disease persistence was esti mated to be 79% one month aft er symptom onset and 64% aft er 400 days. 
Chikungunya persistence was characterized by higher proporti ons of arthralgia, weakness, myalgia and 
age between 41-60 years. Individuals were classifi ed as ‘highly aff ected’, ’mildly aff ected’ and ‘recovered’. 
‘Highly aff ected’ disease status was associated with clinical complaints (arthralgia, weakness, loss of 
vitality, and being diabeti c) and major decreases in QoL scores.  
Conclusion
In the Caribbean, a high proporti on of chikungunya pati ents remain chronically aff ected. We propose the 
CLTCS as a suitable score to easily and rapidly classify the severity of chikungunya chronic disease, and to 




Chikungunya is a viral vector-borne disease transmitted by the day-biting mosquitoes Aedes aegypti and 
Ae. albopictus [1]. The disease has become a global health problem of increasing importance given its 
recent rapid spread and the extent and impact of chronic disease. To date, the literature lacks consensus 
on how to define chronic chikungunya disease.
The first locally acquired chikungunya cases in the Caribbean island of Saint Martin in December 2013 
indicated the introduction of chikungunya virus (CHIKV) in the Americas, which resulted in over one million 
confirmed or suspected cases throughout the continent [2-4].  
In Curaçao, the epidemic of chikungunya became evident in June/July 2014. The explosive behaviour of this 
epidemic resulted in 835 reported laboratory-confirmed cases and thousands of clinical cases by October 
2014 [4]. These accumulated to an estimated 50,000-75,000 by the end of the outbreak in January 2015 
(IG, unpublished).
Chikungunya disease typically manifests itself with an abrupt onset of high fever, headache, in a certain 
percentage with rash, and almost invariably musculoskeletal pain with predominantly incapacitating 
arthralgia. Treatment of the disease is purely symptomatic, focusing on pain relief through the use of 
non-steroidal anti-inflammatory drugs [1]. Although the acute phase of chikungunya could be considered 
as relatively short (7-10 days), the disease commonly evolves into a sub-acute (< 3 months) or chronic 
(> 3 months) phase. The latter has been characterized by long-lasting relapsing or lingering rheumatic 
musculoskeletal pain, arthralgia, fatigue, and depression [5-8]. Notwithstanding the wide range of 
symptoms that chikungunya can cause, research mainly focuses on musculoskeletal manifestations when 
investigating persistence of chikungunya, thereby neglecting other disease manifestations [9]. Studies 
estimate that up to 60% of chikungunya patients remain symptomatic 12-36 months after infection [8,10-
12]. After five years, up to 12% of the infected population might still report chikungunya-related symptoms 
[13-15]. 
It seems likely that the chronic phase of chikungunya can cause a significant decrease in quality of life (QoL), 
becoming an important and under-estimated public health problem [10,16].  However, to date, research 
on QoL related to chikungunya chronicity remains scarce and especially lacks a thorough description 
combined with musculoskeletal, psychological and neurological manifestations. 
The aim of this study was (1) to estimate the burden of the first chikungunya outbreak in Curaçao in terms 
of symptoms and duration of chronic disease, and the impact on QoL 3-16 months after diagnosis; (2) to 
develop a practical tool to classify chronic chikungunya disease; and (3) to identify factors associated with 




Study design and population
Following the chikungunya epidemic of 2014-2015 in Curaçao, a cross-sectional survey of adult subjects 
with a confirmed chikungunya infection diagnosed during the epidemic was performed between June and 
July 2015. Chikungunya infection was confirmed based on diagnosis of a general practitioner including 
a laboratorial assessment outcome of either a positive IgM or IgG (since this was the first documented 
chikungunya epidemic in Curaçao), positive reverse transcription polymerase chain reaction (RT-PCR) or 
positive indirect fluorescent antibody (IFA). ELISA (ELISA: IBL, Germany) was performed by the Analytical 
Diagnostic Centre (ADC N.V.) in Curaçao according to the manufacturers’ protocol. Assessment by RT-PCR or 
IFA concerned samples transferred to the National Institute for Public Health and the Environment of The 
Netherlands (RIVM). Twenty general practitioners working in 14 different practices representative of the 
population of Curaçao, both geographically and socio-economically, provided patient data. The selected 
subjects were either contacted by phone or visited at their residence for inclusion. Those consenting to 
participate were interviewed at home.
Study site
Curaçao is an island in the southern Caribbean Sea with a surface of 444 km2 and approximately 150,000 
inhabitants. The population of Curaçao is mainly concentrated in the capital, Willemstad [16]. Curaçao 
has a semi-arid climate with a rainy season from September to January and a dry season from February to 
August [17]. 
Data collection
Study participants were interviewed using a questionnaire containing pre-coded and open questions 
on socio-demographic characteristics (Table 1).  Experienced local interviewers working for the Central 
Bureau of Statistics of Curaçao (CBS) and speaking Papiamentu, Dutch, English and Spanish performed the 
interviews. The questionnaire was prepared in Dutch, piloted, corrected, and translated into Papiamentu, 
Spanish and English.
Subjects were asked to provide the date of onset of the acute chikungunya episode and the duration 
of symptoms and complaints. They were asked if they (still) suffered from the pre-coded symptoms at 
the time of interview to which they could answer ‘yes’, ‘somewhat’, or ‘no’ (Supplementary Tables 1, 2). 
Finally, participants were asked to fill in a RAND-36 (SF-36) questionnaire in order to assess their current 
Quality of Life (QoL) [19,20]. The RAND-36 was used because this tool provides a short but comprehensive 
assessment of QoL, including physical and emotional dimensions of health, and was previously applied to 
the population of Curaçao [21].
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Table 1. Socio economic characteristics of the study population, stratified by chronic disease status 
applying the CLTCS Score
*Fisher’s exact test; ap-value corresponds to the comparison of the proportions between the groups recovered, mildly affected and 
highly affected; bTotal recovered group n=109; cTotal recovered group n=107, total mildly affected group n=104, total highly affected 
group n=87; dAntillian Guilder; 1 ANG = 0.56 USD eCardiovascular disease group includes hypercholesterolemia and hypertension; 
fOther diseases includes chronic lung diseases, thyroid diseases, auto-immune diseases, gastro-intestinal complaints, unspecified 
pain, allergies and other.
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Age n (%) n (%) n (%) n (%)  
18-40 years 66 (21.7) 36 (32.7) 17 (14.6) 13 (14.6)  
41-60 years 158 (52.0) 44 (40.0) 63 (57.3) 51 (57.3)  
>60 years 80 (26.3) 30 (27.3) 25 (23.8) 25 (28.1) 0.005 
Sex          
Female 225 (73.0) 76 (69.1) 75 (71.4) 74 (83.1)  
Male 79 (26.0) 34 (30.9) 30 (28.6) 16 (16.9) 0.061 
Education          
Illiterate/ primary school 70 (23.0) 25 (22.7) 24 (22.9) 21 (23.6)  
Secondary school 110 (36.2) 36 (32.7) 35 (33.3) 39 (43.8)  
Intermediate vocational 
education 
80 (26.3) 33 (30.0) 32 (30.5) 15 (16.9)  
University (of applied sciences) 44 (14.5) 16 (14.5) 14 (13.3) 14 (15.7) 0.367 
Occupationb          
Unemployed/student/housewife/
voluntary 
58 (19.1) 19 (17.4) 18 (17.1) 21 (23.6)  
Paid job (domestic or manual) 129 (42.6) 42 (38.5) 50 (47.6) 37 (41.6)  
Paid job (not domestic or 
manual) 
61 (20.1) 28 (25.7) 20 (19.0) 13 (14.6)  
Retired 55 (18.2) 20 (18.3) 17 (16.2) 18 (20.2) 0.435 
Incomec,d           
0-999 ANG 30 (10.1) 7 (6.5) 16 (15.4) 7 (8.0)  
1000-2499 ANG 121 (40.6) 40 (37.4) 41 (39.4) 40 (46.0)  
2500-4999 ANG 110 (36.9) 43 (40.2) 36 (34.6) 31 (35.6)  
>5000 ANG 37 (12.4) 17 (15.9) 11 (10.6) 9 (10.3) 0.265 
          
Underlying chronic disease          
Absence of underlying disease 152 (50.0) 61 (55.5) 60 (57.1) 31 (34.8) 0.003 
Joint disease 42 (13.8) 8 (7.3) 14 (13.3) 20 (22.5) 0.008 
Cardiovascular diseasee 73 (24.0) 20 (18.2) 26 (24.8) 27 (30.3) 0.133 
Neurologic disease 11 (3.6) 4 (3.6) 4 (3.8) 3 (3.4) 1.000* 
Diabetes mellitus 39 (12.8) 10 (9.1) 8 (7.6) 21 (23.6) 0.001 
Other diseasesf 30 (9.9) 13 (11.8) 6 (5.7) 11 (12.4) 0.209 
 519 
*Fisher’s exact test; ap-value corresponds to the comparison of the proportions between the 520 
groups recovered, mildly affected and highly affected; bTotal recovered group n=109; cTotal 521 
recovered group n=107, total mildly affected group n=104, total highly affected group n=87; 522 
dAntillian Guilder; 1 ANG = 0.56 USD eCardiovascular disease group includes 523 
133
6
Severity of chronic chikungunya disease – development of a novel classifying 
system
To classify chronicity of chikungunya disease, subjects were asked whether they still perceived complaints 
of chikungunya at the time of interview. Thenceforth, four standard statements were assessed with a five-
point scoring scale (Table 2). Cronbach’s Alpha Test, which assesses the reliability, or internal consistency, 
of the four-statement scale yielded a high score (0.891). Subsequently, a severity score was obtained by 
summing-up the scores of the four questions. This score was categorized into ‘recovered’ (score=4), ‘mildly 
affected’ (score=5-12) and ‘highly affected’ (score=13-20) (Supplementary Table 3). Hereinafter, we refer to 
this score as the Curaçao Long-Term Chikungunya Sequelae (CLTCS) Score.
Table 2. CLTCS Score assessment form
Using the CLTCS (long-term chikungunya sequelae) Score to assess chronic chikungunya disease. Perform the following steps:
1. Ask the patient to fill in the form; all answers are required.
2. Recode the scores of question 1 & 2 as follows: 5=1; 4=2; 3=3; 2=4; 1=5.
3. After recoding, sum the scores of questions 1, 2, 3 & 4 to obtain the CLTCS Score.
4. Classify chikungunya chronic disease status: 
• Recovered (no complaints) = 4
• Mildly affected = 5-12
• Highly affected = 13-20
Data analysis
Data was entered into a database using SPSS Data Entry Station (SPSS Inc. 1996-2003, version 4.0.0). Data 
was checked for consistency and analysed anonymously. Based on their neighbourhood, participants were 
allocated to geozones [17]. The distribution of the study population was analysed and presented in a map 
using ArcGIS (ArcGIS Desktop: Release 10.3. Redlands, CA: Environmental Systems Research Institute). Chi-
square test or Fisher’s exact test was used to test associations between categorical variables. Continuous 
variables were converted into ordered categorical variables when suitable. For normally distributed 
quantitative data, means were compared using Students t-test or ANOVA; for skewed distributions, the 
Mann-Whitney U or Kruskal Wallis test was used. A survival curve was created using the Kaplan-Meier 
 28




Using the CLTCS (long-term chikungunya sequelae) Score to assess chronic chikungunya 
disease. Perform the following steps: 
1. Ask the patient to fill in the form; all answers are required. 
2. Recode the scores of question 1 & 2 as follows: 5=1; 4=2; 3=3; 2=4; 1=5. 
3. After recoding, sum the scores of questions 1, 2, 3 & 4 to obtain the CLTCS Score. 
4. Classify chikungunya chronic disease status:  
x Recovered (no comp aints) = 4 
x Mildly affected = 5-12 
x Highly affected = 13-20 
  
  
Please, check the box according to how much you agree or not with the 
following statements: 
     
1 2 3 4 5 
1. I am fully functional again after having had chikungunya…………………………….      
2. I don’t have chikungunya complaints any more ………………………………………….      
3. I still feel the effects of chikungunya disease every day……………………………….      
4. The chikungunya effects seem to return again and again in my case............. 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estimator. A multivariate binary logistic regression was performed to describe characteristics of chronic 
chikungunya disease. General characteristics and symptoms (‘no’ vs. ‘somewhat’ plus ’yes’) with a p-value 
≤0.2 in the univariate analysis were included in a multivariate model to test their influence on disease 
status. Variables with highest p-values were eliminated backwards, until all variables in the model showed 
significance. Significance was determined at 5% level. Data was analysed using SPSS (SPSS Inc., version 
22.0, Chicago, Illinois). 
Ethical committee approval 
The study was approved by the Medical Ethical Board of the Sint Elisabeth Hospital (METC SEHOS) Curaçao 





Descripti on of the study populati on
A total of 411 parti cipants with a recent acute chikungunya infecti on were contacted and invited to join the 
study, of which 339 consented and parti cipated (response rate 82.5%). The reasons for non-contacti ng and 
non-response are summarized in Supplementary Table 4. Of the 337 parti cipants, 304 had a laboratory-
confi rmed CHIKV infecti on and were included in this study. Date of onset of acute chikungunya disease 
ranged from April 2014 – March 2015, i.e. 92-460 days before the interview. The socio-demographic 
characteristi cs and comorbidity of the study populati on are summarized in Table 1. The parti cipants’ age 
range was 18-94 years (Quarti le (Q)1=41 years; median=51 years; Q3=61 years). Most parti cipants were 
female (n=225; 74.0%), and 40.8% (n=124) had an educati onal level of intermediate vocati onal educati on 
or university. The majority had a paid job (n=190; 62.7%) and approximately half of the parti cipants had 
an income up to 2500 ANG (Anti llean Guilder; 1 ANG = 0.56 USD). Forty-seven (72.3%) of all 65 geozones 
[17] of Curaçao were represented in this study. Figure 1 shows the proporti on of parti cipants per 1,000 
inhabitants per geozone.
Figure 1. Distributi on of the study populati on among geozones of Curaçao (cases per 1,000 inhabitants)
Willemstad (capital) covers the indicated area from the south to the north of Curaçao.
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Chikungunya chronic disease status
To characterize chikungunya chronic disease status, the CLTCS Score was developed (see Methods, Data 
collection). This score was stratified in three categories: ‘recovered’, ‘mildly affected’ and ‘highly affected’. 
The classification showed consistency with the ‘yes or no’-question regarding chronic disease persistence 
(Supplementary Table 3). Therefore, the population of this study is further described using the new 
classification system, i.e. the CLTCS Score.
Duration of chikungunya disease
At the time of interview, 36.2% (n=110) were defined as fully recovered from chikungunya, while the 
remaining 63.8% (n=194) were defined as still being mildly affected (n=105, 34.5%) or highly affected 
(n=89; 29.3%) by chronic chikungunya disease. The ‘recovered’ study population estimated their disease 
duration between 1-240 days (n=107; Q1=14 days; median=30 days; Q3=90 days; Figure 2). The ‘mildly 
affected’ population reported an ongoing disease duration of 273 days on average, ranging from 94 – 
426 days (n=105; SD=69.4). Finally, the ‘highly affected’ population reported having complaints for 267 
days on average, ranging from 101 – 422 days (n=89; SD=55.8). Out of the 304 individuals, sixty-two 
(20.6%) reported to be fully recovered from chikungunya within one month (Figure 2). Figure 2 shows the 
probability to remain affected with chronic chikungunya disease over time. The model estimates that in 
79.4% (95% CI: 83.9%-74.9%) of patients, long-term sequelae persist after a month, and in 64.0% (95% CI: 
69.5%-58.5%) after 400 days.
Figure 2. Distribution of disease status duration and cumulative incidence of disease persistence
The horizontal axis shows the maximum duration of disease (days) of the specific category; the number of subjects is expressed in 
the vertical axis. The recovered population is shown in white, the still mildly/highly affected population is shown in grey/black. The 
disease duration of the mildly/highly affected population is the time between disease onset and interview (ranging from 92-460 days), 
meaning that chronic disease was ongoing and may last longer than presented here. The Kaplan-Meier curve presents the cumulative 
incidence of disease persistence by follow-up time.
Symptoms of chronic chikungunya disease
Symptoms present at the time of interview were assessed. Subjects that answered ‘somewhat’ or ‘yes’ 
were recorded as symptomatic. These were stratified by chronic disease status and compared (Figure 
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3). All symptoms showed a significant association with disease status (Supplementary Table 5). The total 
data on the (severity of) symptoms is shown in Supplementary Tables 1, 2. The most frequently reported 
symptoms within the mildly and highly affected population were arthralgia and weakness in the upper or 
lower extremities, myalgia and tiredness. Other symptoms significantly associated with mildly or highly 
affected subjects were arthralgia and weakness in the back/neck, insomnia, sombreness, loss of vitality, 
numbness, paraesthesia (tingling), nausea, vomiting, abdominal pain and hair loss.
Figure 3. Symptoms of chronic chikungunya stratified by chronic disease status (CLTCS Score)
Determinants of chronic chikungunya disease status
To characterize the different chronic chikungunya disease statuses, the ‘recovered’ population vs. the 
‘affected’ population (mildly plus highly affected groups) and the mildly vs. highly affected groups were 
compared in univariate analyses (Supplementary Tables 1,2,6,7) and a binary multiple logistic regression. 
Supplementary Tables 8 and 9 show the general characteristics and symptoms independently associated 
with chronic chikungunya disease status. Individuals with chronic chikungunya disease were more likely 
to have arthralgia in upper (OR=4.9; p=0.002) and/or lower extremities (OR=12.3; p<0.001), weakness in 
upper extremities (OR=14.9; p=0.001) and myalgia (OR=3.1; p=0.030), and an age of 41-60 years (p=0.007) 
compared to recovered subjects. Within the non-recovered subjects, the highly affected individuals were 
distinguished from the mildly affected by presenting more frequently arthralgia in upper (OR=7.0; p<0.001) 
and/or lower extremities (OR=3.3; p=0.015), weakness in lower extremities (OR=4.2; p=0.005) and loss of 
vitality (OR=3.5; p=0.004); and having a history of diabetes (OR=3.7; p=0.013). Being mildly affected was 
mainly associated with reporting weakness in the back or neck (OR=6.67; p=0.001) compared to the highly 
affected. 
Quality of life of a population with chronic chikungunya symptoms
Figure 4 shows the influence of chronic chikungunya disease on the QoL measured with the RAND-36 
questionnaire. RAND-36 scores range from 0-100 and higher scores reflect better health outcomes. The 
recovered population showed the highest scores on all QoL dimensions, followed by the mildly affected 
and the highly affected population respectively (p≤0.001; Kruskal-Wallis test). Supplementary Table 10 
provides the total data on RAND-36 QoL score of this population.
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Figure 4. Mean scores RAND-36 QoL by chronic disease status




A cross-sectional study including 304 individuals with a laboratory-confirmed recent chikungunya infection 
was conducted to assess the duration, symptomatology and impact on the quality of life (QoL) of chronic 
chikungunya disease in Curaçao. This study provides comprehensive insights into the different degrees, 
clinical extent and associated factors of chronic chikungunya disease. Furthermore, it introduces the 
CLTCS Score, an easy and fast instrument for health workers to characterize the severity grades of chronic 
chikungunya in their patients.
The CLTCS Score was developed and applied to characterize chronic chikungunya disease. Compared 
to other published arthritis assessment instruments (e.g. the Health Assessment Questionnaire (HAQ) 
[23], Arthritis Impact Measurement Scales (AIMS) [22], Rheumatiod Arthritis Severity Scale (RASS) [24]), 
the CLTCS Score is swifter to use (than e.g. the HAQ, AIMS) and captures the broad clinical presentation 
of chikungunya (unlike the RASS, HAQ). Most studies describe chronic chikungunya disease based on 
rheumatic manifestations, classifying individuals binary as ‘(clinically) recovered’ vs ‘not recovered’ with 
self-reported recovery of chikungunya disease [25,26] or presence of (self-perceived) persistent/relapsing 
rheumatic manifestations [8,10,27,28] as criterion. The CLTCS Score differs from most of these approaches 
by comprehensively assessing the patient and not solely focusing on the presence of rheumatic disease 
(mainly arthralgia). We believe that this score enables the health care worker to estimate the severity of 
chikungunya symptoms quickly but accurately. As a consequence, using the CLTCS Score, 64% of our study 
population was defined as chronically affected, compared to the 51% who referred being affected when 
using simpler classification methods (‘recovered’ vs. ‘affected’) (Supplementary Table 3). The results of the 
present study imply that previous classifications might underestimate disease persistence.
Previous studies, as recently reviewed by van Aalst and colleagues [9], have shown that in 18-60% of the 
individuals chronic chikungunya persisted for a period of 12-36 months [8,10,11,12] while in 2-12% of the 
subjects chronic disease may last for up to 5 years or longer [13-15]. Our study showed a relatively high 
proportion of disease persistence amongst the population, on the basis of our classification method of 
chronic chikungunya. In our study population, 20.6% were defined as fully recovered within one month. 
Consistent with another study [27], the Kaplan-Meier estimate (Figure 2) showed a 64% chance of disease 
persistence for over 400 days. Disease persistence remained at the same proportions between 90 and 400 
days (Figure 2). Likewise, the contribution of the highly affected to the total study population demonstrated 
a constant level (Figure 2). This implies that those who may suffer from severe disease for a longer period, 
might be already identified three months after disease onset using the CLTCS Score. 
A wide range of chronic symptoms was associated with the different disease statuses (Supplementary 
Table 5). All symptoms except for ‘vomiting’, showed a higher proportion and severity in the highly affected 
group (Supplementary Table 2,5). The affected individuals reported most frequently musculoskeletal 
symptoms, corresponding with other studies [8,10,12,25-28), but a considerable proportion referred 
concomitant tiredness, sleeplessness and neuropsychological symptoms [12,16,26,29]. The importance of 
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the scarcely described neurologic chronic manifestations associated with CHIKV [30-32] was demonstrated 
in this study.
This study is the first to assess the RAND-36/SF-36 QoL questionnaire combined with a wide range of 
symptoms. The symptoms associated with chronic disease statuses are likely to explain the differences 
in QoL. The QoL scores of the recovered group were comparable with or higher than those of a normal 
population, in contrast to the decrease in scores in all domains of the mildly affected population, and a 
major decrease in QoL in the highly affected group. The QoL scores of our ‘recovered’ group of individuals 
were also comparable to those of ‘healthy normal’ individuals as observed in a previous study in Curaçao 
(Supplementary Table 10) [21]. This consistency between a chikungunya-‘recovered’ population and 
a ‘healthy normal’ population was shown before [25], indicating that subjects in a ‘recovered’ group 
might serve as a control group when assessing chronic chikungunya sequelae. The latter is in particular 
relevant for areas with high attack rates during chikungunya outbreaks like in Curaçao, where 33-50% of 
the population was infected in the first chikungunya epidemic. A chikungunya-negative ‘healthy normal’ 
control group is hard to recruit in such situations. That notwithstanding, lack of inclusion of this ‘healthy 
normal’ group is still considered as a limitation of this study. 
RAND-36 measured QoL scores were highly associated with chronic disease statuses. This is consistent 
with other studies using the RAND-36/SF-36 QoL questionnaire [10,25,29], while a study using the (shorter 
QoL questionnaire) SF-12 found a moderate impact on physical, but no impact on mental status [16]. 
Generally, a difference of 5-10 points in the domains of the RAND-36 is considered to be a Minimally Clinical 
Important Difference (MCID) [33-36]. The major drop in QoL scores from the highly affected population 
exceeds the 10-point border on all domains when compared with the QoL scores of the recovered (score 
difference: 16-34) and the mildly affected population (score difference: 10-22) (Figure 4, Supplementary 
Table 10). This finding is alarming and stresses the importance of identifying and treating these ‘highly 
affected’ patients early and appropriately. However, the decrease in QoL of the ‘mildly affected’ individuals 
is considerably less (Figure 4) and  implies that, although a MCID on QoL can still be achieved on some of 
the QoL domains, no intensive monitoring is needed for this group. Consequently, efficient psychological 
and physical care for chronic chikungunya patients should focus on the highly affected group. 
This study investigated the characteristics that differentiate the severity of chronic chikungunya disease 
status. The main characteristics associated with a (highly) affected disease status were higher proportions 
of arthralgia and weakness in the extremities. Other studies show higher proportions of rheumatic 
manifestations in older participants [12,25,37], which is in line with the data from our study. However, 
participants older than 60 years had a higher chance to be defined as recovered of chronic chikungunya than 
those between 41-60 years old; implying that rheumatic manifestations in individuals older than 60 years 
may have been less often attributed to a previous chikungunya infection. For example, arthrosis/arthritis 
(degenerative/inflammatory joint disease) may be responsible for chronic joint complaints of those stating 
to be recovered of chikungunya while remaining with joint pain. Hence, classification methods of chronic 
chikungunya sequelae in future studies should not solely hinge on articular manifestations, or explicitly 
control for articular/rheumatic comorbidities. The described characteristics associated with disease status 
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contribute to the understanding of which conditions and symptoms make patients perceive their chronic 
chikungunya disease as severe. Accordingly, physicians should be aware that chronic chikungunya patients 
presenting with the above-mentioned characteristics as well as loss of vitality and having diabetes, have a 
higher risk of being highly affected.
The recruitment procedure of this study via general practitioners resulted in a study population who is 
known by their physicians for their CHIKV infection, which might have implications for the generalizability 
of the study. The study population consisted of 26.0% of males, compared to 45.7% males in the total 
population of Curaçao [17]. Results on QoL and symptoms might differ if assessed in more gender-balanced 
studies, since females tend to assess their QoL lower than males [38]. The higher percentage of females 
in this study might be explained by the findings that they visit a doctor more often [39]. Nonetheless, 
selection bias was limited given the high response rate of this study (82.5%).  Further limitations of this 
study which should be taken into account are the following: co-infections (e.g. dengue) were not excluded, 
the assessment of onset of chikungunya disease (at time of interview) might have led to recall bias, time 
between disease onset and time of interview differed, and the different interviewers performing the 
interviews may have induced investigator bias. The strengths of this study were its comprehensive nature 
and the availability of extensive qualitative data, which gave the researchers a wider context to interpret 
the results. Patients were visited and surveyed at home, providing a safe and confident environment. 
Moreover, the study population is representative of the neighbourhoods, nationalities and socio-economic 
classes of the whole island (Figure 1).
In conclusion, this study characterized chikungunya chronic disease into ‘recovered’, ‘mildly affected’ 
and ‘highly affected’. The symptoms and major impact on QoL associated with this classification plead to 
prioritize the highly affected group in chronic chikungunya care. This group can easily be identified using 
the CLTCS score (presented and explained in Table 2).
Acknowledgements
We are very grateful to the study individuals who volunteered their time to participate in the study. We 
would like to thank the interviewers and general practitioners for their support in the data collection. 
We thank the Ministry of Health, Environment and Nature of Curaçao for hosting and assisting JE during 






1. Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis, 
2007; 7(5):319-27. 
2. WHO Global Alert and Response (GAR). Chikungunya in the French part of the Caribbean isle of Saint Martin. 
Available at: http://www.who.int/csr/don/2013_12_10a/en/. Accessed 21 March 2017.  
3. Institut de Veille Sanitaire. Virus Chikungunya sur l’île de Saint Martin et en Martinique. Point de situation au 19 
décembre 2013. Available at: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-
transmission-vectorielle/Chikungunya/Donnees-epidemiologiques/Virus-Chikungunya-sur-l-ile-de-Saint-Martin-
et-en-Martinique.Point-de-situation-au-19-decembre-2013/(pdf)/1. Accessed January 2015.  
4. PAHO. Number of reported cases of Chikungunya Fever in the Americas - EW 1 (January 9, 2015). Available at: 
http://www.paho.org/hq/index.php?option=com_topics&view=rdmore&cid=7929&Itemid=40931&lang=en. 
Accessed 21 March 2017 
5. Pan American Health Organisation. Chikungunya. Available at: http://www.paho.org/hq/index.
php?option=com_content&view=article&id=8303&Itemid=40023&lang=en. Accessed 21 March 2017. 
6. Borgherini G, Poubeau P, Jossaume A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 
adult patients on reunion island. Clin Infect Dis, 2008; 47(4): 469-475.  
7. Larrieu S, Pouderoux N, Pistone T, et al. Factors associated with persistence of arthralgia among chikungunya 
virus-infected travellers: Report of 42 French cases. J Clin Virol, 2010; 47(1):85-88.  
8. Sissoko D, Malvy D, Ezzedine K, et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic 
manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis, 2009; 3(3):e389.  
9. Van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP. Long-term sequelae of chikungunya virus disease: a 
review. Travel Med Infect Dis, 2017; 15:8-22 [epub ahead of print] 
10. Ramachandran V, Malaisamy M, Ponnaiah M, et al. Impact of Chikungunya on Health Related Quality of Life 
Chennai, South India. PLoS One, 2012; 7(12): e51519.  
11. Brighton SW, Prozesky OW, de la Harpe AL. Chikungunya virus infection. A retrospective study of 107 cases. S Afr 
Med J, 1983; 63: 313–315. 
12. Schilte C, Staikovsky F, Couderc T, et al. Chikungunya virus-associated long-term arthralgia: a 36-month 
prospective longitudinal study. PLoS Negl Trop Dis, 2013; 7(3), e2137. 
13. Economopoulou A, Dominguez M, Helynck B, et al. Atypical Chikungunya virus infections: clinical manifestations, 
mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect, 2009; 
137(4):534-41. 
14. Torres JR, Leopoldo Códova G, Castro JS, et al. Chikungunya fever: Atypical and lethal cases in the Western 
hemisphere: A Venezuelan experience. IDCases, 2015; 2(1):6-10. 
15. Renault P, Josseran L, Pierre V. Chikungunya-related fatality rates, Mauritius, India, and Reunion Island. Emerg 
Infect Dis, 2008; 14(8):1327 
16. Soumahoro MK, Gerardin P, Boelle PY, et al. Impact of Chikungunya Virus Infection on Health Status and Quality 
of Life: A Retrospective Cohort Study. PLoS One, 2009; 4(11): e7800.  
17. Ter Bals M. Demography of Curaçao; Census 2011. Available at: http://www.cbs.cw/website/statistical-
information_229/item/census-2011-publications_163.html. Accessed 21 March 2017.  
143
6
18. Meteorological Department Curaçao. Summary of climatological data, period 1971-2000; Available at: http://
www.meteo.cw/climate.php?Lang=Eng&St=TNCC&Sws=R11. Accessed 21 March 2017. 
19. Van der Zee K, Sanderman R, Heyink JW, de Haes H. Psychometric qualities of the RAND 36-item Health Survey 
1.0: a multidimensional measure of general health status. Int J Behav Med, 1996; 3, 104-122.  
20. Van der Zee KI, Sanderman R. RAND-36. Groningen: Northern Centre for Health Care Research, University of 
Groningen, the Netherlands. 1993; 28. 
21. Alberts JF, Gerstenbluth I, Halabi YT, Koopmans PC, O’Niel J, van den Heuvel WJA. The Curacao Health Study, 
methodology and main results. Assen: Van Gorcum, 1996; 119. 
22. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis. Arthritis Rheum. 1980 Jan 1;23(2):146-
52. 
23. Bardwell WA, Nicassio PM, Weisman MH, Gevirtz R, Bazzo D. Rheumatoid Arthritis Severity Scale: a brief, 
physician-completed scale not confounded by patient self-report of psychological functioning. Rheumatology 
(Oxford). 2002 Jan 1;41(1):38-45. 
24. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE. Determining minimally important changes in generic and 
disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis 
Rheum. 2000 Jul 1;43(7):1478. 
25. Couturier E, Guillemin F, Mura M, et al. Impaired quality of life after chikungunya virus infection: a 2-year follow-
up study. Rheumatology (Oxford). 2012; 51(7):1315-22. 
26. Yaseen HM, Simon F, Deparis X, Marimoutou C. Identification of initial severity determinants to predict arthritis 
after chikungunya infection in a cohort of French gendarmes. BMC Musculoskelet Disord, 2014; 15(1):249. 
27. Rahim AA, Thekkekara RJ, Bina T, Paul BJ. Disability with persistent pain following an epidemic of Chikungunya in 
rural South India. J Rheumatol, 2016; 43(2), 440-444. 
28. Gérardin P, Fianu A, Michault A, et al. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to 
the TELECHIK cohort study. Arthritis Res Ther, 2013; 15(1):R9. 
29. Marimoutou C, Ferraro J, Javelle E, Deparis X, Simon F. Chikungunya infection: self-reported rheumatic morbidity 
and impaired quality of life persist 6 years later. Clin Microbiol Infect. 2015; 21(7):688-93.. 
30. De Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D. Chronic pain associated with the Chikungunya Fever: 
long lasting burden of an acute illness. BMC Infect Dis, 2010;10(1):31. 
31. Manimunda SP, Vijayachari P, Uppoor R, et al. Clinical progression of chikungunya fever during acute and 
chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 
2010;104(6):392-9. 
32. Gérardin P, Fianu A, Malvy D, et al. Perceived morbidity and community burden after a Chikungunya outbreak: 
the TELECHIK survey, a population-based cohort study. BMC med, 2011;9(1):5. 
33. Bruce B, Fries JF. The Stanford health assessment questionnaire: dimensions and practical applications. Health 
Qual Life Outcomes. 2003 Jun 9;1(1):20. 
34. Ward MM, Guthrie LC, Alba MI. Clinically important changes in Short Form 36 health survey scales for use in 
rheumatoid arthritis clinical trials: the impact of low responsiveness. Arthritis Care Res (Hoboken). 2014 Dec 
1;66(12):1783-9. 
35. Strand V, Singh JA. Newer Biological Agents in Rheumatoid Arthritis: impact on health-related quality of life and 




36. Strand V, Rentz AM, Cifaldi MA, Chen N, Roy S, Revicki D. Health-related quality of life outcomes of adalimumab 
for patients with early rheumatoid arthritis: results from a randomized multicenter study. J Rheumatol. 2012 
Jan;39(1):63-72. 
37. Essackjee K, Goorah S, Ramchurn SK, Cheeneebash J, Walker-Bone K. Prevalence of and risk factors for chronic 
arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus. Postgrad 
Medical J, 2013; 89(1054):440-7. 
38. Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in 
population health? Results from the Whitehall II study. Bmj. 1997 Nov 15;315(7118):1273-9. 
39. Verstraeten S, Jansen I, Pin R, Brouwer W. De Nationale Gezondheidsenquête Curaçao, Methodologie en 




Supplementary table 1. Univariate analysis of clinical presentation comparing recovered vs. affected 
population
*Fisher’s exact test; ap-value corresponds to the comparison of the proportion of individuals answering ‘yes’ (proportion of individuals 
answering ‘somewhat’ and ‘yes’ summed) and those responding ‘no’ between the groups ‘recovered’ and ‘affected’ (mildly and highly 
affected groups pooled together); bTotal affected group n=193; cTotal recovered group n=109
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*Fisher’s exact test; ap-value corresponds to the comparison of the proportion of individuals answering ‘yes’ (proportion of individuals 
answering ‘somewhat’ and ‘yes’ summed) and those responding ‘no’ between the groups ‘recovered’ and ‘affected’ (mildly and highly affected 
groups pooled together); bTotal affected group n=193; cTotal recovered group n=109 
 Total (n=304) Recovered (n=110) Affected (n=194)  
 No Yes No Yes No Yes p-valuea Somewhat Yes Somewhat Yes Somewhat Yes 
 n (%) n (%) n   (%) n (%) n (%) n (%) n (%) n (%) n (%)  
Joint pain in the …                    
upper extremities 170 (55.9) 72 (23.7) 62 (20.4) 103 (93.6) 4 (3.6) 3 (2.7) 67 (34.5) 68 (35.1) 59 (30.4) <0.001 
lower extremities 173 (56.9) 62 (20.4) 69 (22.7) 101 (91.8) 2 (1.8) 7 (6.4) 72 (37.1) 60 (30.9) 62 (32.0) <0.001 
back/neck 220 (72.4) 46 (15.1) 38 (12.5) 102 (92.7) 4 (3.6) 4 (3.6) 118 (60.8) 42 (21.6) 34 (17.5) <0.001 
Weakness in the …                     
upper extremities 194 (63.8) 67 (22.0) 43 (14.1) 108 (98.2) 1 (0.9) 1 (0.9) 86 (44.3) 66 (34.0) 42 (21.6) <0.001 
lower extremities 201 (66.1) 54 (17.8) 49 (16.1) 103 (93.6) 4 (3.6) 3 (2.7) 98 (50.5) 50 (25.8) 46 (23.7) <0.001 
back/neck 236 (77.6) 34 (11.2) 34 (11.2) 103 (93.6) 4 (3.6) 3 (2.7) 133 (68.6) 30 (15.5) 31 (16.0) <0.001 
Myalgiab  197 (65.0) 65 (21.5) 41 (13.5) 102 (92.7) 6 (5.5) 2 (1.8) 95 (49.2) 59 (30.6) 39 (20.2) <0.001 
Fatigue 209 (68.8) 56 (18.4) 39 (12.8) 97 (88.2) 8 (7.3) 5 (4.5) 112 (57.7) 48 (24.7) 34 (17.5) <0.001 
Insomnia 218 (71.7) 49 (16.1) 37 (12.2) 99 (90.0) 6 (5.5) 5 (4.5) 119 (61.3) 43 (22.2) 32 (16.5) <0.001 
Sombrenessb  253 (83.5) 31 (10.2) 19 (6.3) 107 (97.3) 2 (1.8) 1 (0.9) 146 (75.6) 29 (15.0) 18 (9.3) <0.001 
Loss of vitality 229 (75.3) 51 (16.8) 24 (7.9) 103 (93.6) 6 (5.5) 1 (0.9) 126 (64.9) 45 (23.2) 23 (11.9) <0.001 
Numbness 254 (83.6) 32 (10.5) 18 (5.9) 110 (100.0) 0 (0.0) 0 (0.0) 144 (74.2) 32 (16.5) 18 (9.3) <0.001 
Paraesthesia 269 (88.5) 20 (6.6) 15 (4.9) 108 (98.2) 1 (0.9) 1 (0.9) 161 (83.0) 19 (9.8) 14 (7.2) <0.001 
Nausea 271 (89.1) 23 (7.6) 10 (3.3) 109 (99.1) 1 (0.9) 0 (0.0) 162 (83.5) 22 (11.3) 10 (5.2) <0.001 
Vomitingb 294 (97.0) 5 (1.7) 4 (1.3) 110 (100.0) 0 (0.0) 0 (0.0) 184 (95.3) 5 (2.6) 4 (2.1) 0.029* 
Abdominal painc 276 (91.1) 20 (6.6) 7 (2.3) 107 (98.2) 2 (1.8) 0 (0.0) 169 (87.1) 18 (9.3) 7 (3.6) 0.001 
Skin diseases 284 (93.4) 11 (3.6) 9 (3.0) 106 (96.4) 3 (2.7) 1 (0.9) 178 (91.8) 8 (4.1) 8 (4.1) 0.119 
Hair loss 273 (89.8) 12 (3.9) 19 (6.3) 105 (95.5) 3 (2.7) 2 (1.8) 168 (86.6) 9 (4.6) 17 (8.8) 0.014 
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Supplementary table 2. Univariate analysis of clinical presentation comparing mildly affected vs. highly 
affected
*Fisher’s exact test;  ap-value corresponds to the comparison of the proportion of individuals answering ‘yes’ (proportion of ‘somewhat’ 
and ‘yes’ summed) and those responding ‘no’ between the groups ‘mildly affected’ and ‘highly affected’; bTotal highly affected group 
n=88; cTotal mildly affected group n=104.
Supplementary Table 2. Univariate analysis of clinical presentation comparing mildly 
affected vs. highly affected 
 
 
*Fisher’s exact t st; ap-value corresponds to the comparison of the proportion of individuals 
answering ‘yes’ (proportion of ‘somewhat’ and ‘yes’ summed) and those responding ‘no’ 
between the groups ‘mildly affected’ and ‘highly affected’; bTotal highly affected group n=88; 
cTotal mildly affected group n=104. 
 Mildly affected (n=105) Highly affected (n=89)  
 No Yes No Yes p-
valuea Somewhat Yes Somewhat Yes 
 n (%) n (%) n (%) n (%) n (%) n (%)  
Joint pain in the …              
upper extremities 54 (51.4) 38 (36.2) 13 (12.4) 13 (14.6) 30 (33.7) 46 (51.7) <0.001 
lower extremities 57 (54.3) 31 (29.5) 17 (16.2) 15 (16.9) 29 (32.6) 45 (50.6) <0.001 
back/neck 70 (66.7) 26 (24.8) 9 (8.6) 48 (53.9) 16 (18.0) 25 (28.1) 0.070 
Weakness in the …               
upper extremities 64 (61.0) 32 (30.5) 9 (8.6) 22 (24.7) 34 (38.2) 33 (37.1) <0.001 
lower extremities 72 (68.6) 25 (23.8) 8 (7.6) 26 (29.2) 25 (28.1) 38 (42.7) <0.001 
back/neck 77 (73.3) 21 (20.0) 7 (6.7) 56 (62.9) 9 (10.1) 24 (27.0) 0.120 
Myalgiab 61 (58.1) 38 (36.2) 6 (5.7) 34 (38.6) 21 (23.9) 33 (37.5) 0.007 
Fatigue 76 (72.4) 22 (21.0) 7 (6.7) 36 (40.4) 26 (29.2) 27 (30.3) <0.001 
Insomnia 78 (74.3) 22 (21.0) 5 (4.8) 41 (46.1) 21 (23.6) 27 (30.3) <0.001 
Sombrenessb 92 (87.6) 10 (9.5) 3 (2.9) 54 (61.4) 19 (21.6) 15 (17.0) <0.001 
Loss of vitality 83 (79.0) 18 (17.1) 4 (3.8) 43 (48.3) 27 (30.3) 19 (21.3) <0.001 
Numbness 87 (82.9) 13 (12.4) 5 (4.8) 57 (64.0) 19 (21.3) 13 (14.6) 0.003 
Paraesthesia 96 (91.4) 6 (5.7) 3 (2.9) 65 (73.0) 13 (14.6) 11 (12.4) 0.001 
Nausea 95 (90.5) 7 (6.7) 3 (2.9) 67 (75.3) 15 (16.9) 7 (7.9) 0.004 
Vomitingc  99 (95.2) 3 (2.9) 2 (1.9) 85 (95.5) 2 (2.2) 2 (2.2) 1.000* 
Abdominal pain 96 (91.4) 6 (5.7) 3 (2.9) 73 (82.0) 12 (13.5) 4 (4.5) 0.051 
Skin diseases 100 (95.2) 3 (2.9) 2 (1.9) 78 (87.6) 5 (5.6) 6 (6.7) 0.055 
Hair loss 96 (91.4) 4 (3.8) 5 (4.8) 72 (80.9) 5 (5.6) 12 (13.5) 0.032 
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Supplementary table 3. Comparison of two possible measures for chikungunya disease persistence





  CLTCS  Score  






Do you still suffer from No 108 (98.2%) 40 (38.1%) 2 (2.2%) 150 (49.3%) 
chikungunya symptoms? Yes 2 (1.8%) 65 (61.9%) 87 (97.8%) 154 (50.7%) 
Total  110 (100.0%) 105 (100.0%) 89 (100.0%) 304 (100.0%) 
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Supplementary table 4. Overview of participants’ selection procedure
 1
Supplementary Table 4. Overview of participants’ selection procedure 
 
 n 
Selected participants 535 
Contacted participants 411 
Consenting participants 339 
Reasons for non-contacting 
 
No attempt was made when project ended, due to lack of fieldwork capacity 25 
Participant was not reached by phone and visit 68 
Non-participant circumstances prevented interviewer from (completing) 
interviewing 
9 
Participant was on holiday/ abroad 20 
Participant died 2 
Reasons for non-response  
Refusal  36 
After contacting, no interview performed due to unforeseen circumstances 25 
Individual had already participated in another local chikungunya study 6 
Individual denied having been infected with chikungunya virus 5 
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Supplementary table 5. Symptoms stratified by chronic disease status
*Fisher’s exact test; ap-value corresponds to the comparison of the proportion of individuals answering ‘yes’ (proportion of individuals 
answering ‘somewhat’ and ‘yes’ summed) and those responding ‘no’ between the groups ‘recovered’, ‘mildly affected’ and ‘highly 
affected’ using the chi-square test; bTotal highly affected group n=88; cTotal mildly affected group n=104; dTotal recovered group n=109
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*Fisher’s exact test; ap-value corresponds to the comparison of the proportion of  
of individuals answering ‘yes’ (proportion of individuals answering ‘somewhat’ and ‘yes’ summed) 
and those responding ‘no’ between the groups ‘recovered’, ‘mildly affected’ and  
‘highly affected’ using the chi-square test; bTotal highly affected group n=88; cTotal mildly affected 










 n (%)  n (%)  n (%) p-valueb 
Joint pain in the …          
upper extremities 7 (6.4)  51 (48.6)  76 (85.4) <0.001 
lower extremities 9 (8.2)  48 (45.7)  74 (83.1) <0.001 
Back/neck 8 (7.3)  35 (33.3)  41 (46.1) <0.001 
Weakness in the …           
upper extremities 2 (1.8)  41 (39.0)  67 (75.3) <0.001 
lower extremities 7 (6.4)  33 (31.4)  63 (70.8) <0.001 
back/neck 7 (6.4)  28 (26.7)  33 (37.1) <0.001 
Myalgiab  8 (7.3)  44 (41.9)  54 (61.4) <0.001 
Fatigue 13 (11.8)  29 (27.6)  53 (59.6) <0.001 
Insomnia 11 (10.0)  27 (25.7)  48 (53.9) <0.001 
Sombrenessb  3 (2.7)  13 (12.4)  34 (38.6) <0.001 
Loss of vitality 7 (6.4)  22 (21.0)  46 (51.7) <0.001 
Numbness 0 (0.0)  18 (17.1)  32 (36.0) <0.001 
Paraesthesia 2 (1.8)  9 (8.6)  24 (27.0) <0.001 
Nausea 1 (0.9)  10 (9.5)  22 (24.7) <0.001 
Vomitingc  0 (0.0)  5 (4.8)  4 (4.5) 0.035* 
Abdominal paind 2 (1.8)  9 (8.6)  16 (18.0) <0.001 
Skin diseases 4 (3.6)  5 (4.8)  11 (12.4) 0.031 
Hair loss 5 (4.5)  9 (8.6)  17 (19.1) 0.003 
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Supplementary table 6. Univariate analysis of general characteristics comparing the recovered vs. the 
affected population
*Fisher’s exact test; ap-value corresponds to the comparison between the groups ‘recovered’ and ‘affected’ (mildly and highly affected 
together) using the chi-square test; bTotal recovered group n=109; cTotal recovered group n=107, total affected group n=191; dCardiac 
disease group includes hypercholesterolemia and hypertension; eOther diseases included chronic lung diseases, thyroid diseases, 
auto-immune diseases, gastro-intestinal complaints, pain complaints, allergies and other.
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 n (%) 
 
n (%) p-valuea 
Age   
 
   
18-40 years 36 (32.7) 
 
30 (15.5)  
41-60 years 44 (40.0) 
 
114 (58.8)  
>60 years 30 (27.3) 
 
50 (25.8) 0.001 
Sex   
 
   
Female 76 (69.1) 
 
149 (76.8)  
Male 34 (30.9) 
 
45 (23.2) 0.141 
Education   
 
   
Illiterate/ primary school 25 (22.7) 
 
45 (23.2)  
Secondary school 36 (32.7) 
 
74 (38.1)  
Intermediate vocational education 33 (30.0) 
 
47 (24.2)  
University (of applied sciences) 16 (14.5) 
 
28 (14.4) 0.690 
Occupationb   
 
   
Unemployed/student/housewife/voluntary 19 (17.4) 
 
39 (20.1)  
Paid job (domestic or manual) 42 (38.5) 
 
87 (44.8)  
Paid job (not domestic or manual) 28 (25.7) 
 
33 (17.0)  
Retired 20 (18.3) 
 
35 (18.0) 0.317 
Incomec    
 
   
0-999ANG 7 (6.5) 
 
23 (12.0)  
1000-2499 ANG 40 (37.4) 
 
81 (42.4)  
2500-4999 ANG 43 (40.2) 
 
67 (35.1)  
>5000 ANG 17 (15.9) 
 
20 (10.5) 0.204 
Underlying chronic disease   
 
   
None 61 (55.5) 
 
91 (46.9) 0.152 
Joint disease 8 (7.3) 
 
34 (17.5) 0.013 
Cardiac diseased 20 (18.2) 
 
53 (27.3) 0.073 
Neurologic disease 4 (3.6) 
 
7 (3.6) 1.000* 
Diabetes mellitus 10 (9.1) 
 
29 (14.9) 0.142 
Other diseasee 13 (11.8) 
 
17 (8.8) 0.391 
 
*Fisher’s exact test; ap-value corresponds to the comparison between th roups  
‘recovered’ and ‘affected’ (mildly and highly affected together) using the chi-square  
test; bTotal recovered group n=109; cTotal recovered group n=107, total affected group  
n=191; dCardiac disease group includes hypercholesterolemia and hypertension;   
eOther diseases included chronic lung diseases, thyroid diseases, auto-immune  




Supplementary table 7. Univariate analysis of general characteristics comparing mildly affected vs. 
highly affected population
*Fisher’s exact test; ap-value corresponds to the comparison between the groups ‘mildly affected’ and ‘highly affected’ using a Chi-
square test; bTotal mildly affected group n=104, total highly affected group n=87; cCardiac disease group includes hypercholesterolemia 
and hypertension;  dOther diseases included chronic lung diseases, thyroid diseases, auto-immune diseases, gastro-intestinal 
complaints, pain complaints, allergies and other.
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*Fisher’s exact test; ap-value corresponds to the comparison between the groups  
‘mildly affected’ and ‘highly affected’ using a Chi-square test; bTotal mildly affected  
group n=104, total highly affected group n=87; cCardiac disease group includes  
hypercholesterolemia and hypertension;  dOther diseases included chronic lung  
diseases, thyroid diseases, auto-immune diseases, gastro-intestinal complaints, pain  













 n (%)  n (%) p-valuea 
Age       
18-40 years 17 (16.2)  13 (14.6)  
41-60 years 63 (60.0)  51 (57.3)  
>60 years 25 (23.8)  25 (28.1) 0.787 
Sex       
Female 75 (71.4)  74 (83.1)  
Male 30 (28.6)  15 (16.9) 0.054 
Education       
Illiterate/ primary school 24 (22.9)  21 (23.6)  
Secondary school 35 (33.3)  39 (43.8)  
Intermediate vocational education 32 (30.5)  15 (16.9)  
University (of applied sciences) 14 (13.3)  14 (15.7) 0.152 
Occupation       
Unemployed/student/housewife/voluntary 18 (17.1)  21 (23.6)  
Paid job (domestic or manual) 50 (47.6)  37 (41.6)  
Paid job (not domestic or manual) 20 (19.0)  13 (14.6)  
Retired 17 (16.2)  18 (20.2) 0.497 
Incomeb       
0-999ANG 16 (15.4)  7 (8.0)  
1000-2499 ANG 41 (39.4)  40 (46.0)  
2500-4999 ANG 36 (34.6)  31 (35.6)  
>5000 ANG 11 (10.6)  9 (10.3) 0.455 
Underlying chronic disease       
None 60 (57.1)  31 (34.8) 0.002 
Joint disease 14 (13.3)  20 (22.5) 0.095 
Cardiac diseasec 26 (24.8)  27 (30.3) 0.421 
Neurologic disease 4 (3.8)  3 (3.4) 1.000* 
Diabetes mellitus 8 (7.6)  21 (23.6) 0.002 
Other diseased 6 (5.7)  11 (12.4) 0.103 
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Supplementary table 8. Final model of factors independently associated  with being defined as chronically 
affected vs. recovered from chikungunya disease
 1
Supplementary Table 8. Final model of factors independently associated  
with being defined as chronically affected vs. recovered from chikungunya  
disease 
 
 OR (CI95) p-value 
Arthralgia in upper extremities    
No 1  
Yes (somewhat/yes) 4.93 (1.78 – 13.64) 0.002 
Arthralgia in lower extremities   
No 1  
Yes (somewhat/yes) 12.29 (4.86 – 31.09) <0.001 
Weakness in upper extremities   
No 1  
Yes (somewhat/yes) 14.93 (3.05 – 72.99) 0.001 
Myalgia   
No 1  
Yes (somewhat/yes) 3.08 (1.11 – 8.52) 0.030 
Age   
18-40 years 1 0.007 
41-60 years 2.24 (0.96 – 5.22) 0.061 






Supplementary table 9. Final model of factors independently associated with being defined as highly 
affected vs. mildly affected by chronic chikungunya disease
 1
Supplementary Table 9. Final model of factors independently associated 
with being defined as highly affected vs. mildly affected by chronic 
chikungunya disease 
 
 OR (CI95) p-value 
Arthralgia in upper extremities    
No 1  
Yes (somewhat/yes) 6.97 (2.84 – 17.10) <0.001 
Arthralgia in lower extremities   
No 1  
Yes (somewhat/yes) 3.28 (1.26 – 8.54) 0.015 
Weakness in lower extremities   
No 1  
Yes (somewhat/yes) 4.23 (1.53 – 11.70) 0.005 
Weakness in back/neck   
No 1  
Yes (somewhat/yes) 0.15 (0.05 – 0.45) 0.001 
Loss of vitality   
No 1  
Yes (somewhat/yes) 3.45 (1.49 – 8.02) 0.004 
Diabetes mellitus   
No 1  




Supplementary table 10. RAND-36 quality of life scores strati fi ed by chronic disease status
Maximum RAND-36 score for each domain= 100; IQR= 25th-75th percenti le; ap-value corresponds to the comparison of the RAND-36 
domains between the recovered, mildly aff ected and highly aff ected populati on using a Kruskal-Wallis test; c(daily life) role limitati ons 
due to physical health; bMean scores derived from ‘the Curaçao health study’ (1)  dTotal group: n=303; Recovered: n=107; eIndicati on 
of perceived change in health over the past year.
Reference: 
1. Alberts, J. F., Gerstenbluth, I., Halabi, Y. T., Koopmans, P. C., & O’Niel, J. Heuvel van den WJA, 1996: The Curacao 




Supplementary Table 10. RAND-36 quality of life scores stratified by chronic disease status 
 
Maximum RAND-36 score for each domain= 100; IQR= 25th-75th percentile; ap-value corresponds to the comparison of the RAND-36 domains between the 
recovered, mildly affected and highly affected population using a Kruskal-Wallis test; c(daily life) role limitations due to physical health; bMean scores 
derived from ‘the Curaçao health study’ (1)  dTotal group: n=303; Recovered: n=107; eIndication of perceived change in health over the past year. 
 
Reference:  
(1) Alberts, J. F., Gerstenbluth, I., Halabi, Y. T., Koopmans, P. C., & O’Niel, J. Heuvel van den WJA, 1996: The Curacao Health Study, methodology and main 
results. Assen: Van Gorcum, 119. 
 
 Total group (n=304) Recovered (n=110)  Mildly affected (n=107) Highly affected (n=89) Kruskal-Wallis test  Curaçao 1996b 
Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) p-valuea mean 
Physical functioning 85.0 (55.0-100.0) 75.4 (27.8) 100.0 (80.0-100.0) 87.5 (21.1) 90.0 (70.0-100.0) 78.7 (25.3) 60.0 (37.5-80.0) 56.6 (28.2) <0.001 89.3 
Social functioning 87.5 (75.0-100.0) 83.8 (19.9) 100.0 (87.5-100.0) 91.0 (14.1) 87.5 (75.0-100.0) 85.1 (18.3) 75.0 (62.5-87.5) 73.3 (23.4) <0.001 87.7 
Physical role functioningc 100.0 (50.0-100.0) 75.0 (39.0) 100.0 (100.0-100.0) 90.0 (28.0) 100.0 (50.0-100.0) 75.5 (38.6) 75.0 (0.0-100.0) 55.9 (43.0) <0.001 82.5 
Emotional health perceptions 100.0 (66.7-100.0) 79.9 (37.4) 100.0 (100.0-100.0) 93.3 (23.4) 100.0 (100.0-100.0) 82.2 (35.5) 100.0 (0.0-100.0) 60.7 (45.1) <0.001 87.4 
Mental health 80.0 (68.0-88.0) 76.8 (17.2) 88.0 (76.0-92.0) 83.6 (12.2) 80.0 (62.0-88.0) 77.7 (14.5) 68.0 (58.0-80.0) 67.3 (20.8) <0.001 78.4 
Vitality 70.0 (60.0-85.0) 70.7 (19.2) 85.0 (70.0-90.0) 80.3 (15.0) 70.0 (60.0-82.5) 70.5 (17.7) 60.0 (50.0-70.0) 59.1 (19.2) <0.001 74.6 
Bodily pain 77.6 (57.1-100.0) 75.0 (23.2) 100.0 (79.6-100.0) 86.6 (21.6) 77.6 (67.3-89.8) 75.4 (20.0) 67.3 (44.9-73.5) 60.2 (20.4) <0.001 85.1 
General health perception 70.0 (60.0-80.0) 67.8 (18.6) 77.5 (65.0-85.0) 74.7 (14.9) 70.0 (60.0-82.5) 69.4 (17.0) 60.0 (45.0-75.0) 57.5 (20.2) <0.001 68.0 




Supplementary Table 10. RAND-36 quality of life scores stratified by chronic disease status 
 
Maximum RAND-36 score for each domain= 100; IQR= 25th-75th percentile; ap-value corresponds to the comparison f the RAND-36 domains between the 
recovered, mildly affected and highly affected population using a Kruskal-Wallis test; c(daily life) rol  limitations due o physical ealth; bMean scores 
derived from ‘the Curaçao health study’ (1)  dTotal group: n=303; Recovered: n=107; eIndication of perceived change in health over the past ye r. 
 
Reference:  
(1) Alberts, J. F., Gerstenbluth, I., Halabi, Y. T., Koopmans, P. C., & O’Niel, J. Heuvel van den WJA, 1996: The Curacao Health Study, methodology and main 
results. Assen: Van Gorcum, 119. 
 
 Total group (n=304) Recovered (n=110)  Mildly affected (n=107) High y affected (n=89) Kruskal-Wallis test  Curaçao 1996b 
Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD)  ( ) p-valuea mean 
Physical functioning 85.0 (55.0-100.0) 75.4 (27.8) 100.0 (80.0-100.0) 87.5 (21.1) 90.0 (70.0-100.0) 78.7 (25.3) 60 37 5 8 .0) 56.6 ( 8.2) < .0 1 9 3
Social functioning 87.5 (75.0-100.0) 83.8 (19.9) 100.0 (87.5-100.0) 91.0 (14.1) 87.5 (75.0-100.0) 85.1 (18.3) 75 0 62 5 87.5) 7 .3 (23.4) < .0 1 87 7
Physical role functioningc 100.0 (50.0-100.0) 75.0 (39.0) 100.0 (100.0-100.0) 90.0 (28.0) 100.0 (50.0-100.0) 75.5 (38.6) 75.0 (0.0-100.0) 5 .9 (43. ) < .0 1 82 5
Emotional health perceptions 100.0 (66.7-100.0) 79.9 (37.4) 100.0 (100.0-100.0) 93.3 (23.4) 100.0 (100.0-100.0) 82.2 (35.5) 0.0-10 .0) 60.7 (45.1) < .0 1 87 4
Mental health 80.0 (68.0-88.0) 76.8 (17.2) 88.0 (76.0-92.0) 83.6 (12.2) 80.0 (62.0-88.0) 77.7 (14.5) 68 5 0 67.3 (20.8) <0 01 78 4
Vitality 70.0 (60.0-85.0) 70.7 (19.2) 85.0 (70.0-90.0) 80.3 (15.0) 70.0 (60.0-82.5) 70.5 (17.7) 6 5 70 59.1 ( . ) <0 01 74 6
Bodily pain 77.6 (57.1-100.0) 75.0 (23.2) 100.0 (79.6-100.0) 86.6 (21.6) 77.6 (67.3-89.8) 75.4 (20.0) 6 3 44 9 73.5) 60.2 ( 0.4) < .0 1 5 1
General health perception 70.0 (60.0-80.0) 67.8 (18.6) 77.5 (65.0-85.0) 74.7 (14.9) 70.0 (60.0-82.5) 69.4 (17.0) 6 45 75 5 .5 (20.2) <0 001 68 0
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Maximum RAND-36 score for each domain= 100; IQR= 25th-75th percentile; ap-value corresponds to the comparison of the RAND-36 domains between the 
recovered, mildly ffected and highly affected population using a Kruskal-Wallis test; c(daily life) role limitations due to physical health; bMean scores 
derived from ‘the Curaçao health study’ (1)  dTotal group: n=303; Recovered: n=107; eIndication of perceived change in health over the past year. 
 
Reference:  
(1) Alberts, J. F., Gerstenbluth, I., Halabi, Y. T., Koopmans, P. C., & O’Niel, J. Heuvel van den WJA, 1996: The Curacao Health Study, methodology and main 
results. Assen: Van Gorcum, 119. 
 
 Total group (n=304) Recovered (n=110)  Mildly affected (n=107) Highly affected (n=89) Kruskal-Wallis test  Curaçao 1996b 
Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) Median (IQR) Mean (SD) p-valuea mean 
Physical functioning 85.0 (55.0-100.0) 75.4 (27.8) 100.0 (80.0-100.0) 87.5 (21.1) 90.0 (70.0-100.0) 78.7 (25.3) 60.0 (37.5-80.0) 56.6 (28.2) <0.001 89.3 
Social functioning 87.5 (75.0-100.0) 83.8 (19.9) 100.0 (87.5-100.0) 91.0 (14.1) 87.5 (75.0-100.0) 85.1 (18.3) 75.0 (62.5-87.5) 73.3 (23.4) <0.001 87.7 
Physical role functioningc 100.0 (50.0-100.0) 75.0 (39.0) 100.0 (100.0-100.0) 90.0 (28.0) 100.0 (50.0-100.0) 75.5 (38.6) 75.0 (0.0-100.0) 55.9 (43.0) <0.001 82.5 
Emotional health perceptions 100.0 (66.7-100.0) 79.9 (37.4) 100.0 (100.0-100.0) 93.3 (23.4) 100.0 (100.0-100.0) 82.2 (35.5) 100.0 (0.0-100.0) 60.7 (45.1) <0.001 87.4 
Mental health 80.0 (68.0-88.0) 76.8 (17.2) 88.0 (76.0-92.0) 83.6 (12.2) 80.0 (62.0-88.0) 77.7 (14.5) 68.0 (58.0-80.0) 67.3 (20.8) <0.001 78.4 
Vitality 70.0 (60.0-85.0) 70.7 (19.2) 85.0 (70.0-90.0) 80.3 (15.0) 70.0 (60.0-82.5) 70.5 (17.7) 60.0 (50.0-70.0) 59.1 (19.2) <0.001 74.6 
Bodily pain 77.6 (57.1-100.0) 75.0 (23.2) 100.0 (79.6-100.0) 86.6 (21.6) 77.6 (67.3-89.8) 75.4 (20.0) 67.3 (44.9-73.5) 60.2 (20.4) <0.001 85.1 
General health perception 70.0 (60.0-80.0) 67.8 (18.6) 77.5 (65.0-85.0) 74.7 (14.9) 70.0 (60.0-82.5) 69.4 (17.0) 60.0 (45.0-75.0) 57.5 (20.2) <0.001 68.0 
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Maximum RAND-36 score for each domain= 100; IQR= 25th-75th percent le; ap-value corresponds to the comparison f the RAND-36 domains between the 
recovered, mildly affected and highly affecte  popula ion using a Kruskal-Wallis test; c(daily life) role limitations due to physical hea th; bMean scores
derived from ‘the Curaçao health stu y’ (1) dTotal group: n=303; Recovered: n=107; eIndication of perceived change in health over th  past ye r. 
 
Reference:  
(1) Alberts, J. F , Gerstenblu , I., Halabi, Y. T., Koopmans, P. C., & O’N el, J. Heuvel v  den WJA, 1996: The C racao Health Study, methodology nd main
results. Assen: Van Gorcum, 119. 
 
 Total group (n=304) Recove ed (n=11 )  Mildly affected (n=107) Highly affected (n=89 Kruskal-Wallis test  Curaçao 1996b 
Median (IQR) Mean (SD) i  (I ) Mean (SD) Median (IQR) Mean (SD) Median (IQR) ean (SD) p-valuea mean 
Physical functioning 85.0 (55.0-100.0) 75.4 (27.8) 100.0 (80.0-1 0.0) 87.5 (21.1) 9 .  (7 . - . ) 8.7 (25.3) 60.0 (37.5-8 56.6 (28.2) < 01 89.3 
Social functioning 87.5 (75.0-100.0) 83.8 (19.9) 100.0 (87.5-1 0.0) 91.0 (14.1) 87.5 (75.0- . ) 85.1 (18.3) 5.0 (62.5-87 5 73.3 (23.4) <0 01 87.7 
Physical role functioningc 100.0 (50.0-100.0) 75.0 (39.0) .  (1 0.0-1 0.0) 90.0 (28.0) 1 0.0 (5 . - . ) 75.5 (38.6) 75 0.0-10 .0) 55.9 (43.0) <0 01 82.5 
Emotional health perceptions 100.0 (66.7-100.0) 79.9 (37.4) .  (100.0-1 0.0) 3.3 (23.4) 1 0.0 (1 0.0-1 0.0) 82.2 ( 5.5) 1 0.0 ( .0-10 .0) 60.7 (45.1) < .0 1 8 .4 
Mental health 80.0 (68.0-88.0) 76.8 (17.2) 8.  (76. -92. ) 83.6 (12.2) 0.0 ( 2.0-88.0) 77.7 (14.5) 68.0 (58.0- 0.0) 67.3 (20.8) <0 01 78.4 
Vitality 70.0 (60.0-85.0) 70.7 (19.2) 85.  (7 . -90. ) 80.3 (15.0) 70.0 (60.0-82.5) 70.5 (17.7) 60.0 (50.0-70.0) 59.1 (19.2) < 01 74.6 
Bodily pain 77.6 (57.1-100.0) 75.0 (23.2) 100.0 ( 9.6-1 0.0) 86.6 (21.6) 77.6 (67.3-89.8) 75.4 (20.0) 67.3 (44.9-73.5) 60.2 (20.4) <0 001 85.1 
General health perception 70.0 (60.0-80.0) 67.8 (18.6) 7.5 ( 5. - 5. ) 4.7 (14.9) 0.0 (60.0-82.5) 69.4 (17.0) 60.0 (45.0-75.0) 57.5 (20.2) < 01 68.0 
Health changed,e 50.0 (50.0-75.0) 61.0 (25.4) 75.  ( . -100.0) 67.9 (23.6) 0.0 (50.0-75. ) 60.7 (22.4) 50.0 (25.0-75.0) 52.8 (28.6) 0.0 1 89.3 
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Supplementary fi le 1. Instrument.
This document is presented in the following chapter: ‘Survey instruments and interview guides’.
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7 AbstractIntroducti onChikungunya is an emerging public health problem in tropical and subtropical regions, due to ongoing transmission and its incapacitati ng acute disease phase, and chronic sequelae. The disease is responsible for a major impact on Health Related Quality of Life (HRQoL), which may last several years. To our knowledge, this study is the fi rst qualitati ve examinati on of HRQoL and coping strategies of chikungunya-infected individuals. MethodsQualitati ve research methods consisted of 20 in-depth interviews and seven Focus Group Discussions (FGDs), n=50. Analysis was based on the principles of the grounded theory.
Results
Diff erent impacts on HRQoL were reported. The physical and emoti onal domains of the HRQoL were 
mainly aff ected by chikungunya, while social and individual fi nancial consequences were limited. Individual 
fi nancial impact was limited through the universal health care program of Curaçao. Long-term lingering 
musculoskeletal and other manifestati ons caused signifi cant pain and limited mobility. Hence, parti cipants 
experienced dependency, impairment of normal daily life acti viti es, moodiness, hopelessness, a change 
of identi ty, and insecurity about their future. The unpredictable nature and consequences of chikungunya 
gave rise to various coping strategies. Problem-focused coping styles led to higher uptake of medical care 
and were linked to more negati ve impact of HRQoL, whereas emoti onal coping strategies focusing on 
acceptance of the situati on were linked to less uptake of medical care and more positi ve impact on HRQoL.
Conclusion
This study provides an in-depth understanding of acute and long-term HRQoL impact of chikungunya. 
The results can bett er inform health promoti on policies and interventi ons. Messages to the public should 





Chikungunya is a disease caused by a virus, which is transmitted by mosquitoes. During the past years, 
major outbreaks of chikungunya have occurred in the Americas. Normally, chikungunya presents with an 
acute, fever-like disease. After acute disease, many people develop chronic disease manifestations, which 
are mainly characterized by joint pain. In this study, we examined the impact of chikungunya on quality of 
life and how people coped with these consequences. The results of this study show that people infected 
with chikungunya reported long-term pain and limitation of mobility. Consequently, impairment of normal 
daily life activities and several emotions were experienced; for example dependency, moodiness, and 
insecurity about their livelihood and their future. People narrated visiting a doctor and using treatment to 
cope with these consequences. However, the participants who accepted their chronic ‘diseased’ condition 
could better cope with the consequences of chikungunya than the participants who could not accept their 
chronic condition. The latter group kept searching for new treatments and frequently consulted doctors. 
It is important that doctors and health authorities are aware of these results, because this will aid them to 





Chikungunya is an arboviral disease mainly transmitted by the mosquito species Aedes aegypti and Aedes 
albopictus [1]. Chikungunya has (re-)emerged in the Americas in 2013 [2], when it rapidly spread from 
the islands of the Caribbean to the Latin-American mainland [2-4]. Since then, the Pan American Health 
Organization reported an approximated one million chikungunya cases per annum in the Americas [5]. 
However, during this introduction of chikungunya virus (CHIKV) in the Americas, more people might have 
been infected, since studies describing attack rates have reported that 35-90% of the population in these 
regions were infected by CHIKV [6,7]. 
Curaçao witnessed a chikungunya outbreak in 2014-2015, which culminated in October and November 
2014. The epidemic ended early in 2015, when up to approximately 50,000 – 75,000 (attack rate: 33 – 50%) 
individuals had been infected in Curaçao [6].
Chikungunya typically consists of an acute phase and a (sub-)chronic phase [8]. The acute phase commonly 
presents with a sudden onset of fever and severe musculoskeletal pain lasting up to twelve days [8]. Other 
manifestations during acute disease may include, rash, fatigue, joint swelling and nausea [8,9]. Acute 
disease signs and symptoms eventually subside, but in the majority of cases linger on for months or years. 
Persistent joint or musculoskeletal pain and weakness are characteristic in its chronic presentation, and 
may be accompanied by fatigue, loss of vitality and neurologic manifestations [10]. This chronic disease 
course has major impact on the quality of life (QoL) of affected people [10]. 
Health Related Quality of Life (HRQoL) describes QoL in its relation with health conditions. The World 
Health Organisation (WHO) defines health as ‘a state of complete physical, mental, and social well-being 
not merely the absence of disease…’ [11]. The latter description is widely considered as a definition of QoL 
[12]. Hence, HRQoL is a multidimensional concept typically referring to physical, emotional and social well-
being and may often include a measure of socio-economic well-being [12-14]. 
Studies addressing the impact of chikungunya on the HRQoL of an individual have been performed using 
standardized questionnaires for HRQoL as the SF-36 questionnaires. Most of these studies associate 
chronic chikungunya with reduced HRQoL-scores on both physical and mental components [6,15-17]. The 
impact on HRQoL varies with severity of disease, showing in particular substantial drops in HRQoL when 
patients are more severely affected by chikungunya [6]. The decrease of HRQoL-scores in both physical and 
mental components is remarkable and alarming, given the emerging spread of CHIKV. 
HRQoL is influenced by individual subjective perceptions, expectations and coping strategies towards 
the health condition. Individuals showing the same clinical presentation of disease may exhibit different 
coping strategies, which can either positively or negatively impact the HRQoL [18]. Lazarus’s model of 
coping describes that emotional (e.g. acceptance, positive reappraisal) and problem-focused (targeting 
the cause of stress, e.g. treatment, physician visit) coping strategies are interdependent responses towards 
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perceived stress. Hence together, these coping strategies account for an overall coping response [19,20]. 
Previous research on malaria and HIV have revealed that both emotional and problem-focused coping 
strategies can be linked to HRQoL outcomes [21-23]. Generally, problem-focused coping strategies are 
considered to improve HRQoL. However, a shift towards emotional coping strategies might be more 
appropriate when there is no treatment available [24]. Therefore, with their objective to improve HRQoL, 
health interventions should be grounded in knowledge on coping strategies that are employed by the 
targeted study population for various diseases.
Previous studies on HRQoL of chikungunya have linked decreased HRQoL scores to chikungunya 
manifestations, but have not attempted to obtain in-depth understanding of the different concepts of 
HRQoL; nor have they assessed coping strategies influencing the HRQoL [6,15-17].
This study is part of a larger mixed methods project, which was set up to investigate how chikungungya 
impacts on HRQoL. This qualitative study was designed to obtain an in-depth understanding of this 
topic, while a simultaneously performed survey provided a representative quantitative assessment of 
the impact of chikungunya on HRQoL in Curaçao [6]. Therefore, the two main research questions of the 
study presented here are (a) how is the impact of chikungunya on HRQoL concepts (physical, emotional, 
social life and economic well-being) experienced by people in Curaçao? and (b) what coping strategies are 





The study was approved by the Medical Ethical Board of the Sint Elisabeth Hospital Curaçao (METC SEHOS; 
reference number: 2015-002). All subjects consented in writing to study participation.
Study site and population
Curaçao is an island in the Caribbean Sea, formerly part of the Dutch Antilles but since 2010 an autonomous 
country within the Kingdom of the Netherlands [25]. Curaçao is located close to the Venezuelan coast and 
consists of an area of 444 square kilometres. The approximately 150 thousand inhabitants live mainly in 
Willemstad, the capital of Curaçao. The GDP per capita is 22,600 dollar (2012), which renders Curaçao a 
comparably affluent Caribbean island. Willemstad covers a big part of the South-Eastern part of Curaçao 
and constitutes the most important economic area of the island [26]. Urbanisation and Curaçao’s semi-arid 
climate with a rainy season from October to December [27], provide favourable living conditions for Aedes 
spp. The population consists of an Afro-Caribbean majority and diverse minorities being Latin American, 
Dutch, Portuguese, French, Levantine and South- or East-Asian people [27]. Generally, all inhabitants of 
Curaçao are insured for most medical expenses through a state sponsored health insurance scheme (Social 
Insurance Bank), through their employer, or through a private health insurance. The health system consists 
of a network of general practitioners for primary care. For hospitalization and specialized care patients are 
referred to the Sint Elisabeth Hospital, which is the main hospital of the island. 
Study design and participants recruitment
This study was set up as an exploratory, qualitative study using in-depth interviews (IDIs) and focus group 
discussions (FGDs). The consolidated criteria for reporting qualitative studies (COREQ) [28] were followed 
and presented in S1 Table. FGDs and IDIs were performed simultaneously, which allowed us to use FGDs 
to verify and contextualise topics which had emerged in IDIs. On the other hand, themes arising in FGDs 
could be more profoundly understood in IDIs. Interviews were performed in June and July 2015 up to the 
point of data saturation, which was evaluated and agreed upon within the research group. A total of 75 
people participated in this study (age range: 18-97), of which 50 participated in one of the seven FGDs (4-
10 participants per FGD) and 20 in IDIs (Table 1). To understand the caretakers’ perspectives, we conducted 
key-informant interviews with family members of chikungunya patients.
Participant recruitment IDIs
Potential participants of the IDIs were contacted via key informants (general practitioners) and snowballing 
(performed by the research group). Eligible participants were then recruited by the research group via 
telephone. Inclusion criteria for IDIs were adults with either (1) a serologically confirmed CHIKV infection 
during the chikungunya epidemic of 2014-2015 based on a positive IgM/IgG, using an ELISA test or (2) a 
history of an acute disease with chronic musculoskeletal pain during the chikungunya epidemic of 2014-
2015, plus a positive IgM/IgG performed on screening for inclusion in this study. Participants were selected 
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from different socio-economic strata, age categories and genders. IDIs were performed to provide deeper 
insights on HRQoL concepts and coping strategies, the interplay of coping strategies and HRQoL. 
Table 1. Participants’ characteristics
Participant recruitment FGDs
Seven FGDs were performed amongst adults (regardless of having (had) chikungunya or not), which 
were invited for the FGDs via volunteers of neighbourhood centres and key informants (of social groups). 
Individuals from various representative socio-economic groups (ranging from low, middle, and high socio-
economic statuses) of Curaçao were included, i.e. 1) residents born in the Netherlands, 2) local youth, 
3-6) people from the neighbourhoods Koraalspecht, Seru Fortuna, Rooi Santu and Souax. Local survey-
investigators had additional contextual information, which they received during the simultaneously 
performed quantitative survey on HRQoL of chikungunya, which has been published elsewhere [6]. Hence, 
a FGD was conducted among the survey-investigators to cross-check information that we received from 
IDIs, surveys and FGDs.
Data collection
Prior to data-collection study procedures and confidentiality were discussed, after which all participants 
consented in writing to study participation. Two local social workers with a wide experience with group 
discussions performed the FGDs and the IDIs, together with Jelte Elsinga. Interviews were conducted 
in neighbourhood centres, at the homes of participants, or in another place which was chosen by the 
participants. Only interviewers and participants were present during the IDIs and FGDs, which were 
held in Dutch, Papiamentu or Spanish. The concepts of the HRQoL (physical, emotional, social life and 
financial well-being) and coping strategies served as theoretical framework (Figure 1) for the interview 
and focus group guides (S2 Text and S3 Text). As reflected in the theoretical framework, we expected 
that chikungunya disease manifestations could induce stress to all concepts of the HRQoL. The ability to 
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 # participants # female Age range 
Focus groups (n=7)    
Residents from the Netherlands 8 6 61-71 
Local youth 4 2 19-24 
Koraalspecht 10 10 55-97 
Seru Fortuna 9 8 18-70 
Rooi santu 8 4 51-80 
Souax 7 4 34-72 
Interviewers of the survey 4 3 64-67 
    
In-depth interviews (n=20)    
Participants with chikungunya 20 12 36-87 
Family members 5 2 - 
 158 
 159 
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cope with the consequences of this stress determined the impact on HRQoL of an individual concept. 
The impact on all four concepts (i.e. physical, emotional, social life and financial well-being) of the HRQoL 
resulted in the final/overall impact on HRQoL of chikungunya (Figure 1). Interview and focus group guides 
were prepared and used as a guide in the FGDs and IDIs (S2 Text and S3 Text). These interview guides were 
evaluated and adapted after pilot interviews in Curaçao. The pilot interviews were included in the analyses 
of this study. Interviews were recorded, translated into Dutch and transcribed in verbatim. Field notes 
were made during and after interviews. When information started to repeat itself (data-saturation) the 
researcher discussed with the team the themes covered and decided to stop data collection.
Figure 1. Theoretical framework
Data analysis
Data analysis was based on principles of the Grounded Theory [29], which helped to visualize the analyses 
and to move from data to theoretical explanations. Analyses were performed using Atlas.ti (version 7.5.4) 
software. Two cycles of inductive and/or deductive coding were employed. The first cycle of inductive and 
deductive coding resulted in 31 codes. In the second cycle, only deductive coding was employed. In the 
second cycle, the codes of the first cycle were categorized as per the concepts of the theoretical frame 
HRQoL and coping mechanisms, resulting in five (deductive) code families: (1) physical impact (codes: 
e.g. acute/chronic symptoms, lingering symptoms, daily life problems); (2) emotional impact (codes: e.g. 
emotions, dependency on others, confusion related to chikungunya symptoms); (3) impact on social life 
(codes: e.g. impact on social life, general impact of chikungunya, impact on society); (4) financial impact 
(codes: e.g. impact on work, insurance, financial costs of chikungunya); and (5) coping strategies (codes: 




The results of this study were structured in sections as per the concepts of the theoretical framework 
(Figure 1). The provided quotes serve to contextualize, illustrate or clarify the results of this study. Quotes 
are transliterations from the interview-recordings, and are presented without extensive editing to remain 
close to the cultural meanings that are in the data.
The epidemic of 2014-2015 in Curaçao was the first chikungunya outbreak on the island in recent times. 
Communities’ knowledge on chikungunya transmission routes and clinical presentation was therefore 
absent, or very limited at the onset of the chikungunya epidemic in Curaçao. During the epidemic, 
participants acquired knowledge of chikungunya from radio, television, newspapers, social media and 
social interactions (e.g. family, friends, neighbours). The key health communication messages came from 
the Ministry of Health of Curaçao, alternative health providers and personal experiences of the community. 
Due to the limited knowledge prior to the outbreak, these communications shaped participants’ knowledge 
regarding chikungunya, giving rise to varying perceptions on chikungunya sequelae and coping strategies. 
Physical impact of chikungunya
The community (as documented in FGDs) recognized chikungunya as being a debilitating disease with major 
acute and chronic impact on physical health. Musculoskeletal pains and stiffness were most prominently 
reported and perceived to cause physical impairment. However, the common symptoms that were 
described by the community included a wide range of symptoms for both the acute and chronic phase of 
chikungunya. Before onset of the disease, some individuals reported to have perceived a prodromal period 
in which they had ‘felt strange’ for days or weeks. Individuals, in the IDI, narrated how acute chikungunya 
had started with a sudden onset of symptoms with varying intensity. The reported symptoms included 
fever, swollen joints, musculoskeletal pains, weakness, stiffness, fainting, difficult breathing, headache, 
dizziness, change in sense of taste, itch, rash, incontinence, anorexia, numbness, tingling, diarrhoea and 
constipation. The sudden nature of acute chikungunya was reflected in situations where people could not 
get out of bed, a chair or car, or fell down when trying, thus increasing the risk of fall-related injuries.
Participant A: The way in which I realized it [that I was ill] was, I rose 
and stepped out of bed and I could not stand because my ankles gave 
away [failed].(…) So I got back in bed and I think ‘help! Am I paralysed 
or so?’ you know? 
(Woman, IDI, aged 60-70 years)
Participants had different experiences with chikungunya symptoms per case, as described above. Some 
had not perceived long-term complaints. Others described a second ‘phase’ of disease, which lingered 
on, or started after acute symptoms had ceased. This second ‘phase’ referred mainly to the long-lasting 
complaints, typically characterized by musculoskeletal pain and weakness. Furthermore, additional chronic 
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symptoms were reported, such as cramps, fatigue, ‘trigger fingers’ and numbness (paraesthesia). These 
long-lasting symptoms could be constant, but could also have a lingering nature, affecting different places 
alternatingly. According to some participants, their weak spots (for example old injuries) were the places 
where complaints of chikungunya particularly manifested. 
Participant B: So, when I was young I do, I did ehm taekwondo and 
gymnastics too. And I had ehm, old pains from my wrists, ankle, tibia, 
shoulder. All the old pains had returned… 
(Man, IDI, aged 30-40 years)
As was narrated by many individuals, the consequences of chikungunya resulted in challenging situations. 
On disease onset, when generally the most intense symptoms were perceived, people were commonly 
forced to stay in bed, sometimes without the ability to leave bed without help. The latter inconvenience 
was commonly described together with the difficulties participants faced in reaching the toilet. The 
activities of daily living were affected for almost all the participants of the IDIs. 
Participant C: When lying in bed, you cannot push yourself up; you 
cannot use your shoulders so you must laboriously roll in order to get 
on, on your knees next to your bed and then try to get your feet under 
yourself to get up. And then, well, try to sit on the toilet if, if you, if you 
don’t have any control. 
(Man, IDI, aged 70-80 years)
Participant D: My husband, my husband had to carry [me] out of bed… 
I had to go to the toilet, he had to put me on the toilet. I had to take a 
shower, he had to shower me. Everything, because I couldn’t. I couldn’t 
even [hold] this glass in my hand because it just fell on the ground. 
(Woman, IDI, aged 60-70 years)
Individuals reported other long-term daily life inconveniences, which could vary from crucial daily life 
activities to minor problems. Amongst these inconveniences where the inability to dress themselves 
because of impairment of movement, to wear shoes because of their swollen feet, to drive a car, to cook, 
to sport, to sleep well, and other inconveniences. It also affected the participants’ interpersonal relations 
with some mentioning that it was difficult for them to have sexual intercourse. A few of these were 
described as follows.
Participant E: I couldn’t dress myself (…) my husband had to help me. 
[If my husband would not be there to help] I would go without a bra 
[laughing] (…). Yes yes, I couldn’t do it [dressing], really, really. 
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(Woman, IDI, aged 50-60 years)
Participant B: eeeh. I couldn’t cook. That, that, that, heath, that heath 
of the kitchen was too much for me. 
(Man, IDI, aged 30-40 years)
Participant D: Until today, from the seventh of October last year, I 
cannot wear high heels, I come to the office with slippers. Have to wear 
[them]. My ankles are entirely swollen. 
(Woman, IDI, aged 60-70 years)
As a consequence of chronic chikungunya, people continued perceiving musculoskeletal impairment and 
other sequelae, leading to long-term dependency on others, loss of mobility and emotional concerns.
Emotional impact of chikungunya
Within the community, different ways of how chikungunya influenced emotions were expressed. Depending 
on duration of disease and clinical presentation, people perceived minimal to major emotional impact 
caused by chikungunya. More specifically, individuals reported feelings of moodiness, anxiety, frustration, 
anger, and feeling left out, desperate, ashamed, confused or in some case perceived them self to be a 
different person. Emotional distress in the acute and chronic phase was related to lower knowledge on 
chikungunya. A distinction could be observed between emotions individuals perceived in the acute phase 
of disease and those referring to the long-lasting sequelae of chikungunya. Whereas initial emotional 
reactions were mainly triggered by the abrupt nature of the acute symptoms, the unpredictable and long-
lasting nature of the chronic sequelae was responsible for an emotional impact on the longer term.
Emotions in the acute phase of chikungunya
Study participants perceived the acute phase of chikungunya as overwhelming. Anxiety was a commonly-
described emotion and could be linked to lower reported knowledge of the symptoms and impact of 
chikungunya. This limited knowledge on chikungunya made it hard for participants to recognize associated 
complications, while participants thought they might be paralyzed, having a seizure, or even perceived 
dying from the disease. 
Participant 1: I became nervous – Participant 2: Yes nervous – Participant 
1: I asked the Lord, help me! Wat is happening here. – Participant 3: Yes 
even crying – FGD: Praying, ask God. Yes, because you were afraid. 
(Women, FGD, aged 60-70 years)
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Participant C: [I was afraid to fall asleep, because] I thought well, 
suppose that you eh just fall asleep and, and I can’t get it [hands/arms] 
started and that it just dies and that I then just *** [curse] have to miss 
a paw [hand/arm] because it died. 
(Man, IDI, aged 70-80 years)
Within the community, it was believed that chikungunya might be lethal for people with a ‘weaker 
resistance [immune system]’ like little children, older people, or those with comorbidities. Consequently, 
family or friends of this ‘vulnerable’ group were in particular worried when these people got chikungunya. 
Young men, normally relying on their physical strength explained that chikungunya was especially tough 
since they couldn’t rely on their bodies at that moment. 
Participant B: But that, that, pain in my body wasn’t frustrating. So I 
can, I can easily handle that but I couldn’t do nothing at all and thát 
was frustrating. I could walk ‘aaah it hurts’, I still walked but ááh! The 
leg doesn’t work, nothing at all. And, thát was frustrating. But the pain 
was ‘ah yea, whatever’. 
(Man, IDI, aged 30-40 years)
Emotions in the chronic phase of chikungunya
Participants had to live with pain, impairing the patient not only physically, but also emotionally. People 
perceived the long-lasting sequelae of chikungunya as unpredictable, which led to situations where 
they suspiciously evaluated symptoms, doubting whether their new or lingering symptoms were caused 
by chikungunya, or maybe by another disease. As participants were aware that there was no cure for 
chikungunya, this left them wondering if their pain and other symptoms would ever fade away. The 
perspective that the disease might possibly never be cured and that one might have to live with pain for a 
long time, left patients with feelings of hopelessness. 
Participant F: That it hurts and you see that it, there’s no eeeh, no eeeh, 
there’s no way to remove the pain. There’s no eh and then you hear ‘o 
they [people] don’t have it [chikungunya] anymore?’ But I still have it! 
(laughs) you know? And then it stays and keeps lingering and lingering 
and that is depressing. You cannot do what you did earlier. For sure. 
(…) Oh! And then are there people who got it eh, only have it a week 
and then it’s completely gone. Nothing. (…) So that’s not fair. That’s 
depressing. 
(Woman, IDI, aged 50-60 years)
168
7
Moreover, a perceived lack of efforts and resources to help chikungunya patients made them feel left out. 
Participant G: Sometime the doctor tells you, ‘What now, what should 
we do now?’ and, ‘let’s try this and let’s try that’. Then you get the 
feeling that the person, the doctor himself doesn’t know what to do 
with ehm, with that chichingunya. 
(Woman, IDI, aged 80-90 years)
The aforementioned feelings of helplessness were grounds for feelings of depression, which could be 
fostered when patients did not find themselves understood by others. 
Participant 1: that was the thing the thing that people kept stating: it 
is not curable and there is no treatment. With the result that you sat at 
home and kept fretting about what you have and that there is no way 
to cure. 
Participant 2: You go outside to do what? To talk with people? And 
then? What are you going to talk about? Because, they are not going 
to help you. And you start thinking nobody can never help me. 
(Women, FGD, aged under 30 years)
Besides that, the emotional impact that was caused by hopelessness and helplessness resulting from 
ongoing chronic sequelae bothered chikungunya patients in their daily lives. Patients narrated that the 
unceasing pains made them easily irritable or temperamental during the chronic phase of chikungunya. 
Participant H: I, I just didn’t know that I would become such a *** 
[curse for someone complaining a lot] you know? You can really turn 
temperamental by it [by the situation of having chronic chikungunya]. 
(Woman, IDI, aged 40-50 years)
This moodiness was also perceived by the people surrounding chikungunya patients, which was reflected 
when unaffected people in FGDs spoke about chikungunya patients, as follows: 
FGD: You hear people giving comments. Being mad. They talk dirty 
words. – Participant 1: I think I’ve heart from people that you get a 
bit irritated, you know? Because you remain with pain continuously. 
– Participant 2: It works on your nerves. It is like [name] also said, you 
start fights more easily. You become mad. 
(Men and women, FGD, aged 50-80 years)
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A significant topic on emotional impact emerging from FGDs and IDIs was the perceived accelerated 
aging of the body. This perceived aging was mainly linked to the pain and physical impairment, which is a 
frequent sign of aging. However, the sudden onset of aging forced patients to adapt their lifestyle, which 
was reported to make people feel like having transformed into another person by chikungunya.
Participant H: I feel like 80. (…) But I want to be again… what I want 
is just don’t feel anything anymore, that I am again like … come on, 
you know, I used to do classic ballet? I mean, I am just [in my young 
forties]. Then it should be possible to become the old [me] again? That’s 
it. (Woman, IDI, aged 40-50 years)
Commonly, participants stated that chikungunya had turned them into another person due to the perceived 
aging of their body, to moodiness or due to loss of vitality. Moreover, some participants perceived having 
turned into another person because they were unable to do things, which were part of their identity, like 
dancing, wearing high heels, going out or cooking.
Participant G: I love physical exercise, I love to go out I love, eh having 
fun. I love eh.. eh.. cooking. I love everything what can keep me busy, 
that’s what I love. But when I got that chichingunya, it was, it was gone 
…. [long silence, woman starts crying] …. Sorry (…) I had never thought 
that a disease can transform a person like this. (Woman, IDI, aged 80-
90 years)
Some older adults became (more) dependent on care of others. For them, the question of how long 
chikungunya would last became a significant question, since independency was an important value for 
these people. The fact that their physical condition had prompted their family or friends to care for them 
was difficult to accept. Some of the older adults narrated how during intense disease manifestations, they 
were more willing to accept the possibility of death. Older adults having severe chronic complaints were 
(more) dependent on care of others.
Participant I: So like I told you before, I have always asked God that I 
don’t want to be a burden to anyone. So, if the day comes that I cannot 
do anything anymore, God takes me. 
(Man, IDI, aged 70-80 years)
The emotional consequences of chikungunya varied, and in some cases left people with uncertainty about 
their future and indecisiveness on what to do next.
Impact of chikungunya on social life
Among the community, chikungunya was held responsible for varying consequences regarding social life 
of patients. These consequences varied depending on manifestation, duration and severity of disease and 
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concerned inabilities to join social activities or to visit friends and being avoided by family or friends. 
However, some patients had not experienced any impact on their social life. This could be the case when 
people did not have a social life of notice, or if disease manifestations were so mild that no impact on social 
activities was perceived. 
Individuals narrated how they, due to their physical impairments and loss of vitality, could not join social 
activities such as going to the cinema, compete in sport matches, drinking with friends, play golf, do physical 
exercise or walk with friends. These created a situation where participants could perceive weakening of 
social bounds. 
Participant B: Normally yes, I went out, I go to movies or eh, (…) Do a 
drink with friends, yes…. But back then with the chikungunya I just did 
nothing. Just stayed at home, calm. 
(Man, IDI, aged 30-40 years)
Participant F: Yes I eh at Thursdays, every Thursday I walk with a group 
into the mondi [forest, country side] and I have not done that for months 
because I cannot bend and crawl because it hurts. 
(Woman, IDI, aged 50-60 years)
Others explained that even if the activity only concerned visiting friends, they would not be able to go, 
because they were not able to drive a car, due to the symptoms of chikungunya. Furthermore, people 
stated not being in the mood of acting social, as was also reflected before in the section ‘emotional impact 
of chikungunya’. 
Limited knowledge on transmission routes of disease could cause an impact on social life. Namely the 
belief that people with chikungunya could infect others left some participants without having their family 
or friends visiting them. Also, some participants did not want to visit others, since they were afraid to infect 
them.
Participant J: Yes but you know that if you sometimes stay to talk [with 
people] you could infect them so I rather stayed at home. 
(Woman, IDI, aged 50-60 years)
The belief that chikungunya was contagious by patient contact was not the only reason to avoid visiting 
others. Participants described how family living abroad cancelled their planned stay, or did not come 




Participant I: I have a brother who didn’t want to come. (…) Because 
of chikungunya. He already has arthritis problems and he wants to 
prevent additional [articular problems]. He looks to me and says ‘no 
thank you!’ He didn’t go to a funeral of my mother. And afterwards he 
hasn’t come either because of chikungunya. 
(Woman, IDI, aged 50-60 years)
Thus, social impact of chikungunya was not perceived as substantial, but could still lead to social isolation.
 
Coping with the impact of chikungunya
Participants reacted to the consequences of disease described above by performing different coping 
strategies, which we describe in the following sections. 
Within the community, problem-focused coping was commonly performed by using (natural) medicines 
and by visiting a physician to cope with the physical impact of chikungunya. In general, chikungunya 
patients stayed in bed during the acute phase of chikungunya and depended on the care of family or 
friends. Their physical condition permitting, most of them went to see a physician, normally accompanied 
by someone to transfer them. Otherwise, a physician was visited one or two days later. 
Some of the participants did not visit a physician. These participants did not recognize visiting a physician 
as a problem-focused coping strategy, because they would not be treated with more than the regular 
symptom relief-providing medications, i.e. paracetamol and nonsteroidal anti-inflammatory drugs. 
Furthermore, some participants found the symptoms obvious and consequently did not want to waste 
time to seek the opinion of a physician. At some point of time during the epidemic, participants reported 
that people were not being laboratory tested any more, and this also discouraged people from visiting a 
pysician. Although some decided not to go to see a physician, others decided to visit a physician many 
times (up to approximately 20 times in some cases) for the complaints caused by chikungunya. Frequent 
physician visits were linked to desperation, a desire for solace, persistence of symptoms, a desire to try 
new treatment. Frequent physician visits were also performed because people needed to prove disease 
persistence in order to be reimbursed for the absence from their work. 
Participant D: Every week I was at the doctor, because I had pain here, 
pain at the feet, uh! (…) it didn’t disappear and according to me I say 
‘yes, there should be something that I can use or so’ (…) I don’t know if 
20 times, the first months for sure every day at the doctor told me ‘I can 
really not do anything for you’. 
(Woman, IDI, aged 60-70 years)
Many participants had used medicines to treat their physical complaints. Those included the medicines 
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bought over the counter or prescribed by the physician, amongst which were mainly paracetamol or 
NSAID’s. Furthermore, natural or other alternative medicines were very popular since they had been 
prominently presented in advertisements and media by alternative healers. Hence, people recommended 
these medicines to each other. Some individuals with persistent complaints reported to have used more 
than ten different medicines. Amongst the most popular medicines were mango and papaya leaves, lemon 
grass, aloe and vitamin B.
Participant E: Everyone, so many people got it [chikungunya]. Because 
all say ‘do you know what I took? Do you know what I have done?’ So 
you hear from everybody and yes, you try [the promoted medicines]. 
(Woman, IDI, aged 50-60 years)
Using frequent physician visits and different medical treatments was a pattern of problem-focused coping, 
which was illustrative for people who perceived severe impairment from chikungunya, which they could 
hardly accept. Frequent visits of health care providers as coping strategy led to unmet expectations for cure 
or treatment, resulting in stress (negative impact on QoL). In contrast, people with lingering complaints 
while reporting less impact of chikungunya also showed different coping strategies, i.e. emotional coping 
strategies. The participants using emotional coping strategies went less often to a physician, used less 
medications and reported trying to do as many physical/social activities as possible. For example, they 
tried to mobilize by performing the physical exercises or movements they could do. With this in mind, 
people were more willing to accept that symptoms would eventually subside. 
Participant C: maybe it is my mindset too, I mean see it a bit philosophic. 
I mean it goes… it’s the truth of matter and it goes... and if you worry 
about it you will perceive a higher burden so eh, you know it when you 
see it. 
(Man, IDI, aged 70-80 years)
Participants believed that chikungunya stayed in the system (the body), which made them susceptible for 
lingering symptoms during that time. This period of having ‘chikungunya in the system’ could range from 6 
months up to 2 years. During the chikungunya epidemic, people believed that a ‘high resistance’ [immune 
system] was a vital way of preventing chikungunya, or to make sure that chikungunya would not cause 
major symptoms or linger on during infection. Some participants combined the latter two perceptions, and 
consequently coped with chronic chikungunya sequelae by living healthy during the time that they thought 
that chikungunya would be in their system, in order to diminish the lingering of chikungunya symptoms. 
Participant: it is not to eat healthy, the vitamins etcetera, not to eat 
healthy but the resistance [against diseases] should stay high, so that it 
[chikungunya symptoms] doesn’t return. 
(Woman, FGD, aged 60-70 years)
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Actions participants performed to ‘strengthen the immune system’ were: eating healthy, physical activity, 
not visiting sex workers and using herbs or vitamins.
Individuals coped with social consequences by calling their family and friends instead of visiting them. 
Social HRQoL impact was also diminished by emotional coping strategies relying on social support. People 
passed by to inform about the situation of the ill people and tried to help each other by offering advices 
and remedies, or made fun of each other. Moreover, people started helping each other by bringing people 
to the physician or to the Social Insurance Bank. Others obtained emotional support from others in order 
to deal emotionally with chikungunya sequelae.
 
Participant: The community, (…) not specifically that is cures, but that 
it makes you feel better because someone understood what’s going on. 
(Woman, FGD, aged under 30 years)
The financial impact due to chikungunya on participant’s personal situation was generally perceived as 
limited. In Curaçao, chikungunya patients could rely on an insurance system, which covered health care 
costs, which in turn minimized out-of-pocket expenditures. These insurances covered also parts of the 
income loss of chikungunya patients who could not work. However, participants pointed to financial impact 
on society level. This was attributed to the fact that chikungunya had left many people at home instead of 




Chikungunya constitutes an emerging public health problem, mainly due to its debilitating acute and long-
term musculoskeletal manifestations. Though the disease can cause major impairment of Quality of Life 
(QoL), this is the first study conducted to obtain an in-depth understanding of the impact of chikungunya 
on Health Related (HR)QoL of its patients using qualitative research methods. HRQoL of participants were 
mainly affected on physical and emotional domains, and to a lesser extent on social and financial domains. 
Problem-focused coping strategies aimed at physical healing induced a high uptake of (alternative) 
medicines and consultation of physicians, whereas emotional coping strategies focused on acceptance of 
the situation were linked to lower perceived impacts on HRQoL and less uptake of medical care.
Chikungunya patients reported an acute and chronic disease presentation in agreement with the existing 
literature [30-35]. Additionally, a prodromal period before disease onset and acute symptoms like ‘a 
change in sense of taste’ and incontinence were reported. The latter findings are interesting but should be 
cautiously interpreted since participant expressed their confusion regarding chikungunya sequelae, and 
no comprehensive clinical assessment of the participants of this study was performed. This confusion and 
wide variety of symptoms that participants linked to acute and chronic chikungunya are in agreement with 
the current situation of knowledge on chikungunya. Clinical studies are showing a wide variety of disease 
manifestations [10], yet an all-encompassing consensus on the clinical picture of chikungunya is lacking.
The acute and chronic disease presentation of chikungunya was directly responsible for impairment of 
physical HRQoL, and demonstrated indirect consequences for emotional HRQoL. The acute disease was 
described as highly debilitating in which patients perceived strong anxious emotions, sometimes to the 
extent that they thought they might be dying. This could have partly been prevented if people had been 
timely informed of the sudden and tough situation they might face when acquiring chikungunya. Providing 
timely information is important and a key to reduce health-related distress [36,37]. During chikungunya 
outbreaks, it is important that health authorities proactively provide messages on the symptoms and 
normally non-lethal nature of chikungunya. 
The unpredictable lingering nature of mainly musculoskeletal manifestations and its subsequent difficulties 
in normal daily life activities were linked to several consequences for emotional HRQoL. Patients narrated 
how these sequelae influenced their mood and ability to perform their daily-life activities. Hence, 
chikungunya had turned participants into ‘other persons’. Young men linked their physical strength to a 
perceived resistance to diseases, as was also described in a study in Cambodia [38]. When these young 
men were hit by chikungunya and perceived long-lasting impairment of their physical strength, loss of part 
of their identity caused emotional bearing. The same was observed when women could not wear high 
heels, dance or go out, thus impacting negatively on their identity. The notion that chikungunya affected 
patients’ identity was also reflected in the perceived accelerated aging of the body. Being independent 
is an important value for elderly [39,40]. Therefore, by rendering elderly individuals dependent of care, 
chikungunya could have major emotional consequences for these people. Knowledge of the aforementioned 
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emotional concerns is valuable to all health professionals directly working with chikungunya patients, and 
advocate for the need to target emotional concerns in health promotion policies.
Health related impact on social life and the personal financial situation of participants were limited, since 
ways of coping diminished the significance of these concerns. The universal health care program (via the 
Social Insurance Bank or other) covered generally the health care expenses. In the countries where people 
cannot rely on a universal health insurance scheme such as the one available in Curaçao, it is expected that 
chikungunya patients will face a higher financial burden. Consequently, chikungunya has been shown to 
cause major financial burdens on society level across Latin America [41]. 
The perception that chikungunya is transmissible from patient to patient should be targeted in health 
campaigns by promoting transmission methods. Improved knowledge on transmission routes of 
chikungunya could hereby take away the barrier to engage in social activities when having chikungunya. 
Enhancing social activities may additionally improve coping with the impairment of emotional HRQoL [36], 
as social support is an important mediator between life stress and health status [24].
This study describes several ways of how participants coped with the effects of chikungunya. A notable 
coping strategy was high uptake of (natural) medicines or frequent physician visits, which was typically 
performed by subjects with major impacts on HRQoL and difficulties to accept their situation. Since 
effective long-term treatments are not available yet for chronic chikungunya, the latter coping strategy 
will normally not lead to success. The consequent dissatisfaction may only give rise to further emotional 
stress [42,43]. Hence, health professionals should identify patients performing this coping strategy to 
promote healthier coping strategies. For example, participants showing coping strategies focused on 
acceptation of circumstances or on social support showed better HRQoL, which is in line with literature on 
coping strategies [24,36]. Some people solely relied on (natural) medicine or alternative healers; instead 
of attending physicians, as it was also reported from other febrile diseases and populations [e.g. 44,45]. 
Promotion of healthy coping strategies amongst these people might be a challenge, but may be achieved 
via media or community centres. 
Another coping strategy included a ‘healthy lifestyle as long as chikungunya is in the system’. ‘Living healthy’ 
has also been described as a coping strategy with a possible dengue infection [38]. Currently, there is no 
scientific substantiation for this coping strategy. Nevertheless, because no effective long-term treatment 
for chikungunya sequelae is present, this way of coping will under normal conditions only improve health. 
This study used different qualitative methods. Since the participants of the IDIs (except for the family 
members of chikungunya patients) had their chikungunya infection serological confirmed, we focused our 
analysis mainly on the laboratory-confirmed chikungunya patients of the IDIs. The FGDs were used to 
understand perceptions of the community.
This study was limited by its qualitative study design. As is normal for qualitative research, participants 
were not randomly selected. Therefore, generalization of these findings is limited to this specific study 
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site and study population. Furthermore, HRQoL is a broad concept. Although this study was explorative 
and comprehensive in nature, it might not have captured all aspects of the HRQoL. A researcher bias 
may be present in this study. We minimized this by involving the local research group and the research 
group in the Netherlands in the different stages of the study (i.e. study methods, data interpretation and 
data presentation). Additionally, a contamination bias due to sharing of chikungunya knowledge and study 
procedures between investigated communities might be present. We assume that this was no major issue, 
since this study mainly focused on personal experiences of chikungunya episodes. Furthermore, the issue 
of chikungunya was already widely discussed within Curaçao both in the community and in the media.
Because it is vital to understand the impact of a disease in order to develop applicable and effective 
health intervention, these interventions should be grounded in research on HRQoL. This study is the 
first applying qualitative research methods on this topic and providing valuable new in-depth insights on 
HRQoL and coping strategies concerning acute and chronic chikungunya sequelae. These insights help 
health professionals to understand the impact of chikungunya on its patients. The results reveal that 
health promotions strategies could be improved, by (1) providing timely messages to the public about the 
devastating but normally non-lethal nature of chikungunya, to ease chikungunya patients during acute 
disease, (2a) promoting emotional coping strategies and (b) targeting ‘unhealthy’ problem-focused coping 
strategies among chronically affected chikungunya patients, (3) focusing on providing (emotional) support 
to older chikungunya patients.
Further research could include health professionals working in chikungunya endemic areas. This would 
allow to assess clinical management (consultation, treatment recommendations) of chikungunya, and 
to provide insight on how this was put in practice by the patients. Similar qualitative studies should be 
performed in different settings, as these may serve as basis for randomized surveys on HRQoL and coping 
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S1 Table. COREQ - consolidated criteria for reporting qualitative studies
Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist 
No  Item  Guide questions/description  Answer-/ position in article 
Domain 1: Research team and reflexivity   
Personal Characteristics   








Experience and training  
What were the researcher's credentials? E.g. PhD, MD  
What was their occupation at the time of the study?  
Was the researcher male or female?  
What experience or training did the researcher have?  
See box on the left. 
Answers on criteria 2-5. 
Authors: 
- Jelte Elsinga, BSc – male, MD PhD candidate, master courses in qualitative research methods. 
- Martin P. Grobusch  MD PhD – male, professor, extensive experience in clinical practice, 
research and public health. 
- Adriana Tami MD PhD – female, assistant professor, extensive experience in clinical research 
and public health.  
- Izzy Gerstenbluth MD – head of epidemiology and research unit Curaçao, extensive experience 
in clinical practice and public health of Curaçao. 
- Ajay Bailey PhD – male, assistant professor, anthropologist with extensive experience in 
qualitative research and health behaviour. 
 
Interviewers: 
- Martha Gillen – female, retired public health nurse. 
- Billy Hoogenbergen – male, retired psychotherapist. 
Relationship with participants   
6.  Relationship established  Was a relationship established prior to study commencement?  No 
7.  Participant knowledge of the interviewer  
What did the participants know about the researcher? e.g. 
personal goals, reasons for doing the research  
There was an informed consent 
taken, signed by all participants.  
8.  Interviewer characteristics  
What characteristics were reported about the 
interviewer/facilitator? e.g. Bias, assumptions, reasons and 
interests in the research topic  
Researcher-bias; see Discussion. 
    
Domain 2: study design   
Theoretical framework   
9.  Methodological orientation and Theory  
What methodological orientation was stated to underpin the 
study? e.g. grounded theory, discourse analysis, ethnography, 
phenomenology, content analysis  
Principles of grounded theory for 
analyses, but theory informed 
empirical fieldwork. See methods 
- Data collection 
Participant selection   
10.  Sampling  How were participants selected? e.g. purposive, convenience, 
consecutive, snowball  
See methods - Study design and 
participants recruitment 
11.  Method of approach  How were participants approached? e.g. face-to-face, 
telephone, mail, email  
See methods - Study design and 
participants recruitment 
12.  Sample size  How many participants were in the study?  See Table 1 
13.  Non-participation  How many people refused to participate or dropped out? Reasons?  
Refused: not known for those 
recruited via physicians;  
Dropped out: none. 
Setting  
14.  Setting of data collection  Where was the data collected? e.g. home, clinic, workplace  See Methods – Data collection 
15.  Presence of non-participants  
Was anyone else present besides the participants and 
researchers?  See Methods – Data collection 
16.  Description of sample  What are the important characteristics of the sample? e.g. 
demographic data, date  See Table 1 
Data collection   
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Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist 
 
17.  Interview guide  Were questions, prompts, guides provided by the authors? Was it pilot tested?  
Yes. See Methods – Data 
collection & Supporting 
Information 1 and 2 
18.  Repeat interviews  Were repeat interviews carried out? If yes, how many?  No 
19.  Audio/visual recording  Did the research use audio or visual recording to collect the data?  
Yes. See Methods – Data 
collection 
20.  Field notes  Were field notes made during and/or after the interview or focus group?  
Yes. See Methods – Data 
collection 
21.  Duration  What was the duration of the interviews or focus group?  
In-depth interviews: 35-100 
minutes 
Focus group discussions: 65-85 
minutes  
22.  Data saturation  Was data saturation discussed?  Yes. See Methods – Data collection 
23.  Transcripts returned  Were transcripts returned to participants for comment and/or correction?  No 
    
Domain 3: analysis and findings  
Data analysis   
24.  Number of data coders  How many data coders coded the data?  1 
25.  Description of the coding tree  Did authors provide a description of the coding tree?  See Methods – Data Analysis 
26.  Derivation of themes  Were themes identified in advance or derived from the data?  See Methods – Data Analysis 
27.  Software  What software, if applicable, was used to manage the data?  See Methods – Data Analysis 
28.  Participant checking  Did participants provide feedback on the findings?  No, but findings were discussed with local experts. 
Reporting  
29.  Quotations presented  
Were participant quotations presented to illustrate the 
themes / findings? Was each quotation identified? e.g. 
participant number  
See Results 
30.  Data and findings consistent  
Was there consistency between the data presented and the 
findings?  See Results 
31.  Clarity of major themes  Were major themes clearly presented in the findings? See Results 
32.  Clarity of minor themes  Is there a description of diverse cases or discussion of minor themes?  See Results 
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S2 Text. In-depth interview guide
This document is presented in the following chapter: ‘Survey instruments and interview guides’.
S3 Text. Focus group guide
This document is presented in the following chapter: ‘Survey instruments and interview guides’.
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8 AbstractBackground Dengue and chikungunya co-infecti ons are an emerging threat to public health in tropical and sub-tropical areas. This study investi gates acute and long-term clinical presentati on patt erns of chikungunya against a backdrop of preceding dengue infecti on and determines predicti ng factors for long-term chikungunya sequelae.MethodsA retrospecti ve cohort study was performed in 2015, including 299 previously confi rmed chikungunya cases, of which 162 subjects were assessed for dengue serology at disease onset.Results
Those with previous dengue infecti on (35.2% of the examined populati on) presented more frequently 
with long-term arthralgia, myalgia, fati gue, insomnia and neuropsychological symptoms compared to 
chikungunya-only pati ents; however, the associati ons were non-signifi cant. Pati ents with  a  preceding 
dengue infecti on (vs. those without) (OR=4.17; p=0.004), female gender (OR=3.17; p=0.034) and pre-
existi ng joint disease (OR=2.95; p=0.031) had a higher risk of developing severe long-term chikungunya. 
Chronic disease (sequelae lasti ng for longer than 90 days) was predicted by an age between 41 and 60 
(OR=3.07; p=0.009) and concomitant cardiovascular disease (OR=4.08; p=0.010), but not by a preceding 
dengue infecti on. 
Conclusion
This study suggests several predicti ng factors of, and a possible link between preceding dengue and 
chikungunya infecti on and aggravated long-term sequelae, which should be interpret in the light of the 




Dengue and chikungunya are arboviruses transmitted by the day-biting mosquitoes Aedes aegypti and 
Aedes albopictus [1,2]. The vectors of these viruses currently circulate in large parts of the world, rendering 
40% of the world population susceptible to these diseases [3]. Chikungunya led to devastating epidemics 
when introduced in the Americas at the end of 2013 [4,5]. In the same regions, dengue is endemic with an 
increasing spread to previously unaffected areas [6]. Concomitant dengue and chikungunya infection have 
been reported in several regions worldwide, in particular in Africa and Asia [7]. However, considering the 
high transmission rates of both diseases, co-infections of dengue and chikungunya are surprisingly little 
reported [8]. Saint-Martin, a Caribbean island where the first locally transmitted chikungunya cases were 
reported in the Caribbean and America, also described the first co-infections of dengue and chikungunya 
in these regions [9].
Curaçao became affected by the epidemic of chikungunya up from mid-2014. The outbreak rapidly spread 
and at the end of the epidemic in January 2015, an estimated 50,000 to 75,000 inhabitants were infected 
[IG, unpublished]. This epidemic took place in a naïve population for chikungunya against the backdrop of 
well-established dengue transmission, with outbreaks during the rainy season [10]. All four dengue virus 
serotypes co-circulate in Curaçao [10]. 
Dengue and chikungunya lead to similar acute clinical presentations, typically starting with an abrupt 
onset of fever, which may be accompanied by a range of symptoms such as rash, headache, myalgia and 
arthralgia [1,2]. Disease may evolve into severe conditions and cause death in the case of dengue [2], while 
chikungunya is ill-famed for its debilitating long-lasting musculoskeletal symptoms which may persist for 
years [11]. The clinical spectrum of dengue and chikungunya co-infections is not well-described, and focuses 
on acute disease manifestations or complications. These studies do not show substantial differences in 
disease presentation [12-14]; however, complicated disease was described in co-infected patients [14].
To assess the knowledge gap concerning infections of chikungunya and dengue, this study investigates 
the impact of a preceding dengue infection on acute and chronic chikungunya disease presentation and 




During June and July 2015, a retrospective cohort study was set up including laboratory confirmed (by 
positive serology (ELISA), reverse transcription polymerase chain reaction (RT-PCR) or positive indirect 
fluorescent antibody (IFA)) chikungunya cases infected during the 2014 epidemic in Curaçao. Participant 
recruitment procedures and study site were described elsewhere [15].
Data collection
Individuals were surveyed using a structured questionnaire assessing socioeconomic variables, co-
morbidities, chronic chikungunya sequelae and chikungunya disease status; the latter being assessed 
using the formerly described Curaçao Long-Term Chikungunya Sequelae (CLTCS) score, where individuals 
with chronic chikungunya sequelae were classified as ‘recovered’, ‘mildly affected’ or ‘highly affected’ 
[15]. Trained, experienced local interviewers applied the questionnaire, which was piloted and adapted in 
Dutch, and translated to Papiamentu, Spanish and English [15]. 
The Ministry of Health of Curaçao is responsible for disease surveillance. During outbreaks, physicians are 
requested to report any suspected case to the Ministry of Health. Data from acute disease presentation was 
acquired via general practitioners, who assessed suspected chikungunya cases using a standardized form for 
chikungunya surveillance (Table 1) and referred them for dengue serology. Enzyme-linked immunosorbent 
assay (ELISA; DxSelectTM, Focus Diagnostics) of acute samples and (if available) convalescent samples 
were performed by the Analytical Diagnostic Centre (ADC N.V.) in Curaçao according to the manufacturer’s 
protocol, to detect dengue-specific IgM and IgG. Classification of serologic outcomes was determined as 
presented in Table B1. Patients were defined as having an “acute dengue infection”, “presumptive/recent 
dengue” or “past dengue”. A dengue infection was assumed as a ‘laboratory confirmed dengue’ based 
on a conversion of IgM or IgG in paired samples, or on a positive IgM in a previously naïve individual (i.e. 
negative IgG) in the acute sample. Participants were defined as having had a ‘preceding dengue’ infection 
when IgM was positive in one of the samples (i.e. in the acute or convalescent sample). Cases were defined 
as ‘past dengue’ when IgM was negative and IgG positive. When IgG and IgM tests were negative in acute 
(and convalescent) sample(s), cases were defined as (laboratory confirmed) ‘dengue negative’. 
We expected that a positive IgM for dengue and laboratory confirmed dengue could influence clinical 
manifestations. Therefore, patients diagnosed with acute or preceding dengue  infection were merged into 
one group, to which we hereinafter refer as ‘preceding dengue’. On the other hand, the ‘past dengue’ and 
the ‘negative cases’ were merged and are hereinafter referred to as chikungunya-only (i.e. no preceding 
dengue infection).
Data analysis
Data analysis procedures were described elsewhere [15]. Additionally, odds ratios of acute and chronic 
symptoms were calculated and adjusted for confounding factors using a binary logistic regression. 
Sequelae were considered ‘chronic’ if lasting 90 days or longer. A multivariate binary logistic regression was 
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performed to investigate predicting factors of chronic chikungunya disease outcomes. The multivariate 
analyses included all clinical and general characteristic variables which were associated with the dependent 
variables at a significance level of p<0.20. The analyses of acute and chronic clinical presentation presented 
in this manuscript include only the subjects with available dengue serology. To obtain more insights and 
power, additional analyses of acute and chronic disease presentation were performed including the 
participants without available dengue serology in Appendix A. 
Table 1 . Univariate analysis of acute clinical presentation of chikungunya, comparing individuals with vs. 
without preceding dengue infection
*Fisher’s exact test; ap-value and OR corresponds to the comparison of ‘preceding dengue infection’ vs. ‘chikungunya-only infection’, 
adjusted for concomitant diabetes mellitus and cardiovascular disease; bnumber of subjects in the ‘chikungunya-only infection’ group 
and the ‘preceding dengue infection’ group, respectively
Ethics statement
The study was approved by the Medical Ethical Board of the Sint Elisabeth Hospital (METC SEHOS) Curaçao 
(Reference number: 2015-002). All participants enrolled consented in writing.
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 n (%) n (%)   
Acute symptoms (n)b       
Fever (n=56; n=36) 54 (96.4) 32 (88.9) 0.35 (0.06-2.13) 0.253 
Headache (n=57; n=36) 50 (87.7) 30 (83.3) 1.10 (0.64-5.60) 0.890 
Orbital pain (n=53; n=35) 38 (71.7) 21 (60.0) 0.72 (0.90-12.26) 0.512 
Myalgia (n=56; n=35) 53 (94.6) 34 (97.1) 2.96 (0.27-32.31) 0.373 
Arthralgia (n=56; n=36) 53 (94.6) 34 (94.4) 1.65 (0.22-12.52) 0.628 
Arthritis (n=55; n=35)   35 (63.6) 26 (74.3) 1.62 (0.61-4.32) 0.335 
Rash (n=57; n=35) 27 (47.4) 15 (42.9) 1.04 (0.43-2.55) 0.637 
Nausea/vomiting (n=57; n=36)  19 (33.3) 12 (33.3) 0.98 (0.39-2.44) 0.962 
Diarrhoea (n=56; n=36) 14 (25.0) 7 (19.4) 0.75 (0.26-2.18) 0.603 
Cold shivers (n=55; n=36) 29 (52.7) 17 (47.2) 0.89 (0.37-2.17) 0.801 
Cough (n=57; n=35) 16 (28.1) 2 (5.7) 0.14 (0.03-0.71) 0.017 
Haemorrhagic tendencies (n=57; n=35) 3 (5.3) 0 (0.0) - 0.168* 
Icterus (n=56; n=35) 1 (1.8) 1 (2.9) 0.51 (0.02-11.39) 0.669 
 413 
*Fisher’s exact test; ap-value and OR corresponds to the comparison of ‘preceding dengue infection’ 414 
vs. ‘chikungunya-only infection’, adjusted for concomitant diabetes mellitus and cardiovascular 415 
disease; bnumber of subjects in the ‘chikungunya-only infection’ group and the ‘preceding dengue 416 
infection’ group, respectively 417 
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Subjects with dengue serology (n=162) 
-inclusion in analyses of objective 3 
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(n=5) 
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In June and July 2015, 304 laboratory-confirmed chikungunya cases were included in a cohort study 
(Figure 1). The socio-economic characteristics of the individuals were described previously [15]. Of the 
304 individuals, 299 consented to participate in the present study of which 162 were tested for dengue 
exposure. Fifty-seven participants were defined as having had a previous dengue infection. Of those, 
11 had a laboratory confirmed dengue and 46 a  ‘preceding dengue infection’ (Figure 1). Prevalence of 
chikungunya with a preceding dengue infection (which included the 11 laboratory confirmed participants) 
was thereby 35.2% (57/162). Acute clinical presentation was analysed using the subjects with clinical data 
on acute disease presentation and available dengue serology (n=94) (Figure 1). Analyses on predicting 
factors for long-term disease outcomes ( (a) developing severe disease and (b) disease persistence >90 
days) were performed from individuals with available clinical data on acute disease presentation (n=159) 
(Figure 1). Long-term disease presentation of subjects with a preceding dengue infection and chikungunya-
only subjects was analysed using all individuals assessed for dengue (n=162) (Figure 1).
Figure 1. Flowchart inclusion procedure of the study population
Objective 1: To analyse acute clinical presentation of preceding dengue infection and chikungunya-only disease.
Objective 2: To analyse predicting factors of chronic disease outcomes: (a)severe disease development and (b) disease persistence 
>90 days.
Objective 3: To analyse chronic clinical presentation of preceding dengue infection and chikungunya-only disease.
Additional analyses:  these analyses are presented in Appendix A, and were additionally performed since the sample size in the main 
manuscript was limite. The additional analyses also include the sample which was not tested for dengue. Therefore, these results 
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190
8
Correction for possible confounding
Before performing the overall analysis, possible confounding of acute or chronic clinical presentation 
between individuals with chikungunya-only and a recent dengue due to age, sex and co-morbidity was 
explored (Table 2). Further analysis were adjusted for the confounding variables associated with infection 
with recent dengue at a p≤0.200 level, which were concomitant diabetes mellitus and cardiovascular 
disease (for acute and chronic clinical presentation) and age (for chronic clinical presentation) (Table 2).
The same procedures were performed in the additional analyses presented in Appendix A.
Table 2. Analysis of possible confounders on acute and chronic chronic disease presentation
*Fisher’s exact test ; ap-value corresponds to the comparison between the groups ‘chikungunya-only infection’ and ‘preceding dengue 
infection’; cCardiovascular disease group includes hypercholesterolemia and hypertension;
Acute clinical presentation
To understand if the acute disease presentation of chikungunya was influenced by a preceding dengue 
infection, symptoms assessed by general practitioners were compared and adjusted for concomitant 
diabetes mellitus and concomitant cardiovascular disease (Table 1). Cough was more frequently reported 
in individuals with only chikungunya (chikungunya: 18.1% [n=16] vs. preceding dengue infection: 5.7% 
[n=2]; adjusted p-value=0.017). No other symptoms of acute presentation were associated with having a 
chikungunya-only or preceding dengue, neither in the additional analyses in Tables A1, A2.
Predicting factors of disease outcomes
Clinical characteristics of long-term chikungunya sequelae were assessed between 92-419 days after onset 
of acute disease. Uni- and multivariate analyses were performed to identify predicting factors of two disease 
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 Sample with clinical data on acute 
disease presentation (n=94) 


















 n (%) n (%)  n (%) n (%)  
Age           
18-40  16 (27.6) 6 (16.7)  30 (28.6) 9 (15.8)  
41-60 35 (60.3) 24 (66.7)  55 (52.4) 37 (64.9)  
>61  7 (12.1) 6 (16.7) 0.484* 20 (19.0) 11 (19.3) 0.171 
Sex           
Male 14 (24.1) 9 (25.0)  27 (25.7) 12 (21.1)  
Female 44 (75.9) 27 (75.0) 0.925 78 (74.3) 45 (78.9) 0.507 
           
Co-morbidity           
Joint disease 8 (13.8) 6 (16.7) 0.704 15 (14.3) 10 (17.5) 0.584 
Cardiovascular diseasec 9 (15.5) 10 (27.8) 0.150 15 (14.3) 13 (22.8) 0.171 
Neurologic disease 1 (1.7) 1 (2.8) 1.000* 2 (1.9) 3 (5.3) 0.346* 
Diabetes mellitus 4 (6.9) 8 (22.2) 0.053* 9 (8.6) 11 (19.3) 0.047 
 420 
*Fisher’s exact test ; ap-value corresponds to the comparison between the groups ‘chikungunya-only 421 
infection’ and ‘preceding dengue infection’; cCardiovascular disease group includes 422 




outcomes: 1) chikungunya disease persistence >90 days, and 2) development of a ‘highly affected’ CLTCS-
disease status. In 66.5% (n=105) of the cases, chikungunya disease persisted >90 days and 25.8% (n=41) 
were ‘highly affected’ at time of interview. Time-between-interview and disease onset was assessed as 
potential confounder, but showed a similar distribution for the ‘recovered and mildly affected’ and ‘highly 
affected’ individuals (Mean=267 days, SD=75 days vs. Mean=258 days, SD=57 days; T-test: p=0.431). In the 
univariate analysis, disease outcomes were compared with socio-economic characteristics, co-morbidity 
and clinical presentation at acute disease presentation (Table 3). Variables associated at a level of p≤0.20 
were included in the multivariate analysis. The final models of the multivariate analysis are presented in 
Table 4. An age between 41 and 60 (OR=3.07; p=0.009) (baseline category: age of 18-40) and concomitant 
cardiovascular disease (OR=4.08; p=0.010) were independent predictors of chikungunya disease longer 
than 90 days. ‘Highly affected’ disease status was predicted by female sex (OR=3.17; p=0.034), concomitant 
joint disease (OR=2.91; p=0.031) and preceding dengue (OR=4.17; p=0.004) (although the baseline 
category ‘no dengue serology’ was used).
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Table 3 . Univariate analysis of chikungunya disease outcome parameters: disease persistence longer 
than 90 days and highly affected CLTCS-disease status
*Fisher’s exact test; ap-value corresponds to the comparison between the groups ‘0-90 days’ and ‘>90 days’; bp-value corresponds 
to the comparison between the groups ‘recovered and mildly affected’ and ‘highly affected’; cCardiac disease group includes 
hypercholesterolemia and hypertension; n1 refers to the number of subjects of the ‘0-90 days’ and ‘>90 days’ group respectively; n2 
refers to the number of subjects of the ‘Recovered & mildly affected’ and ‘Highly affected’ group respectively
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longer than 90 days and highly affected CLTCS-disease status 426 
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 0-90 days 
(n=53) 
> 90 days 
(n=105) 






 n (%) n (%)  n (%) n (%)  
Age           
18-40  18 (34.0) 15 (14.3)  28 (23.7) 6 (14.6)  
41-60 24 (45.3) 71 (67.6)  65 (55.1) 30 (73.2)  
>61  11 (20.8) 19 (18.1) 0.008 25 (21.2) 5 (12.2) 0.126 
Sex           
Male 15 (28.3) 23 (21.9)  33 (28.0) 5 (12.2)  
Female 38 (71.7) 82 (78.1) 0.374 85 (72.0) 36 (87.8) 0.041 
Education           
Illiterate/primary school 11 (20.8) 23 (21.9)  24 (20.3) 10 (24.4)  
Secondary school 16 (30.2) 37 (35.2)  39 (33.1) 14 (34.1)  
Intermediate vocational education 16 (30.2) 27 (25.7)  37 (31.4) 7 (17.1)  
University (of applied sciences) 10 (18.9) 18 (17.1) 0.895 18 (15.3) 10 (24.4) 0.269 
Occupation           
Unemployed/student/housewife/voluntary 9 (17.0) 12 (11.4)  16 (13.6) 5 (12.2)  
Paid job(domestic or manual) 22 (41.5) 53 (50.5)  54 (45.8) 22 (53.7)  
Paid job(not domestic or manual) 16 (30.2) 23 (21.9)  30 (25.4) 9 (22.0)  
Retired 6 (11.3) 17 (16.2) 0.708* 18 (15.3) 5 (12.2) 0.853 
Income (n1=156; n2=157)           
0-999 ANG 4 (7.7) 9 (8.7)  10 (8.5) 3 (7.5)  
1000-2499 ANG 19 (36.5) 39 (37.5)  39 (33.3) 19 (47.5)  
2500-4999 ANG 20 (38.5) 45 (43.3)  52 (44.4) 14 (35.0)  
>5000 ANG 9 (17.3) 11 (10.6) 0.691 16 (13.7) 4 (10.0) 0.314* 
Co-morbidity            
Joint disease 3 (5.7) 19 (18.1) 0.033 12 (10.2) 10 (24.4) 0.023 
Cardiovascular diseasec 5 (9.4) 31 (29.5) 0.004 25 (21.2) 11 (26.8) 0.457 
Neurologic disease 0 (0.0) 2 (1.9)   0.551* 2 (1.7) 0 (0.0)  1.000* 
Diabetes mellitus 5 (9.4) 12 (11.4) 0.702 11 (9.3) 6 (14.6) 0.382* 
Dengue assessment           
Preceding dengue infection 22 (41.5) 43 (41.0)  21 (17.8) 10 (24.4)  
Past dengue/ dengue negative 21 (39.6) 36 (34.3)  42 (35.6) 16 (39.0)  
No dengue serology 22 (41.5) 43 (41.0) 0.664 55 (46.6) 15 (36.6) 0.014 
Acute symptoms            
Fever (n1=51&101; n2=112&41) 45 (88.2) 95 (94.1) 0.219* 102 (91.1) 39 (95.1) 0.516* 
Headache (n1=52&105; n2=41&117) 41 (78.8) 85 (81.0) 0.755 92 (78.6) 35 (85.4) 0.350 
Orbital pain (n1=51&99; n2=113&38) 28 (54.9) 64 (64.6) 0.246 66 (58.4) 26 (68.4) 0.274 
Myalgia (n1=52&103; n2=116&40) 48 (92.3) 97 (94.2) 0.733* 107 (92.2) 39 (97.5) 0.454* 
Arthralgia (n1=52&104; n2=116&41) 51 (98.1) 97 (93.3) 0.270* 109 (94.0) 40 (97.6) 0.681* 
Arthritis (n1=51&97; n2=108&41) 30 (58.8) 61 (62.9) 0.629 63 (58.3) 29 (70.7) 0.164 
Rash (n1=53&102; n2=115&41) 21 (39.6) 46 (45.1) 0.514 48 (41.7) 20 (48.8) 0.435 
Nausea/vomiting (n1=52&104; n2=116&41) 12 (23.1) 41 (39.4) 0.042 35 (30.2) 18 (43.9) 0.110 
Diarrhoea (n1=51&104; n2=115&41) 11 (21.6) 22 (21.2) 0.953 24 (20.9) 9 (22.0) 0.884 
Cold shivers (n1=51&103; n2=114&41) 22 (43.1) 50 (48.5) 0.527 51 (44.7) 21 (51.2) 0.475 
Cough (n1=53&102; n2=115&41) 8 (15.1) 16 (15.7) 0.923 16 (13.9) 8 (19.5) 0.394 
Haemorrhagic tendencies (n1=53&102; 
n2=115&41) 
2 (3.8) 2 (2.0)   0.607* 4 (3.5) 0 (0.0)   0.574* 
Icterus (n1=53&101; n2=115&40) 2 (3.8) 0 (0.0)   0.117* 2 (1.7) 0 (0.0)  1.000* 
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Table 4. Final model of variables independently associated with chikungunya disease outcome 
parameters: a) duration longer than 90 days  vs. 0-90 days; b) highly affected vs. recovered & mildly 
affected at time of interview
Long-term sequelae
Clinical chronic chikungunya presentation of the 162 individuals was compared between those with and 
without a preceding dengue infection, adjusted for age, concomitant diabetes mellitus and concomitant 
cardiovascular disease. Participants with a preceding dengue infection at disease onset reported higher 
proportions of most chronic symptoms (Table 5, Figure 2, Table A3), but no significant associations were 
found. Chronic joint pain in lower extremities was associated with a preceding dengue infection (OR=1.86; 
p=0.044) in the additional analyses in Table A3.
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Table 4. Final model of variables independently associated with chikungunya disease outcome 435 
parameters: a) duration longer than 90 days  vs. 0-90 days; b) highly affected vs. recovered & 436 
mildly affected at time of interview 437 
438 
 
OR (95% CI) p-value 




18-40  1 0.018 
41-60 3.07 (1.32-7.11) 0.009 
>61  1.31 (0.44-3.89) 0.625 
Co-morbidity: cardiovascular disease  
No 1  
Yes 4.08 (1.39-11.93) 0.010 
 
Highly affected disease status  
Sex 
  
Male 1  
Female  3.17 (1.09-9.23) 0.034 
Co-morbidity: joint disease  
No 1  
Yes 2.95 (1.11-7.86) 0.031 
Dengue assessment  
Preceding (/acute) dengue infection 1 0.016 
Past dengue/ dengue negative 0.52 (0.21-1.29) 0.159 
No dengue serology 0.24 (0.09-0.63) 0.004 
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Table 5. Chronic chikungunya clinical presentati on: preceding dengue infecti on vs. chikungunya-only 
infecti on
*Fisher’s exact test; ap-value and OR corresponds to the comparison of ‘preceding dengue infecti on’ vs. ‘chikungunya-only infecti on’, 
adjusted for age and concomitant diabetes mellitus and cardiovascular disease; bTotal of ‘chikungunya-only infecti on’ group: n=104
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(n=57) Adjusted Adjusted  
 n n n (%) ORa (95% CI) p-valuea 
Joint pain in the …       
upper extremities 45 (42.9) 24 (42.1) 0.80 (0.40-1.59) 0.525 
lower extremities 42 (40.0) 31 (54.4) 1.65 (0.84-3.24) 0.148 
Back/neck 31 (29.5) 17 (29.8) 0.92 (0.44-1.91) 0.826 
Weakness in the …        
upper extremities 39 (37.1) 23 (40.4) 0.98 (0.49-1.95) 0.943 
lower extremities 69 (34.3) 25 (43.9) 1.39 (0.70-2.74) 0.351 
back/neck 26 (24.8) 15 (26.3) 0.95 (0.44-2.06) 0.902 
Myalgiab 31 (29.8) 23 (40.4) 1.36 (0.67-2.74) 0.394 
Fatigue 35 (33.3) 21 (36.8) 1.15 (0.58-2.31) 0.686 
Insomnia 29 (27.6) 21 (36.8) 1.47 (0.72-3.01) 0.292 
Sombreness 16 (15.2) 10 (17.5) 1.02 (0.42-2.51) 0.958 
Loss of vitality 26 (24.8) 18 (31.6) 1.21 (0.58-2.56) 0.610 
Numbness 13 (12.4) 12 (21.1) 1.74 (0.66-3.68) 0.225 
Paraesthesia 13 (12.4) 11 (19.3) 1.40 (0.56-3.51) 0.474 
Nausea 16 (15.2) 6 (10.5) 0.58 (0.21-1.67) 0.312 
Vomiting 4 (3.8) 1 (1.8) 0.42 (0.04-4.24) 0.460 
Abdominal painb 9 (8.7) 7 (12.3) 1.22 (0.40-3.70) 0.731 
Skin diseases 8 (7.6) 5 (8.8) 1.12 (0.33-3.78) 0.856 
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In June and July 2015, a retrospective cohort study was performed to investigate the influence of a 
preceding dengue infection on chikungunya disease development. Chikungunya and a preceding dengue 
infection covered 35.2% of the subjects serologically tested for both diseases, which is amongst the highest 
incidences reported to date. As reviewed by Furuya-Kanamori and colleagues, the vast majority of studies 
report incidences of ‘co-infections’ up to 10% of the study population [16]. Most of these studies assessing 
‘co-infection’ relied, like the present study, (partly) on ELISA-IgM assessment when estimating concomitant 
prevalence of chikungunya and dengue. It is important to note here that ELISA-IgM assessment alone is not 
specific enough to define co-infection. 
Very few studies describe acute clinical disease presentation of chikungunya and a preceding dengue 
infection [8]. Even fewer of these included chikungunya-only infections and show, like the present study, 
no major differences with preceding or co-infected subjects in acute disease presentation [12-14] but 
reported complicated disease manifestations [14]. It is notable that patients with chikungunya and a 
preceding dengue infection were assessed as having more myalgia (OR=3.0) and arthritis (OR=1.6). This 
contradicts the findings of the study by Taraphdar et al., where patients with a preceding dengue infection 
and chikungunya presented with milder musculoskeletal manifestation than the chikungunya-only infected 
population [12]. Acute chikungunya (without preceding dengue) presented more often with cough when 
compared to chikungunya with recent dengue (OR=7.1; p=0.017). Cough is a relatively infrequent symptom 
at acute disease and might differentiate between a chikungunya-only infection and a chikungunya with 
recent dengue, although we could not find a pathophysiological explanation for this finding. Compared 
to other studies on acute chikungunya disease presentation, this study reported similar proportions of 
fever [17-21], arthralgia [17-20,22] and rash [18-21] while myalgia [17,19,20,22] and headache [17,19-21] 
were reported in higher proportions. These results indicate that differentiating between chikungunya-only 
infections and infections of chikungunya with recent dengue at acute presentation remains difficult and 
depends on laboratory assessment. 
This is the first study describing that chikungunya with a recent dengue at acute disease presentation is 
a predicting factor (OR=4.1) for severe chronic disease development. This independent association was 
most prominent when compared to the subjects without available dengue serology, but not significant 
(OR=1.9; p=0.159) when compared to the chikungunya-only subjects. It is likely that the group without 
available dengue serology consisted mainly of ‘past dengue’ or ‘dengue negative’ subjects, whilst a lower 
proportion would be have had a recent dengue. Therefore, we conclude that the latter bias may only have 
led to an underestimation of differences between the two groups. The independent association of dengue 
infection preceding chikungunya and developing a ‘highly affected’ chronic disease status was reflected 
in the chronic clinical presentation, where the vast majority of chronic symptoms  was reported in higher 
proportions in this group (i.e. arthralgia, myalgia, fatigue, insomnia and neuropsychological symptoms). 
In particular the higher proportions of chronic joint pain in the lower extremities, which have previously 
been associated with the ‘highly affected’ disease status [15], may be responsible for this association. The 
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outcomes of the analyses on predicting factors and chronic disease manifestations might suggest that a 
preceding dengue infection aggravates chronic (chikungunya) sequelae. However, the results of this study 
alone are not sufficient enough to draw a strong conclusion about this.
Several studies that focused on predicting chikungunya disease persistence have identified age [23-
25], sex [25], co-morbidity [23,26], or acute disease presentation [23-26] as determinants, but did not 
assess preceding/co-infection of dengue. This study also identified age, co-morbidity (joint disease and 
cardiovascular disease) and female sex as predicting factors for longer or worse disease outcome. These 
predicting factors may aid in assessing the need to follow up chikungunya patients. Furthermore, they 
may guide further fundamental research on the poorly understood pathophysiology of chikungunya and 
dengue co-infections.
An important limitation of this study was the small sample size of participants tested for dengue (162/299), 
with consequent implications for the power and representativeness of the study. Parallel analyses were 
done on acute and long-term clinical presentation to obtain higher power in the analyses (presented in 
Appendix A). The results of Table A1-A3 should be interpreted with caution, because it is likely that some 
of the subjects without dengue serology had a preceding dengue infection. Since little is known about 
clinical presentation of chikungunya with preceding dengue infection in other contexts than in Curaçao, 
generalization of this study should be limited. Due to the recruiting procedures, a referral bias can be 
present in this study. Also, in some cases laboratorial assessment relied on serology of one sample, which 
may have lowered the probability to determine a dengue infection. Further, ELISA-based serological assays 
of dengue are less reliable than RT-PCR or viral isolation and might cross-react with (vaccines of) various 
flaviviruses (e.g. Japanese encephalitis, yellow fever). However, based on the epidemiological situation 
of Curaçao at the time of the study, we have no reasons to assume that cross-reaction has significantly 
influenced the results of this study.
Chikungunya sequelae were prominent in the population with a preceding dengue infection (which 
included patients with an acute dengue infection) and chikungunya disease, suggesting survival of 
chikungunya virus during concurrent dengue infection. Though severe dengue disease manifestations 
were not assessed in this study, they have been described during co-infection with chikungunya [14]. 
Under which circumstances these sequelae present might be understood through further research 
regarding (pathophysiology of) chikungunya and (preceding) dengue (co-)infections. For example, clinical 
manifestations might be influenced by order of infection or viral load of the two viruses.  
The high incidence of dengue infection preceding chikungunya disease and the presence of concurrent 
infection advocate for a critical clinical assessment of patients presenting with fever-like diseases in a 
chikungunya epidemic against the backdrop of a high dengue endemicity. As co-infections are not easily 
distinguishable from chikungunya-only infections based on acute clinical presentation, concomitant 
dengue might be missed in diagnosis. In the latter case, dengue disease can still develop into severe disease 
conditions. Hence, when a patient presents with acute fever in an area where dengue and chikungunya 
circulate, it is important to perform laboratory diagnosis to confirm presence of these viruses. Additionally, 
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this will provide valuable information for further chronic disease development, as patients with preceding 
dengue infection and chikungunya disease might have higher chances to develop a severe long-term 
disease associated with decreased long-term quality of life [15].
This study described several risk factors for prolonged and severe long-term chikungunya sequelae. 
Furthermore, it presents clinical presentation of preceding dengue infection with chikungunya and suggest 
that there might be a link between preceding dengue infection and aggravated chronic sequelae. However, 
considering the limitations of this study, this possible link should be further investigated before a conclusion 
can be drawn. The possible consequences, but little knowledge on the consequences of the ongoing 
spread of these viruses, raise an urgent call to investigate the clinical presentation and pathophysiology of 
co-circulating (i.e. chikungunya, dengue and Zika) arboviruses.
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The analysis performed in this document includes also the subjects who were not serologically assessed 
for dengue. This group was included in the ‘Chikungunya infection’-group, and concerned 137 individuals 
(of which 65 had data available on acute disease presentation) (See flowchart in Figure 1). The remaining 
individuals were classified as was described in the main manuscript. At interpretation of these data, this 
limitation should be taken into account.
Table A1 . Univariate analysis of acute clinical presentation chikungunya, comparing individuals with vs. 
without preceding dengue infection
*Fisher’s exact test; ap-value and OR corresponds to the comparison of ‘dengue infection preceding chikungunya’ vs. ‘chikungunya 
infection’, adjusted for comorbid diabetes mellitus; bnumber of subjects in the chikungunya-solo infection group and the ‘preceding 
dengue infection’ group, respectively
Table A1 . Univariate analysis of acute clinical presentation chikungunya, comparing individuals 













 n (%) n (%)   
Acute symptoms (n)b       
Fever (n=117; n=36) 109 (93.2) 32 (88.9) 0.71 (0.19-2.63) 0.603 
Headache (n=122; n=36) 97 (79.5) 30 (83.3) 1.36 (0.50-3.72) 0.364 
Orbital pain (n=116; n=35) 71 (61.2) 21 (60.0) 0.92 (0.42-2.03) 0.841 
Myalgia (n=121; n=35) 112 (92.6) 34 (97.1) 4.33 (0.48-39.50) 0.193 
Arthralgia (n=121; n=36) 115 (95.0) 34 (94.4) 1.11 (0.20-6.20) 0.904 
Arthritis (n=114; n=35)   66 (57.9) 26 (74.4) 1.96 (0.83-4.63) 0.126 
Rash (n=121; n=35) 53 (43.8) 15 (42.9) 1.12 (0.51-2.46) 0.782 
Nausea/vomiting (n=121; n=36)  41 (33.9) 12 (33.3) 0.96 (0.43-2.16) 0.927 
Diarrhoea (n=120; n=36) 26 (21.7) 7 (19.4) 0.95 (0.37-2.47) 0.923 
Cold shivers (n=119; n=36) 55 (46.2) 17 (47.2) 1.04 (0.48-2.25) 0.917 
Cough (n=121; n=35) 22 (18.2) 2 (5.7) 0.25 (0.05-1.15) 0.075 
Haemorrhagic tendencies (n=121; n=35) 4 (3.3) 0 (0.0) - 0.575*b 
Icterus (n=120; n=35) 1 (0.8) 1 (2.9) 1.14 (0.06-21.87) 0.929 
 
*Fisher’s exact test; ap-value and OR corresponds to the comparison of ‘dengue infection preceding 
chikungunya’ vs. ‘chikungunya infection’, adjusted for comorbid diabetes mellitus; bnumber of 




Table A2. Analysis of possible confounders on acute and chronic clinical disease presentation
*Fisher’s exact test ; ap-value corresponds to the comparison between the groups ‘chikungunya infection’ and ‘dengue infection 
preceding chikungunya’; cCardiovascular disease group includes hypercholesterolemia and hypertension;
Table A2. Analysis of possible confounders on acute and chronic clinical disease presentation 






















 n (%) n (%)  n (%) n (%)  
Age           
18-40  28 (22.8) 6 (16.7)  57 (23.6) 9 (15.8)  
41-60 71 (57.7) 24 (66.7)  117 (48.3) 37 (64.9)  
>61  24 (19.5) 6 (16.7) 0.614 68 (28.1) 11 (19.3) 0.079 
Sex           
Male 29 (23.6) 9 (25.0)  67 (27.7) 12 (21.1)  
Female 94 (76.4) 27 (75.0) 0.860 175 (72.3) 45 (78.9) 0.307 
           
Co-morbidity           
Joint disease 16 (13.0) 6 (16.7) 0.588* 31 (12.8) 10 (17.5) 0.350 
Cardiovascular diseasec 26 (21.1) 10 (27.8) 0.402 58 (24.0) 13 (22.8) 0.853 
Neurologic disease 1 (0.8) 1 (2.8) 0.403* 8 (3.3) 3 (5.2) 0.444* 
Diabetes mellitus 9 (7.3) 8 (22.2) 0.026* 27 (11.2) 11 (19.3) 0.097 
 
*Fisher’s exact test ; ap-value corresponds to the comparison between the groups ‘chikungunya 




Table A3. Chronic chikungunya clinical presentation: recent/concomitant dengue vs. chikungunya 
infection
*Fisher’s exact test; ap-value and OR corresponds to the comparison of ‘dengue infection preceding chikungunya’ vs. ‘chikungunya 
infection’, adjusted for age and concomitant diabetes mellitus; bTotal chikungunya infection group n=241










(n=57) Adjusted  Adjusted  
 n (%) n (%) ORa (95% CI) p-valuea 
Joint pain in the …       
upper extremities 106 (43.8) 24 (42.1) 0.78 (0.42-1.43) 0.418 
lower extremities 98 (40.5) 31 (54.4) 1.86 (1.02-3.40) 0.044 
Back/neck 66 (27.3) 17 (29.8) 1.12 (0.58-2.14) 0.741 
Weakness in the …        
upper extremities 84 (34.7) 23 (40.4) 1.06 (0.57-1.96) 0.852 
lower extremities 77 (31.8) 25 (43.9) 1.71 (0.93-3.12) 0.083 
back/neck 53 (21.9) 15 (26.3) 1.18 (0.60-2.32) 0.643 
Myalgiab 80 (33.2) 23 (40.4) 1.32 (0.71-2.44) 0.379 
Fatigue 73 (30.2) 21 (36.8) 1.30 (0.71-2.41) 0.400 
Sleeplessness 63 (26.0) 21 (36.8) 1.64 (0.88-3.05) 0.121 
Sombrenessb 40 (16.6) 10 (17.5) 0.99 (0.45-2.17) 0.974 
Loss of vitality 57 (23.6) 18 (31.6) 1.36 (0.71-2.59) 0.354 
Numbness 38 (15.7) 12 (21.1) 1.30 (0.62-2.72) 0.490 
Paraesthesia 24 (9.9) 11 (19.3) 1.85 (0.83-4.11) 0.130 
Nausea 27 (11.2) 6 (10.5) 0.86 (0.33-2.23) 0.752 
Vomitingb 8 (3.3) 1 (1.8) 0.42 (0.05-3.63) 0.432 
Abdominal painb 20 (8.3) 7 (12.3) 1.45 (0.56-3.73) 0.447 
Skin diseases 15 (6.2) 5 (8.8) 1.37 (0.47-3.99) 0.567 










































































Table B1. Categorisati on of ELISA assessments
P= positi ve test outcome; N= negati ve test outcome; aTotal subjects with dengue serology: n=162; bThis concerned one case. Because 
values of the convalescent sample raised by more than 5 ti mes, this sample was considered as IgG seroconversion.
Acute sample Convalescent sample  Classification Binary categorisation for analyses 
IgM IgG IgM IgG n (%)a   
P N P P 1 (0.6) Acute dengue Preceding dengue infection and chikungunya 
N P P P 6 (3.7) Acute dengue Preceding dengue infection and chikungunya 
N N N P 2 (1.2) Acute dengue Preceding dengue infection and chikungunya 
P N - - 1 (0.6) Acute dengue Preceding dengue infection and chikungunya 
N P N P 1 (0.6) Acute dengue b Preceding dengue infection and chikungunya 
P P - - 38 (23.5) Presumptive/recent dengue Preceding dengue infection and chikungunya 
P P N P 2 (1.2) Presumptive/recent dengue Preceding dengue infection and chikungunya 
P P P P 4 (2.5) Presumptive/recent dengue Preceding dengue infection and chikungunya 
- - P P 2 (1.2) Presumptive/recent dengue Preceding dengue infection and chikungunya 
N P N P 26 (16.0) Past dengue Chikungunya-only 
N P - - 70 (43.2) Past dengue Chikungunya-only 
- - N P 6 (3.7) Past dengue Chikungunya-only 
N N N N 1 (0.6) Confirmed dengue negative Chikungunya-only 
N N - - 2 (1.2) Presumptive dengue negative Chikungunya-only 
 
Table B1. Categorisation of ELISA s ssments. P= positive tes  outco e; N= negative t st outcom ; aT tal subjects with dengue serology: n=162; bThis 
concerned one case. Because values of the convalescent sample raised by more than 5 times, this sample was considered as IgG seroconversion. 
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The viruses dengue and chikungunya are a major public health threat for aff ected countries. In this thesis, 
we focused on improving health care and preventi on of these diseases in two countries situated at the 
Caribbean Sea: Curaçao and Venezuela. We examined access to care and health seeking behaviour for 
dengue and fever in a community in Venezuela. Communiti es’ preventi ve practi ces and mosquito control 
practi ces were investi gated in Venezuela and Curaçao. Furthermore, we examined the impact on QoL of 
chikungunya, and the infl uence of co-infecti on with dengue on these sequelae in Curaçao. The research 
methods from this thesis originate from various disciplines, amongst these are medical, psychological and 
sociological sciences.
Dengue and health behaviours in Venezuela
Venezuela faces a challenging public health situati on. In the last decades, dengue has emerged in 
Venezuela as a result of urbanisati on and insuffi  cient mosquito control policies [1,2]. Within the same year 
as the major dengue outbreak of 2010 [3], a cohort study was set up in the city Maracay, to investi gate 
epidemiological, behavioural, clinical and viral characteristi cs related with dengue disease and transmission 
[2]. The studies presented in this thesis were performed in 2013-2014 as part of one of the annual surveys. 
During the past years, Venezuela’s politi cal and healthcare systems have been unstable, at a background of 
ongoing anti -governmental protests [4-6]. At the ti me the fi eldwork of these studies was performed, anti -
governmental protests intensifi ed, resulti ng in an unsafe situati on for the staff  performing the fi eldwork. 
The research team therefore had to cease the fi eldwork aft er a sample size of 105 individuals. Hence, the 
results provide unique insights in atti  tudes and behaviours of a populati on facing a complex politi cal and 
healthcare situati on.
In Chapter 2, we examined the dynamics of health seeking behaviour (HSB) of fever and dengue, in order 
to fi nd ways to improve early healthcare seeking. In Venezuela, people tend to seek care relati vely late 
[7]. As dengue can develop into severe disease conditi ons, early health centre att endance is important 
in order to reduce the mortality rate of dengue [1,2]. We used the Health Belief Model (HBM) and the 
Theory of Planned Behaviour (TPB) for interpreti ng and analysing the results, and for providing a bett er 
understanding of social and psychological moti ves of intended behaviour and atti  tudes. We found that if 
people suspected a dengue infecti on, they would go to a doctor at day one or two. On the other hand, 
when they were confronted with a ‘fever’, people fi rst provided household remedies. These are important 
fi ndings, meaning that people perceive dengue as a threat, which would prompt them to go to a doctor 
early if they know they are having dengue. Hence, a diagnosti c tool for dengue to be used at home could 
possibly improve prompt doctor visits and reduce the mortality rate of dengue in Venezuela. To understand 
the HSB decisions taken by the parti cipants in Chapter 2, it is important to refl ect on the current health 
system of Venezuela. In Chapter 3, we described the access to health-care in the same populati on in 
which we examined the HSB regarding dengue and fever, using qualitati ve and quanti tati ve methods. 
The health-system of Venezuela currently encompasses a private sector and a public sector. The public 
sector off ers healthcare free of charge and comprises traditi onal public health centres (primary/secondary 
‘ambulatorios’ and terti ary hospitals). Since 2003, a parallel public healthcare system was set up based on 
an agreement with Cuba. In this agreement, Cuba off ered Cuban doctors to work in Venezuela ‘inside the 
208
9
slum’ (in Spanish: ‘Barrio Adentro’) in return for oil from Venezuela. Our quantitative and qualitative results 
revealed the complex situation that people face to obtain timely and proper healthcare in Venezuela. Most 
people (79-81%) preferred to firstly visit a traditional ambulatorio in the case of fever or dengue, since 
the doctors in the traditional HCs were trusted. However, long waiting times and a lack of diagnostic and 
treatment supplies at these HCs were considered as major barriers to attend traditional HCs. On the other 
hand, these barriers were perceived to a lesser extent in the parallel HCs. However, a prominent reason not 
to go to parallel HCs was distrust towards the Cuban staff working at these centres. The private HCs were 
perceived as giving the best care, but these HCs were only available for people with a health insurance. 
The perceived barriers and advantages of the different health centres made people intend to visit multiple 
HCs to obtain satisfactory healthcare. The results of Chapter 3 show the current challenging situation 
people face when they search for healthcare, and highlight the need to improve health seeking behaviour 
(Chapter 2) and access to healthcare (Chapter 3) in Venezuela.
Mosquito control in Curaçao and Venezuela
Severe disease conditions of dengue can be avoided by adequate HSB (Chapter 2) or by appropriate access 
to healthcare (Chapter 3). Nevertheless, the best remedy against the consequences of dengue remains 
prevention [8,9]. Prevention might include personal protection against the vector of dengue, i.e. the 
mosquito of the Aedes spp.. However, preventing mosquitoes from multiplying by mosquito breeding 
site control is more effective on the long term [10,11]. Therefore, we explored which factors influenced 
dengue preventive practices in our study population in Maracay, Venezuela, as described in Chapter 4. 
We observed good knowledge on transmission routes of dengue and a high usage of personal protection, 
but found mosquito breeding sites in 57% of the examined houses. Although personal protection against 
mosquitoes is advised, mosquito breeding site control is more important for dengue control. We concluded 
in Chapter 4, that dengue control campaigns in Maracay should focus on promoting mosquito breeding 
site control in people’s houses and yards. Furthermore, complementary to the conclusions of Chapter 
4, we examined the intentions to perform ‘Mosquito Breeding Site Control’ (MBSC) in Chapter 5. In this 
chapter, we incorporated theories of health behaviours in each stage of research, by designing, performing, 
analysing and interpreting studies based on a solid theoretical framework. A multidisciplinary research 
project in Curaçao including 339 participants for a (quantitative) survey, and 75 participants for qualitative 
research was set up. The mixed-methods (qualitative and quantitative methods) of this study were highly 
complementary, because both methods used an integrated theoretical framework based on the Health 
Belief Model (HBM) [12,13] and the Theory of Planned Behaviour (TPB) [14]. The introduction of this book 
provides an explanation of these health behaviour theories and in Chapter 5 the theoretical framework is 
presented. People reported high levels of knowledge, and high performance of MBSC. However, still 37% 
of the study population had a lower intention to perform MBSC. We identified factors related with this 
lower intention and presented three possible intervention methods to improve community participation 
in MBSC. These interventions are: (1) Ongoing, repetitive media coverage on MBSC to remind people of 
the importance of MBSC. These messages should be grounded in communities’ realities. (2) Visibility of 
governmental MBSC practices, which might motivate people to engage in MBSC. Hence, messages to the 
public concerning governmental MBSC practices should be provided. However, these messages should 
include that people’s own MBSC remain essential, preventing that people lose their sense of responsibility 
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to perform MBSC. (3) Usage of local community key persons serving as ‘ambassadors’ to promote MBSC 
in their community. A limitation of this study was that we relied on the ‘intention’ of participants, and did 
not measure the actual performed MBSC practices of our study population. On the other hand, this study 
is unique because of its multidisciplinary approach, which led to comprehensive and applicable outcomes. 
Since Chapter 4 and 5 have revealed important social and behavioural determinants of community 
participation in MBSC, these studies provide practical implications, which might also be useful for other 
countries and communities. Therefore, performing similar studies in other contexts might expose more 
targets to enhance MBSC and lower the burden of arboviral diseases.
The impact of chikungunya on quality of life
The research in Curaçao was set up against the backdrop of a recent chikungunya epidemic and established 
dengue transmission of all four serotypes [15,16]. We used mixed-methods to investigate the impact of 
chronic chikungunya disease on quality of life (QoL). Quantitative data was collected using the RAND-36/
SF-36 QoL questionnaire as described in Chapter 6. We obtained additional in-depth insights on chronic 
chikungunya sequelae and its impact on QoL of infected people by applying qualitative research methods 
in Chapter 7. Based on the definition of health from the World Health Organisation (WHO) [17], we 
investigated QoL by examining physical, emotional, social and economic well-being of chikungunya infected 
people. These were similar QoL concepts as were measured in Chapter 6 with the RAND-36/SF-36. The 
coping strategies were analysed using the principles of Lazarus’ theory on coping strategies [18,19].
 
Chapter 6 shows that QoL-scores from chikungunya patients were reduced on emotional, social and 
physical domains of QoL. The people who were characterized as suffering more severe from chikungunya 
(‘highly affected’) scored the lowest QoL scores. The in-depth interviews and focus group discussions 
in Chapter 7 show that impact on QoL concerned mainly physical and emotional well-being, whereas 
impact on social and economic well-being was limited. Physical impact of chikungunya was caused by 
musculoskeletal manifestations and other symptoms, leading to pain and limited mobility. Hence, e.g. 
dependency, hopelessness, a change of identity, and moodiness were experienced by participants. The 
employed coping strategies influenced the impact on QoL. A higher uptake of medical care and higher 
impact on QoL where linked to problem-focused coping strategies, whereas lower impact on QoL was 
observed by those performing emotion-focused coping strategies (focused on acceptation of the situation). 
The work we present in Chapter 7 is the first qualitative assessment on this topic. 
The highly complementary findings of Chapter 6 and 7 highlight the unique value of mixed-methods 
research in public health, by providing important generalizable and in-depth knowledge on chikungunya 
and may inform public health policies. As QoL is often severely reduced for years, development of effective 
long-term treatment for chikungunya needs to be prioritized. Meanwhile, healthy coping strategies should 
be promoted in order to lessen the impact of chronic chikungunya in affected populations.
Clinical manifestations of chikungunya
Chikungunya causes a major public health impact in affected countries given its long-term sequelae 
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responsible for significant impairment of patients’ physical and mental quality of life [20]. Nevertheless, 
chronic chikungunya disease still lacks a proper definition and classification. In Chapter 6, we investigated 
the chronic clinical presentation in a population infected by chikungunya during the epidemic of 2014/2015 
in Curaçao. Based on a novel classification tool, the Curaçao Long Term Chikungunya Sequelae (CLTCS) 
score, we classified the participants as being ‘recovered’, ‘mildly affected’ or ‘highly affected’ by long-term 
chikungunya sequelae. We estimated that people had a 79% chance to remain affected for longer than 
one month. Furthermore, 64% of the population was estimated to remain affected after 400 days. Long-
term chikungunya sequelae typically included musculoskeletal manifestations. Tiredness, sleeplessness 
and neurological symptoms were also commonly reported. QoL scores were decreased in those still being 
affected by chikungunya, particularly in the ‘highly affected’ population. Therefore, this group should be 
targeted in health promotion strategies and monitored by health professionals. We propose the CLTCS 
score as an easily applicable tool for physicians to classify chronic chikungunya sequelae and quickly 
estimate the need for symptom-alleviating treatment. 
As stated before, chikungunya and dengue both circulate in Curaçao and are transmitted by the same 
mosquito. Therefore, it is not unlikely that co-infections of these diseases occur in Curaçao. Nevertheless, 
concomitant dengue and chikungunya infection are not abundantly examined. We analysed acute and 
chronic disease manifestations of chikungunya mono-infections vs. chikungunya with preceding dengue 
in Chapter 8. We found a high prevalence of chikungunya with preceding dengue infection in our study 
population (36.3%). Furthermore, we found that preceding dengue infection at disease onset predicted an 
aggravated chronic disease. An important limitation of this study concerned the classification criteria of 
preceding dengue infection. Dengue was mainly based on a positive IgM, and therefore, dengue should be 
considered as ‘dengue infection preceding chikungunya’. Notwithstanding the limitations of this study, the 
association of preceding dengue and aggravated chronic disease is a new finding in the field of co-infections, 
with important implications for public health and research on (pathophysiology of) co-infections. Many 
areas are currently facing simultaneous dengue and chikungunya transmission [21]. In the light of the 
results of Chapter 8, the impact of the diseases in these areas might be bigger than previously thought.
Future perspectives
In this thesis, we investigated ways to improve HSB of dengue-infected patients in Venezuela. At the time 
the fieldwork was performed (2013-2014), Venezuela already faced an instable political situation with 
deterioration of the health system [4-6]. Though Chapter 2, 3 and 4 offer valuable recommendations for 
health authorities in Venezuela, the political situation became even more unstable in the following years. 
Prioritizing prevention of (severe) dengue infection and improving access to care might currently not be 
feasible in Venezuela, given the political instability and other major public health concerns Venezuela 
confronts. Based on this thoughts it is very difficult to come out with future perspectives. However, if 
Venezuela overcomes these challenges, the results of Chapter 2, 3 and 4 could aid in shaping new health 
policies.
Since after intensive mosquito control policies the Aedes spp. re-emerged in the Americas [22], there is 
a growing consensus that mosquito control will only be sustainable if relying on mutual efforts of both 
communities and governments [23]. As reflected upon in Chapter 4, it remains difficult to engage a 
211
9
community in mosquito breeding site control (MBSC). Chapter 5 revealed several practical interventions 
that could potentially enhance community participation in MBSC. New techniques in mosquito control are 
being developed. Because exact efficacy of these techniques are not yet known, it remains important that 
community mobilization in MBSC is fostered. Currently, and possibly in the future as well, this is one of 
the most efficient and sustainable components of mosquito control. Though there is still much to improve 
in policies aimed at enhancing community participation in MBSC, a start can be made by applying the 
principles presented in this thesis (Chapter 5).
Chikungunya remains a neglected tropical disease. In the last years, outbreaks of chikungunya have 
been overshadowed by other global health concerns, in particular by Zika and its association with 
microcephaly [24]. The WHO defined this threat as ‘a public health emergency of international concern’ 
[25]. Consequently, researchers focused on Zika, but at that time chikungunya received considerably less 
attention. Therefore, still relatively little is known about chikungunya. The novel classification method 
presented in Chapter 6, the first qualitative study on impact of chikungunya on QoL (Chapter 7) and the 
novel finding that suggest that dengue infection preceding chikungunya predicts severe chronic sequelae 
(Chapter 8), which are all presented in this thesis, reflect the lack of research regarding chikungunya. 
Moreover, it suggests that the findings of this thesis are just the tip of the iceberg when it concerns 
knowledge on chikungunya. Since chikungunya causes major long-term impact on QoL of its patients and 
there is no efficient treatment available yet, we recommend to foster chikungunya research. There is still 
much to unravel in pathophysiology (of co-infections) and to improve in the treatment and prevention of 
this devastating disease.
A call for intervention-focused research
Lastly, we would like to stress the importance of performing applicable health research. Health is defined 
by the WHO as ‘a state of complete physical, mental, and social well-being not merely the absence of 
disease’ [17]. In clinical sciences, research is often limited to ‘curing diseases’, thereby neglecting the 
mental, social and cultural determinants of health. Health interventions will result in poorer promotion of 
health, when one of these determinants of health is overlooked. 
This thesis reflects that a holistic (and multidisciplinary) view provide comprehensive insights in health 
problems. Chapter 5 demonstrates that mixed- methods based on health behaviour theories aid 
substantially in unravelling the complex dynamics of human behaviour (in this thesis: MBSC practices 
of communities). Furthermore, Chapter 6 and 7 demonstrate how quantitative and qualitative research 
on health-related QoL complement each other, by giving both in-depth and generalizable results. These 
chapters have all let to new and important implications for public health policies (as was discussed before). 
It is important to mention here, that at all stages of research (design, collection, analyses and interpretation 
of results) theory and practice of the different disciplines were applied.
Therefore, to achieve applicable and sustainable health interventions, researchers from different 
disciplines (e.g. epidemiologists, biologists, sociologists and psychologists) should bundle their strengths. 
A multidisciplinary effort is needed to move from attaining absence of disease to an all-encompassing 
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Chapter 6, Supplementary fi le 1: Instrument.
Questionnaire chikungunya 2015 
 
  
PLEASE WRITE YOUR PERSONAL DATA:  
Project nr. __ __ __ 
1. Date of interview: Day __ __ Mth __ __ Year __ __ __ __  
2. Date of birth: Day __ __ Mth __ __ Year __ __ __ __   
3. Initials: ___  ___   
Personal data  
-Date of birth, gender and place of residence was obtained from the informed consent form 
4. Have you had chikungunya? Yes No (stop with this questionnaire) 
5. Which of the following chronic (long lasting) disorders do you have? (check all boxes that 
apply) 
Please note!: this concerns the disorders you already had before getting chikungunya. 
Joint pain Nerve or brain disorders Diabetes 
Heart disease / vascular disease / 
high blood pressure Other:______________________________________________________ 
6. What is the highest level of education you completed? (check appropriate box) 
 No education  Lower secondary vocational training (LBO/ MBO level 1  or 2) 
 Primary education  Higher secondary vocational training (MBO level 3 or  4) 
 Intermediate/lower education: VMBO/MAVO   University of applied sciences (HBO) 
 Higher secondary education up to 3th grade: 
HAVO/ VWO (Atheneum);  University bachelor 
 HAVO/ VWO (Atheneum)   University master 
 Other: _________________________________________________________________________________ 
7. What kind of work do you do? (check one box that describes your situation the best) 
 No work/ unemployed  Paid work; especially active, physical work,  (e.g. salesperson,  guard, bus driver, cleaner, construction worker)  
 Student  Paid work; especially mental work  (e.g. manager, advisor, teacher, physician) 
 House wife  Retired, pensioned 
 Volunteer  Other: ___________________________________________ 
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8. What is your household’s net monthly income?  (Check box) 
 0 - 999 NAF per month  2500 - 4999 NAF per month 
 1000 – 2499 NAF per month   More than 5000 NAF per month  




On what date did you feel the first symptoms of chikungunya?  
If you don’t remember exactly, make your best possible estimate. 
Fill in:  Day __ __   Month _______________   Year __________________ 
   
10. Do you still suffer the symptoms of chikungunya? 
 Yes (Skip question 10b!)                      No (Answer question 10b!)             
10b. If no, for how long have you suffered from the symptoms? Estimate how long below: 
 _______months _______ weeks _______days 
Questionnaire chikungunya 2015 
 
 







11. The effects of chikungunya  
Please, check the box according to how much you agree or not with the 
following statements: 
     
1 2 3 4 5 
1. I am fully functional again after having had chikungunya…………………..      
2. I don’t have chikungunya complaints any more …………………………………      
3. I still feel the effects of chikungunya disease every day………………….….      
4. The chikungunya effects seem to return again and again in my case...      
12. Currently I suffer from the following symptoms: 
Joint pains in the: Muscles aches:.. No  Somewhat Yes 
- Arms-/wrists/hands 
/fingers:……………………….. No  Somewhat Yes 
Tiredness:……….. No  Somewhat Yes 
Somberness/ 
Feeling blue:…… No  Somewhat Yes 
- Hips/knees/feet/ 
ankles/toes:…………………. No  Somewhat Yes 
Sleeplessness:…. No  Somewhat Yes 
Hair loss:…………. No  Somewhat Yes 
- Back/neck:…………………. No  Somewhat Yes Nausea:…………… No  Somewhat Yes 
Weakness in the: 
Vomiting:………… No  Somewhat Yes 
- Arms/wrists/hands 





No  Somewhat Yes 
Skin diseases:….. No  Somewhat Yes 




No  Somewhat Yes 
Tingles:…………… No  Somewhat Yes 
Loss of vitality:… No  Somewhat Yes 
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11. The effects of chikungunya  
Please, check the box according to how much you agree or not with the 
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Survey instrument Theory of Planned Behaviour and Health Belief Model, 
ordered by concept  
(cues to action and knowledge are described in ‘Methods’) 










Behavioural intention to perform mosquito breeding site control (BIMBSC) 
The BIMBSC-score is obtained by adding up the values of the three answers. 
The coming rainy season, I will check my house and yard for mosquito breeding 
sites every week and eliminate them if necessary… 
 1 2 3 4 5  
I will definitely not do      I will definitely do 
I will not even try      I will definitely try 
I’m not planning to      I am planning to 
Susceptibility (chikungunya and dengue) 
 
 
Check to what extent you agree with the following statements: 
     
1 2 3 4 5 
I expected to get chikungunya …………………………..................................................      
I think I had a greater chance of getting chikungunya compared to others……….      
Everyone in Curaçao runs a great risk of getting chikungunya  …………………………      
I think I run the risk of getting chikungunya once more…………………………………….      
I think I have a greater chance of getting dengue compared to others……………..      
Everyone in Curaçao runs a great risk of getting dengue  …………………………………      
I think I run the risk of getting dengue (once more) …………………………………………      
Chapter 5, Additional file 2: Survey instrument Theory of Planned 
Behaviour and Helth belief model ordered by concept.






Severity (chikungunya and dengue) 
 
 
Check to what extent you agree with the following statements: 
     
1 2 3 4 5 
Chikungunya is a serious disease………………………………………………………………………      
People who get chikungunya  can die of it………………………………………………………..      
People who have chikungunya are limited in their social activities……………………      
An infection with chikungunya leads to loss of income……………………………………..      
An infection with chikungunya costs the patient a lot of money……………………….      
Dengue is a serious disease………………………………………………………………………………      
People who get dengue  can die of it………………………………………………………………..      
People who have dengue are limited in their social activities……………………………      
An infection with dengue leads to loss of income……………………………………………..      
An infection with dengue costs the patient a lot of money……………………………….      
 
Perceived benefits 
If, during the coming rainy season, I check for mosquito breeding sites and eliminate 
them from my house and yard if necessary,  … 
 1 2 3 4 5  
I will not get chikungunya      I will get chikungunya 
My family will not get chikungunya      my family will get chikungunya 
My neighbours will not get 
chikungunya 
     my neighbours will get 
chikungunya 
       
I will not get dengue      I will get dengue 
My family will not get dengue      my family will get dengue 





Perceived barriers  
During the coming rainy season I will not check for mosquito 
breeding sites and eliminate them if necessary because… 
     
1 2 3 4 5 
I do not know how to check for breeding sites…………………………………………………….      
I do not like to eliminate breeding sites……………………………………………………….……..      
Neighbours do not do it either, so it makes no sense for me to do it……………….…      
I never have mosquitoes in my house or yard………………………………………………………      
There are many other breeding sites the government does nothing about………….      
I cannot get rid of my garbage/debris/rubbish at another place than in my yard…      
I live near a mondi/dam where more mosquitoes come from than from my yard.      
Someone else from my family will do it already……………………………………………………      
I do not have the physical ability to check my yard every week…………………………..      
I’m only at home when it is dark and I cannot see the breeding sites then………….      
Self-efficacy 
Checking my house and yard for mosquito breeding sites every week and if necessary 
eliminating them during the coming rainy season….  
 1 2 3 4 5  
is absolutely impossible for me      is absolutely possible for me 
Is not manageable for me, even if 
I want to      
is doable for me, if I want to 
 
 
Attitudes towards behaviour 
Checking for mosquito breeding sites and if necessary eliminating them 
from my house and yard during the coming rainy season, for me is… 
 1 2 3 4 5  
Unnecessary      Necessary 
Tedious      Fun 
Bad      Good 
Stressful      Relaxing 
Harmful      Beneficial 




Perceived barriers  
During the coming rainy season I will not check for mosquito 
breeding sites and eliminate them if necessary because… 
     
1 2 3 4 5 
I do not know how to check for breedi g sites…………………………………………………….      
I do not like to eliminate breeding sites……………………………………………………….……..      
Neighbours do not do it either, so it makes no sense for me to do it……………….…      
I never have mosquitoes in my house or yard……………………………………………………… 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I live near a mondi/dam where more mosquitoes come from than from my yard. 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I do not have the physical ability to check my yard every week…………………………..      
I’m only at home when it is dark and I cannot see the breeding sites then………….      
Self-efficacy 
Checking my house and yard for mosquito breeding sites every week and if necessary 
eliminating them during the coming rainy season….  
 1 2 3 4 5  
is absolutely impossible for me      is absolutely possible for me 
Is not manageable for me, even if 
I want to      




Attitudes towards behaviour 
Checking for mosquito breeding sites and if necessary eliminating them 
from my house and yard during the coming rainy season, for me is… 
 1 2 3 4 5  
Unnecessary      Necessary 
Tedious      Fun 
Bad      Good 
Stressful      Relaxing 
Harmful      Beneficial 




Whether I will check for mosquito breeding sites and if necessary eliminate them 
from my house and yard during the coming rainy season, …. 
 1 2 3 4 5  
is not dependent on what other 
people think of it      
Depends on what other people 
think of it 
Subjective norms 
My weekly checking for mosquito breeding sites and eliminating them from my house 
and yard during the coming rainy season will be …. 
 1 2 3 4 5  
Disapproved of by people who are 
important to me       
Approved  by people who are 
important to me  
Advised against by people whose 
opinion I value      
Advised  by people whose opinion 
I value  
Discouraged by my neighbours      Encouraged by my neighbours 
Not be expected from me      Expected from me 
Not be stimulated by the 
government      Stimulated by the government  
Checking house and yard for mosquito breeding sites every week and if necessary 
eliminating them during the coming rainy season, …. 
 1 2 3 4 5  
Is never done by people whose 
opinion is important to me       
is always done by people whose 
opinion is important to me 
Is never done by people who are 
important to me       
is always done by people who are 
important to me 




Whether I will check for mosquito breeding sites and if necessary eliminate them 
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 1 2 3 4 5  
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Is never done by people who are 
important to me       
is always done by people who are 
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Subjective norms 
My weekly checking for mosquito breeding sites and eliminating them from my house 
and yard during the coming rainy season will be …. 
 1 2 3 4 5  
Disapproved of by people who are 
important to me       
Approved  by people who are 
important to me  
Advised against by people whose 
opinion I value      
Advised  by people whose opinion 
I value  
Discouraged by my neighbours      Encouraged by my neighbours 
Not be expected from me      Expected from me 
Not be stimulated by the 
government      Stimulated by the government  
Checking house and yard for mosquito breeding sites every week and if necessary 
eliminating them during the coming rainy season, …. 
 1 2 3 4 5  
Is never done by people whose 
opinion is important to me       
is always done by people whose 
opinion is important to me 
Is never done by people who are 
important to me       
is always done by people who are 
important to me 
Is never done by my neighbours      is always done by my neighbours 
 
 
Perceived behavioural control (recode: 1=5; 2=4; 3=3; 4=2; 5=1) 
Whether I will check for mosquito breeding sites and if necessary eliminate them 
from my house and yard during the coming rainy season, …. 
 1 2 3 4 5  
is not dependent on help from 
other people       
is dependent on help from 
other people 
Satisfaction on governmental mosquito breedingsite control 
The government does enough to prevent and eliminate breeding sites 
 1 2 3 4 5  
Do not agree at all       Fully agree 
 
 
Perceived behavioural control (recode: 1=5; 2=4; 3=3; 4=2; 5=1) 
Whether I will check for mosquito breeding sites and if necessary eliminate them 
from my house and yard during the coming rainy season, …. 
 1 2 3 4 5  
is not dependent on help from 
other people       
is dep nde t on help from 
other people 
Satisfaction on governmental mosquito breedingsite control 
The government does enough to prevent and eliminate breeding sites 
 1 2 3 4 5  
Do not agree at all       Fully agree 
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Interview guide – in-depth interviews QoL Chikungunya 
This interview guide was designed and used in Dutch and Papiamentu, and upon publication of the 
study translated to English. This is a summarized version of the original interview guide. Only the 
parts that were relevant for this study were translated and presented. 
 
Introduction 
This concerned a repetition of the purposes of this study, the interview procedures, ethical 
considerations and the rights of the interviewer. After this, the participant had an additional chance 
to ask questions. 
 
Background information 
Sex, place of residence, living situation (with whom?), education, employment, country of origin 
participant’s parents, country of origin of participant, religion. 
 
A. Opening questions 
1. When is somebody ill? 
Probe: severity, symptoms, daily life limitations 
 
2. What should somebody do when he/she has a fever? 
Probe: wait (how long?), treat at home (with what?), doctor, traditional treatment 
 
3. Could you describe the most common diseases in Curaçao? 
Probe: short-lasting diseases, long-lasting diseases, dengue, chikungunya 
 
B. Knowledge about chikungunya  
1. Via which sources/where have you heard about chikungunya? 
Probe: mass media (television, newspaper, internet), government, family/friend/acquaintances, 
medical centres 
 
2. How does a person get chikungunya? 
Probe: mosquito, air, being near to a chikungunya patient, water 
2b. How did you get chikungunya? 
 
3. Can someone protect him/herself against chikungunya? How? 
Probe: Deet, Aloe, long-sleeved clothes, van/air conditioning 
3b. How do you protect yourself? 
3c. How did you protect yourself (before getting chikungunya) against chikungunya? 
 
4. What are the symptoms of chikungunya? 
Probe: Fever, joint pain, skin diseases, hair loss, muscle aches 
 
C. Risk perception 
1. What put you at risk for getting chikungunya? 
Probe: places, activities, role of preventive measures 
 
The next question concerns the time before you got chikungunya. I would like to ask you to remember 
as good as possible your situation at that time. 
 
2. Had you expected to get chikungunya? Why/ why not? 
 
D. Attitudes and choices during chikungunya infection 
The following questions concern the disease course of your chikungunya infection. When answering 
these questions, try to remember as good as possible what choices you made at the time of disease. 
224
Interview guide – in-depth interviews QoL Chikungunya 
This interview guide was designed and used in Dutch and Papiamentu, and upon publication of the 
study translated to English. This is a summarized version of the original interview guide. Only the 
parts that were relevant for this study were translated and presented. 
 
Introduction 
This concerned a repetition of the purposes of this study, the interview procedures, ethical 
considerations and the rights of the interviewer. After this, the participant had an additional chance 
to ask questions. 
 
Background information 
Sex, place of residence, living situation (with whom?), education, employment, country of origin 
participant’s parents, country of origin of participant, religion. 
 
A. Opening questions 
1. When is somebody ill? 
Probe: severity, symptoms, daily life limitations 
 
2. What should somebody do when he/she has a fever? 
Probe: wait (how long?), treat at home (with what?), doctor, traditional treatment 
 
3. Could you describe the most common diseases in Curaçao? 
Probe: short-lasting diseases, long-lasting diseases, dengue, chikungunya 
 
B. Knowledge about chikungunya  
1. Via which sources/where have you heard about chikungunya? 
Probe: mass media (television, newspaper, internet), government, family/friend/acquaintances, 
medical centres 
 
2. How does a person get chikungunya? 
Probe: mosquito, air, being near to a chikungunya patient, water 
2b. How did you get chikungunya? 
 
3. Can someone protect him/herself against chikungunya? How? 
Probe: Deet, Aloe, long-sleeved clothes, van/air conditioning 
3b. How do you protect yourself? 
3c. How did you protect yourself (before getting chikungunya) against chikungunya? 
 
4. What are the symptoms of chikungunya? 
Probe: Fever, joint pain, skin diseases, hair loss, muscle aches 
 
C. Risk perception 
1. What put you at risk for getting chikungunya? 
Probe: places, activities, role of preventive measures 
 
The next question concerns the time before you got chikungunya. I would like to ask you to remember 
as good as possible your situation at that time. 
 
2. Had you expected to get chikungunya? Why/ why not? 
 
D. Attitudes and choices during chikungunya infection 
The following questions concern the disease course of your chikungunya infection. When answering 
these questions, try to remember as good as possible what choices you made at the time of disease. 
Interview guide – in-depth interviews QoL Chikungunya 
It could be possible that at this time, you would have done something else. Therefore, you will get 
the opportunity at the end of the interview to reflect on this. But now, I would like to know why you 
made certain choices at the time you had chikungunya. 
 
1. How long ago started the symptoms of chikungunya? 
 
2. What were your first thoughts about the cause of the symptoms? Why? 
Probe: dengue 
 
3. What made you realize that you had chikungunya?  
Probe: fever, symptoms 
 
4. What was the first thing you did when you knew you were ill? Why? 
Probe: reason for this behaviour, desired effect, how long and when, evaluation (did it work?) 
 
5. What was the next thing what you did? Why? 
Probe: reason for this behaviour, desired effect, how long and when, evaluation (did it work?), next 
action 
 
6. What medication did you use? 
Probe: why (+inducement), recommendation (by whom?), when, how much 
 
7. Could you describe what symptoms you had and how long they lasted? 
 
8. Which caregivers did you consult? 
Probe: general practitioner, hospital, traditional healer, why (+inducement), when, evaluation (did it 
work?) 
 
E. Barriers in health seeking behaviour 
1. Did you face difficulties to obtain the care you desired? If yes: Which? 
Probe:  Fast diagnosis, access to- and availability of care, quality of care, costs, daily life duties 
 
F. Impact of the chikungunya infection 
1. How severe is chikungunya? Why? 
Probe: lethal, hospital-admission, doctor visit, social/economic consequences 
 
2.  What impact has the chikungunya infection had on you? 
Probe: physical, emotional, financial, social (family/friends) 
 
3. Do you experience the consequences of chikungunya disease, at this moment? What 
consequences/how? 
Probe: physical, emotional, financial (work), social 
 
4. How severe is a dengue infection? Why? 
Probe: Compared to chikungunya. 
 
G. Evaluation of disease course and health seeking behaviour 
1. Looking back to what you did when you had chikungunya: would you have done something 
different if you got chikungunya now? 
Probe: go earlier to the doctor, don’t go to the doctor, wait longer, medication, rest 
 
2. What would you advise to people with chikungunya (what should they do?)? 
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Interview guide – in-depth interviews QoL Chikungunya 
It could be possible that at this time, you would have done something else. Therefore, you will get 
the opportunity at the end of the interview to reflect on this. But now, I would like to know why you 
made certain choices at the time you had chikungunya. 
 
1. How long ago started the symptoms of chikungunya? 
 
2. What were your first thoughts about the cause of the symptoms? Why? 
Probe: dengue 
 
3. What made you realize that you had chikungunya?  
Probe: fever, symptoms 
 
4. What was the first thing you did when you knew you were ill? Why? 
Probe: reason for this behaviour, desired effect, how long and when, evaluation (did it work?) 
 
5. What was the next thing what you did? Why? 
Probe: reason for this behaviour, desired effect, how long and when, evaluation (did it work?), next 
action 
 
6. What medication did you use? 
Probe: why (+inducement), recommendation (by whom?), when, how much 
 
7. Could you describe what symptoms you had and how long they lasted? 
 
8. Which caregivers did you consult? 
Probe: general practitioner, hospital, traditional healer, why (+inducement), when, evaluation (did it 
work?) 
 
E. Barriers in health seeking behaviour 
1. Did you face difficulties to obtain the care you desired? If yes: Which? 
Probe:  Fast diagnosis, access to- and availability of care, quality of care, costs, daily life duties 
 
F. Impact of the chikungunya infection 
1. How severe is chikungunya? Why? 
Probe: lethal, hospital-admission, doctor visit, social/economic consequences 
 
2.  What impact has the chikungunya infection had on you? 
Probe: physical, emotional, financial, social (family/friends) 
 
3. Do you experience the consequences of chikungunya disease, at this moment? What 
consequences/how? 
Probe: physical, emotional, financial (work), social 
 
4. How severe is a dengue infection? Why? 
Probe: Compared to chikungunya. 
 
G. Evaluation of disease course and health seeking behaviour 
1. Looking back to what you did when you had chikungunya: would you have done something 
different if you got chikungunya now? 
Probe: go earlier to the doctor, don’t go to the doctor, wait longer, medication, rest 
 
2. What would you advise to people with chikungunya (what should they do?)? 
Interview guide – in-depth interviews QoL Chikungunya 
Probe: treatment at home, doctor, medicines, herbs 
 
3. In your opinion, what could the government do to help people with a chikungunya infection?  
Probe: Health seeking behaviour themes. 
 
H. Would you like to say anything else? 
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Focus group guide – Focus group discussions QoL Chikungunya 
 
This interview guide was designed and used in Dutch and Papiamentu, and upon publication of the 
study translated to English. This is a summarized version of the original interview guide. Only the 
parts that were relevant for this study were translated and presented. 
 
Introduction 
This concerned a repetition of the purposes of this study, the interview procedures, ethical 
considerations and the rights of the interviewer. After this, participants had an additional chance to 
ask questions. Then, participants shortly introduced themselves. 
 
Opening questions 
- Could you describe the health problems in Curaçao? 
- What is your opinion about the quality of the health care in Curaçao? 
 
Topic 1 Knowledge about chikungunya 
1. Where do people obtain information from about chikungunya?  
Probe: what kind of information? 
2. What do you know about chikungunya? 
Probe: cause of disease: mosquito, symptoms: acute & long-lasting, protection against 
chikungunya 
 
Topic 2 Health seeking behaviour of chikungunya 
3. Who can get chikungunya? What puts people at risk for getting chikungunya?  
Probe: Men/women, places, activities 
4. How do people on Curaçao protect themselves against chikungunya? 
Probe: DEET, long-sleeved clothes, removal of mosquito breeding sites 
5. What do people on Curaçao do when they get chikungunya? Why? 
Probe: treat chikungunya at home (with herbs), medication, doctor (where), traditional 
healer. 
6. Some people said that they use(d)/tried many different medicines for chikungunya. What do 
you think about that? 
7. Some people visited a doctor more than 10 times for chikungunya, what are reasons for this? 
What is your opinion about this? 
Probe: People are desperate? 
 
Topic 3 The impact of chikungunya 
8. What are the physical consequences of a chikungunya infection? 
Probe: short term, long term 
9. What are the social consequences of a chikungunya infection? 
Probe: contact with family/friends, performance of normal daily life activities 
10. What is the emotional impact of a chikungunya infection? 
Probe: depression, temperamental/moodiness 
11. What financial costs does a chikungunya patient have? 
Probe: medication, costs of treatment, loss of income, short and long term costs 
12. What is the impact on the family/friends who care for the chikungunya patients? 
13. Do people die because of chikungunya? 
14. One of the participants told: ‘Chikungunya can stay for two years in your system, so you must 
be strong during this time (/have a good immune system), because chikungunya strikes when 
you are weak, on your weak spots.’  
What is your opinion about this? 
 
Topic 4 Recommendations towards policy of chikungunya 
15. What can be done to improve the help/care of chikungunya patients? 
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Focus group guide – Focus group discussions QoL Chikungunya 
 
This interview guide was designed and used in Dutch and Papiamentu, and upon publication of the 
study translated to English. This is a summarized version of the original interview guide. Only the 
parts that were relevant for this study were translated and presented. 
 
Introduction 
This concerned a repetition of the purposes of this study, the interview procedures, ethical 
considerations and the rights of the interviewer. After this, participants had an additional chance to 
ask questions. Then, participants shortly introduced themselves. 
 
Opening questions 
- Could you describe the health problems in Curaçao? 
- What is your opinion about the quality of the health care in Curaçao? 
 
Topic 1 Knowledge about chikungunya 
1. Where do people obtain information from about chikungunya?  
Probe: what kind of information? 
2. What do you know about chikungunya? 
Probe: cause of disease: mosquito, symptoms: acute & long-lasting, protection against 
chikungunya 
 
Topic 2 Health seeking behaviour of chikungunya 
3. Who can get chikungunya? What puts people at risk for getting chikungunya?  
Probe: Men/women, places, activities 
4. How do people on Curaçao protect themselves against chikungunya? 
Probe: DEET, long-sleeved clothes, removal of mosquito breeding sites 
5. What do people on Curaçao do when they get chikungunya? Why? 
Probe: treat chikungunya at home (with herbs), medication, doctor (where), traditional 
healer. 
6. Some people said that they use(d)/tried many different medicines for chikungunya. What do 
you think about that? 
7. Some people visited a doctor more than 10 times for chikungunya, what are reasons for this? 
What is your opinion about this? 
Probe: People are desperate? 
 
Topic 3 The impact of chikungunya 
8. What are the physical consequences of a chikungunya infection? 
Probe: short term, long term 
9. What are the social consequences of a chikungunya infection? 
Probe: contact with family/friends, performance of normal daily life activities 
10. What is the emotional impact of a chikungunya infection? 
Probe: depression, temperamental/moodiness 
11. What financial costs does a chikungunya patient have? 
Probe: medication, costs of treatment, loss of income, short and long term costs 
12. What is the impact on the family/friends who care for the chikungunya patients? 
13. Do people die because of chikungunya? 
14. One of the participants told: ‘Chikungunya can stay for two years in your system, so you must 
be strong during this time (/have a good immune system), because chikungunya strikes when 
you are weak, on your weak spots.’  
What is your opinion about this? 
 
Topic 4 Recommendations towards policy of chikungunya 
15. What can be done to improve the help/care of chikungunya patients? 
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Focus group guide – Focus group discussions QoL Chikungunya 
 
This interview guide was designed and used in Dutch and Papiamentu, and upon publication of the 
study translated to English. This is a summarized version of the original interview guide. Only the 
parts that were relevant for this study were translated and presented. 
 
Introduction 
This concerned a repetition of the purposes of this study, the interview procedures, ethical 
considerations and the rights of the interviewer. After this, participants had an additional chance to 
ask questions. Then, participants shortly introduced themselves. 
 
Opening questions 
- Could you describe the health problems in Curaçao? 
- What is your opinion about the quality of the health care in Curaçao? 
 
Topic 1 Knowledge about chikungunya 
1. Where do people obtain information from about chikungunya?  
Probe: what kind of information? 
2. What do you know about chikungunya? 
Probe: cause of disease: mosquito, symptoms: acute & long-lasting, protection against 
chikungunya 
 
Topic 2 Health seeking behaviour of chikungunya 
3. Who can get chikungunya? What puts people at risk for getting chikungunya?  
Probe: Men/women, places, activities 
4. How do people on Curaçao protect themselves against chikungunya? 
Probe: DEET, long-sleeved clothes, removal of mosquito breeding sites 
5. What do people on Curaçao do when they get chikungunya? Why? 
Probe: treat chikungunya at home (with herbs), medication, doctor (where), traditional 
healer. 
6. Some people said that they use(d)/tried many different medicines for chikungunya. What do 
you think about that? 
7. Some people visited a doctor more than 10 times for chikungunya, what are reasons for this? 
What is your opinion about this? 
Probe: People are desperate? 
 
Topic 3 The impact of chikungunya 
8. What are the physical consequences of a chikungunya infection? 
Probe: short term, long term 
9. What are the social consequences of a chikungunya infection? 
Probe: contact with family/friends, performance of normal daily life activities 
10. What is the emotional impact of a chikungunya infection? 
Probe: depression, temperamental/moodiness 
11. What financial costs does a chikungunya patient have? 
Probe: medication, costs of treatment, loss of income, short and long term costs 
12. What is the impact on the family/friends who care for the chikungunya patients? 
13. Do people die because of chikungunya? 
14. One of the participants told: ‘Chikungunya can stay for two years in your system, so you must 
be strong during this time (/have a good immune system), because chikungunya strikes when 
you are weak, on your weak spots.’  
What is your opinion about this? 
 
Topic 4 Recommendations towards policy of chikungunya 
15. What can be done to improve the help/care of chikungunya patients? 
Focus group guide – Focus group discussions QoL Chikungunya 
 
Probe: Aid of patients with long-lasting complaints, role of government, role of doctors. 
 
Conclusion 
Do you have further comments on, or additions to this discussion? 
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Inleiding
Dengue en chikungunya zijn een belangrijke dreiging voor de volksgezondheid in aangedane landen. Dit 
proefschrift  beschrijft  hoe de gezondheidszorg en preventi e van deze ziektes kan worden verbeterd in 
twee landen gelegen aan de Caribische zee: Curaçao en Venezuela. We onderzochten de toegang tot de 
gezondheidszorg en het gezondheidszoekende gedrag van een gemeenschap in Venezuela. Preventi eve 
maatregelen tegen de ziektes en muggenbroedplaatsen werden onderzocht in Venezuela en Curaçao. 
Daarnaast onderzochten we de impact van chikungunya op de kwaliteit van leven en de invloed van een 
voorafgaande dengue-infecti e op het ziekteverloop van chikungunya. De onderzoeksmethodes komen uit 
verschillende disciplines, namelijk uit medische, psychologische en sociale hoek.
Dengue en gezondheidsgedrag in Venezuela
Volksgezondheid in Venezuela is een complexe situati e. In de laatste ti entallen jaren is dengue opgekomen 
door verstedelijking en onvoldoende maatregelen tegen muggen [1,2]. In hetzelfde jaar als de grote 
dengue-uitbraak van 2010, [3] werd in Maracay een studie opgezet om epidemiologische, gedragsmati ge, 
klinische en virale karakteristi eken van dengue (transmissie) te onderzoeken [2]. De studies die in dit 
proefschrift  worden gepresenteerd, werden in 2013-2014 uitgevoerd als onderdeel van een van de jaarlijkse 
enquêtes. In de voorafgaande jaren was Venezuela op politi ek gebied erg instabiel en intensiveerden 
protesten tegen de overheid [4-6]. De situati e waarin het onderzoeksteam moest werken, was hierdoor te 
onveilig en het veldwerk stopte na 105 interviews. Deze onderzoeken geven daarom een uniek inzicht in 
gezondheidsgedrag van mensen in een onveilige situati e ti jdens politi eke instabiliteit.
In hoofdstuk 2 onderzochten we de dynamiek van het gezondheidszoekende gedrag bij koorts en dengue 
om manieren te vinden om mensen sneller bij gezondheidszorg te krijgen. In Venezuela hebben mensen de 
neiging om relati ef laat gezondheidszorg te zoeken [7]. Dengue kan zich ontwikkelen tot een ernsti ge ziekte 
en daarom is het belangrijk dat mensen vroeg gezondheidszorg zoeken. Dit zorgt ervoor dat minder mensen 
overlijden door dengue [1,2]. Bij de interpretati e van de resultaten gebruikten wij principes van het ‘Health 
Belief Model’ (HBM) en de ‘Theory of Planned Behaviour’ (TPB). Dit zijn gezondheidsgedragtheorieën, die 
ons hielpen om sociale en psychologische moti even voor houdingen en gedrag te begrijpen. Wij ontdekten 
dat mensen, die vermoeden een dengue-infecti e te hebben, de eerste of tweede dag naar een dokter 
zouden gaan. Aan de andere kant, als ze ‘gewoon koorts’ zouden hebben, werd zelfmedicati e verkozen als 
eerste behandeling. Dit zijn belangrijke uitkomsten, die betekenen dat mensen dengue als een dreiging 
ervaren en dat zij eerder naar een dokter gaan als ze weten dat ze dengue hebben. Daarom kan een 
diagnosti sche hulp, die thuis gebruikt zou kunnen worden, ervoor zorgen dat mensen eerder naar een 
dokter gaan en een kleinere kans hebben op een ernsti g verloop van dengue. Om de beslissingen rondom 
het gezondheidszoekende gedrag van de parti cipanten uit hoofdstuk 2 te begrijpen, is het belangrijk om 
te refl ecteren op de situati e van het gezondheidssysteem waar deze mensen mee te maken hebben. In 
hoofdstuk 3 beschrijven we daarom de toegang tot gezondheidszorg in Venezuela, waarbij we gebruikmaken 
van kwalitati eve en kwanti tati eve onderzoeksmethodes. Het gezondheidssysteem van Venezuela bestaat 
uit een private en een publieke sector. De publieke sector verschaft  grati s gezondheidszorg en bestaat 
uit de traditi onele gezondheidscentra (primair/secundaire ‘ambulatorios’ en terti aire ziekenhuizen). 
Sinds 2003 zijn er ook ‘parallelle’ publieke gezondheidscentra, die voortkomen uit een overeenkomst 
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met Cuba. In deze overeenkomst verschafte Cuba Cubaanse artsen om te werken ‘in de sloppenwijken’ 
(in het Spaans: ‘Barrio Adentro’) in ruil voor olie uit Venezuela. De kwantitatieve en kwalitatieve 
resultaten laten de huidige complexe situatie van mensen uit Venezuela zien waarin zij goede en tijdige 
gezondheidszorg moeten zien te krijgen. De meeste mensen (79-81%) gaven de voorkeur om eerst een 
traditionele ‘ambulatorio’ te bezoeken als ze koorts of dengue hadden, omdat zij de artsen vertrouwden. 
De lange wachttijden en het ontbreken van behandelingen en diagnostische middelen waren belangrijke 
barrières om de traditionele gezondheidscentra te bezoeken. Deze barrières werden minder ervaren in 
de parallelle gezondheidscentra. Desalniettemin was de Cubaanse nationaliteit van de medewerkers een 
belangrijke barrière om de parallelle gezondheidscentra te bezoeken. Participanten vonden dat de private 
gezondheidscentra de beste zorg gaven, maar slechts weinigen konden ook daadwerkelijk gebruik maken 
van deze zorg. De barrières en voordelen van de verschillende gezondheidscentra zorgden ervoor dat 
door één persoon verschillende centra bezocht werden om goede zorg te verkrijgen. De resultaten van 
hoofdstuk 3 laten de complexe en uitdagende situatie zien waarmee mensen geconfronteerd worden in 
hun zoektocht naar gezondheidszorg en onderstreept de noodzaak om het gezondheidszoekende gedrag 
(hoofdstuk 2) en de toegang tot gezondheidszorg (hoofdstuk 3) in Venezuela te verbeteren.
Muggenbestrijding in Curaçao en Venezuela
Een ernstig ziekteverloop van dengue kan voorkomen worden door adequate gezondheidszoekend gedrag 
(hoofdstuk 2) of door toereikendheid en bereikbaarheid van gezondheidszorg (hoofdstuk 3). Desalniettemin 
is het beste middel tegen de consequenties van dengue natuurlijk het voorkomen (preventie) van de ziekte 
[8,9]. Preventie kan verwijzen naar persoonlijke bescherming tegen muggenbeten van de Aedes-mug. Op 
de lange termijn is het echter efficiënter om te voorkomen dat muggen zich kunnen voortplanten [10,11]. 
Daarom onderzochten wij welke factoren van invloed zijn op preventieve maatregelen bij dengue in de 
studiepopulatie in Maracay, Venezuela (hoofdstuk 4). We vonden dat mensen een adequate kennis hadden 
over de transmissie van dengue en dat ze veel preventieve maatregelen namen tegen muggenbeten. 
Toch vonden we in 57% van de huishoudens muggenbroedplaatsen. Hoewel persoonlijke bescherming 
tegen muggenbeten wordt geadviseerd, is het belangrijker om muggenbloedplaatsen te voorkomen. We 
concluderen in hoofdstuk 4 dat campagnes tegen dengue in Maracay gefocust moeten zijn op het verwijderen 
van muggenbroedplaatsen in huizen en tuinen. Daarnaast, aansluitend op de conclusies van hoofdstuk 4, 
onderzochten we de intenties van de gemeenschap om muggenbroedplaatsen te gaan verwijderen in eigen 
huis en tuin in hoofdstuk 5. In dit hoofdstuk was elk stadium van onderzoek (de opzet, uitvoer, analyse en 
interpretatie) gebaseerd op een theoretisch raamwerk met principes van gezondheidsgedragtheorieën. 
Een multidisciplinair onderzoek werd opgezet in Curaçao met 339 enquêtedeelnemers en 75 deelnemers 
aan het kwalitatieve deel van het onderzoek. De gecombineerde onderzoeksmethodes (kwantitatieve en 
kwalitatieve methodes) waren complementair aan elkaar, omdat beide methodes gebaseerd waren op een 
geïntegreerd theoretisch raamwerk van gezondheidsgedragtheorieën, namelijk het ‘Health Belief Model’ 
[12,13] en de ‘Theory of Planned Behaviour’ [14]. De inleiding van dit boek geeft een uitgebreidere uitleg 
over deze gezondheidsgedragtheorieën en in hoofdstuk 5 is het theoretische raamwerk weergegeven. 
Mensen lieten een hoog niveau van kennis over transmissie van de ziektes zien en vertelden dat zij 
vaak muggenbroedplaatsen verwijderen in hun huis en tuin. Toch had 37% van de studiepopulatie 
minder de neiging om deze preventieve maatregel te nemen. We identificeerden factoren die ervoor 
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zorgden dat mensen minder de neiging hadden om muggenbroedplaatsen te verwijderen en op basis 
hiervan ontwikkelden wij drie mogelijke interventies om mensen te motiveren om toch deze preventieve 
maatregelen te nemen. Deze drie interventies zijn: (1) voortdurende aandacht in de media om mensen 
te herinneren dat het belangrijk is om muggenbroedplaatsen te voorkomen in hun huizen en tuinen. 
Deze boodschappen moeten aansluiten bij de kennis, realiteit en houdingen van de lokale mensen. (2) 
Zichtbaarheid van de preventieve maatregelen die de overheid uitvoert tegen muggenbroedplaatsen. 
Hiervoor kan de media gebruikt worden. Het is wel belangrijk dat met het belichten van de preventieve 
maatregelen de lokale bevolking haar eigen verantwoordelijkheid blijft nemen. De media kan ook hierin 
een rol spelen: als zij laten zien wat de overheid doet tegen muggenbroedplaatsen, moeten zij ook 
meteen benadrukken dat deze acties alleen succesvol zullen zijn als de lokale bevolking ook hun eigen 
huizen en tuinen vrijhouden van muggenbroedplaatsen. (3) Het gebruik van lokale sleutelpersonen 
binnen gemeenschappen als ‘ambassadeurs’ die preventieve maatregelen tegen muggenbroedplaatsen 
promoten. Een limitatie van deze studie was dat we de ‘intentie’ van de participanten hebben onderzocht, 
die in de praktijk zou kunnen afwijken van wat zij ook daadwerkelijk gaan doen. Aan de andere kant is dit 
een unieke studie omdat de studie gebaseerd was op een multidisciplinaire studieopzet, die heeft geleid 
tot omvangrijke en toepasbare uitkomsten. 
De uitkomsten zijn (mogelijk ook in andere landen en gemeenschappen) praktisch toepasbaar, omdat 
hoofdstuk 4 en 5 belangrijke inzichten geven in sociale en gedragsmatige drijfveren van hoe gemeenschappen 
kunnen worden gemotiveerd om deel te nemen aan het voorkomen van muggenbroedplaatsen. Het is 
belangrijk dat soortgelijke studies in andere contexten worden uitgevoerd, omdat deze kunnen leiden tot 
nieuwe inzichten en een verminderde impact van de ziektes die verspreid worden door muggen.
De impact van chikungunya op kwaliteit van leven
In Curaçao circuleren vier verschillende serotypes van het dengue virus. Het onderzoek in Curaçao 
werd opgezet toen net een chikungunya-uitbraak geweest was [15,16]. We gebruikten gecombineerde 
onderzoeksmethodes om de impact van de langdurige klachten van chikungunya op de kwaliteit van 
leven te onderzoeken. Kwantitatieve data werd verzameld door middel van de RAND-36/SF-36 kwaliteit 
van leven vragenlijst, zoals ook is beschreven in hoofdstuk 6. Daarnaast verkregen we door kwalitatieve 
onderzoeksmethodes verdiepende inzichten over hoe kwaliteit van leven wordt beïnvloed door 
langdurige klachten in hoofdstuk 7. Gebaseerd op de definitie van de World Health Organization (WHO) 
[17], onderzochten we de kwaliteit van leven op de volgende aspecten: fysiek, emotioneel, sociaal en 
economisch welzijn. Deze concepten waren vergelijkbaar met de concepten die gemeten werden met de 
RAND-36 in hoofdstuk 6. Copingstrategieën werden geanalyseerd gebaseerd op de principes van Lazarus’ 
theorie over copingstrategieën [18,19].
Hoofdstuk 6 laat zien dat op emotioneel, sociaal en fysiek gebied de kwaliteit van leven-scores waren 
verlaagd. De mensen die gecategoriseerd werden als ‘ernstig aangedaan’ door langdurige chikungunya, 
scoorden ook de laagste kwaliteit van leven-scores. De diepte-interviews en de groepsdiscussies in 
hoofdstuk 7 laten zien dat de impact op de kwaliteit van leven voornamelijk van fysieke en emotionele 
aard was, terwijl de sociale en economische impact als minder erg werd ervaren. De fysieke impact van 
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chikungunya werd veroorzaakt door gewrichts- en spierklachten en andere symptomen, die leidden tot pijn 
en beperking van mobiliteit. Hierdoor werden (onder andere) gevoelens van afhankelijkheid, hopeloosheid, 
een verandering van identiteit en chagrijnigheid ervaren door de deelnemers. Hoe mensen omgingen met 
de ziekte (hun ‘coping-strategieën’) beïnvloedde ook de impact op de kwaliteit van leven. Mensen die 
gericht waren op genezing van de klachten (probleemgefocuste coping) kregen veel behandelingen en 
probeerden veel verschillende medicatie, maar ervaarden een mindere kwaliteit van leven. De mensen 
die de symptomen juist probeerden te accepteren en steun zochten bij anderen (emotiegefocuste coping) 
ervaarden een betere kwaliteit van leven. Deze studie (hoofdstuk 7) is de eerste kwalitatieve studie die 
over dit onderwerp is uitgevoerd.
De bevindingen uit hoofdstuk 6 en 7 vullen elkaar goed aan en onderstrepen de unieke waarde van 
gecombineerde onderzoeksmethodes voor beleid op het gebied van volksgezondheid door representatieve 
resultaten (kwantitatief onderzoek), maar daarnaast ook door een dieper inzicht in het onderwerp te 
geven (door kwalitatief onderzoek). Omdat de kwaliteit van leven vaak voor jaren is verminderd, is het 
belangrijk om effectieve en veilige behandelingen te ontwikkelen voor de lange termijn. Ondertussen kan 
de kwaliteit van leven van patiënten verbeterd worden door hen voor te lichten hoe zij op een gezonde 
manier met hun ziekte om kunnen gaan.
Klinische verschijnselen van chikungunya
Chikungunya is een groot volksgezondheidsprobleem voor de landen waar deze ziekte voorkomt. Dit 
komt voornamelijk door de langdurige klachten die een grote impact hebben op de fysieke en mentale 
gezondheid van patiënten [20]. Toch is er nog steeds geen duidelijke definitie of classificatie voor deze 
langdurige klachten. In hoofdstuk 6  onderzochten we de klinische presentatie van de langdurige klachten 
van chikungunya na de epidemie van 2014/2015 in Curaçao. Gebaseerd op het nieuw ontwikkelde 
classificatiesysteem, de ‘Curaçao Long Term Chikungunya Sequelae (CLTCS) score, werden de participanten 
gedefinieerd als ‘hersteld’, ‘mild aangedaan’ of ‘ernstig aangedaan’ door chikungunya. We schatten dat 
mensen in 79% van de gevallen langer dan een maand en in 64% van de gevallen langer dan 400 dagen 
last blijven houden van klachten van chikungunya. Deze langdurige klachten bestonden voornamelijk 
uit gewrichts- en spierpijnen, maar ook moeheid, slapeloosheid en neurologische symptomen kwamen 
vaak voor. De kwaliteit van leven scores waren verminderd bij de mensen die nog steeds klachten van 
chikungunya hadden, vooral bij degene die gedefinieerd waren als ‘ernstig aangedaan’. Daarom moeten 
professionals hun behandeling en gezondheidsbeleid vooral op deze laatste groep (de ‘ernstig aangedane’) 
richten. Wij presenteren de CLTCS score als een eenvoudig en makkelijk toepasbaar hulpmiddel voor artsen 
om langdurige klachten van chikungunya te classificeren en snel de noodzaak van verdere behandelingen 
in te schatten.
Zoals ook eerder beschreven, komen zowel dengue als chikungunya voor in Curaçao en worden deze 
ziektes door dezelfde mug verspreid. Het is daarom niet onwaarschijnlijk dat deze ziektes op hetzelfde 
moment in dezelfde persoon kunnen voorkomen. Toch zijn dit soort co-infecties niet vaak beschreven. 
Daarom analyseerden wij in hoofdstuk 8 de acute en langdurige ziekteverschijnselen van chikungunya 
infecties en vergeleken die met de verschijnselen van de patiënten die een voorafgaande dengue-infectie 
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hadden. We vonden een hoge prevalentie van chikungunya met een voorafgaande dengue-infectie in 
onze studiepopulatie (36.3%). Bovendien vonden wij dat de mensen met een voorafgaande dengue-
infectie een ernstiger verloop hadden van hun langdurige ziekte. Een belangrijke limitatie van deze studie 
was de diagnostische criteria die wij gebruikten om een voorafgaande dengue-infectie vast te stellen. 
We gebruikten hiervoor een serologische test (IgM) en daarom is het belangrijk dat de patiënten ook 
gezien worden als hebbende een ‘chikungunya met voorafgaande dengue-infectie’. Hoewel deze studie 
belangrijke zwaktes heeft, is dit wel de eerste studie die een mogelijk verband vind met een voorafgaande 
dengue-infectie en ernstigere langdurige klachten van chikungunya. Dit kan belangrijke implicaties hebben 
voor (de) volksgezondheid en (het) onderzoek naar (pathologie van) co-infecties. Wereldwijd zijn er steeds 
meer gebieden die te maken krijgen met gelijktijdige chikungunya en dengue epidemieën [21]. In het licht 
van de resultaten van hoofdstuk 8, kan dit mogelijk een grotere invloed hebben op de volksgezondheid dan 
van te voren gedacht werd.
Toekomst perspectieven
In dit proefschrift onderzochten we hoe we het gezondheidszoekende gedrag van dengue patiënten in 
Venezuela kunnen verbeteren. Toen de dataverzameling werd uitgevoerd (in 2013 en 2014) had Venezuela 
al een politiek instabiele situatie en was het gezondheidssysteem aan het verslechteren [4-6]. Hoewel 
de hoofdstukken 2,3 en 4 waardevolle aanbevelingen bevatten voor gezondheidsbeleid in Venezuela, 
werd de politieke instabiliteit hierna alleen groter. Omdat de huidige autoriteiten op dit moment heel 
andere problemen en prioriteiten hebben dan de preventie van (ernstige) dengue en het verbeteren van 
toegang tot gezondheidszorg, is het erg moeilijk om met een perspectief voor de toekomst te komen. 
Maar, mochten de problemen die nu in Venezuela spelen verbeteren en gezondheidsbeleid weer meer 
prioriteit krijgen, dan kunnen hoofdstukken 2, 3 en 4 gebruikt worden in het vormen van nieuw beleid.
Sinds de Aedes mug weer terugkeerde na intensieve maatregelen om muggen uit te roeien in Latijns- en 
Zuid-Amerika [22], is er een groeiende consensus dat blijvende controle over de muggenpopulatie alleen 
bereikt kan worden door samenwerking van overheid en bevolking [23]. Zoals vermeld in hoofdstuk 4, blijft 
het moeilijk om gemeenschappen te betrekken bij de maatregelen die genomen worden tegen muggen. 
Hoofdstuk 5 onthulde verschillende praktische interventies die de participatie van gemeenschappen in 
de maatregelen tegen muggen kunnen verbeteren. Nieuwe technieken om de overdracht van ziektes via 
muggen te bestrijden zijn in ontwikkeling. Omdat het nog niet duidelijk is of deze technieken effectief zijn 
en wanneer deze technieken op grote schaal toegepast zullen worden, blijft het belangrijk om te investeren 
in participatie van gemeenschappen in de strijd tegen de muggen. Op dit moment, en mogelijk ook in de 
toekomst, is dit namelijk één van de meest efficiënte en duurzame strategieën om de muggenpopulatie 
te bestrijden. Er is nog steeds veel te verbeteren in hoe gemeenschappen worden gestimuleerd om deel 
te nemen aan preventie van muggenbroedplaatsen en daarom kunnen gezondheidsautoriteiten beginnen 
met het toepassen van de principes die worden voorgesteld in dit proefschrift (hoofdstuk 5).
Chikungunya blijft een verwaarloosde tropische ziekte. In de afgelopen jaren zijn de uitbraken van 
chikungunya overschaduwd door andere problemen voor de wereldwijde gezondheid, vooral door Zika en 
de mogelijke link met microcefalie [24]. De WHO riep Zika uit tot een ‘noodgeval voor de volksgezondheid 
234
van internationale zorg’ [25]. Hierdoor ging er meer geld en onderzoekscapaciteit naar Zika-onderzoek en 
kreeg chikungunya veel minder aandacht. Er is daarom nog steeds relatief weinig bekend over chikungunya. 
De nieuwe classificatiemethode (hoofdstuk 6), de eerste kwalitatieve studie over impact van chikungunya 
op de kwaliteit van leven (hoofdstuk 7) en de ontdekking dat een voorafgaande dengue-infectie ernstigere 
langdurige klachten zou kunnen veroorzaken (hoofdstuk 8) zijn allemaal nieuwe ontwikkelingen, die laten 
zien dat kennis over chikungunya nog relatief schaars is. Daarnaast suggereren de uitkomsten van dit 
proefschrift dat wat wij weten over chikungunya nog maar het topje van de ijsberg is. Omdat chikungunya 
een grote langdurige impact op de kwaliteit van leven kan hebben en er nog geen goede behandeling 
voor is, is het belangrijk dat er meer onderzoek naar chikungunya komt. Er is nog steeds veel te ontdekken 
over de pathofysiologie (van co-infecties) en te verbeteren aan de behandeling en preventie van deze 
verwoestende ziekte.
Een oproep voor interventiegericht onderzoek
Als laatste willen wij benadrukken dat praktisch en toepasbaar gezondheidsonderzoek erg belangrijk is. 
Gezondheid is door de WHO gedefinieerd als ‘een staat van compleet fysiek, mentaal en sociaal welzijn, 
en niet alleen de absentie van ziekte’ [17]. In klinische wetenschap gaat het meestal alleen om het 
‘genezen van’ ziektes, waarbij de mentale, sociale en culturele componenten van gezondheid vaak worden 
vergeten. Gezondheidsinterventies zijn minder effectief als zij niet rekening houden met de voorgenoemde 
determinanten van gezondheid.
Dit proefschrift laat zien dat een holistische (en multidisciplinaire) kijk op gezondheidsproblemen een 
compleet beeld van gezondheidsproblematiek verschaft. Hoofdstuk 5 demonstreert dat gecombineerde 
onderzoeksmethodes gebaseerd op gezondheidsgedragtheorieën substantieel helpen om de complexe 
dynamiek van gedrag te ontrafelen (in dit proefschrift: het verwijderen van muggenbroedplaatsen door 
gemeenschappen). Bovendien laten hoofdstuk 6 en 7 zien hoe kwantitatief en kwalitatief onderzoek 
complementair zijn en dat een combinatie van deze methodes zowel verdiepende als generaliseerbare 
resultaten geeft. De voorgenoemde hoofdstukken hebben allemaal geleid tot nieuwe en belangrijke 
implicaties voor volksgezondheid (zoals eerder beschreven). Het is belangrijk om hier te vermelden dat in 
elke fase van onderzoek (onderzoeksopzet, datacollectie, analyses en bij interpretatie van de resultaten) 
theorie en praktijk van de verschillende disciplines zijn geïmplementeerd. We concluderen daarom 
dat voor praktische en duurzame gezondheidsinterventies onderzoekers van verschillende disciplines 
(bijv. epidemiologen, biologen, sociologen en psychologen) hun krachten moeten bundelen. Een 
multidisciplinaire inspanning is nodig om van ‘het streven naar absentie van ziekte’ naar een alomvattend 
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de vormgeving van dit boek en Tamar voor de spellingscheck van de Nederlandse samenvatti  ng van dit 
proefschrift . Junior Scienti fi c Masterclass (JSM), hartelijk dank voor het verschaff en van de grant die mij 
de mogelijkheid gaf om dit MD-PhD traject te starten… en af te ronden! Last, my sincere thanks to all who 
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